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Summary 
α-Quaternary prolines are considered structurally unique α-amino acids of great 
importance in peptide chemistry, as well as in the area of natural products and 
biologically active substances. The most widely employed strategy for their asymmetic 
synthesis is based on metal catalyzed [3 + 2] cycloadditions of azomethine ylides and 
electron-deficient olefins. In contrast, the synthesis of α-quaternary prolines through 
cycloadditions involving the use of isocyanoacetates has been much less developed. In 
addition, the use of isocyanoacetates in [3+2] cycloadditions has required very reactive 
dipolarophiles as reaction partner and with few exceptions, the presence of metal to 
promote the reaction (Figure 1). However, isocyanoacetates have demonstrated in the 
last decades their great synthetic potential, particularly due to the chemical diversity 
conferred by the isonitrile (isocyano) group and, thus, the reactions involving their use 
are considered interesting alternative routes and worthy of being studied. 
 
Figura 1. 
The aim of this thesis has been to contribute to the enantioselective synthesis of α-
quaternary prolines and other α-quaternary amino acid derivatives through reactions 
with isocyanoacetates. With this purpose, the organocatalytic asymmetric Michael 
reaction between α-substituted isocyanoacetates and vinyl ketones has been studied for 
the first time, whose corresponding cycloaddition reaction previously reported had 
provided unsatisfactory stereochemical results. 
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Scheme 1. 
The results obtained with the commonly known bifunctional organocatalysts could be 
successfully improved thanks to the design of a new family of squaramide/tertiary amine 
type catalysts (Figure 2). The key for the success of these catalysts relies in the steric 
hindrance generated by the gem,gem-(bis) diaryl bulky group which, in addition to 
providing an excellent stereocontrol, prevents the frequent self-aggregate through 
hydrogen-bonding between different squaramide molecules that usually hinders the 
activity as a catalyst. On the other hand, the polyaryl group increases the solubility of 
the catalyst in both polar and apolar solvents. 
 
Figure 2. 
By catalyzing the reaction in the absence of a metal, it has been possible to favor the 
protonation of the carbanionic Michael adduct and avoid the intramolecular cyclization 
step that commonly follows to this type of 1,4-addition reactions giving rise to [3+2] 
cycloaddition process. This has allowed us to take full advantage of the chemical 
diversity of the isonitrile group in the enantioenriched Michael addition products and to 
design a new divergent route for the synthesis of α-quaternary Δ5-dehydroprolines and 
Δ4-dehydroprolines, which formally derive from [3 + 2] cycloadditions (Scheme 2). 
However, while the asymmetric Michael reaction gives very good results when α-aryl 
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substituted isocyanoacetates are used, when the substitution is α-alkyl, the nucleophile 
is not sufficiently reactive and no reaction occurs. 
 
Scheme 2. Enantioselective Michael addition of α-substituted isocyanoacetates to vinyl ketones. 
Inspired by how Nature has found an elegant solution using thioesters as active oxo-
esters surrogates in the synthetic route of polyketides and fatty acids, we proposed to 
address the Michael addition to vinyl ketones with α-alkyl isocyanothioesters, substrates 
never before used in asymmetric catalytic reactions. 
 
Figure 3. 
Although these nucleophiles prove to be sufficiently reactive to give the Michael 
addition to vinyl ketones in a stereocontrolled manner, the reaction pathway is strongly 
dependent on the thioester nature. In this sense, the best results are produced using 
isocyanothioacetates with sterically more demanding thioester group such as ortho-
disubstituted aryl thioesters (Scheme 3). 
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Scheme 3. Desired Michael reaction vs unwanted reaction pathways. 
As a result, asymmetric Michael reaction with vinyl ketones promoted by the new 
catalyst and using isocyanothioacetates bearing a variety of α-alkyl substituents provides 
the desired Michael products with good yields and excellent enantiomeric excesses. 
Thus obtained Michael products can be easily transformed into Δ4- and Δ5-
dehydroprolines. On the whole, asymmetric Michael reaction to vinyl ketones provides a 
new divergent synthetic route for the enantioselective synthesis of various α-aryl and α-
alkyl substituted quaternary prolines. 
Based on these α-alkyl isocyanothioacetates, it has been possible to address for 
the first time the stereocontrolled Michael addition between an α-alkyl substituted 
isocyanoacetate equivalent and a vinyl sulfone. In this latter case the reaction 
stereoselectivities were a little bit lower than with vinyl ketones as acceptor. 
 
Scheme 4. Enantioselective Michael reactions with α-alkyl isocyanoacetates. 
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On the other hand, the Mannich reaction involving α-substituted isocyanoacetates still 
has many limitations, especially when we refer to the α-alkyl substituted 
isocyanoacetates in combination with the use of organocatalysts. Nevertheless, this 
reaction provides a route for the synthesis of α-quaternary 2-imidazolines, structural 
subunits of biologically active compounds and ideal precursors of α,β-diamino acids. 
Accordingly, the organocatalytic asymmetric Mannich reaction of α-alkyl 
isocyanothioacetates with activated aldimines (N-Tosyl) and less active aldimines (N-Aril) 
has also been explored. The preliminary results indicated, as in the previous case, that 
the reaction takes place even though the products were obtained with low enantiomeric 
excess. 
 
Scheme 5. Enantioselective Mannich reactions with α-alkyl isocyanoacetates.
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Resumen 
Las prolinas α-cuaternarias son α-aminoácidos estructuralmente únicos de gran 
importancia en química de péptidos, así como en el área de productos naturales y 
sustancias biológicamente activas. La estrategia más utilizada para la síntesis catalítica 
asimétrica de prolinas α-cuaternarias se basa en las cicloadiciones [3+2] con iluros de 
azometino y olefinas deficientes en electrones haciendo uso de catalizadores metálicos. 
En comparación, la síntesis de prolinas α-cuaternarias a través de cicloadiciones que 
implican el uso de isocianoacetatos ha sido mucho menos desarrollada. Estos métodos 
además han requerido dipolarófilos muy reactivos y salvo alguna excepción, la presencia 
de metal para promover la reacción (Figura 1). No obstante, a lo largo de la historia los 
isocianoacetatos han demostrado su potencial sintético, en gran medida gracias a la 
diversidad química que le confiere el grupo isonitrino (isociano) y en consequencia, las 
reacciones que implican su uso son consideradas rutas alternativas de gran interés. 
 
Figura 1. 
Por lo tanto, el objetivo de esta tesis ha sido contribuir a la síntesis de prolinas α-
quaternarias y otros derivados de amino ácidos α-cuaternarios a través de reacciones 
con isocianoacetatos. Para ello se ha estudiado por primera vez la reacción 
organocatalítica asimétrica de Michael entre isocianoacetatos α-sustituidos y vinyl 
cetonas, cuya correspondiente reacción de cicloadición estudiada previamente había 
proporcionado resultados estereoquímicos insatisfactorios.  
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Esquema 1. 
Los resultados obtenidos con los organocatalizadores bifuncionales comunmente 
conocidos se pudieron mejorar con éxito gracias al diseñó de una nueva familia de 
catalizadores del tipo escuaramida/amina terciaria (Figura 2). La clave del éxito de estos 
catalizadores reside en el impedimento estérico generado por el grupo voluminoso 
gem,gem-(bis)diaril que, además de proporcionar un estereocontrol excelente, impide la 
frecuente auto-agregación entre distintas moléculas de escuaramidas que suele 
dificultar las reacciones. Por otro lado, el grupo poliarilo favorece la solubilidad del 
catalizador en disolventes tanto polares como apolares. 
 
Figura 2. 
Al catalizar la reacción en ausencia del metal se ha conseguido favorecer la protonación 
del aducto de Michael carbaniónico frente a la ciclación intramolecular que 
comúnmente ocurre en estas reacciones de adición 1,4 dando lugar a cicloadiciones 
[3+2]. Esto ha permitido sacar partido a la diversidad química del grupo funcional 
isonitrilo en los productos enantioenriquecidos de la reacción de Michael y diseñar una 
ruta sintética divergente para la síntesis de Δ4-dehidroprolinas que formalmente derivan 
de las cicloadiciones [3+2] y Δ5-dehidroprolinas con un estereocentro cuaternario en la 
posición α (Esquema 2). Sin embargo, mientras que la reacción asimétrica de Michael da 
muy buenos resultados cuando se emplean isocianoacetatos α-aril sustituidos, cuando la 
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sustitución es α-alquílica, el nucleófilo no resulta lo suficientemente reactivo y no se 
produce reacción. 
 
Esquema 2. Adición de Michael enantioselectiva de isocianoacetatos α-sustituidos a vinil cetonas. 
Inspirados en como la naturaleza ha encontrado una solución elegante utilizando 
tioesteres como sustitutos activos de oxo-ésteres en la ruta sintética de policétidos y 
ácidos grasos, propusimos abordar la adición de Michael a vinyl cetonas con 
isocianotioésteres α-alquílicos, sustratos nunca antes empleados en reacciones de 
catálisis asimétrica. 
 
Figura 3. 
Aunque estos nuevos nucleófilos demuestran ser lo suficientemente reactivos para dar 
la adición a vinil cetonas de forma perfectamente estereocontrolada, el transcurso de la 
reacción está estrechamente relacionado con la naturaleza del tioester. En este sentido, 
los mejores resultados se producen empleando isocianotioacetatos con un grupo 
tioester con demanda estérica, como por ejemplo tioesteres con grupos aril orto-
disustituidos (Esquema 3). 
Resumen 
 
 
 
Esquema 3. Reacción de Michael vs reacciones secundarias no deseadas. 
De este modo, la reacción asimétrica asistida por el nuevo catalizador y empleando 
isocianotioacetatos con una variedad de sustituyentes alquílicos en la posición alfa y 
diversas vinyl cetonas proporciona los productos de Michael deseados con buenos 
rendimientos y excelentes excesos enantioméricos. Los productos de Michael obtenidos 
pueden ser fácilmente transformados en Δ4- y Δ5-dehidroprolinas. En conjunto, la 
reacción asimétrica de Michael a vinyl cetonas proporciona una nueva ruta sintética 
para la síntesis enantioselectiva de diversas prolinas cuaternarias α-aril y α-alquil 
sustituidas.  
Gracias a estos nuevos nucleófilos, se ha podido realizar por primera vez la 
adición de Michael estereocontrolada entre un equivalente de isocianoacetato α-alquil 
sustituido y una vinil sulfona, aunque empleando el mismo catalizador la reacción da 
resultados inferiores a los logrados con las vinil cetonas. 
 
Esquema 4. Isocianotioacetatos α-alquilados en adiciones de Michael enantioselectivas. 
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Por otro lado, la reacción de Mannich de isocianoacetatos α-sustituidos aun presenta 
muchas limitaciones, sobre todo cuando se trata de nucleófilos α-alquil sustituidos en 
combinación con el uso de organocatalizadores. No obstante, esta reacción proporciona 
una vía para la síntesis de 2-imidazolinas α-cuaternarias, subunidades estructurales de 
compuestos biológicamente activos y precursores ideales de α,β-diamino ácidos. Por 
consiguiente, la reacción de Mannich asimétrica de isocianotioacetatos α-alquilados con 
aldiminas activadas (N-Tosyl) y aldiminas menos activas (N-Aril) también ha sido 
explorada mediante el uso de organocatalizadores. Los resultados preliminares 
indicaron, igual que en el caso anterior, que la reacción tiene lugar si bien los productos 
se obtuvieron con bajos excesos enantioméricos. 
 
Esquema 5. Isocianotioacetatos α-alquilados en reacciones de Mannich enantioselectivas.
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1. Introduction 
1.1. Asymmetric (Organo)Catalysis 
Chirality1 is a property of certain three-dimensional objects by virtue of which they 
cannot be superposed onto its mirror image. The first investigations in relation to the 
molecular chirality date back to the XIX century, with the studies of the optical activity vs 
molecular asymmetry carried out by Luis Pasteur.2 These studies helped to better 
understand what is known today by stereochemistry, even before Kekulé proposed the 
tetravalence of carbon.3 As a result of these findings, in 1874 the tetrahedral three-
dimensional model for the carbon atom was proposed4 in such a way that a tetravalent 
carbon (stereocenter) joined to four different substituents could generate two 
molecules of identical composition and constitution (connectivity) but different spatial 
distribution of atoms, which are known as enantiomers (Figure 1).  
 
Figure 1. Both enantiomers of a chiral molecule containing a stereogenic carbon. 
When a chiral compound is in an achiral environment, the two enantiomers of it behave 
chemically and physically in an almost identical way. However, both enantiomers may 
have different response to a chiral environment, as happens in most biochemical 
processes.5 The thalidomide scandal case in the 60´s 70´s was a social event that 
                                                     
1
 a) Riehl, J. P.; Mirror-Image Asymmetry. An Introduction to the Origin and Consequences of Chirality 
(John Wiley & Sons, New Jersey) 2009. b) Bentley, R. Chirality 2010, 22, 1–2. 
2
 a) Pasteur, L. C. R. Acad. Sci. Paris 1848, 26, 535–538. b) Pasteur, L. Ann. de Chim. et. de Phys. 1848, 24, 
442–459. c) Pasteur, L. Ann. de Chim. et. de Phys. 1853, 38, 437–483. d) Vallery-Radot, R.; La vie de Pasteur 
(Hachette et cie., Paris) 1900. 
3
 Kekulé, A. Annals 1858, 106, 154. 
4
 a) Van´t Hoff, J. H. Arch. Neerl. Sci. Exacles. Nat. 1874, 4, 445–454. b) Le Bel, J. A. Bull. Soc. Chim. Fr. 
1874, 22, 337–347. 
5
 Triggle, D. J., Chirality in Natural and Applied Science; Lough, W. J., Wainer, I. W., Eds.; Blackwell Science, 
Ltd. Bodwin, Cornwall, 2002; pp. 108–138. 
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unconversed this phenomenon leading to thousands of personal victims. 6 To avoid this 
undesired responses, pharmaceutical-, agricultural- and food-chemistry have set as 
synthetic goal the obtaining of enantiomerically pure molecules, and as a consequence, 
in 2006, more than 80% of the drugs approved by the FDA were enantiomerically pure.7 
Chemical transformations involving new carbon-carbon and carbon-heteroatom 
bond formations lead to a racemic chiral product in the absence of an asymmetric 
inductor. Conversely, the synthesis of enantiomerically pure compounds requires a 
chiral inductor. Furthermore, to be used on an industrial scale, they must be 
economically viable and compatible with the environment. As shown in Figure 2, the 
strategies for obtaining enantiopure products can be divided into three main groups: 1) 
racemic resolution, 2) chiral-pool and 3) asymmetric synthesis. 
 
Figure 2. The strategies for obtaining enantiopure compounds. 
Today, the most used strategy in the pharmaceutical industry8 to obtain enantiopure 
compounds is the resolution of racemates.9 The enantiopure compound is separated 
                                                     
6
 Stephens, T.; Brynner, R.; Dark Remedy: The Impact of Thalidomide and Its Revival as a Vital Medicine 
(Perseus, Cambridge, MA) 2001.  
7
 Thayler, A. N. Chem. Eng. News 2007, 9, 105–110. 
8
 Breuer, M.; Ditrich, K.; Habicher, T.; Hauer, B.; Keβeler, M.; Stürmer, R.; Zelinski, T. Angew. Chem. Int. Ed. 
2004, 43, 788–824. 
9
 Anderson, N. G. Org. Proc. Res. Dev. 2005, 9, 800–813. 
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from an initially racemic mixture by crystallization, chromatographical resolution, kinetic 
resolution or dynamic kinetic resolution techniques. As a general limitation, the total 
yield of the process can be at most 50%, having to discard the unwanted enantiomer, 
except in the case of dynamic kinetic resolution,10 which combines kinetic resolution 
with an in situ racemization process allowing the formation desired enantiomer with a 
theoretical 100% yield. 
The chiral pool strategy consists of generating the desired enantioenriched 
products through stereoselective transformations starting from enantiomerically pure 
products obtained from diverse natural sources.11 Therefore, it is necessary to find in 
Nature a chiral compound with the desired configuration and that can be efficiently 
transformed into the desired product, which sometimes is not easy. In addition, 
although Nature offers a variety of enantiopure amino acids,12 carbohydrates,13 
hydroxyacids,14 terpenes and alkaloids, their abundance may be another limitation for 
use in industrial processes.15 
The third strategy for obtaining enantiopure compounds is the asymmetric 
synthesis,16 which encompasses all the processes in which at least one new stereogenic 
element is generated stereoselectively. Within the asymmetric synthesis, one of the 
alternatives is the use of a chiral auxiliary,17 which is temporarily anchored to the 
substrate to control the stereochemical outcome of the reaction and thus the 
                                                     
10
 a) Ward, R. S. Tetrahedron: Asymmetry 1995, 6, 1475–1490. b) Huerta, F. F.; Minidis, A. B. E.; Bäckvall, 
J.-E. Chem. Soc. Rev. 2001, 30, 321–331. c) Pellissier, H. Tetrahedron 2011, 67, 3769–3802. 
11
 X) Hanessian, S.; Franco, J.; Larouche, B. Pure Appl. Chem. 1990, 62, 1887–1910. X) Blaser, H.-U. Chem. 
Rev. 1992, 92, 935–952. c) S. Hanessian, Pure Appl. Chem. 1993, 65, 1189–1204. d) Nicolaou, K. C.;  
Sorensen, E. J.; Classics in Total Synthesis I (Wiley-VCH, Weinheim) 1996. e) Nicolaou, K. C.; Spyder, S. A.; 
Classics in Total Synthesis II (Wiley-VCH, Weinheim) 2003.  
12
 a) Coppola, G. M.; Shuster, H. F.; Asymmetric Synthesis, Construction of Chiral Molecules Using Amino 
Acids (John Wiley, New York) 1982. b) Sardina, F. J.; Rapoport, H. Chem. Rev. 1996, 96, 1825–1872. 
13
 a) Diéguez, M.; Pamies, O.; Ruiz, A.; Diaz, Y.; Castillón, S.; Claver, C. Coord. Chem. Rev. 2004, 248, 2165–
2192. b)Lehnert, T.; Özüduru, G.; Grugel, H.; Albrecht, F.; Telligmann, S. M.; Boysen, M. M. K. Synthesis 
2011, 17, 2685–2708. 
14
 Coppola, G. M.; Shuster, H. F.; α-Hydroxy Acids in Enantioselective Synthesis, (Wiley-VCH, Weinheim) 
2009. 
15
 Hannessian, S. Total Synthesis of Natural Products (Pergamon Press, Oxford) 1983. 
16
 a) Hassner, A.; Advances in Asymmetric Synthesis (JAI Press, Greenwich) 1995. b) Gawley, R. E.; Aube, J.; 
Baldwin, J. E.; Magnus, P. D.; Principles of Asymmetric Synthesis (Pergamon Press, Oxford) 1996. c) Lin, G.-
Q.; Li, Y.-M.; Chan, A. S. C. Principles and Applications of Asymmetric Synthesis (John Wiley & Sons, New 
York) 2001. d) Christmann, M.; Brase, S.; Asymmetric Synthesis: The Essentials (Wiley-VCH, New York) 
2007. 
17
 a) Seyden-Penne, J.; Chiral Auxiliaries and Ligands in Asymmetric Synthesis (Willey, New York) 1995. b) 
Ager, D. J.; Prakash, I.; Schaad, D. R. Chem. Rev. 1996, 96, 835–875. X) Seebach, D.; Beck, A. K.; Heckel, A. 
Angew. Chem. Int. Ed. 2001, 40, 92–138. c) Paquette, L. A.; Handbook of Reagents for Organic Synthesis: 
Chiral Reagents for Asymmetric Synthesis (Willey, New York) 2003. d) Glorious, F.; Gnass, Y. Synthesis 
2006, 12, 1899–1930. 
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configuration of the new stereogenic elements generated during the process. In 
addition, the obtained diastereomeric mixture can be enriched by physical processes, 
whereby the auxiliary cleavage would lead to an enantiomerically enriched compound. 
Asymmetric catalysis18 is a major third approach to enantioenriched chiral 
products. As compared to chiral auxiliaries, in this latter approach the auxiliary 
anchoring and release stages are avoided. In addition, subestequiometric (catalytic) 
quantity of the chiral source of information is sufficient to control the stereochemistry of 
the product. Depending on the catalyst used, three areas are distinguished: biocatalysis, 
organometallic catalysis and organocatalysis. 
Biocatalysis19 is mainly based on high regio-, chemo- and stereoselective 
enzymatic processes which are commonly limited to certain substrates and reaction 
categories. Organometallic catalysis20 and organocatalysis21 are more compatible with 
the development of numerous asymmetric transformations with a great variety of 
structurally different substrates. In this context, organocatalytic methods have attracted 
much interest in the last two decades, since they are cheaper and more harmless to the 
environment than those involving the use of organometallic catalysts, besides being 
usually stable so they do not require inert or anhydrous conditions. 
                                                     
18
 Trost, B M. Proc. Nat. Acad. Sci. 2004, 101, 5348–5355. b) Mikami, K.; Lautens, M.; New Fronteries in 
Asymmetric Catalysis (Wiley-VCH, Weinhelm) 2007. c) Phipps, R. J.; Hamilton, G. L.; Toste, F. D. Nature 
Chemistry 2012, 4, 603–614.  
19
 a) Drauz, K.; Waldmann, H.; Enzyme Catalysis in Organic Synthesis: A Comprehensive Handbook; Vol. I–III 
(Wiley-VCH, Weinheim) 1995. b) Reetz, M. T.; Brunner, B.; Schnerider, F.; Schulz, C. M.; Clouthier, M. M.; 
Kayser, M. Angew. Chem. Int. Ed. 2004, 43, 4075–4078. c) Zagrebelny, N. Russ. Chem. Rev. 2005, 74, 285–
296. d) Bornscheuer, U. T.; Huisman, G. W.; Kazlauskas, R. J.; Lutz, S.; Moore, J. C.; Robins, K. Nature 2012, 
485, 185–194. 
20
 a) Noyori, R.; Asymmetric Catalysis in Organic Synthesis (Wiley, New York) 1994. b) Jacobsen, E. N.; 
Pfaltz, A.; Yamamoto, H.; Comprehensive Asymmetric Catalysis; Vol. I–III (Springer) 1999. c) Ma, J.-A.; 
Cahard, D. Angew. Chem. Int. Ed. 2004, 43, 4566–4583. d) Beller, M.; Bolm, C.; Transition Metals for 
Organic Synthesis; 2º edition (Wiley-VCH, Weinheim) 2004. e) Pradal, A.; Toullec, P. Y.; Michelet, V. 
Synthesis 2011, 10, 1501–1514. f) Hashmi A. S. K. Acc. Chem. Res. 2014, 47, 864–876. 
21
 a) Dalko, P. I.; Moisan, L. Angew. Chem. Int. Ed. 2001, 40, 3726–3748. b) Movassaghi, M.; Jacobsen, E. N. 
Science, 2002, 298, 1904–1905. c) Berkessel, A.; Groger, H.; Metal-Free Organic Catalysis in Asymmetric 
Synthesis (Wiley-VCH, Weinheim) 2004. d) Dalko, P. I.; Moisan, L. Angew. Chem. Int. Ed. 2004, 43, 5138–
5175. e) List, B. Science, 2006, 313, 1584–1586. f) Dalko, P. I.; Enantioselective Organocatalysis (Wiley-
VCH, Weinheim) 2007. g) Melchiorre, P.; Marigo, M.; Carlone, A.; Bartoli, G. Angew. Chem. Int. Ed. 2008, 
47, 6138–6171. h) Jacobsen, E. N.; MacMillan, D. W. C. Proc. Natl. Acad. Sci. 2010, 107, 20618–20619. i) 
List, B. Science of Synthesis; Vol. I (Georg Thieme Verlag KG, New York) 2012. j) Maruoka, K. Science of 
Synthesis; Vol. II (Georg Thieme Verlag KG, New York) 2012. k) Quin, Y.; Zhu, L.; Luo, S. Chem. Rev. 2017, 
117, 9433–9520. 
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1.1.1. Asymmetric bifunctional organocatalysis 
The term organocatalysis refers to a form of catalysis whereby the rate of a chemical 
reaction is increased by an organic catalyst referred to as an "organocatalyst" consisting 
of carbon, hydrogen, sulfur and other nonmetal elements found in organic compounds. 
Organocatalysts can activate the nucleophiles, electrophile or both reagents 
(bifunctional catalysis) through strong covalent bonding or weaker non-covalent 
interactions such as hydrogen bonding or ion pairing (Figure 3). 
 
Figure 3. Organocatalysis. 
Covalent-based activation is based on the ability of a catalyst to covalent bind a 
substrate in a reversible fashion to form a chiral reactive intermediate. In this context, 
aminocatalysis has been the most developed strategy;22 primary or secondary chiral 
amines are used to promote the reaction by activation of carbonyl substrate through 
iminium,23 enamine,24 dienanime25 and trienamine26 intermediate or through SOMO 
                                                     
22
 For a general reviews related to the aminocatalysis, see: a) Yu, X.; Wang, W. Org. Biomol. Chem. 2008, 6, 
2037–2046. b) Barbas III, C. F. Angew. Chem. Int. Ed. 2008, 47, 42–47. c) Aleman, J.; Cabrera, S. An. Quím. 
2009, 105, 189–197. d) List, B. Angew. Chem. Int. Ed. 2010, 49, 1730–1734. e) Nielsen, M.; Worgull, D.; 
Zweifel, T.; Gschwend, B.; Bertelsen, S.; Jørgensen, K. A. Chem. Commun. 2011, 47, 632–649. f) Marqués-
López, E.; Herrera, R. P. Curr. Org. Chem. 2011, 15, 2311–2327. g) Jensen, K. L.; Dickmeiss, G.; Jiang, H.; 
Albrecht, L.; Jørgensen, K. A. Acc. Chem. Res. 2012, 45, 248–264. h) Albrecht, L.; Jiang, H.; Jørgensen, K. A. 
Chem. Eur. J. 2014, 20, 358–368. 
23
 a) Lelais, G.; MacMillan, D. W. C. Aldrichimica Acta, 2006, 39, 79–87. b) Pihko, P. M.; Majander, I.; 
Erkkila, A. Chem. Rev. 2007, 107, 5416–5470. c) Bartoli, G.; Melchiorre, P. Synlett, 2008, 12, 1759–1772. d) 
Brazier, J. B.; Tomkinson, N. C. O. Top. Curr. Chem. 2010, 291, 281–347. 
24
 a) Marigo, M.; Jorgensen, K. A. Chem. Commun. 2006, 2001–2011. b) Guillena, G.; Ramon, D. J. 
Tetrahedron: Asymmetry, 2006, 17, 1465–1492. c) Mukherjee, S.; Woon, J.; Hoffmann, S.; List, B. Chem. 
Rev. 2007, 107, 5471–5569. d) Pihko, P. M.; Majander, I.; Erkkila, A. Top. Curr. Chem. 2010, 291, 29–75. 
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activation.27 Other types of catalysts, such as N-heterocyclic carbenes28 or less 
frequently used tertiary amines,29 alkyl pyridines30 and trialkylphosphines31 are also 
employed in covalent organocatalysis. These activation modes enable the 
stereoselective functionalization of unmodified carbonyl compounds at the ipso, α and β 
positions. 
Non-covalent approaches are based on the cooperation of weak interactions 
between the catalyst and a basic functional group on the substrate, through π stacking, 
polar-, ion pair- and H-bond associations, remembering the ways in which many 
enzymes activate their substrates. In chiral phase-transfer catalysis (PTC),32 the chiral 
catalyst (generally a chiral ammonium salt) and the substrate form a chiral ion pair 
(being the responsible of asymmetric induction in a biphasic reaction) (Figure 4, a).  
 
Figure 4. Substrate activation in non-covalent catalysis. 
                                                                                                                                                              
25
 a) Ramachary, D. B.; Reddy, Y. V. Eur. J. Org. Chem. 2012, 865–887. b) Jurberg, I. D.; Chatterjee, I.; 
Tannert, R.; Melchiorre, P. Chem. Commun. 2013, 49, 4869–4883. 
26
 a) Jia, Z.-J.; Jiang, H.; Li, J.-L.; Gschwend, B.; Li, Q.-Z.; Yin, X.; Grouleff, J.; Chen, Y.-C.; Jorgensen, K. A. J. 
Am. Chem. Soc. 2011, 133, 5053–5061. b) Jiang, H.; Gschwend, B.; Albrecht, L.; Hansen, S. G.; Jorgensen, K. 
A. Chem. Eur. J. 2011, 17, 9032–9036. c) Jia, Z.-J.; Zhou, Q.; Zhou, Q.-Q.; Chen, P.-Q.; Chen, Y.-C. Angew. 
Chem. Int. Ed. 2011, 50, 8638–8641. d) Kumar, I.; Ramaraju, P.; Mir, N. A. Org. Biomol. Chem. 2013, 11, 
709–716. 
27
 Beeson, T. D.; Mastracchio, A.; Hong, J.-B.; Ashton, K.; MacMillan, D. W. C. Science 2007, 316, 582–585. 
28
 a) Enders, D.; Kallfass, U. Angew. Chem. Int. Ed. 2002, 41, 1743–1745. b) Marion, N.; Diez-Gonzalez, S.; 
Nolan, S.-P. Angew. Chem. Int. Ed. 2007, 46, 2988–3000. c) Enders, D.; Niemeier, O.; Henseler, A. Chem. 
Rev. 2007, 107, 5606–5655. d) Bugaut, X.; Glorius, F. Chem. Soc. Rev. 2012, 41, 3511–3522. 
29
 a) McGarrigle, E. M.; Myers, E. L.; Illa, O.; Shaws, M. A.; Riches, S. L.; Aggarwal, V. K. Chem. Rev. 2007, 
107, 5841–5883. b) Gaunt, M. J.; Johanson, C. C. C. Chem. Rev. 2007, 107, 5596–5605. 
30
 Wurz, R. P. Chem. Rev. 2007, 107, 5570–5595. 
31
 a) Masson, G.; Housseman, C.; Zhu, J. Angew. Chem. Int. Ed. 2007, 46, 4614–4628. b) Krishna, P. R.; 
Sachwani, R.; Reddy, P. S. Synlett, 2008, 2897–2912. c) Declerck, V.; Martinez, J.; Lamaty, F. Chem. Rev. 
2009, 109, 1–48. 
32
 a) Ooi, T.; Maruoka, K. Angew. Chem. Int. Ed. 2007, 46, 4222–4266. b) Hashimoto, T.; Maruoka, K. Chem. 
Rev. 2007, 107, 5656–5682. c) Maruoka, K.; Asymmetric Transfer Catalysis (Wiley-VCH, Weinheim) 2008. 
d) Shirakawa, S.; Maruoka, K. Angew. Chem. Int. Ed. 2013, 526, 4312–4348. e) Kaneko, S.; Kumatabara, Y.; 
Shirakawa, S. Org. Biomol. Chem. 2016, 14, 5367–5376. 
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On the other hand, chiral Brønsted acid catalysts33 (commonly organophosphoric acids 
and derivatives) increase the substrate electrophilicity by protonation at the same time 
that the chiral ion pair is formed. However, catalysis by H-bond donors (diols, biphenols, 
ureas, thioureas, squaramides, etc)34 is effected decreasing the electron-density of an 
acceptor (typically a π system) or increasing the acidity of the carbon nucleophiles upon 
coordination of a heteroatom through H-bond forming. Thanks to this coordination a 
chiral environment is generated close to the reagent (Figure 4, b). 
Finally, catalysis by chiral Brønsted bases (BB),35 relies on the activation of the 
substrate by deprotonation leading to a chiral ion pair (Figure 4, c). Tertiary amines, 
guanidines, amidines and imidazoles are the most prominent nitrogen-containing 
functionalities used for the design of chiral BB catalysts. In this context, natural cinchona 
alkaloids constitute very popular source of enantiopure BB which provide diversity in 
stereochemical and constitutional terms (Figure 5). 
 
Figure 5. Alkaloids from the cinchona family. 
As a result of the non-directional nature of the electrostatic interactions of the formed 
ionic complexes, it is difficult to predict the stereochemical course of the BB-catalyzed 
reactions. Incorporating some hydrogen donor group into the BB catalyst structure 
(bifunctional catalyst) would allow to simultaneously activate the pronucleophile and 
the electrophile of the reaction providing greater stereochemical control of the process 
                                                     
33
 a) Akiyama, T.; Itoh, J.; Fuchible, K. Adv. Synth. Catal. 2006, 348, 999–1010. b) Terada, M. Chem. Comm. 
2008, 4097–4112. c) Lv, F.; Liu, S.; Hu, W. Asian J. Org. Chem. 2013, 2, 824–836. 
34
 a) Taylor, M. S.; Jakobsen, E. N. Angew. Chem. Int. Ed. 2006, 45, 1520–1543. b) Doyle, A. G; Jacobsen, E. 
N. Chem. Rev. 2007, 107, 5713–5743. c) Akiyama, Y. Chem. Rev. 2007, 107, 5744–5758. d) Yu, X.; Wang, W. 
Chem. Asian. J. 2008, 3, 516–532. e) Zhang, Z.; Scheriner, P. R. Chem. Soc. Rev. 2009, 38, 1187–1198. f) 
Pihko, P. M.; Hydrogen Bonding in Organic Synthesis (Wiley-VCH, Weinheim) 2009. g) Sohtome, Y.; 
Nagasawa, K. Synlett, 2010, 1–22. h) Nishikawa, Y. Tetrahedron Lett. 2018, 59, 216–223. 
35
 a) France, S.; Guerin, D. J.; Miller, S. J.; Lectka, T. Chem. Rev. 2003, 103, 2985–3012. b) Wurz, R. P.; 
Chem. Rev. 2007, 107, 5570–5595. c) Denmark, S. E.; Beutner, G. L. Angew. Chem. Int. Ed. 2008, 47, 1560–
1638. d) Palomo, C.; Oiarbide, M.; López, R. Chem. Soc. Rev. 2009, 38, 632–653. e) Ishikawa, T. Superbases 
for Organic Synthesis: Guanidines, Amidines, Phosphazenes and Related Organocatalysis; (Wiley, New 
York) 2009. f) Tiang, A.; Goss, J. M.; McDougal, N. T.; Schaus, S. E. Top. Curr. Chem. 2010, 291, 145–200. 
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(Figure 6).36 Within bifunctional catalysts, those based on Brønsted bases are especially 
useful tool on asymmetric catalysis due to the availability of alkaloids usually employed 
in BB in Nature. 
 
Figure 6. Bifunctional catalysis. 
Although previous examples of cinchona alkaloids-based catalytic transformation were 
seldom documented, in 1975 Wynberg published the first example of Brønsted base 
catalyzed reaction in which cinchona alkaloids operated as bifunctional catalyst in 
enantioselective addition of α-ketoesters to vinyl ketones (Figure 7, a).37 The tertiary 
amine activates the pronuclephile by deprotonation while the hydroxyl group activates 
the electrophile by hydrogen-bond.38 In 2003, Takemoto and co-workers developed 
cyclohexyldiamine derived thiourea catalysts, in which they proposed that the thiourea 
moiety activated the nitroalkenes by H-bond forming, while the tertiary amine 
deprotonated the dimethylmalonate in the Michael addition (Figure 7, b).39 Since 2003, 
a variety of thiourea-subtituted cinchona alkaloid catalyst systems have been developed, 
demonstrating their effectiveness in many transformations.40 More recently, since in 
                                                     
36
 For reviews related to bifunctional organometallic catalysts, see: a) Kanai, M.; Kato, N.; Ichikawa, E.; 
Shibasaki, M. Synlett 2005, 10, 1491–1508. b) Shibasaki, M.; Kanai, M.; Matsunaga, S.; Kumagai, N. Acc. 
Chem. Res. 2009, 42, 1117–1127. c) Cao, Z.-Y.; Brittain, W. D. G.; Fossey, J. S.; Zhou, F. Cat. Sci. Technol 
2015, 5, 3441–3451. For reviews related to bifunctional organocatalysts, see: d) Marcelli, T.; van 
Maarseveen, J. H.; Hiemstra, H. Angew. Chem. Int. Ed. 2006, 45, 7496–7504. e) Liu, X.; Lin, L.; Feng, X. 
Chem. Commun. 2009, 6145–6158. f) Wang, S.-X.; Han, X.; Zhong, F.; Wang, Y.; Lu, Y. Synlett 2011, 19, 
2766–2778. g) Tsakos, M.; Kokotos, C. G. Tetrahedron 2013, 69, 10199–10222. 
37
 a) Wynberg, H.; Helder, R. Tetrahedron Lett. 1975, 16, 4057–4060. b) Hermann, K.; Wynberg, H. J. Org. 
Chem. 1979, 44, 2238–2244. 
38
 For mechanistic studies on bifunctional catalysis promoted by cinchona alkaloids, see: Cucinotta, C. S.; 
Kosa, M.; Melchiorre, P.; Cavalli, A.; Gervasio, F. Chem. Commun 2009, 15, 7913–7921. 
39
 Okino, T.; Hoashi, Y.; Takemoto, Y. J. Am. Chem. Soc. 2003, 125, 12672–12673. 
40
 For a reviews on bifunctional catalysis promoted by urea/thiourea Brønsted base catalysts, see: a) 
Connon, S. J.; Chem. Commun. 2008, 2499–2510. b) Fang, X.; Wang, C.-G. Chem. Commun. 2015, 51, 1185–
1197. For pionering examples, see: c) Li, B. J.; Jiang, L.; Liu, M.; Cheng, Y. C.; Ding, L. S.; Wu, Y. Synlett 2005, 
603–606. d) Vaculya, B.; Varga, S.; Csámpai, A.; Soós, T. Org. Lett. 2005, 7, 1967–1969. e) McCooey, S. H.; 
Connon, S. J. Angew. Chem. Int. Ed. 2005, 44, 6367–6370. f) Ye, J.; Dixon, D. J.; Hynes, P. S. Chem. 
Commun. 2005, 4481–4483. For some recent examples, see: g) Montesinos-Magraner, M.; Vila, C.; 
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2008 Rawal´s group demonstrated the capacity of the squaramides as bifunctional 
catalysts (Figure 7, c)41, they have been the focus of much attention.42 
 
Figure 7. Representative first reported reaction using bifunctional Brønsted base organocatalysts. 
1.1.1.1. Squaramides vs thioureas 
As mentioned above, several H-bond donors such as diols, biphenols, ureas, thioureas, 
squaramides, etc. have been employed in asymmetric catalysis, of which the thioureas 
and squaramides are the most common in bifunctional Brønsted base catalysts so far. 
                                                                                                                                                              
Cantón, R.; Blay, G.; Fernández, I.; Muñoz, M. C.; Pedro, J. R. Angew. Chem. Int. Ed. 2015, 54, 6320–6324. 
h) Wang, J.-J.; Yang, H.; Gou, B.-B.; Zhou, L.; Chen, J. J. Org. Chem. 2018, 83, 4730–4738. 
41
 Malerich, J. P.; Hagihara, K.; Rawal, V. H. J. Am. Chem. Soc. 2008, 130, 14416–14418. 
42
 For reviews on bifunctional catalysis promoted by squaramides Brønsted base catalysts, see: a) Storer, 
R. I.; Aciro, C.; Jones, L. H. Chem. Soc. Rev. 2011, 40, 2330–2346. b) Alemán, J.; Parra, A.; Jiang, H.; 
Jørgensen, K. A. Chem. Eur. J. 2011, 17, 6890–6899. c) Chauhan, P.; Mahajan, S.; Kaya, U.; Hack, D.; Enders, 
D. Adv. Synth. Catal. 2015, 357, 253–281. d) Held, F. E.; Tsogoeva, S. B. Catal. Sci. Technol. 2016, 6, 645–
667. e) Rouf, E.; Tanyel, C. Curr. Org. Chem. 2016, 20, 2996–3013. 
Introduction 
14 
 
In general, squaramides have demonstrated higher reactivity than thiourea 
catalysts in asymmetric transformations, and hence, the catalyst loading needed to 
complete the full conversion of the substrate is lower. This extraordinary performance is 
due to the special characteristics that the squaramide skeleton gives to these catalysts. 
The additional advantage of squaramides is their facile preparation from easily available 
starting materials, besides that in many cases, as the catalyst is formed, it precipitates in 
the reaction solution, so is available by filtration and the chromatographic purification is 
not nesesary. 
In terms of structural differences, squaramide posses four-membered ring with 
two hydrogen-bond acceptors at the carbonyl groups and two N-H hydrogen-bond 
donor groups (Figure 8, a). In addition, crystallographic structure reported by Rawal has 
demonstrated that these N–H groups are coplanar with the cyclobutendione rigid unit 
and that the distance between them is longer than in case of thioureas.43 The square 
geometric also induces the disposition of N–H groups with an angle of approximately 6° 
(Figure 8, b). 
 
Figure 8. Structural differences between squaramide and thiourea skeletons. 
Even so, probably the structural difference that justifies its greater reactivity than the 
thioureas is their further capacity to delocate the nitrogen lone pair through the partially 
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 Okino, T.; Hoashi, Y.; Furukawa, T.; Xu, X. N.; Takemoto, Y. J. Am. Chem. Soc. 2005, 127, 119–125. 
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aromatic cyclobutenedione system (Figure 8, c).44 Thus, as Cheng's study confirmed,45 
the acidity of squaramides is higher compared to thiourea and the hydrogen bonds that 
are formed with the substrates are stronger. 
Accordingly, in this thesis work special interest has been placed on the design of 
new squaramide-based bifunctional Brønsted base catalysts, particularly, to be 
employed in the stereoselective synthesis of α- quaternary amino acid derivatives. 
 
1.2. α-Quaternary Amino Acids 
The design and synthesis of polyfunctionalized molecules not present in Nature have 
caused much interest among organic, bioorganic, peptide and medicinal chemists in the 
21st century. One category of such rationally functionalized molecules might be 
foldamers (firstly named by Gellman),46 that are polymers with a strong tendency to 
adopt a specific compact conformation. The last foldamers designed and developed by 
evolution in Nature might be the natural enzymes and receptors, which can adopt a 
three-dimensional defined form and have specific biological functions.47  
In this context, naturally occurring L-α-amino acids have an essential role as 
building blocks of oligopeptides and proteins, and the synthesis of these building blocks 
has attracted considerable interest.48 The diverse functionalities of peptides are 
conditioned by physical and chemical properties of specific side chain of the amino acid 
residues and their three-dimensional structures (secondary structures). However, 
oligopeptides composed by natural L-α-amino acids often form unstable or unordered 
                                                     
44
 Tomàs, S.; Prohens, R.; Vega, M.; Rotger, M. C.; Deyá, P. M.; Ballester, P.; Costa, A. J. Org. Chem. 1996, 
61, 9394–9401. 
45
 For study related to the pKa of thioureas, see: a) Li, X.; Deng, H.; Zhang, B.; Li, J.; Zhang, L.; Luo, S. Z.; 
Cheng, J.-P. Chem. Eur. J. 2010, 16, 450–455. b) Jakab, G.; Tancon, C.; Zhang, Z. G.; Lippert, K. M.; 
Schreiner, P. R. Org. Lett. 2012, 14, 1724–1727. For study related to the pKa of squaramides, see: c) Ni, X.; 
Li, X.; Wang, Z.; Cheng, J. P. Org. Lett. 2014, 16, 1786–1789.  
46
 Gellman, S. H.; Acc. Chem. Res. 1998, 173–181. 
47
 a) Solomon, E. I.; Brunold, T. C.; Davis, M. I.; Kemsley, J. N.; Lee, S.-K.; Lehnert, N.; Neese, F.; Skulan, A. 
J.; Yang, Y.-S.; Zhou, J. Chem. Rev. 2000, 100, 235–349. b) Champoux, J. J. Annu. Rev. Biochem. 2001, 70, 
369–413. c) Vieille, C.; Zeikus, G. J. Microbiol. And Molec. Biol. Rev. 2001, 65, 1–43. 
48
 For selected reviews on the asymmetric synthesis of α-amino acids, see: a) Nájera, C.; Sansano, J. M. 
Chem. Rev.  2007, 107, 4584–4671. b) Martens, J. ChemCatChem  2010, 2, 379–381. c) Luo, Y.-C.; Zhang, 
H.-H.; Wang, Y.; Xu, P.-F. Acc. Chem. Res.  2010, 43, 1317–1330. d) Jakubowska, A.; Kulig, K. Curr. Org. 
Synth.  2013, 10, 547–563. e) Sorochinsky, A. E.; Aceña, J. L.; Moriwaki, H.; Sato, T.; Soloshonok, V. Amino 
Acids  2013, 45, 1017–1033. f) Aceña, J. L.; Sorochinsky, A. E.; Soloshonok, V. Amino Acids  2014, 46, 2047–
2073. For leading books on the topic, see: g) R. M. Williams, Synthesis of Optically Active α-Amino Acids 
(Pergamon, Oxford) 1989. h) Asymmetric Synthesis and Application of α-Amino Acids (V. A. Soloshonok & 
K. Izawa ed., American Chemical Society, Washington DC) 2009.  
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secondary structures and can adopt several conformations in solution, particularly in the 
case of short peptides due to their flexible nature. Only a few conformers are 
responsible for their diverse biological properties, so this instability in the secondary 
structure is a drawback in the use of the oligopeptides as drug candidates and 
functionalized-deviced molecules.49 In addition, α-amino acids are employed as chiral 
source in chemical catalysis and synthesis.50  
The modification of native peptides constitutes a powerful means to modulate 
the biological properties and conformation of peptides. Thus, organic chemists have 
demonstrated great interest in the design of non-proteinogenic α-amino acids.51 α-
Quaternary α-amino acids, which derive from the replacement of the α-hydrogen atom 
of L-α-amino acids with an alkyl or aryl substituent, change the properties of the native 
L-α-amino acids and derived peptides as follow:52 1) increasing the stability against 
chemical and enzymatic hydrolysis, 2) increasing hydrophobicity, and 3) increasing helix-
inducing potencial (Scheme 1). These effects have been attributed to the loss of 
conformational freedom due to the steric constraint, which restricts the secondary 
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 Adessi, C.; Soto, C.; Curr. Med. Chem. 2002, 9, 963–975. 
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auxiliaries, see: b) W. Maison, Comprehensive Chirality (E. M. Carreira & K. Yamamoto ed., Elsevier B.V., 
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Chavan, A. S. J. Org. Chem.  2013, 78, 12288–12313. g) Kotha, S.; Bandarugattu, V. B.; Krishna, N. G. 
Tetrahedron  2014, 70, 5361–5384. h) Harkiss, A. H.; Sutherland, A. Org. Biomol. Chem. 2016, 14, 8911–
8921. For leading book on the topic, see: i) J. Vidal, Amino Acids, Peptides and Proteins in Organic 
Chemistry (A. B. Hughes ed., Wiley-VCH Verlag GmbH & Co. KGaA) 2009. j) M. Ikunaka & K. Maruoka, 
Asymmetric Catalysis on Industrial Scale (H.-U. Blaser & H.-J. Federsel ed., Wiley-VCH Verlag GmbH & Co. 
KGaA 2nd ed.) 2010.   
52
 For some reviews on the biological properties of quaternary α-amino acids, see: a) Karle I. L; Balaram P.; 
Biochemistry 1990, 29, 6747—6756. b) Heimgartner H., Angew. Chem. Int. Ed. Engl. 1991, 30, 238—264. c) 
Crisma, M.; Valle, G.; Bonora, G. M.; Toniolo, C.; Lelj, F.; Barone, V.; Fraternall, F.; Hardy, P. M.; Maia, H. L. 
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structure of peptides. Besides the application in peptide chemistry, quaternary α-amino 
acids are found in many natural and biologically active compounds as well (Figure 9).53,54 
 
Scheme 1. General structure of the L-α-amino acids, quaternary α-amino acids and derived peptide. 
 
 
 
Figure 9. Examples of biologically active quaternary α-amino acids. 
Due to the great importance of α,α-disubstituted amino acids, a variety of  approaches 
to their stereoselective synthesis have been developed.55,56 Here, we should distinguish 
those based on the stoichiometric of a chiral source, either an auxiliary or a molecule 
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18, 569–623. e) Cativiela, C.; Ordóñez, M. Tetrahedron: Asymmetry  2009, 20, 1–63. f) Soloshonok, V.; 
Sorochinsky, A. Synthesis  2010, 2319–2344. g) Baer, K.; Dückers, N.; Hummel, W.; Gröger, H. 
ChemCatChem  2010, 2, 939–942. h) Bera, C.; Namboothiri, I. N. N. Asian J. Org. Chem. 2014, 3, 1234–
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Angew. Chem. Int. Ed.  1996, 35, 2708–2748.  For a recent example employing chiral auxiliaries to 
synthesize quaternary α- amino acids, see: b) Netz, I.; Kucukdisly, M; Opatz, T.  J. Org. Chem. 2015, 80, 
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from the chiral pool, from the catalytic methods. Methods based on chiral catalysts are 
more attractive and atom-economic than stoichiometric methods.  
Catalytic asymmetric methods for the synthesis of α,α-disubstituted amino acids 
can be classified  in four main groups, based on the type of reaction disconnection 
(Scheme 2). The strategy based on the nucleophilic addition of masked amino acids is 
the most obvious and Figure 10 shows the most useful α-amino acid derivatives within 
this strategy. This thesis is focused on the use of α-substituted isocyano(thio)acetates, 
particularly, their Michael addition to α,β-unsaturated ketones as a route to α-
quaternary proline derivatives. A preliminary study of the Mannich reaction to several 
imines has also been carried out, a very useful reaction commonly used for the synthesis 
of α-quaternary α, β-diamino acids. 
 
Scheme 2. Retrosynthetic analysis of quaternary α-amino acids. 
 
Figure 10. Most common α-amino acid derived nucleophiles. 
 
1.3. α-Quaternary Prolines 
Among all the α-amino acids, proline analogues are of special interest given their ability 
to constrain the conformation of peptides once incorporated in their backbone 
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structure. Such significance is due to the exceptional rigidity conferred by its cyclic 
structure and the hinge behaviour thanks to the participation of pyrrolidine nitrogen in 
peptide bonds (Figure 11).57 The interest of proline analogues is also due to protein-
protein interactions mediated by link domains rich in these amino acids58 and to their 
capacity to generate β-turn secondary structures in peptidomimetics.59 α-Quaternary 
proline analogues constitute a particularly relevant subclass. The number of studies 
carried out in relation to the incorporation of α-methylated proline into peptides and 
other biologically active compounds demonstrates the relevance of these proline 
analogues.60 Although many aspects of the α-quaternary prolines conformational 
preference are still unknown, their use as templates in studies of the structure-function 
relationship of biologically active conformations is widespread.61 In addition, α-
quaternary prolines are valuable building blocks for the design and construction of 
organic catalysts and chiral auxiliaries for asymmetric synthesis.62 
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Figure 11. Peptides composed by α-quaternary acyclic AAs VS α-quaternary proline analogues. 
Besides this, according to the study carried out by Njardarson et al. in relation to the 
relevance of the nitrogen heretocycles in the pharmaceutical industry,63 among the 
nitrogen heterocycle containing drugs approved by the US Food and Drug 
Administration, pyrrolidine is ranked number five, appearing in 37 drugs. Among all 
these drugs the proline core is the most commonly employed pyrrolidine structural 
fragment (Figure 12). Also, this structure can be found in many natural products and 
biologically active substances (Figure 13).64,65,66 
 
Figure 12. Pharmaceuticals containing proline core. 
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Figure 13. Examples of biologically active α-quaternary prolines  
For all these reasons, in recent years, special interest has been paid to the asymmetric 
synthesis of prolines containing an α-quaternary stereocenter.67 The strategies can be 
classified according to two main groups as depicted in Figure 14: 1) α-functionalization 
of proline analogues and 2) nucleophilic addition of α-substituted amino acid derivatives 
to electron-deficient olefins. An alternative classification would distinguish whether the 
chiral inductor is used in stoichiometric or catalytic amount. In this thesis, emphasis will 
be made in catalytic asymmetric approaches which are, as said before, more attractive 
and atom-economic. 
 
Figure 14. Strategies to complete the α-quaternary proline skeleton. 
1.3.1. Estereoselective synthesis of α-quaternary prolines 
1.3.1.1. α-Functionalization of a proline analogue 
The α-functionalization of a chiral proline analogue, frequently by reaction with an 
electrophilic alkylating reagent, is one of the general approaches to optically active α-
quaternary proline derivatives. In this context, in 1981 Seebach developed the self-
regeneration of stereocentres strategy (SRS),68 which consists of a chirality rely on a 
temporary formed stereogenic center (auxiliary) via diastereoselective formation of a 
bicyclic hemiaminal (Scheme 3). Then, the diastereoselective alkylation at the Cα 
followed by aminal hydrolysis provides α-quaternary prolines with retention of the 
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 For selected reviews of α-quaternary proline synthesis, see: a) Calaza, M. I.; Cavitiela, C. Eur. J. Org. 
Chem. 2008, 3427–3448. b) ref.55a page 17. c) ref.55e page 17. d) ref.55h page 17.  
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configuration. The strategy has been further developed, to broaden the scope of the 
reaction, modulate the diastereoselectivity and explore new variations.69 
 
Scheme 3. Seebach´s self-regenation of stereocenters strategy 
Alternatively, the diastereoselective Cα alkylation of substituted L-proline esters can be 
achieve if the initial proline contains a second stereocenter with the set configuration.70 
The spatial orientation of the substituents on the second stereocenter determines the 
approach of the incoming group R. Based on this strategy, recently the 
diastereoselective Cα arylation of L-proline derivatives have also been achieved by 
Claiden (Scheme 4).70e 
Scheme 4.  Diastereoselective Cα arylation of L-proline derivatives. 
On the other hand, there is one example of catalytic asymmetric construction of α-
quaternary stereocentre from racemic 3-oxoproline analogue, developed by Maruoka in 
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2005.71 α-Quaternary proline analogues were enantioselectively obtained by asymmetric 
allylic alkylation of the precursor 3-oxoproline under phase-transfer condition using 
binaphthyl-derived spiranic chiral ammoniun bromide as catalyst (Scheme 5). 
 
Scheme 5. Phase-transfer-catalyzed alkylation of racemic 3-oxo proline analogue. 
1.3.1.2. Nucleophilic (cyclo)additions of α-amino acid derivatives 
Methods involving de novo formation of the pyrrolidine ring have been developed to a 
relatively larger extent based primarily on the use of the chiral pool or chiral 
auxiliaries,72 but also asymmetric catalysis. Within all strategies, asymmetric [3+2] 
cycloaddition (also known as 1,3-dipolar cycloaddition) of α-amino acid derivatives has 
been extensively studied for the stereoselective synthesis of α-quaternary pyrrolidines.73 
Both strategies, the use of chiral dipole74/dipolarophile75 as starting material or the 
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reaction between achiral starting materials under the control of a chiral catalyst, are 
plausible. 
With respect to the strategies focused on the use of chiral catalysts, most of the 
progress relies on the Lewis acid type catalysts, formed by complexation of a transition 
metal and a coordinating chiral ligand. However, in recent years, protocols based on 
organocatalysts have become popular.76 
The majority of examples of organocatalytic [3+2] cycloadditions so far reported 
involve α-unsubstituted glycine derivatives as 1,3-dipoles (ylides); ylides derived from α-
substituted amino acids, especially α-alkyl substituted, have been much less used. In 
general, dipoles derived from α-substituted α-amino acids require very reactive 
dipolarophiles for the cycloadditions to proceed conveniently. Commonly, this is 
achieved by employing α-iminoesters (azomethine ylide precursors) with an additional 
activating group at α-position to increase the acidity of this Cα,77 most commonly two 
ester groups.78 However, in the resulting prolines the cleavage of one of the electron-
withdrawing group would require in order to prepare biologically and catalytically 
important proline scaffolds, hence, the quaternary centre is lost. In short, the most 
persecuted strategy for the synthesis of α-quaternary proline has been [3+2] 
cycloaddition involving α-aryl or α-alkyl substituted amino acid derivatives (Figure 15). 
 
Figure 15. General [3+2] cycloaddition involving α-aryl or α-alkyl substituted amino acid derivatives. 
                                                     
76
 For reviews of organocalytic [3+2] cycloadditions: a) Held, F. E.; Tsogoeva, S. B.; Catal. Sci. Technol. 
2016, 6, 645–667. c) Vicario, J. L. Synlett 2016, 27, 1006–1021. 
77
 For examples involving dipoles bearing different EWG groups, see: a) Reboredo, S.; Vicario, J. L.; Badía, 
D.; Carrillo, L.; Reyes, E. Adv. Synth. Catal. 2011, 353, 3307–3312. b) Lin, S.; Deiana, L.; Zhao, G.-L.; Sun, J.; 
Córdova, A. Angew. Chem. Int. Ed. 2011, 50, 7624–7630. 
78
 For examples involving α-diester dipoles, see: a) Vicario, J. L.; Reboredo, S.; Badía, D.; Carrillo, L. Angew. 
Chem. Int. Ed. 2007, 46, 5168–5170. b) Chen, X.-H.; Zhang, W.-Q.; Gong, L.-Z. J. Am. Chem. Soc. 2008, 130, 
5652–5653. c) Yu, J.; He, L.; Chen, X.-H.; Song, J.; Chen, W.-J.; Gong, L.-Z. Org. Lett. 2009, 11, 4946–4949. 
d) Chen, X.-H.; Wei, Q.; Luo, S.-W.; Xiao, H.; Gong, L.-Z. J. Am. Chem. Soc. 2009, 131, 13819–13825. e) 
Wang, C.; Chen, X.-H.; Zhou, S.-M.; Gong, L.-Z. Chem. Commun. 2010, 46, 1275–1277. f) Tian, L.; Xu, G.-Q.; 
Li, Y.-H.; Liang, Y.-M.; Xu, P.-F. Chem. Commun. 2014, 50, 2428–2430. 
CHAPTER 1 
 
25 
 
Below are collected the main studies carried out with α-aryl or α-alkyl substituted amino 
acid derivatives, namely: 1) azomethyne ylide precursors, 2) α-nitroesters and 3) α-
isocyanoacetates. 
1.3.1.2.1. Azomethine ylides 
1.3.1.2.1.1. [3+2] Cycloadditions 
Definitely, one major thoroughly investigated approach for the synthesis of 
polyfunctionalized prolines relies on the metal-catalyzed79 [3+2] cycloaddition involving 
azomethine ylides and electron-deficient olefins.80 In this context, α-alkyl or α-aryl 
substituted azomethine ylides have been applied in [3+2] cycloadditions reactions with 
many types of dipolarophiles (Table 1, entry 1). In addition to the best-known 
azomethine ylides, azlactones also have been used as cyclic azomethine equivalents in 
some catalytic asymmetric [3+2] cycloadditions for the synthesis of α-quaternary 
prolines (entry 2).81  
Acrylates,82, fumarates/maleates,83 maleimides,84 nitroalkenes85 and enones86 
have been the most used dipolarophiles in these reactions. To a lesser extent, 
                                                     
79
 For metal-catalyzed [3+2] cycloaddition involving azomethine ylides, see: Adrio, J; Carretero, C Chem. 
Commun. 2011, 47, 6784–6784. 
80
 For selected reviews related to the catalytic [3+2] cycloaddition involving azomethine ylides, see: a) 
Coldham, I.; Hufton, R. Chem. Rev. 2005, 105, 2765–2809. b) J. Adrio, J. C. Carretero, Chem. Commun. 
2014, 50, 12434–12446; c) K. Jiang, Y.-C. Chen, Tetrahedron Lett. 2014, 55, 2049–2055; d) R. Narayan, M. 
Potowski, Z.-J. Ja, A. P. Antonchick, H. Waldman, Acc. Chem. Res. 2014, 47, 1296–1310; e) C. Nájera, J. M. 
Sansano, M. Yus, Org. Biomol. Chem. 2015, 13, 8596.  
81
 For [3+2] cycloadditions involving azlactones, see:  a) Melhado, A. D.; Luparia, M.; Toste, D. J. Am. Chem. 
Soc. 2007, 129, 12638−12639. b) Melhado, A. D.; Amarante, G. W.; Wang, Z. J.; Luparia, M.; Toste, F. D. J. 
Am. Chem. Soc. 2011, 133, 3517−3527. c) Martín-Rodríguez, M.; Nájera, C.; Sansano, J. M. Synlett 2012, 
23, 62−65. d) Sun, W.; Zhu, G.; Wu, C.; Li,  G.; Hong, L.; Wang, R. Angew. Chem. Int. Ed. 2013, 52, 
8633−8637. e) Zhang, Z.; Sun, W.; Zhu, G.; Yang, J.; Zhang, M.; Hong, L.; Wang, R. Chem. Commun. 2016, 
52, 1377−1380. 
82
 For [3+2] cycloadditions between azomethine ylides and acrylates, see: a) Tsubogo, T.; Saito, S.; Seki, K.; 
Yamashita, Y.; Kobayashi, S J. Am. Chem. Soc. 2008, 130, 13321–13332. b) Nájera, C.; Retamosa, M. G.; 
Martín-Rodríguez, M.; Sansano, J. M.; Cózar, A.; Cossío F. P. Eur. J. Org. Chem. 2009, 5622–5634. c) Tong, 
M.-C.; Li, J.; Tao, H.-Y.; Li, Y.-X.; Wang, C.-J. Chem. Eur. J. 2011, 17, 12922–12927.  d) Li, Q.-H.; Tong, J.; Li, 
H.-Y.; Tao, H.-Y.; Wang, C.-J. Chem. Commun. 2011, 47, 11110–11112. e) Li, Q.-H.; Liu, T.-L.; Wei, Zhou, X.; 
Tao, H.-Y.; Wang, C.-J. Chem. Commun. 2013, 49, 9642–9644.  
83
 For [3+2] cycloadditions between azomethine ylides and fumarates/maleates, see: a) Wang, C.-G.; Liang, 
G.; Xue, Z.-Y.; Gao, F. J. Am. Chem. Soc. 2008, 130, 17250−17251. b) He, L.; Chen, X.-H.; Wang, D.-N.; Lou, 
S.-W.; Zhang, W.-Q.; Yu, J.; Ren, L.; Gong, L.-Z. J. Am. Chem. Soc 2011, 133, 13504−13518. c) Liu, T.-L.; He, 
Z-L.; Tao, H.-Y.; Wang, C.-J. Chem. Eur. J 2012, 18, 8042−8046. d) Guo, C.; Song, J.; Gong, L.-X. Org. Lett. 
2013, 15, 2676−2679. e) Wang, H.; Deng, Q.; Zhou, Z.; Hu, S.; Liu, Z.; Zhou, L.-Y. Org . Lett. 2016, 18, 
404−407. 
84
 For [3+2] cycloadditions between azomethine ylides and maleimides, see: a) Nájera, C.; Retamosa, M. 
De G.; Sansano, J. M. Org. Lett. 2007, 9, 4025−4028. b) Martin-Rodriguez, M.; Nájera, C.; Sansano, J. M.; 
Introduction 
26 
 
allenoates,87 alkylidene malonates,88  methyleneindolinones83d,89 and vinyl sulfones90 
have also been studied.  
Table 1.  
Entry Ylide precursors Dipolarophiles 
1 
 
acrylates, fumarates/maleates, maleimides, allenoates, 
alkylidene malonates, methyleneindolinones, 
nitroalkenes, vinyl sulfones, enones 
2 
 
(azlactones) 
acrylates, fumarates/maleates, maleimides, 
methyleneindolinones 
 
Among the great variety of works reported, one of the works to be highlighted from the 
point of view of the substrate could be the Cu(I)-Fesulphos-catalyzed [3+2] cycloaddition 
                                                                                                                                                              
Cozar, A.; Cossio, F. P.  Chem. Eur. J. 2011, 17, 14224−14233. c) Mancebo-Aracil, J.; Martín-Rodriguez, M.; 
Nájera, C.; Sansano, J. M.; Costa, P. R. R.; Crizanto de Lima, E.; Dias, A. G. Tetrahedron: Asymmetry 2012, 
23, 1596−1606. d) Tada, A.; Watanabe, S.; Kimura, M.; Tokoro, Y.; Fukuzawa, S.-i. Tetrahedron Lett. 2014, 
55, 6224–6226. e) Xue, Z.-Y.; Xiong, Y.; Wang, C.-J. Synlett 2014, 25, 2733−2737. f) Molina, A.; Pascual-
Escudero, A.; Adrio, J.; Carretero, J. C. J. Org. Chem. 2017, 82, 11238–11246.  
85
 For [3+2] cycloadditions between azomethine ylides and nitroalkenes, see: a) Arai, T.; Mishiro, A.; 
Yokoyama, N.; Suzuki, K.; Sato, H. J. Am. Chem. Soc. 2010, 132, 5338−5339. b) Castelló, L. M.; Nájera, C.; 
Sansano, J. M.; Cozar, A.; Cossío, F. P. Org. Lett. 2013, 15, 2902−2905. c) Castelló, L. M.; Nájera, C.; 
Sansano, J. M.; Larrañaga, O.;  Cozar, A.; Cossío, F. P. Adv. Synth. Catal. 2014, 356, 3861−3870. d) Narayan, 
R.; Bauer, J. O.; Strohmann, C.; Antonchick, A P.; Waldmann, H. Angew. Chem. Int. Ed. 2013, 52, 
12892−12896. e) Narayan, R.; Bauer, J. O.; Strohmann, C.; Antonchick, A P.; Waldmann, H. Angew. Chem. 
2013, 125, 13130−13134. f) Castello, L. M.; Nájera, C.; Sansano, J. M.; Larrañaga, O.; Cózar, A.; Cossío, F. P. 
Synthesis 2015, 47, 934−943. g) Gerten, A. L.; Stanley, L. M. Org. Chem. Front. 2016, 3, 339−343. h) 
Esteban, F.; Ciéslik, W.; Arpa, E. M.; Guerrero-Corella, A.; Díaz-Tendero, S.; Perles, J.; Fernández-Salas, J. 
A.; Fraile, A.; Alemán, J. ACS Catal. 2018, 8, 1884−1890. 
86
 For [3+2] cycloadditions between azomethine ylides and enones, see: a) see ref 82b. b) Robles-Machín, 
R.; González-Esguevillas, M.; Adrio, J.; Carretero, J. C. J. Org. Chem. 2010, 75, 233−236. c) Wang, C.; Chen, 
X.-H.; Zhou, S.-M.; Gong, L.-Z. Chem. Commun. 2010, 46, 1275−1277. d) Liu, K.; Teng, H.-L.; Yao, L.; Tao, H.-
Y.; Wang, C.-J. Org. Lett. 2013, 15, 2250−2253. e) Liu, H.-C.; Liu, K.; Xue, Z.-Y.; He, Z.-L.; Wang, C.-J. Org. 
Lett. 2015, 17, 5440−5443. f) Li, J.-Y.; Kim, H. Y.; Oh, K. Adv, Synth. Catal. 2016, 358, 984−993. g) Xu, S.; 
Zhang, Z.-M.; Xu, B.; Liu, B.; Liu, Y.; Zhang, J. J. Am. Chem. Soc. 2018, 140, 2272−2283. 
87
 For [3+2] cycloaddition between azomethine ylides and allenoates, see: Xue, Z.-Y.; Fang, X.; Wang, C.-J.; 
Org. Biomol. Chem. 2011, 9, 3622–3624. 
88
 For [3+2] cycloadditions between azomethine ylides and alkylidene malonates, see: a) Xue, Z.-Y.; Liu, T.-
L.; Lu, Z.; Huang, H.; Tao, H.-Y.; Wang, C.-J. Chem. Commun. 2010, 46, 1727–1729. b) Xue, Z.-Y.; Fang, X.; 
Wang, C.-J. Org. Biomol. Chem. 2011, 9, 3622–3624.  
89
 For [3+2] cycloadditions between azomethine ylides and methyleneindolinones, see: Wang, L.; Shi, X.-
M.; Dong, W.-P.; Zhu, L.-P.; Wang, R. Chem. Commun. 2013, 49, 3458−3460. 
90
 For [3+2] cycloadditions between azomethine ylides and vinyl sulfones, see: a) Llamas, T.; Arrayás, R. G.; 
Carretero, J. C. Synthesis 2007, 6, 950−956. b) Fukuzawa, S.-I.; Oki, H. Org. Lett. 2008, 10, 1747−1750. c) 
López-Pérez, A.; Adrio, J.; Carretero, J. C. J. Am. Chem. Soc. 2008, 130, 10084−10085. d) Liang, G.; Tong, 
M.-C.; Wang, C.-J. Adv. Synth. Catal. 2009, 351, 3101−3106. 
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of azomethine ylides and bis-sulfonyl ethylene reported by Carretero and colaborators 
in 2008.91 The reductive elimination of both sulfonyl groups resulted in 3-pyrrolines, and 
hence, bis-sulfonyl ethylene acted as masked acetylene, unreactive dipolarophile in this 
reaction (Scheme 6). 
 
Scheme 6. The synthesis of α-quaternary 3-pyrrolidines through the [3+2] cycloaddition between 
azomethine ylides and bis-sulfonyl ethylene. 
Another work to highlight could be one that recently Liu, Zhang and co-workers reported 
based on Cu(I)-Fesulphos-catalyst.92 They have developed for the first time a 
regiodivergent method in which the regioselectivity of the cycloaddition involving β-
fluoromehtyl β,β-disubstituted enones may be modulated by the ligand used (Scheme 
7). According to the theoretical DFT calculations, the formation of a Cu−Oenone bond with 
the amine nitrogen of L2 (dissociated from the Cu(I) center) results in a swich on the 
regioselectivity. 
                                                     
91
 See ref. 90c. page 26. 
92
 See ref. 86g, page 26. 
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Scheme 7. Ligand-controlled regiodivergent Cu(I)-Fesulphos-catalyzed asymmetric [3+2] cycloaddition. 
A feature of these methods is that metal catalysis is required in most cases with few 
exceptions.93 In addition, in the organocatalytic methods the scope of the reaction has 
been limited by the reactivity of the reagents, requiring highly reactive olefins and 
azomethine ylides, as reflected for example in the reaction shown in the Scheme 8. 
Gong and co-workers reported the sole example of organocatalytic [3+2] cycloaddition 
of azomethine ylides to enones, which was promoted by phosphoric acid (Brønsted acid) 
catalyst employing α-iminoesters with an additional activating group at α-position as 
nucleophiles and quinone derivatives (highly reactive enone) as dipolarophiles.93a   
                                                     
93
 For organocatalytic [3+2] cycloadditions involving azomethine ylides, see: a) see ref. 86c, page 26. b) see 
ref. 83b, page 25. c) see ref. 81d, page 25. d) see ref. 81e, page 25. e) see ref. 85h, page 26.  
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Scheme 8. The organocatalytic [3+2] cycloaddition between highly reactive azomethine ylides and enones. 
In the above context, a reamarkable advance has been achieved very recently by Fraile 
and Alemán.93e They were able to develop an organocatalytic strategy for the synthesis 
of tetrasubstituted proline derivatives from β-substituted nitroalkenes and azomethine 
ylides bearing only one activating group, even with α-methyl substitution (Scheme 9). 
The key for success is the intramolecular activation of the azomethine ylide precursor via 
hydrogen bond. 
 
Scheme 9. The organocatalytic [3+2] cycloaddition between azomethine ylides bearing only one activating 
group and β-substituted nitroalkenes. 
While α-substituted azomethine ylides are commonly prepared via deprotonation of 
imino esters, the last years alternative protocols have been devised. Carretero et. al 
reported the first catalytic asymmetric synthesis of α-quaternay prolines through [3+2] 
cycloadditions to maleimide and alkenyl sulfones using α-silylimines as azomethine 
ylides precursors (Table 2).94 It is interesting to note that the 2,3-dicarboxylate ester 
                                                     
94
 Hernández-Toribio, J.; Padilla, S.; Adrio, J.; Carretero, J. C. Angew. Chem. Int. Ed. 2012, 51, 8854−8858.  
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pyrrolidine that coming from the desulfonylation of the 2,3-dicarboxy-4-sulfonyl 
pyrrolidine displayed the opposite regioselectivity to what would be obtained using 
typical acrylate dipolarophiles (see desulfonylation step, Table 2). More recently, Kumar 
and collaborators have extended the use of these α-silylimines to the asymmetric [3+2] 
cycloaddition with benzopyrone derivatives. 95 
Table 2. The [3+2] cycloaddition of α-silylimines to different activated olefins developed by Carretero. 
 
Dipolarophile LA* Product Results 
 
 
/ Cu(MeCN)4PF6  
(10 mol%) 
 
R = Alk., Ar. 
58-80% trans  
92-98% ee 
 
(R = 2-ClPh, 
no reaction) 
 
 
R = Alk. 
48-89% trans 
55-99% ee 
.  
On the other hand, the use of nitrone ylides in [3+2] cycloadditions has also provided a 
new entry to pyrrolidine scaffold synthesis.96 The change of the nitrone standard 1,3-C,O 
conventional reactivity into a less conventional 1,3-C,C reactivity has been achieved 
enhancing the acidity of the α-position with electron-withdrawing groups (Scheme 10). 
                                                     
95
 Kesava-Reddy, N.; Golz, C.; Strohmann, C.; Kumar, K. Chem. Eur. J. 2016, 22, 18373−18377. 
96
 a) Hanessian, S.; Bayrakdarian, M. Tetrahedron Lett. 2002, 43, 967−971. b) Merino, P.; Tejero, T.;  Díez-
Martínez, A.; Gültekin, Z. Eur. J. Org. Chem. 2011, 6567−6573. 
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Scheme 10. General dipolar cycloadditions of nitrones and nitrone ylides. 
Following this strategy, nitrone ylides have been applied in organocatalytic asymmetric 
[3+2] cycloadditions with enals under iminiun activation to obtain α-quaternary prolines 
(Table 3).97 
Table 3. α-Quaternary prolines synthesis by [3+2] cycloadditions involving nitrone ylides. 
 
Nitrone Base/Additive Product Results Ref. 
 
Et3N (20 mol%) 
 
 
R = Alk, Ar 
45-90% endo 
89-99% ee 
97a 
 
Et3N (20 mol%)/ 
 
(20 mol%) 
 
R = Alk 
45-96% exo 
90-99% ee 
97b 
 
                                                     
97
 a) Chen, Y.-R.; Zhan, G.; Du, W.; Chen, Y.-C. Adv. Synth. Catal. 2016, 358, 3759−3764. b) Prieto, L.; Juste-
Navarro, V.; Uria, U.; Delso, I.; Reyes, E.; Tejero, T.; Carrillo, L.; Merino, P.; Vicario, J. L. Chem. Eur. J. 2017, 
23, 2764−2768. 
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1.3.1.2.1.2. Michael additions 
In most cases, the Michael addition of azomethine ylides is followed by the 
intramolecular cyclization step leading to a [3+2] cycloadditions. However, sometimes 
the reaction stops in the 1,4-addition, providing the possibility of releasing the amine 
and thus preparing another type of prolines as shown in Scheme 11. 
 
 
 
 
 
Scheme 11. Synthesis of α-quaternary prolines through the Michael adducts coming from azomethine 
ylide precursors. 
Wang and co-workers could synthesize α-quaternary pyroglutamates via Cu (I)/BINAP-
catalyzed tandem Michael addition-elimination of azomethine ylide with Morita-Baylis-
Hillman (MBH) carbonates followed by deprotection/lactamization (Scheme 12).98 In this 
case, the conventional [3+2] cycloaddition was avoided thanks to the elimination step 
that occurred after the Michael addition. 
 
Scheme 12. Tandem Michael addition-elimination followed by deprotection/lactamization. 
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 Teng, H.-L.; Luo, F.-L.; Tao, H.-Y.; Wang, C.-J. Org. Lett. 2011, 20, 5600–5603. 
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Even so, azlactones have turned out to be more suitable nucleophiles for catalytic 
asymmetric Michael addition to α,β-unsaturated aldehydes and ketones. Jørgensen et 
al. developed the first method for the stereocontrolled addition of azlactones to α,β-
unsaturated aldehydes which relies on an iminium ion activation strategy, catalyzed by 
diarylprolinol ethers (Scheme 13). The products of the reaction could be transformed 
diastereoselectively into α-quaternary proline derivatives via hemiaminal formation.99 
 
Scheme 13.  
Afterward, Peter et al. reported the first catalytic asymmetric conjugate addition of 
azlactones to enones and the subsequent estereoselective transformation to the proline 
derivatives (Scheme 24, Transformation A).100a Two years later, they extended the 
reaction to the ¨in situ¨ formation of azlactone from unprotected α-amino acids100b,c and 
they could make a new transformation to obtain the N-unprotected pyroglutamic acid 
(Scheme 24, Transformation B). More recently, other studies have been carried out 
dealing with the conjugate addition of azlactones to enones,101 expanding the reaction 
to different enones and the use of organocatalysts.  
                                                     
99
 For organocatalytic Michael addition of azlactones to α,β-unsaturated aldehydes, see: a) Cabrera, S.; 
Reyes, E.; Aleman, J.; Milelli, A.; Kobbelgaard, S; Jørgensen, K. A. J. Am. Chem. Soc. 2008, 130, 
12031−12037. b) Hayashi, Y.; Obi, K.; Ohta, Y.; Okamura, D.; Ishikawa, H. Chem. Asian J. 2009, 4, 246−249. 
100
 For the first catalytic asymmetric Michael additions of azlactones to α,β-unsaturated ketones, see: a) 
Weber, M.; Jautze, S.; Frey, W.; Peters, R. J. Am. Chem. Soc. 2010, 132, 12222−12225. b) Weber, M.; Frey, 
W.; Peters. R. Adv. Synth. Catal. 2012, 354, 1443−1449. c) Weber, M.; Peters, R. J. Org. Chem. 2012, 77, 
10846−10855.  
101
 For the conjugate additions of azlactones to trichloromethyl enones, see: a) Zhang, J.; Liu, X.; Wu, C.; 
Zhang, P.; Chen, J.; Wang, R. Eur. J. Org. Chem. 2014, 7104−7108. For organocatalytic  conjugate additions 
of azlactones to different enones, see: b) Avila, E.; Mello, A.; Diniz, R.; Amarante, G. W. Eur. J. Org. Chem. 
2013, 1881−1883. c) Wang, C.-H.; Xiao, J.-A.; Wang, J.; Wang, S.-S.; Deng, Z.-X.; Yang, H. J. Org. Chem. 
2016, 81, 8001−8008.  
Introduction 
34 
 
 
Scheme 14.  
Finally, in recent years, the use of azomethine ylides with preformed pyrrolidine 
structures has allowed the stereocontrolled α-functionalization of pyrrolidines through 
Michael additions (Table 4).102 In this particular case, the Michael additions provide 
directly α-quaternary proline scaffolds without needing a second cyclization step. 
Furthermore, the reduction of the resulting imine moiety of the products can be carried 
out in a diastereoselective manner.102 
  
                                                     
102
 To nitroalkenes: a) Li, C.-Y.; Yang, W.-L.; Luo, X.; Deng, W.-P. Chem. Eur. J. 2015, 21, 19048–19057. b) 
Koizumi, A.; Kimura, M.; Arai, Y.; Tokoro, Y.; Fukuzawa, S.-i. J. Org. Chem. 2015, 80, 10883–10891. To 
enones, see: c) Koizumi, A.; Harada, M; Haraguchi, R.; Fukuzawa S.-i. J. Org. Chem. 2017, 82, 8927–8932. 
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Table 4. Catalytic asymmetric Michael additions using azomethine ylide precursors with preformed 
pyrrolidine structures. 
 
 
Electrophile (E+) Cat.* Product Results Ref. 
 
 
 
(5.5 mol%) 
AgOAc (5 mol%)/DBU (20 
mol%) 
 
 
syn 
>50% 
>95:5 dr 
83-99% ee 
102c 
 
 
(5.5 mol%) 
CuOAc (5 mol%)/Py (5 
mol%) 
 
74:26‒92:8 
syn/anti 
94‒99% ee 
(1:99 anti 
 with AgOAc)  
102b 
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1.3.1.2.1.3. Alkylation 
In few cases, the catalytic asymmetric C-alkylation of azomethine ylides has also served 
for the formation of chiral α-quaternary proline precursors (Table 5). 103  
Table 5. Catalytic asymmetric C-alkylation of azomethine ylides 
 
 R1 R2X Cat.* Product Results Ref. 
1 
Alk 
Ph 
 
 
(1 mol%)/CsOH.H2O 
(5 equiv.) 
 
 
75-94% 
98-99% ee 
(R1=Ph 64% 
ee) 
103b 
2 Alk 
 
 
44-64% 
96‒97% ee 
3 Ph 
 
 
(1 mol%)/CsOH.H2O 
(5 equiv.) 
 
81% 
97% ee 
103a 
 
The hydrolysis of the imine moiety in the acyclic chiral compound directly leads to an 
intramolecular N-alkylation providing the corresponding α-quaternary proline in cases of 
entry 1 and entry 2. Nevertheless, in case of entry 3 more steps are required to get the 
cyclic product (Scheme 15).104 
                                                     
103
 a) Ooi, T.; Takeuchi, M.; Ohara, D.; Maruoka, K. Synlett 2001, 7, 1185–1187. b) Kano, T.; Sakamoto, R.; 
Mii, H.; Wang, Y.-G.; Maruoka, K. Tetrahedron 2010, 66, 4900–4904. 
104
 Maeda, K.; Miller, R. A.; Szumigala, R. H.; Shafiee, A.; Karady, S.; Armstrong, J. D. Tetrahedron Letters 
2005, 46, 1545–1549. 
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Scheme 15. Transformation from chiral α-allyl functionalized compound to proline. 
Finally, there is one example in which the catalytic enantioselective Cα-alkylation of 
azomethine ylides with preformed pyrrolidine has also allowed the synthesis of α-
quaternary proline derivatives (Scheme 16).105 The reduction of the imine moiety even 
could be modulated according to the reducing agent used. 
 
 
Scheme 16. The catalytic enantioselective Cα-alkylation of azomethine ylides with preformed pyrrolidine. 
 
1.3.1.2.2. α-Nitroesters 
Since the nitro group can be converted into amine very easily, the asymmetric Michael 
additions of α-nitroesters has provided an alternative route for the enantioselective 
synthesis of α-quaternary prolines as shown in Scheme 17. 
                                                     
105
 Lee, M.; Lee, Y.; Park, E; Park, Y.; Ha, M. W.; Hong, S; Lee, Y.; Kim, T.; Kim, M.; Park, H. Org. Biomol. 
Chem. 2013, 11, 2039–2046. 
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Scheme 17. Synthesis of α-quaternary prolines through the Michael addition of α-nitroesters. 
Several catalytic Michael reactions have been developed where α-nitroesters was 
enantioselectively added to vinyl ketones, even using organocatalysts; nevertheless, the 
scope of the reaction remains limited in most to α-alkyl nitroesters (Table 6).106 
Table 6. Michael addition of α-alkyl nitroacetates to vinyl ketones. 
 
Only one example is known in which it was possible to carry out the asymmetric catalytic 
1,4-addition between α-fluoro nitroesters and β-substituted enones, although the 
diastereoselectivity of the reaction was no good (Scheme 18).107 
                                                     
106
 a) Keller, E.; Veldman, N.; Spek, A. L.; Feringa, B. L. Tetrahedron: Asymmetry 1997, 8, 3403−3413. b) 
Keller, E.; Feringa, B. L. Synlett  1997, 842−844. c) Duvall, J. R.; Wu, F.; Snider, B. B. J. Org. Chem.  2006, 71, 
8579–8590. d) Bera, K.; Satam, N. S.; Namboothiri, N. N. J. Org. Chem.  2016, 81, 5670–5681.  
107
 Cui, H.-F.; Li, P.; Wang, X.-W.; Chai, Z.; Yang, Y.-Q.; Cai, Y.-P.; Zhu, S.-Z.; Zhao, G. Tetrahedron  2011, 67, 
312–317. 
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Scheme 18. Asymmetric Michael addition between α-fluoro nitroesters and β-substituted enones. 
The cyclization step of these adducts for obtaining reduced proline scaffolds consists of 
an intramolecular reductive amination involving an intermediate nitrone for which 
optimized conditions are described in Table 7.  
Table 7. Optimization of the reduction-cyclization step. 
 
 Cyclization conditions Results Ref. 
1 
1 atm H2, Pd/C 
EtOH, 72 h 
2:1 dr 
(cis/trans) 
106b 
2 
1) 1 atm H2, Pd/C, EtOH, 15 h 
2) 3 equiv. HCl, 3.3 atm H2, 36h 
>20:1 dr 
(cis/trans) 
106c 
 
1.3.1.2.3. α-Isocyanoacetates 
The catalyst-controlled [3+2] cycloaddition involving isocyanoacetates has been much 
less developed than those based on azomethine ylides. However, the acidic α-carbon 
atom and the electrophilicity of the isocyanide group make these amino acid derivatives 
perfect dipole precursors for α-quaternary proline scaffold synthesis through [3+2] 
cycloadditions. In addition, isocyanoacetates allow the C4-unsubstituted proline 
synthesis, what is not feasible with conventional azomethine ylides because the aryl-
substitution in the iminic carbon is mandatory (Scheme 19). 
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Scheme 19. α-Quaternary prolines derivated from isocyanoacetates. 
Most examples of [3+2] cycloadditions of isocyanoacetates, involve very reactive 
dipolarophiles such as nitroalkenes,108 α,β-unsaturated ketoesters,109 maleimides,110 
methyleneindolinones,111 allenoates,112 cyclopentenediones113 and activated 
acrylates114, and aside from Brønsted base, the presence of a metal is required in most 
cases with few exceptions (Table 8, entry 1 and 3). Generalization of metal Lewis 
acid/Brønsted base cooperative catalysis is often hampered by self-quenching problem, 
which obstructs the proper coordination of catalyst and thus stereocontrol is lost, 
especially during the formation of α-quaternary alkyl stereocenters as entry 2 clearly 
shows. Furthermore, while the reactions are commonly compatible with a wide variety 
of α-aryl isocyanoacetates (active), the use of α-alkyl isocyanoacetates has been much 
more restricted (see entry 1, 3 and 6). Meanwhile, a sole example is known regarding 
the cycloaddition involving simple vinyl ketone as the reaction partner, which has a close 
relationship with this thesis (Table 8, entry 7),115 affording the corresponding proline 
derivatives with poor enantioselectivity, especially in case of the α-quaternary prolines 
(≤36% ee). 
 
                                                     
108
 Guo, C.; Xue, M.-X.; Zhu, M.-K.; Gong, L.-Z. Angew. Chem. Int. Ed. 2008, 47, 3414−3417.  
109
 Song, J.; Guo, C.; Chen, P.-H.; Yu, J.; Luo, S.-W.; Gong, L.-Z. Chem. Eur. J. 2011, 17, 7786−7790. 
110
 a) Zhao, M.-X.; Wei, D-K.; Ji, F.-H.; Zhao, X.-L.; Shi, M. Chem. Asian J. 2012, 7, 2777−2781. b) Padilla, S.; 
Adrio, J.; Carretero, J. C. J. Org. Chem. 2012, 77, 4161−4166. 
111
 a) Wang, L.-L.; Bai, J.-F.; Peng, L; Qi, L.-W.; Jia, L.-N.; Guo, Y.-L.; Luo, X.-Y.; Xu, X.-Y.; Wang, L.-X. Chem. 
Commun. 2012, 48, 5175−5177. b) Peng, X.-J.; Ho, Y. A.; Wang, Z.-P.; Shao, P.-L.; Zhao, Y.; He, Y. Org. 
Chem. Front. 2017, 4, 81−85. 
112
 Liao, J.-Y.; Shao, P.-L.; Zhao, Y. J. Am. Chem. Soc. 2015, 137, 628−631. 
113
 George, J.; Kim, H. Y.; Oh, K. Org. Lett. 2018, 20, 2249−2252. 
114
 a) Cheng, H.; Zhang, R.; Yang, S.; Wang, M.; Zeng, X.; Xie, L.; Xie, C.; Wu, J.; Zhong, G. Adv, Synth, Catal. 
2016, 358, 970−976. b) Wang, Z.-P.; Wu, Q.; Jiang, J.; Li, Z.-R.; Peng, X.-J.; Shao, P.-L.; He, Y. Org. Chem. 
Front. 2018, 5, 36−40. 
115
 Arroniz, C.; Gil-González, A.; Semak, V.; Escolano, C.; Bosch, J.; Amat, M. Eur. J. Org. Chem. 2011, 
3755−3760. 
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Table 8. Selected examples of [3+2] cycloaddition between isocyanoacetates and reactive olefins. 
 
 Electrophile Cat.* Product Results Ref. 
1 
 
 
R2 = Alk, Ar 
(20 mol%) 
 
 
R1 = Ar, only Bn 
51-99% 
4:1->20:1 dr 
90-99% ee 
108 
2 
 
R2 = Ar, Alk 
(5 mol%)/AgSbF6 (10 mol%) 
 
R1 = Ar, iPr, Bn, 
H 
(R1 = Ar) 
76-98% 
>20:1 dr 
53-92% ee 
110a 
(R1 ≠ Ar) 
67-85% 
>20:1 dr 
10-13% ee 
3 
 
PG = Boc, 
phenylamide (10 mol %) 
 
R1 = only Ph 
41-65% 
1.9:1-8:1 dr 
90‒99% ee 
111a 
4 
 
R = Ar, vinyl 
(20 mol%)/ Ag2O (10 mol%) 
 
R1 = Me, Bn 
58-90% 
4:1-11:1 dr 
82-96% ee 
112 
5  
R2 = Alk, Ar, Ts 
(20 mol%)/ Ag2O (10 mol%) 
 
R1 = Alk, Ar  
86-99% 
52:48-75:25 dr 
92-98% ee 
114b 
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 Electrophile Cat.* Product Results Ref. 
6 
 
(10 mol%)/ AgNO3 (10 
mol%) 
 
R1 = Ar, only iPr 
63-91% 
>84:16 dr 
80-98% ee 
113 
7  
Alk = Me, Et 
 
 
 
 
 
 
(10 mol%)/ AgNO3 (5 mol%) 
R1 = H, Bn 
(R1 = H) 
20-59% 
52-89% ee 
115 
(R1 = Bn) 
68-85% 
16-36% ee 
 
As a conclusion for this section, the development of organocatalytic methods for the 
synthesis of α-quaternary prolines through cycloaddition reaction with isocyanoacetates 
is still a challenge, especially with α-alkyl isocyanoacetate derivatives. In this context, the 
use of simple vinyl ketone as dipolarophile is virtually unexplored. 
1.4. α-Quaternary α,β-diamino acids 
α,β-Diamino acids have played a central role in replacing natural amino acids in peptidic 
structures to modify their biological activities and stabilities to peptidases. For example, 
the specific substitution of Lys (essential α,ε-diamino acid) by Dpr (an α,β-diamino acid) 
attenuates the hydrophobic mismatched effects with phospholipids in some peptides116 
and the α-helix propensity is decreased.117 Besides the application in peptide chemistry, 
nonproteinogenic α,β-diaminoacids or small peptidomimetics constitute a key 
structutral frangments in many natural and biologically active compounds (Figure 16). 118 
                                                     
116
 a) Liu, F.; Lewis, R. N. A. H.; Hodges, R. S.; McElhaney, R. N. Biochemistry 2002, 41, 9197–9207. b) Liu, 
F.; Lewis, R. N. A. H.; Hodges, R. S.; McElhaney, R. N. Biophys. J. 2004, 87, 2470–2482. 
117
 a) Padmanabhan, S.; York, E. J.; Stewart, J. M.; Baldwin, R. L. J. Mol. Biol. 1996, 257, 726–734. b) Gibson, 
T. J.; Murphy, R. M. Biochemistry 2005, 44, 8898–8907. c) Virdee, S.; Macmillan, D.; Waksman, G. Chem. 
Biol. 2010, 17, 274–284. 
118
 To articles related to the L-mimosine, see: a) Dobbin, P. S.; Hider, R. C.; Hall, A. D.; Taylor, P. D.; 
Sarpong, P.; Porter, J. B.; Xiao, G.; van der Helm, D. J. Med. Chem. 1993, 36, 2448–2458. b) Dong, Z.; 
Zhang, J.-T. Molecular Biology of cell 2003, 14, 3942–3951. To articles related to the BMAA, see: c) Vega, 
A.; Bell, E. A. Phytochemistry 1967, 6, 759–762. d) Murch, S. J.; Cox, P. A.; Banack, S. A.; Steele, J. C.; Sacks, 
O. W. Acta Neurol. Scand. 2004, 110, 267–269. To articles related to imidapril, see: e) Hosoya, K.; 
Ishimitsu, T. Cardiovasc. Drug. Rev. 2002, 20, 93–110. f) Wang, J.-m.; Wang, Y.; Zhu, Z.-S.; Zhang, M.-c.; 
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Figure 16. Biologically active compounds containing α,β-diaminoacid frangments. 
Within α,β-diaminoacids those that contain α-quaternary stereocenters are considered 
particularly relevant owing to their unique structural biases, but their synthesis still 
presents limitations in many aspects. The principal approaches developed for the α,β-
diaminoacids asymmetric synthesis can be classified depending on the bond formed to 
complete de skeleton (Scheme 20).119 The first approach consists in the addition of 
nucleophilic synthetic equivalent of carboxyl group to electrophilic Cα (pathway a), 
commonly by Strecker reaction (cyanation of imines).120 Second approach is focused in 
the introduction of the nitrogen atoms in the carbon backbone (pathway b), those 
proceed mostly through β-amination from readily available α-amino acids121, 
diamination of α,β-unsaturated alkanoates122 or electrophilic amination of enolates.123 
                                                                                                                                                              
Zou, Y.; Li, J.-j.; Li, M.-J.; Jiang, X.-j.; Li, X.-Y. Life Sci. 2004, 75, 407–420. To articles related to TAN-1057A/B, 
see: g) Brands, M.; Endermann, R.; Gahlmann, R.; Krüger, J.; Raddatz, S.; Stoltefuss, J.; Belov, V. N.; 
Nizamov, S.; Sokolov, V. V.; de Meijere, A. J. Med. Chem. 2002, 45, 4246–4253. h) Zhang, L.; Kim, C. U.; Xu, 
L. Tetrahedron Lett. 2007, 48, 3273–3275. 
119
 Viso, A.; de la Pradilla, R. F.; Tortosa, M.; García, A.; Flores, A. Chem. Rev. 2011, 111, PR1–PR42, and 
references cited therein. 
120
 For representative examples, see: a) Myers, A. G.; Kung, D. W.; Zhong, B.; Movassaghi, M.; Kwon, S. J. 
Am. Chem. Soc. 1999, 121, 8401–8402. b) Fondekar, K. P. P.; Volk, F.-J.; Khaliq-uz-Zaman, S. M.; Bisel, P.; 
Frahm, A. W. Tetrahedron: Asymmetry 2002, 13, 2241–2249. c) Hazelard, D.; Fadel, A.; Guillot, R. 
Tetrahedron: Asymmetry 2008, 19, 2063–2067. 
121
 For representative examples, see: a) Baldwin, J. E.; Adlington, R. M; Mellor, L. C. Tetrahedron 1994, 50, 
5049–5066. b) Strazzolini, P.; Dall´ Arche, M. G.; Zossi, M.; Pavsler, A. Eur. J. Org. Chem. 2004, 4710–4716. 
c) Couturier, C.; Blanchet, J.; Schlama, T.; Zhu, J. Org. Lett. 2006, 8, 2183–2186. 
122
 For representative examples, see: a) Han, H.; Yoon, J.; Janda, K. D. J. Org. Chem. 1998, 63, 2045–2048. 
b) Li, G.; Kim, S. H.; Wei, H.-X. Tetrahedron Lett. 2000, 41, 8699–8703. c) Muñiz, K.; Nieger, M. Synlett 
2003, 211–214. 
123
 For representative examples, see: a) Badorrey, R.; Cavitiela, C.; Díaz-de-Villegas, M. D.; Gálvez, J. A. 
Tetrahedron: Asymmetry 1995, 6, 2787–2796. b) Capone, S.; Guaragna, A.; Palumbo, G.; Pedatella, S. 
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However, for the total synthesis of optically pure α,β-diaminoacids, many steps and 
chiral source or chiral auxiliary are required in both approaches, besides being little 
explored the methods involving the formation of α-quaternary stereocenters. In this 
sense, the majority of catalytic asymmetric methods developed so far are based on the 
Mannich addition of masked aminoacids (pathway c),124 requiring less steps for the 
synthesis of α,β-diaminoacids and even providing in much cases the products with α-
quaternary stereocenter. Even so, owing to the congestion provided by the additional 
substituent in Cα, the studies carried out with α-subtituted amino acids still show 
important limitation; in special when α-alkyl nucleophiles and organocatalysts are used.  
 
 
Scheme 20. Principal approaches for α,β-diaminoacids asymmetric synthesis. 
To facilitate the compression of the reader, the analysis of these precedents is 
developed in the section corresponding to the Mannich reaction, with emphasis on the 
catalytic asymmetric Mannich reaction of isocyanoacetates (Chapter 3, section 3.5., 
page 125). 
 
                                                                                                                                                              
Tetrahedron 2005, 61, 6575–6579. c) Makino, K.; Kubota, S.; Hara, S.; Sakaguchi, M.; Hamajima, A.; 
Hamada, Y. Tetrahedron 2009, 65, 9468–9473. 
124
 For review on catalytic asymmetric Mannich reaction toward α,β-diamino acids synthesis, see: Arrayás, 
R. G.; Carretero, J. C. Chem. Soc. Rev. 2009, 38, 1940–1948. 
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1.5. Isocyanoacetates 
1.5.1. General considerations 
The isocyano (isonitrile) group was obtained for the first time by Lieke in 1859125 and 
hundred years later its synthesis became available from primary amines by dehydration 
of formamides.126 The most relevant knowledge acquired about the exceptional nature 
of the isocyano group are attributed to Ugi, who appreciated the diverse possibilities of 
this functional group for the first time. 
Being stable carbene, isonitrile is an unusual functionality that can react with 
almost any type of compounds: electrophiles, nucleophiles and radicals (Figure 17, a). As 
a consequence, isonitriles are very versatile building blocks in organic chemistry, 
especially for the synthesis of various heterocycles127 as well as interesting ligands to 
form metal complexes.128 In addition, the isocyano group can undergo various 
transformations such as isocyanide-cyanide rearrangement and different types of 
oxidations/reductions, enhancing their synthetic potential (Figure 17, b).129 
 
Figure 17. General resonance structure of an organo isocyanide and its possible transformations. 
The carbon acidity of CH units attached to an isocyanide is enhanced by the moderate 
electron-withdrawing effect imparted by the isocyanide. Because of this effect, 
isocyanoacetates are good candidates for base-promoted nucleophilic additions through 
                                                     
125
 Lieke, W; Justus Liebigs Ann. Chem. 1859, 112, 316–321. 
126
 Ugi, I.; Meyr, R. Angew. Chem. 1958, 70, 702–703. 
127
 a) Ono, N. Heterocycles 2008, 75, 243–284. b) Lygin, A. V.; de Meijere, A. Angew. Chem. Int. Ed. 2010, 
49, 9094–9124. 
128
 Malatesta , L.; in Progress in Inorganic Chemistry, (ed. F.A. Cotton ), John Wiley & Sons, Inc , Hoboken, 
New York, 1959; Vol. 1,  pp. 283 – 379 . 
129
 For leading book related to isocyanide, see: a) Isocyanide Chemistry: Applications in Synthesis and 
Material Science (Nenajdenko, V.  ed., Wiley-VCH Verlag GmbH & Co. KGaA) 2012, and references therein. 
For reviews related to isocyanide, see: b) Boyarskiy, V. P.; Bokach, N. A.; Luzyanin, K. V.; Kukushkin, V. Y. 
Chem. Rev. 2015, 115, 2698–2779. c) Chakrabarty, S.; Choudhary, S.; Doshi, A.; Liu, F.-Q.; Mohan, R.; 
Ravindra, M. P.; Shah, D.; Yang, X.; Fleming, F. F. Adv. Synth. Catal. 2014, 356, 2135–2196. 
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Cα and cycloadditions reactions. However, due to the electrophilic character of the 
isonitrile group, many times the cycloaddition reaction that follows to the nucleophilic 
addition cannot be avoided or even the presence of certain functional groups can 
disturb the desired reaction pathway. 
Since the first isocyanoacetate was obtained by Ugi in 1961,130 these compounds 
have received much attention and nowadays are commonly available. Due to their 
interesting structure isocyanoacetates are especially attractive among other isocyanides 
(Figure 18). 131 
 
Figure 18. Reactivity centers of α-isocyanoacetate derivatives. 
Each of these molecules contains four reaction centers: 
1. Isocyanide group: multicomponent reaction, nucleophilic addition, 
electrophilic attacks, metal coordination, etc. 
2. Active CH fragment: Michael, alkylation, Mannich, etc. 
3. R substituent: also can handle functional groups. 
4. Carboxylic acid: acylation, etc. 
Thanks to the combination of these potential reaction centers, isocyanoacetates 
are very attractive in different branches of organic, inorganic, coordination, polymeric, 
combinatorial and medicinal chemistry. Multicomponents reactions132 with 
isocyanoacetates are used for the synthesis of a variety of biochemically relevant 
compounds such as peptides and peptide mimetics. In addition, such molecules are 
efficient building blocks for the synthesis of biologically active molecules,133 nitrogen 
                                                     
130
 Ugi, I.; Betz, W.; Fetzer, U.; Offerman, K.; Chem. Ver. 1961, 94, 2814. 
131
 Gulevich, A. V.; Zhdanko, A. G.; Orru, R. V.; Nenajdenko, V. G. Chem. Rev. 2010, 110, 5235–5331. 
132
 a) Dömling, A.; Ugi, I Angew. Chem. Int. Ed 2000, 39, 3168–3210. b) Dömling, A. Chem. Rev. 2006, 106, 
17–89. c) Ramon, D. J.; Yus, M. Angew. Chem. Int. Ed. 2005, 44, 1602–1634. d) Hulme, C.; Dietrich, J. Mol. 
Divers. 2009, 13, 195–207. e) Berkel, S. S.; Bögels, B. G. M.; Wijdeven, M. A.; Westermann, B.; Rutjes, F. P. 
J. T. Eur. J. Org. Chem. 2012, 3543–3559. f) Alemán, J.; Cabrera, S.; Alvarado, C. Recent Advances in the Ugi 
Multicomponent Reactions, Herrera, R. P., Marqués-López, E., Eds.; Wiley; 2015; pp 247–282. 
133
 For some examples related to amino sugar compound synthesis: a) Hamada, Y.; Shioiri, T. Tetrahedron 
Lett. 1982, 23, 1193–1196. b) Hamada, Y.; Kawai, A.; Matsul, T.; Hara, O.; Shioiri, T. Tetrahedron 1990, 46, 
4823–4846. 
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heterocycles134 and in total synthesis of complex natural products.135 In this context and 
closely related to this thesis, isocyanoacetaes have proven to be perfect candidates for 
the synthesis of amino acid derivatives. 
1.5.2. Synthesis of α-amino acids involving isocyanoacetates 
The isocyano group stabilizes effectively the negative charge eventually formed at the α-
position in α-isocyanoacetates and also can be easily transformed into an amino group, 
commonly by treatment with protic acid. Therefore, α-isocyanoacetates may serve as 
convenient synthetic equivalents of amino acids carbanion.136 As such they have been 
demonstrated useful for the synthesis of different kinds of α-amino acids through 
reaction with carbonyl compounds, imines, activated olefin and acylating and alkylating 
agents (Scheme 21). 
                                                     
134
 See ref 127, page 45. 
135
 For some examples related to the total synthesis of complex natural products: a) Ortuno, J.-C.; Langlois, 
Y. Tetrahedron Lett. 1991, 32, 4491–4494. b) Adamczyk, M.; Johnson, D. D.; Reddy, R. E. Angew. Chem. Int. 
Ed. 1999, 38, 3537–3539. c) Dömling, A.; Beck, B.; Eichelberg, U.; Sakamuri, S.; Menon, S.; Chen, Q.-Z.; Lu, 
Y.; Wessjohann, L. A. Angew. Chem. Int. Ed. 2006, 45, 7235–7239. d) Faure, S.; Hjelmgaard, T.; Roche, S. P.; 
Aitken, D. J. Org. Lett. 2009, 11, 1167–1170. 
136
 For review related to the synthesis of amino acid derivatives from glycine equivalents, see: a) Kotha, S.; 
Halder, S. Synlett 2010, 3, 337–354. For selected reviews on the synthesis of amino acids, see: b) see ref 
48, page 15 y 51, page 16. 
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Scheme 21. Synthesis of α-amino acids based on the α-functionalization of α-isocyanoacetates.  
As mentioned in the previous section, α-quaternary amino acids are of especial interest, 
but their synthesis involves α-substituted isocyanoacetates which present decreased 
reactivity and therefore increased challenge. 
In this context, a comparison of the carbon acidities of several common masked 
α-amino acid equivalents would be informative. As data in Figure 19 show, among a 
series of N-containing functional group, isocyanide is the weakest EWG, inducing a 
limited enhancement of Cα acidity.137 Thus, isocyanoacetates are among the less acidic 
α-amino acid equivalents which causes the necessity of using stronger bases or larger 
amount of metal promoter to perform the reaction with the corresponding electrophile, 
especially when the isocyanoacetates have no-activating α-substituents (i.e. an alkyl 
chain). 
                                                     
137
 For pKa values of common organic compounds, see: a) Bordwell, F. G.; Bares, J. E.; Bartmess, J. E.; 
McCollum, G. J.; Van Der Pui, M.; Vanier, N. R.; Matthews, W. S. J. Org. Chem. 1977, 42, 321–325. b) 
Bordwell, F. G. Acc. Chem. Res. 1988, 21, 456–463. 
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Figure 19. The effect of the amine precursor group in the acidity of α-position. 
These characteristics justify the limitations in the scope indicated in the section on α-
quaternary prolines synthesis (see Table 8, page 41), and equally, precedents regarding 
to the Mannich addition that are analyzed later (chapter 3, page X-X) reflect  that these 
limitations are not exclusive to the synthesis of prolines.  
Nevertheless, due to the synthetic diversity that confers the structure of 
isocyanoacetates, reactions involving them for the synthesis of α-quaternary amino 
acids are considered valuable alternatives to those involve other masked α-amino acids. 
So, in order to extend α-substituted isocyanoacetates application, especially in metal-
free methods, the design of a more active structure of isocyanoacetates is a field that 
deserves to be further studied. 
 
1.6. Objetives 
As mentioned in the general introduction, α-quaternary prolines are structurally unique 
α-amino acids of great significance in peptide chemistry as well as the fields of natural 
products and biologically active substances. Besides, their unique structural bias makes 
them particularly relevant within the α-amino acids family. 
The most widely investigated approach for the enantioselective synthesis of α-
quaternary prolines relies on the catalytic [3+2] cycloadditions reaction between 
azomethine ylides and electron-deficient olefins, involving in most cases metal catalysis 
(page 25-37). In this context, α-substituted isocyanoacetates have been seldom 
employed owing to the low acidity of Cα, despite this approach would be a complement 
alternative. Most studies dealing with catalytic enantioselective cycloadditions of α-
substituted isocyanoacetates involve very reactive olefins as reaction counterparts and 
require combined metal/Brønsted base catalysis. In addition, the use of α-alkyl 
isocyanoacetates is still a challenge (section 1.3.1.2.3, page 39). 
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The overall aim of this Thesis investigation consists of the development of a new 
approach for the organocatalytic asymmetric synthesis of α-aryl and α-akyl substituted 
prolines from α-substituted isocyanoacetates and simple vinyl ketones, a transformation 
that has been scarcely explored. If successful, one feature of the approach is that, thanks 
to the chemical diversity of the isocyanide group, the eventually formed Michael adduct 
would allow a divergent route to either Δ4- and Δ5-Dehydroprolines (Scheme 22).  
 
Scheme 22. Divergent synthesis of quaternary Δ
4
- and Δ
5
-Dehydroprolines. 
The two main challenges to overcome are the reactivity for BB-based activation and 
control of stereochemistry during the formation of the quaternary stereocenter, 
especially when the reaction is performed with α-alkyl (least reactive) isocyanoacetates. 
To address these challenges we planned the screen of several common bifunctional 
BB/H-bond catalysts and eventually the development of novel catalysts that best fit this 
particular transformation. Once the optimal conditions for this objective were found, 
the idea was to see the scope of these reaction conditions with another type of 
electrophiles, such as other Michael acceptors or imines. The catalytic asymmetric 
Mannich addition of these nucleophiles would provide α-quaternary 2-imidazolines, 
commonly used for the synthesis of α,β-diamino acid precursors. 
 
Scheme 23. Synthesis of α-quaternary α,β-diamino acids via Mannich addition of isocyanoacetates.
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2. Bifunctional Brønsted base/H-bond catalysis assisted 
Michael addition of α-aryl isocyanoacetates to vinyl 
ketones: divergent synthesis of Δ4- and Δ5-
Dehydroprolines. 
2.1. Introduction 
2.1.1. Organocatalytic asymmetric Michael additions 
The asymmetric Michael addition or conjugate addition is one of the most powerful 
methods in organic chemistry for C–C or C–heteroatom bond formation and thus for the 
preparation of chiral complex molecules.138 In this process, the nucleophile or Michael 
donor attacks to the β-carbon of an electron-deficient olefin or Michael acceptor, giving 
rise a stabilized carbanionic intermediate. This anionic intermediate can either capture a 
proton or another electrophile. So, up to two new stereocenters at α- and β-position 
may be created (Scheme 24). Thus, the control of enantio- and diastereoselectivity in 
the processes is of considerable significance. 
  
Scheme 24. General scheme of the Michael addition reaction.  
Considering that Michael reactions may be part of a tandem, domino or cascade 
process139 and the variety of donors and acceptors that can be used, this approach 
offers great synthetic utility/versatility often constituting a key strategic transformation 
in the synthesis of bioactive compounds of high complexity. The Michael acceptors are 
                                                     
138
 For reviews on asymmetric conjugate addition, see: a) Rossiter, B. E.; Swingle, N. M. Chem. Rev. 1992, 
92, 771–806. b) Sibi, M. P.; Manyem, S. Tetrahedron 2000, 56, 8033–8061. c) Krause, N.; Hoffmann-Röder, 
A. Synthesis, 2001, 2, 171–196. For a leading book on the topic, see: d) Perlmutter, P.; Conjugate Addition 
Reactions in Organic Chemistry (Pergamon, Oxford) 1992.  
139
 For general reviews related to Michael addition in cascade reactions, see: a) Nicolaou, K. C.; Edmonds, 
D. J.; Bulger, P. G. Angew. Chem. Int. Ed. 2006, 45, 7134–7186. b) Nicolaou, K. C.; Chen, J. S. Chem. Soc. 
Rev. 2009, 38, 2993–3009. c) Grondal, C.; Jeanty, M.; Enders, D. Nature Chemistry 2010, 2, 167–178. d) 
Volla, C. M. R.; Atodiresei, I.; Rueping, M. Chem. Rev. 2014, 114, 2390–2431. For leading book on the topic, 
see: e) Tietze, L. F.; Brasche, G.; Gerike, K. Domino Reactions in Organic Chemistry (Wiley-VCH, Weinheim). 
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usually α,β-unsaturated carbonyl compounds (aldehydes, ketones, esters, amides, etc.) 
but other electron-poor olefins with activating groups such as nitro, nitrile, sulfonate, 
sulfoxide, phosphate and phosphonate have also been employed successfully. 
Additionally, the nucleophilic atom can be either carbon or heteroatom (oxa-, aza-, 
sulfa- and phospha-Michael reaction).140 
Arthur Michael reported the first racemic example of Michael reaction in 1887141 
and since them, the reaction has been investigated and applied to organic synthesis with 
no interruption. In the last decades, focus has been in the development of catalyst-
controlled asymmetric versions involving metal-based 138,142 and organocatalysis.143 
Interactions between the catalyst and the substrates in organocatalytic asymmetric 
Michael reactions are different from those involving metal catalysis. As shown in the 
introduction (section 1.1.1, page 9), the chiral organocatalysts can activate the 
nucleophile, the electrophile or both the reagents through covalent bonding or non-
covalent bonding.144 In this sense, different approaches have been studied for the 
asymmetric Michael addition (Figure 20). 
 
                                                     
140
 For reviews on aza-Michael reactions, see: a) Xu, L.-W.; XIa, C.-G. Eur. J. Org. Chem. 2005, 633–639. b) 
Enders, D.; Wang, X.; Liebich, J. X. Chem. Eur. J. 2009, 15, 11058–11076. c) Krishna, P. R.; Sreeshailam, A.; 
Srinivas, R. Tetrahedron 2009, 65, 9657–9672. For a review of oxa-Michael reactions, see: d) Nising, C. F.; 
Bräse, S. Chem. Soc. Rev. 2008, 37, 1218–1228. For a reviews of sulfa-Michael reactions, see: e) Enders, D.; 
Lüttgen, K.; Narine, A. A. Synthesis 2007, 959–980. f) Clayden, J.; MacLellan, P. Beilstein J. Org. Chem. 
2011, 7, 582–595. For a review of phospha-Michael reactions, see: g) Enders, D.; Saint-Dizier, A.; Lannou, 
M.-I.; Lenzen, A. Eur. J. Org. Chem. 2006, 29–49. 
141
 Michael, A. Prakt. J. Chem. 1887, 36, 349–356. 
142
 For general reviews on general metal-catalized asymmetric conjúgate addition, see: a) Hayashi, T.; 
Yamasaki, K. Chem. Rev. 2003, 103, 2829–2844. b) Hawner, C.; Alexakis, A. Chem. Commun. 2010, 46, 
7295–7306. c) Hui, C.; Pu, F.; Xu, J. Chem. Eur. J. 2017, 23, 4023–4036. 
143
 For reviews on organocatalyzed  asymmetric conjúgate addition, see: a) Tsogoeva, S. B. Eur. J. Org. 
Chem. 2007, 1701–1716. b) Almasi, D.; Alonso, D. A.; Nájera, C. Tetrahedron: Asymmetry 2007, 18, 299–
365. c) Vicario, J. L.; Badía, D.; Carrillo, L. Synthesis 2007, 14, 2065–2092. d) Zhang, Y.; Wang, W. Catal. Sci. 
Technol. 2012, 2, 42–53.  For leading books on the topic, see: e) Vicario, J. L.; Badía, D.; Carrillo, L.; Reyes, 
E. Organocatalytic Enantioselective Conjugate Addition Reactions (RSC Publishing, Cambridge) 2010. f) 
Zhang, Y.; Wang, W. Stereoselective Organocatalysis, Rios, R., Eds.; Wiley: Hoboken; 2013; pp 147–203. 
144
 Marcus, Y:; Hefter, G. Chem Rev. 2006, 103, 4585–4621. 
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Figure 20. Organocatalytic activations in asymmetric Michael additions. 
With respect to covalent activation, chiral aminocatalysts in Michael addition can 
operate through two mechanisms, namely: enamine activation (Nu reagent activated)145 
and iminium activation (E reagent activated).146 Regarding to non-covalent activations, 
chiral phase-transfer catalysis (PTC)147 can be used in conjugate additions for 
enantioface discrimination. In addition to this non-covalent activation pathway, chiral H-
bond donors (diols, biphenols, ureas, thioureas, squaramides, etc.)148 are useful tools for 
substrate activation in asymmetric Michael additions.  
At the same time, soft deprotonation/enolization promoted by proton transfer is 
often the key step to the activation of certain types of carbonyl compounds in 
asymmetric Michael additions. However, deprotonation of esters and other carboxylic 
acid derivatives, such as amino acid derivatives, by soft bases have been challenging due 
to the low acidity of such species. Although stronger Brønsted base catalysts have been 
developed to overcome this reactivity issue,149,150 the main problem with these bases 
often is the proton transfer from the protonated Brønsted base leading the product and 
regenerating the catalyst (catalyst turnover). Likely for this reason most efforts still focus 
                                                     
145
 Sulzer-Mossé, S.; Alexakis, A. Chem. Commun. 2007, 3123–3135. 
146
 See Chapter 1, ref. 23a, page 9. 
147
 a) Maruoka, K.; Ooi, T. Chem. Rev. 2003, 103, 3013–3028. b) Maruoka, K. Organic Process Research & 
Development 2008, 12, 679–697. 
148
 a) Taylor, M. S.; Jacobsen, E. N. Angew. Chem. Int. Ed. 2006, 45, 1520–1543. b) Nishikawa, Y. 
Tetrahedron Letters 2018, 59, 216–223. 
149
 See Chapter1, ref. 35, page 11. 
150
 For reviews in chiral guanidines, see: a) Ishikawa, T.; Isobe, T. Chem. Eur. J. 2002, 8, 553–557. b) 
Ishikawa, T.; Kumamoto, T. Synthesis 2006, 737–752. c) Leow, D.; Tan, C.-H. Chem. Asian. J 2009, 4, 488–
507. d) Ishikawa, T. Chem. Pharm. Bull. 2010, 58, 1555–1564. e) Fu, X.; Tan, C.-H. Chem. Commun. 2011, 
47, 8210–8222. f) Selig, P. Synthesis 2013, 45, 703–718. For reviews in chiral iminophosphoranes, see: ) 
Krawcyk, H.; Dzigielewski, M.; Deredas, D.; Albrecht, A.; Albrecht, L. Chem. Eur. J. 2015, 21, 10268–10277. 
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on the development of more effective bifunctional Brønsted base catalysts or new 
pronucleophilic templates suitable for soft enolization. 
2.1.2. Isocyanoacetates in catalytic asymmetric Michael additions 
Conjugate additions of isocyanoacetates have been used for the synthesis of 
nitrogen-containing compounds such as branched amino acids. The first non-asymmetric 
variant was reported by Schöllkopf in 1970, in which the conjugate addition of ethyl 
isocyanoacetates to acrylates and their derivatives was successfully implemented. One 
of the problems in this method is the formation of the bis-adduct sideproduct (Scheme 
25).151  
 
Scheme 25. The first non-asymmetric Michael addition of isocyanoacetates. 
After this first racemic version, similar racemic reactions were studied with Michael 
acceptors other than acrylates and the reaction adducts were submitted to ulterior 
transformations, demonstrating the synthetic versatility of thus obtained adducts 
(Scheme 26).152 While the transformation A provides the product that would derive from 
the corresponding [3+2] cycloaddition, the transformation B is a pathway to avoid in 
asymmetric Michael additions if we want to conserve the Cα stereocenter. 
                                                     
151
 Schöllkopf, U.; Hantke, K. Angew. Chem. Int. Ed. Engl. 1970, 9, 896–897. 
152
 a) Saegusa, T.; Ito, Y.; Kinoshita, H.; Tomita, S. J. Org. Chem. 1971, 36, 3316–3323. b) Schöllkopf, U.; 
Porsch, P.-H. Angew. Chem. Int. Ed. 1972, 11, 429–431. c) Schöllkopf, U.; Hantke, K. Liebigs Ann. Chem. 
1973, 1571–1582. d) Schöllkopf, U.; Porsch, P.-H. Chem. Ber. 1973, 106, 3382–3390. e) Murakami, M.; 
Hasegawa, N.; Tomita, I.; Inouye, N.; Ito, Y. Tetrahedron Lett. 1989, 30, 1257–1260. f) Murakami, M.; 
Hasegawa, N.; Hayashi, M.; Ito, Y. J. Org. Chem. 1991, 56, 7356–7360. 
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Scheme 26. Subsequent elaboration of the isocyanoacetate adducts. 
Nowadays, in contrast to the long history of non-asymmetric variants, catalytic 
enantioselective Michael additions of isocyanoacetates have been much less developed. 
One of the problems is that, the carbanionic Michael adducts spontaneously cyclize by 
subsequent intramolecular nucleophilic addition to the isocyano group. So obtaining the 
acyclic product has been possible in very few cases (Scheme 27). The electron-
withdrawing group stabilizes the negative charge in the Cα of the intermediate, making 
the isocyano group insertion more favorable than the α-protonation. In addition, as has 
been shown in the introduction (see page 39), in most developments very reactive 
olefins in conjunction with metal catalysts are required. In the presence of the metal 
(Lewis acid) catalyst, the electrophilicity of the isocyano group is increased by 
coordination, so the cyclization process of the intermediate carbanion is faster than in 
the absence of the metal.  
 
Scheme 27. The most common reaction pathway involving asymmetric Michael additions of 
isocyanoacetates leads to cyclization products. 
In this context, if the cyclization step could be avoided, and so the isocyano group 
preserved, in the products then full advantage of its synthetic potential would be 
realized (being practically necessary to overcome the use of metals for it). However, the 
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organocatalytic Michael additions of this type of nucleophiles still remains a challenge in 
part because of the relative low acidity of α-substituted isocyanoacetates and also the 
steric constrains imposed by the formation of a quaternary stereocenter. The few 
studies dealing with Michael reaction leading to acyclic adducts are collected in (Table 
9).153 
 
 
Table 9. Reported asymmetric Michael additions of α-substituted isocyanoacetates that stop at the acyclic 
adduct. 
 
 Electrophile Cat.* Product Results Ref 
1 
 
R2 = Ar, Alk (10 mol%) 
 
 
R1 = Ar, Me, Bn 
R1/R2 = Ar/Ar 
91-98% 
80:20-99:1 dr 
86-98% ee 
153a 
R1 = Me, Bn 
65-71% 
55:45 dr 
54-58% ee 
R2 = Me, Bn 
72-77% 
70:30-75:25 dr 
72-77% ee 
2  
 
 
 
 
 
 
 
(10 mol%) 
 
R1 = Ar 
62-96% 
75-96% ee 
 
153b 
                                                     
153
 a) Bai, J.-F.; Wang, L.-L.; Peng, L.; Guo, Y.-L.; Jia, L.-N.; Tian, F.; He, G.-Y.; Xu, X.-Y.; Wang, L.-X. J. Org. 
Chem. 2012, 77, 2947–2953. b) Buyck, T.; Wang, Q.; Zhu, J. Angew. Chem. Int. Ed. 2013, 52, 12714–12718. 
c) Zhao, M.-X.; Ji, F.-H.; Wei, D.-K.; Shi, M. Tetrahedron 2013, 69, 10763–10771. d) Zhao, M.-X.; Zhu, H.-K.; 
Dai, T.-L.; Shi, M. J. Org. Chem. 2015, 80, 11330–11338. 
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 Electrophile Cat.* Product Results Ref 
3  
R2 = Ar, 
 -CH2CH2Ph 
(20 mol %) 
 
R1 = Ar, Bn 
R1/R2 = Ar/Ar 
45-97% 
>21:1 dr 
79‒99% ee 
153d R
1 = Bn, 2-
MeC6H4 
No reaction 
R2 = -CH2CH2Ph 
No reaction 
 
In these works, only very specific Michael acceptor have been employed and mainly with 
α-aryl isocyanoacetates. Shi and collaborators extended the addition to N-aryl 
maleimides employing squaramide bifunctional bronsted bases,153c even so, they did not 
improve the results of entry 1. Closely related to this thesis, once our work was in 
progress, Zhao and co-workers reported the first asymmetric Michael addition of 
isocyanoacetates to enones (Table 9, entry 3). One limitation of this method is that the 
Michael reaction did not work with α-alkyl isocyanoacetates. The same happened with 
α-aryl isocyanoacetates bearing an orto-substituted aryl group, probably by steric 
reasons. Furthermore, the reaction worked only with enones bearing an aryl group at R2 
postition. 
Looking at these precedents, it is reflected that the enantioselective Michael 
addition of isocyanoacetates still presents challenges in many aspects and deserves to 
be studied more thoroughly. 
 
2.2. Synthetic plan 
As mentioned above, commonly, the conjugate addition of isocyanoacetates to electron-
deficient olefin is followed by the subsequent intramolecular cyclization giving rise to 
[3+2] cycloaddition products. This phenomenon has caused that the synthesis of acyclic 
adducts by asymmetric Michael addition had been scarcely developed. However, the 
linear products offer great synthetic possibilities since they contain the isocyano group 
intact which would allow performing a variety of ulterior transformations (see Figure 17, 
page 45). 
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Significally, a brief review of the precedents reported related to the possible 
transformations with this type of compounds (Scheme 25 and Scheme 26, page 58-59), 
we envisioned that these chiral Michael addition products could be a common 
intermediate for the synthesis of different types of α-quaternary proline derivatives 
(Scheme 28). On the one hand, the hydrolysis of the isocyano group would release the 
amine which would cause the cyclization by intramolecular nucleophilic addition to the 
carbonyl group, providing Δ5-dehydroprolines. On the other hand, the electrophile 
character of the isocyano group would allow us to perform the intramolecular 
nucleophilic addition of the relatively acidic Cα to this isocyano, giving rise Δ4-
dehydroprolines by means of a two-step [3+2] cycloaddition. 
 
Scheme 28. Synthetic plan. 
As a result, we set out to study the catalytic asymmetric Michael addition of α-
substituted isocyanoacetates to simple vinyl ketones which had not previously been 
documented (Scheme 29, right). In addition, a sole example was known related to the 
[3+2] cycloaddition variant of these substrate partners affording the corresponding 
dihydroproline products with moderate (52-74% ee, R1 = H) or poor (16-36% ee, R1 = Bn) 
enantioselectivity (Scheme 29, left).154 
 
Scheme 29. State of the art. 
                                                     
154
 See ref. 115, Chapter 1, page 40. 
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Considering that the absence of a metal catalyst would slow down the subsequent 
intramolecular cyclization step, we envisaged to study metal-free organocatalytic 
approach. The previous studies proved that the bifunctional Brønsted bases were 
suitable candidates to catalyze the reaction, but we would probably have to design a 
more effective catalyst than those reported to date, owing to the low reactivity of 
simple vinyl ketones as compared with N-aryl maleimides (entry 1, Table 9) and vinyl 
selenones (entry 2, Table 9). In this context, bifunctional squaramides have 
demonstrated higher reactivity than thiourea catalysts, so in this thesis work special 
interest has been placed in the development of more effective squaramide catalysts. 
Summarizing, we envisaged developing a general asymmetric bifunctional 
Brønsted base catalyzed Michael addition of α-substituted isocyanoacetates to vinyl 
ketones, which could be applicable to the synthesis of different type of enantioenriched 
α-quaternary proline derivatives. 
 
2.3. Catalyst screening and design 
2.3.1. Preliminary studies 
The study began by assessing the behaviour of some bifunctional BB/H-bond catalysts 
on the reaction of α-phenyl tert-butyl isocyanoacetate 1A and methyl vinyl ketone 2a to 
produce 3Aa. The preliminary screening with previously known bifunctional Brønsted 
base organocatalysts demonstrated that tertiary amine/squaramide were the best 
catalysts (Table 10). While C1-C4 catalysts (DHQ2Pyr, (–)-Quinine, thiourea and 
ureidopeptide) gave essentially no stereocontrol, the squaramide C5 provided the 
product with good enantiopurity (86% ee). 
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Table 10. Screening of H-bond donors. 
[a] Reaction conduced on a 0.1 mmol scale in 0.2 mL CH2Cl2 (molar ratio 1/2/catalyst 1:2:0.1). Conversion 
into the corresponding adduct determined by 
1
H-RMN spectroscopy and the ee values by chiral HPLC on 
the reaction crude. [b] Reaction carried out at 0 °C. 
Then, a series of bifunctional tertiary amine/squaramide catalysts were tested. Here two 
strategic variations were studied: the structure of the basic amine site and the structure 
of the side group attached to the squaramide. In order to evaluate the basic motif, 3,5-
bis(trifluromethyl)phenyl group was chosen as achiral activating group of squaramides. 
This group seems to be a key structural motif for the success in most of (thio)urea and 
squramide-based bifunctional Brønsted bases, introduced by Schreiner and Wittkop for 
the first time (Figure 21).155  
                                                     
155
 a) Schreiner, P. R.; Wittkopp, A. Org. Lett. 2002, 4, 217–220. b) Zhang, Z.; Schreiner, P. R. Chem. Soc. 
Rev. 2009, 38, 1187–1198. 
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Figure 21. Activation model proposed by Zhong and Schreiner. 
From the results using squaramide bases C5-C8, the first one was the most appropriate 
given product 3Aa with 84% ee (Table 11, up). In order to improve the ee, we tested 
next the Rawal´s squaramide C9 and the silylated catalysts C10 and C11 designed in our 
group for the Michael addition reactions involving cyanomethyl azaarene N-oxides.156 
However, in our Michael addition these catalysts gave 3Aa with moderated 
stereocontrol (50-60% ee). In addition, catalysts C12 and C13, which had already been 
used successfully in other asymmetric Michael additions in our group, were also 
tested.157 The results indicated that catalyst C13 was more effective than C12 in terms of 
enantioselectivity (C12: 56% ee vs C13: 80% ee), giving very similar result to that 
obtained with C5 (84% ee). Since the latter cannot be modified easily, catalyst C13 was 
elected for further improvements. 
  
                                                     
156
 Izquierdo, J.; Landa, A.; Bastida, I.; López, R.; Oiarbide, M.; Palomo, C. J. Am. Chem. Soc. 2016, 138, 
3282–3285. 
157
 a) Etxabe, J.; Izquierdo, J.; Landa, A.; Oiarbide, M.; Palomo, C. Angew. Chem. Int. Ed. 2015, 54, 6883–
6886. b) Badiola, E.; Olaizola, I.; Vázquez, A.; Vera, S.; Mielgo, A.; Palomo, C. Chem. Eur. J. 2017, 23, 8185–
8195. 
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Table 11. Screening of the chiral Brønsted base and the achiral motif. 
[a] Reaction conduced on a 0.1 mmol scale in 0.2 mL CH2Cl2 (molar ratio 1/2/catalyst 1:2:0.1). Conversion 
into the corresponding adduct determined by 
1
H-RMN spectroscopy and the ee values by chiral HPLC on 
the reaction crude. 
2.3.2. Development of a new tertiary amine/squaramide catalyst having a 
polyaryl bulky groups 
The desing of catalyst C13 in this laboratory had been guided by assumption that the 
amide NH would give an internal H- bond interaction with the carbonyl group of the 
squarate (Figure 22), which would provide greater rigidity and H-bond donor ability to 
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the catalyst.158 However, the conformational analysis carried out by Julen Etxabe during 
his tesis in our group could not find direct evidences of the existence of this internal link 
yet.159 
 
Figure 22. Internal H- bond interaction. 
Our idea was to investigate if bulky groups near the squaramide could improve the 
stereocontrol of the reaction. The synthesis of these catalysts was planned to carry out 
by a modification of the previously described procedure for C13 type catalysts (Scheme 
30). Amide-bond formation (step 1) was firstly performed using methyl 
imidazole/methanesulfonyl chloride as coupling reagent, but in the case of ortho-
hydroxy arylamine was unsuccessful. Coupling conditions using oxalyl chloride in 
combination with triethylamine (method B) were more effective, even improving some 
yields that were obtained with the method A. The reduction of the nitro group (step 2) 
was performed successfully using standard reduction conditions, except in the case of 
ortho-chloro substitution in which method B had to use. Once the desired amines were 
obtained, the tertiary amine/squaramide catalysts C14-C19 were prepared using the 
standard procedure. 
                                                     
158
 For studies in relation to catalysts with similar internal coordinations, see: a) Jones, C. R.; Pantos, G. D.; 
Morrison, A. J.; Smith, M. D. Angew. Chem. Int. Ed. 2009, 48, 7391–7394. b) Auvil, T. J.; Schafer, A. G.; 
Mattson, A. E. Eur. J Org. Chem. 2014, 2633–2646. 
159
 For doctoral thesis related to the conformational analysis of C13, see: Etxabe, J. Catalytic Asymmetric 
Synthesis of α,α-Disubtituted α-Thio and α-Amino Acid Derivatives EHU/UPV; 2016; pp 290–292.  
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Scheme 30. Synthesis of ortho-substitued amide catalysts C14-C19. 
Results with the newly prepared catalysts C14-C19 are collected in Table 12. One general 
feature of these catalysts was the low solubility in non polar solvents such as 
dichloromethane, which compromises catalyst activity forcing long reaction times for 
practical conversion (up to 6 days at r.t.): C14: 6 days, conv. 80%, C16: 60h, conv. 75% 
and C18: 4 days, conv. 75%. However, C14 and C18 gave the product with excellent 
enantiopurity (95% and 94% ee, respectively), but when the temperature increased to 
40 °C, the enantiomeric excess dropped considerably (75% and 84% e,e respectively) 
although the conversion was complete. The most promising catalyst in solubility and 
reactivity terms was C17. Even so, the stereocontrol of the reaction was lower (80% ee) 
than in case of C14 and C18. Performing the same experiment at 0 °C and -20 °C the 
enantiomeric excess increased to 86% and 91% ee respectively, but the reaction rate 
dramatically decreases at -20 °C. We also tried catalyst C19 with a longer alkoxy chain in 
but the result was worse (66% ee). 
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Table 12. Screening of ortho-substitued amide catalysts. 
[a] Reaction conduced on a 0.1 mmol scale in 0.2 mL CH2Cl2 (molar ratio 1/2/catalyst 1:2:0.1). Conversion 
into the corresponding adduct determined by 
1
H-RMN spectroscopy and the ee values by chiral HPLC on 
the reaction crude. [b] Reaction carried out at 40 °C. [c] Reaction carried out at 0 °C. [d] Reaction carried 
out at -20 °C. 
In brief, these experiments were conditioned by the low reaction rate, as consequence 
of the low solubility of the catalysts. In cases in which the time required for a total 
conversion was acceptable, the enantiomeric excess of the final product decreased and 
vice versa. However, the data obtained reflect that the steric hindrance around the 
squarate improved the stereocontrol of the reaction. 
With these data in hand, the idea was to find more soluble catalysts that would 
catalyze the reaction more effectively, whereas increasing the steric congestion around 
the squarate might be favorable for the enantiocontrol. Also, although the existence of 
the internal H-bond in amide-type catalysts has not been confirmed, initially the idea 
was to design a new type of catalysts in which this coordination could be possible. Based 
on these ideas, we decided to install a bulky tertiary alcohol in place of the N-H amide. In 
addition, these alcohols would be in principle accessible via nucleophilic addition of the 
corresponding Grignard reagents to a common ester intermediate, making the 
preparation highly versatile for structural variation. 
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Figure 23. Design of the new catalysts and their preparation. 
After several failed attempts (Table 13), it was discovered that for a successful addition 
of the Grignard reagent to the ester group, the amine had to be acetylated previously.  
 
 
Table 13. Assays of the addition of the Grignard reagent to the ester group.  
The full synthetic sequence for the preparation of catalysts C20-C26 is shown in Scheme 
31. Although 6 steps are required from commercial or simply accessible meta-benzoic 
acids to reach the final catalysts, the yields of each step in general are good and in many 
cases, the steps are clean enough to continue without a prior purification of the 
intermediates. As general features, these catalysts are solid and have high molecular 
weight (1500 mg/mmol approximately), so very low catalyst amount can be weighed 
accurately for the catalytic reactions. In addition, they showed excellent solubility in 
both polar and non-polar solvents allowing their use in a broad range of solvents. 
 
R T Result 
NH2 reflux 
Messy crude 
(similar 1H NMR) 
NH2 r.t. 
NO2 reflux 
NO2 r.t. 
NHAc r.t. 86% of product 
CHAPTER 2 
 
71 
 
 
Scheme 31. General procedure for synthesis of new catalysts. 
As shown in the Table 14 the newly prepared catalysts resulted more active allowing the 
reation between isocyanoacetate 1A and vinyl ketone 2a to be essentially complete 
after 14 h. First we evaluated the influence of the groups around the hydroxyl group; 
among methyl (C20: 74% ee), phenyl (C21: 80% ee) and bistrifuoromethylphenyl (C22: 
88% ee), the latter gave the best stereochemical results. So, we took the gem-diaryl C22 
as a reference to further development. Suprisingly, the trimethylsilyl derivative C24 
worked as well as C22 even improving the enantiomeric excess when the catalyst 
loading was lower (5 mol%, 92% ee). However, a more bulky alkylsilyl group (TIPS) 
drastically affected the reactivity (C25: 14h conv. 20%). Finally, the gem,gem-(bis)diaryl 
congener C23 and its silylated derivative C26 were tested, being this last one, with 5 
mol% of catalyst loading, the most selective (95% ee).  
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Table 14. Screening of catalysts containing tertiary alkoxy groups. 
[a] Reaction conduced on a 0.1 mmol scale in 0.2 mL CH2Cl2 (molar ratio 1/2/catalyst 1:2:0.1). Conversion 
into the corresponding adduct determined by 
1
H-RMN spectroscopy and the ee values by chiral HPLC on 
the reaction crude. [b] Reaction with 5 mol% of catalyst. [c] Reaction in 0.2 mL of toluene.  
A comparison of the reaction progress using 2 mol% of catalysts C5, C24 and C26 
demonstrated that both C26 and C24 were a little more active than C5 (Figure 24). 
Although the reaction catalyzed by C24 was faster, 2 mol% of catalyst C26 was enough 
to obtain 90% of conversion in 32h (maintaining the ee values at 95%).    
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[a] Reaction conduced on a 0.2 mmol scale in 0.4 mL CH2Cl2 (molar ratio 1A/2b/catalyst 1:2:0.02). 
Conversion into the corresponding adduct determined by 
1
H-RMN spectroscopy and the ee values by 
chiral HPLC on the reaction crude. 
Figure 24. Reaction rate study. 
Crystalls of catalyst C26 of enough quality for X-ray analysis could be obtained and the 
solved solid structure is worth of coment (Figure 25). The interatomic diamine H--H 
distance is unusually short (2.446 Å) comparing with the typical values previously 
reported for related squaramide catalysts (see Figure 8, Chapter 1, page 14). This feature 
would enhance the resultant dipolar moment and hence, the activation by H-bonds 
should be more effective. In addition, squaramide solid structure does not self-
aggregate through dual hydrogen-bonding as normally happen in squaramides and 
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which usually hinders its activity (left structure).160 This phenomenon was attributed to 
the bulky polyaryl moiety near the squaramide framework which prevents the 
approximation of different squaramide units, causing both N-H bonds of each 
squaramide unit to point toward the quinoline nitrogen of a contiguous molecule. Based 
on these structural information/data, it also seems that there is not any intramolecular 
interaction between the silicon atom and the carbonyl group of squaramide. 
 
 
 
 
 
 
 
 
 
 
Figure 25. X-ray structure and extracted datas of the catalyst C26. 
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 See ref 42, Chapter 1, page 13. 
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Concluding, the gem,gem-(bis)diaryl oxo-silylated catalyst C26 demonstrated to be an 
excellent catalyst for this Michael addition in terms of enantioselectivity, solubility and 
reactivity, so was selected to follow with the study. 
2.4. Scope of the reaction 
2.4.1. Vinyl ketones as Michael acceptors 
Due to the good results obtained with the methyl vinyl ketone 2a, it was considered that 
vinyl ketones deserved to be studied more thoroughly. To explore the scope of the 
reaction, a 5% catalyst loading was used and a range isocyanoacetates/vinyl ketones 
were combined (Table 15). 
As can be seen, the reaction perfectly tolerated meta, para and unsubstituted α-
aryl isocyanoacetates, even decreasing the catalyst load to 2 mol% (3Ac and 3Dd) or 
using electron donating substituent in whichever of the two aryl groups. Also, less 
reactive alkyl vinyl ketone provided de Michael adducts with very good yields and 
enantioselectivities (3Aa, 3Ab and 3Ca). Nevertheless, as in the work reported by Zhao 
et al.161 this reaction also did not tolerate α-alkyl substitution pattern in the nucleophiles 
(3Ee). 
 
 
                                                     
161
 See ref. 153d, page 60. 
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Table 15. Scope of the Michael addition involving vinyl ketones as Michael acceptor. 
[a] Reaction conduced on a 0.2 mmol scale in 0.4 mL CH2Cl2 (molar ratio 1/2/catalyst 1:2:0.05). Yields of 
isolated product after column chromatography. The enantioselectivity determined by chiral HPLC. [b] 2 
mol% of C26 used. 
Subsequently, we wanted to explore the scope of the reaction to other α,β-unsaturated 
carbonyl compounds (Table 16). The Michael addition of isocyanoacetate 1A using 
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methyl acrylate (4) as Michael's acceptor proved to be very slow (entry 1), whereas the 
reaction with acrolein almost finished in 2 h leading to product 8 with low 
enantioselectivity (entry 2). Hence, it seems that α,β-unsaturated esters too poor 
electrophiles for these reactions, while the selectivity control with enals is challenging. 
In view of the good results provided by vinyl ketones, the possibility of using the α´-
hydroxyenones as acrolein and acrylate equivalents was considered. The ketol moety in 
these adducts is easily transformable to aldehyde or ester group through simple 
oxidative cleavage.162 Fortunately, the enantioselective Michael reaction with the α-
hydroxyenone 6a could be successfully carried out affording product 9Aa in good yield 
and 98% ee (entry 3), what encouraged us to see the scope of the reaction. 
Table 16. Michael addition to different α,β-unsaturated carbonyl compounds. 
 
Entry Acceptor t (h) Product 
Conversion 
(%) 
Yield (%) ee (%) 
1 
 
40 7 15 n.d. n.d. 
2 
 
2 8 85 n.d. 34 
3 
 
3 9Aa 90 70 98 
[a] Reaction conduced on a 0.2 mmol scale in 0.4 mL CH2Cl2 (molar ratio 1/2/catalyst 1:2:0.05). Conversion 
into the corresponding adduct determined by 
1
H-RMN spectroscopy and the ee values by chiral HPLC on 
the reaction crude.   
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 Palomo, C.; Oiarbide, M.; Kardak, B. G.; Garía, J. M.; Linden, A. J. Am. Chem. Soc. 2005, 127, 4154–4155.   
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2.4.2. α´-Hydroxyenones as Michael acceptors 
Studies from this laboratory had shown that α´-oxy enones, and particularly α´-hydroxy-
enones are useful achiral bidentate templates in asymmetric catalysis.163 However, to 
date they have never been used as acceptors in the Michael addition with 
isocyanoacetates. 
We explored the scope of the reaction employing α´-hydroxy vinyl-ketone 6a as 
Michael acceptor, C26 (5 mol%) as catalyst and a variety of α-substituted 
isocyanoacetates. As the data in Table 17 show, α-aryl substituted isocyanoacetates 
were competent reaction partners providing the products 9 with good isolated yields 
and ee´s up to 92%, except ortho-substituted aryl isocyanoacetates (1F and 1G), which 
did not react probably due to the steric hindrance around the nucleophilic carbon. Once 
again, the α-alkyl substituted isocyanoacetates (1E) or unsubstituted isocyanoacetates 
(1H) were nonreactive under the present catalytic conditions owing, probably, to their 
lower acidity.  
  
                                                     
163
 a) Palomo, C.; Oiarbide, M.; Halder, R.; Kelso, M.; Gómez-Bengoa, E.; García, J. M. J. Am. Chem. Soc. 
2004, 126, 9188–9189. b) Palomo, C.; Pazos, R.; Oiarbide, M.; García, J. M. Adv. Synth. Catal. 2006, 348, 
1161–1164. c) Palomo, C.; Oiarbide, M.; García, J. M.; Bañuelos, P.; Odriozola, J. M.; Razkin, J.; Linden, A. 
Org. Chem. 2008, 10, 2637–2640. d) Palomo, C.; Oiarbide, M.; García, J. M. Chem. Soc. Rev. 2012, 41, 
4150–4164. e) Badiola, E.; FIser, B.; Gómez-Bengoa, E.; Mielgo, A.; Olaizola, I.; Urruzuno, I.; García, J. M.; 
Odriozola, J. M.; Razkin, J.; Oiarbide, M.; Palomo, C. J. Am. Chem. Soc. 2014, 136, 17869–17881. 
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Table 17. Scope of the Michael addition involving α´-hydroxyeones as Michael acceptor. 
[a] Reaction conduced on a 0.2 mmol scale in 0.4 mL CH2Cl2 (molar ratio 1/2g/catalyst 1:2:0.05). Yields of 
isolated product after column chromatography. The enantioselectivity determined by chiral HPLC. [b] The 
reaction carried out at 40 °C. [c] Reaction carried out at 60 °C. 
Some α- and β-substituted α´-hydroxyenones (6b-d) were also tested, but not 
surprisingly the addition reaction did not work, even heating at 60 °C (Table 18). Taking 
into account that α´-hydroxyenones showed the same or greater reactivity than vinyl 
ketones, we assumed that the vinyl ketones would present these same limitations in the 
reactivity, as it reflected the experiment that was carried out with α-benzyl 
isocyanoacetate 1E and aryl vinyl ketone 2e (see Table 15, compound 3Ee). 
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Table 18. Attempts of the Michael reaction with α- and β-substituted α´-hydroxyeones. 
 
[a] Reaction conduced on a 0.2 mmol scale in 0.4 mL CH2Cl2 (molar ratio 1/2/catalyst 1:2:0.05). 
Summarizing, the C26-catalyzed asymmetric Michael addition of α-aryl isocyanoacetates 
with alkyl- and aryl-vinyl ketones 2a-f and α´-hydroxy vinyl-ketone 6a could be 
performed with very good yields and excellent enantioselectivities. As exception, 
isocyanoacetates with α-alkyl groups or ortho-substituted α-aryl groups were unreactive 
(also see Zhao's work Table 9, entry 3, page 60). 
2.4.3. Transition-state model 
Although the mechanism of the reaction remains to be clarified, based on the 
stereochemical result determined by X-ray crystallographic analysis of the product 26 
(Scheme 36, page 88), we could propose a dual plausible transition-state model. One of 
the possibilities considered was the double coordination of the nucleophiles with the 
catalyst through the enol group and the isocyanide group, in a similar manner to that 
assumed for a metal-mediated process.164 While in second cases the metal coordinated 
the isocyanide group, in bifunctional BB catalysts mediated process this coordination 
could be given through one of the N-H bond donor group, which forces the formation of 
a Z enolate of the isocyanoacetate. However, as can be seen in Figure 26, pathway a, 
this transition-state would favor the attack by the Re face of the nucleohile to the enone 
providing the enantiomer of opposite configuration (S), hence, this model was rejected. 
                                                     
164
 For selected examples, see: a) See ref. 109, page 40. b) See ref. 113, page 40. 
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The other possibility was to consider the coordination of the isocyanide with the 
protonated quinuclidine moiety instead with the N-H bond donor group of the 
squaramide (Figure 26, pathway b), in similar manner to the model proposed by Zhu and 
co-workers in the reaction of isocyanoacetates to vinyl selenones.165 In this case, the 
squaramide motif forced the direction of the nucleophilic attack from the Si face of the Z 
enolate to the enone, providing the corresponding adduct with R configuration. 
Therefore, this transition-state model is plausible.  
 
Figure 26. Possible transition-state models for the Michael addition. 
 
2.5. Elaboration of adducts 
Having developed an organocatalytic and highly enantioselective method for the 
Michael reaction of α-isocyanoacetates to different enone reagents, the potential of the 
resulting enantioenriched adducts in synthesis was briefly explored. 
                                                     
165
 See ref. 153b, page 60. 
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2.5.1. Synthesis of α-quaternary Δ5-dehydroprolines and derivatives 
The release of the amine group upon hydrolysis of the isonitrile group and the 
subsequent cyclization to provide the corresponding α-quaternary Δ5-dehydroprolines 
was performed one pot (Scheme 32). Thus treatment of adducts with concentrated 
hydrochloride acid, led in all cases tested, the corresponding product 10-13 in good 
yields.  
 
Scheme 32. Synthesis of α-quaternary Δ
5
-dehydroprolines. 
Transformation of these dehydroprolines into the parent α-quaternary prolines is easily 
conceivable through reduction of the imine moiety.166 Based on this idea, compound 10 
was first subjected to reduction with L-Selectride. Despite this reagent is rather bulky, 
under these conditions diastereocontrol was really poor and the pirrolidine product was 
obtained as an equimolar mixture of diastereomers (Table 19, entry 1). Instead, 
exposure of 10 to H2 over Pd on charcoal gave product 14 with an excellent 
diastereomeric ratio and good yield (Table 19, entry 2). The X-ray single crystal structure 
analysis of a compound derived from N-acylation of 14 served to determine the 
configuration of both stereocenters, confirming the syn disposition of the methyl group 
with respect to the ester group (Figure 27). These reduction conditions were employed 
to each of the Δ5-dehydroprolines 10-13. In case of 11, product 15 was obtained again 
with very good diastereocontrol (>20:1 dr) and good yield (Table 19, entry 3). 
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 a) Strohmeier, M.; Leach, K.; Zajak, M. A. Angew. Chem. Int. Ed. 2011, 50, 12335–12338. b) see ref. 102, 
page 34. 
CHAPTER 2 
 
83 
 
Table 19. Reduction of dehydroprolines 10-11 to α-quaternary prolines 14-15. 
 
Entry R Reductor Solvent Temp. (°C) cis:trans Product  Yield (%) 
1 
Me 
L-Selectride THF  78→r.t. 1:1 
14 
-- 
2 Pd/C, H2 EtOH r.t. >20:1 80 
3 Et Pd/C, H2 EtOH r.t. >20:1 15 75 
        
 
Figure 27. The X-ray single crystal structure analysis. 
However, starting from Δ5-dehydroprolines containing aromatic R substitution (12-13) 
the reduction proceeded with concomitant hydrogenolytic cleavage of the benzylic C-N 
bond giving rise open chain α,α-disubstituted α-amino esters 17 and 18 respectively, 
which are equally interesting compounds.  
 
Scheme 33. Reduction of α-quaternary Δ
5
-dehydroprolines. 
CHAPTER 2 
84 
 
2.5.2. Synthesis of α-quaternary Δ4-dehydroprolines 
Inspired by the transformation reported by Ito and collaborators in 1991,167  we 
foreesed that Δ4-dehydroproline skeleton could be created starting from enantiopure 
lineal Michael adducts 3 by using a base to generate de corresponding enolate and a 
metal complex to promote the cyclization (Scheme 34). 
 
Scheme 34. Synthetic plan for the α-quaternary Δ
4
-dehydroprolines synthesis. 
The search of optimal conditions for this transformation was focused on the use of silver 
(I) complexes (Table 20) owing to the success of these reagents on other cycloadditions 
reactions.168 Experiments revealed the dramatic dependence of the silver source on the 
reaction outcome. For example, whereas with AgF formation of 19 was completed 
within 5 h, with AgOAc the conversion was lower, and using AgNO3 or AgOTf not even 
traces of products were observed. Thus, AgF was chosen to explore the effect of the 
base. As it was expected, the stronger the base employed the faster was the reaction. 
Thus, while using both Et3N and DIPEA the reaction was incompleted after 5 h, in DBU 
and P4
tBu phosphazene base, 100% conversion was reached. However, among the both 
latter, DBU was the best in terms of clean reaction product. In addition, we could verify 
that the transformation could be executed one pot by adding the AgF and the base once 
the Michael addition reaction was complete. 
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 See ref. 152f, page 58. 
168
 See Table 8, Chapter 1, page 41. 
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Table 20. Screening of reaction conditions for the synthesis of Δ
4
-dehydroproline scaffold. 
 
Entry Metal salt Base t (h) Conversion (%) 
1 AgF P4
tBu 5 100 
2 AgOAc P4
tBu 5 75 
3 AgNO3 P4
tBu 5 0 
4 AgOTf P4
tBu 5 0 
5 AgF DIPEA 
5 35 
24 95 
6 AgF Et3N 
5 25 
24 50 
100 95 
7 AgF DBU 5 100 
 
Once the combination of AgF and DBU was selected optimun, different Michael adducts 
were subjected to the same conditions demonstrating the scope of the transformation 
(Table 21). The reaction worked perfectly with adducts that came from the conjugate 
addition involving simple vinyl ketones (3) providing the corresponding α-quaternary Δ4-
dehydroprolines 19-23 with good yields. However, the reaction that involved adduct 
containing α´-hydroxyketone functionalization (9Aa) gave a messy reaction crude and 
only traces of product 24 were observed, regardless the base employed. 
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Table 21. Scope of the transformation of adducts into α-quaternary Δ
4
-dehydroprolines. 
 
It should be noted that the resulting α-quaternary Δ4-dehydroprolines were not 
completely stable to regular silica-gel column purification. Instead, a rapid filtration 
through a pad of silica-gel was sufficient to remove traces of impurities and excess 
reactants. In general, it is recommended to prepare the products when they are going to 
be used and in any case, store them at low temperature (-40 °C). 
2.5.3. Synthesis of α-quaternary pyroglutamate ester 
Pyroglutamates169 bearing α-quaternary stereocenter serve as the core structures in 
many natural alkaloids and bioactive molecules, as for example Oxazolomycin A170 or 
previously mentioned Salinosporamide A171 and Lactacystin.172 Due to the broad array of 
                                                     
169
 a) Smith, M. B. Alkaloids: Chem. Biol. Perspect. 1998, 12, 229–287. b) Panday, S. K.; Prasad, J.; Dikshit, 
D. K. Tetrahedron: Asymmetry 2009, 20, 1581–1632. 
170
 a) Mori, T.; Takahashi, K.; Kashiwabara, M.; Uemura, D. Tetrahedron Lett. 1985, 26, 1073–1076. 
171
 See ref. 65, Chapter 1, page 20. 
172
 See ref. 54, Chapter 1, page 41. 
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biological and pharmaceutical properties that exhibit, organic chemists have pursued 
efficient synthetic methods for those compounds.173  
Previous works developed in our group have demonstrated the synthetic 
potential of α´-hydroxy ketone moiety as a precursor to the corresponding acid/ester, 
aldehyde or ketone products which could be obtained through different oxidative 
cleavages.174 Accordingly, we anticipated that these Michael adducts subjected to the 
appropriate oxidative conditions would yield the corresponding ester which upon 
isocyanate hydrolysis, could provide the corresponding α-quaternary pyroglutamic 
esters (Scheme 35).  
 
Scheme 35. Synthesis of pyroglutamic esters from Michael adducts. 
We observe that the treatment of adduct 9Aa with sodium periodate proceed as usual 
to produce a carboxylic acid, which upon methylation with TMSCH2N2, provided the 
ester 25 with moderate isolated yield (35%). We observed that the acid intermediate 
was not very stable probably due to interferences between the isocyanide and the 
carboxylic acid groups. Then we modified the conditions by submitting the crude 
material obtained upon the NaIO4 oxidation to the next methylation as soon as possible. 
This way, the overall yield of the two steps was improved to 62%. Of practical interest, 
acetone is the only by-product formed during this two-step transformation and in 
addition, as demonstrated in the preliminary studies, this ester cannot be obtain 
enantioselectively from a direct Michael addition to methyl acrylate under these 
catalytic conditions (see Table 16, page 77). Once the stable ester is obtained, the 
hydrolysis of the isocyano group and the subsequent clycization was carried out by 
treatment with concentrated hydrochloride acid which afforded pyroglutamate ester 26 
in 90% yield (Scheme 36).  
                                                     
173
 a) Bulger, P. G.; Moloney, M. G.; Trippier, P. C. Org. Biomol. Chem. 2003, 1, 3726–3737. b) Onyango, E. 
O.; Tsurunoto, J.; Imai, N.; Takahashi, K.; Ishihara, J.; Hatakeyama, S. Angew. Chem., Int. Ed. 2007, 46, 
6703–6705. c) Shibasaki, M.; Kanai, M.; Fukuda, N. Chem. Asian J. 2007, 2, 20–38. d) Yamada, T.; 
Sakaguchi, K.; Shinada, T.; Ohfune, Y.; Soloshonok, V. A. Tetrahedron: Asymmetry 2008, 19, 2789–2795. e) 
Moore, B. S.; Guilder, T. A. M. Angew. Chem., Int. Ed. 2010, 49, 9346–9367. f) See ref. 98, Chapter 1, page 
56. g) See ref. 99, Chapter 1, page 57. 
174
 a) ref. 162, page 77. b) ref. 163, page 78. 
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Scheme 36. Synthesis of α-quaternary pyroglutamate ester. 
The absolute configuration of product 19 was determined by X-ray crystallographic 
analysis, which coincides with the X-ray result of the compound 16 (Figure 27, page 83). 
Configuration of the remaining adducts was assigned by analogy and by assuming a 
uniform reaction mechanism. 
On the whole, the chemical transformations with these Michael addition adducts 
allowed the enantioselective synthesis of a variety of α-quaternary proline derivatives, 
demonstrating the synthetic potential of this approach.  
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3. Catalytic addition reactions of α-alkyl 
isocyanothioacetates: enantioselective synthesis of α-
quaternary dehydroprolines and imidazolines. 
3.1. Introduction 
3.1.1. Thioesters in catalytic asymmetric C-C bond forming reactions 
As reflected in the precedent discussions, catalytic asymmetric reactions involving the 
use of simple ester as nucleophiles remains challenging. This situation is justified in part 
by the relatively low acidity of simple ester compounds, which has led scientists to 
develop metal-based approaches and also the design of more active ester equivalents 
susceptible for enolization under mild conditions. 
In this context, nature has found an elegant solution to this problem by using 
thioesters as active ester surrogates for the synthesis of medicinally and metabolically 
important polyketides and fatty acid molecules (Scheme 37).175 Polyketide synthase 
enzymes effectively catalyze the reaction of a variety of thioesters like acetyl-CoA, 
propionyl-CoA or malonyl-CoA, giving the desired products. 
 
Scheme 37. The basic pathway of fatty acid and polyketide biosynthesis. 
                                                     
175
 a) Hopwood, D. Chem. Rev. 1997, 97, 2465–2497. b) Staunton, J.; Weissman, K. J. Nat. Prod. Rep. 2001, 
18, 380–416. c) Reeves, C. D.; Murli, S.; Ashley, G. W.; Piagentini, M.; Hutchinson, C. R.; McDaniel, R. 
Biochemistry 2001, 40, 15464–15470. d) Pfeifer, B. A.; Khosla, C. Microbiol. Mol. Biol. Rev. 2001, 65, 106–
118. e) Hill, A. M. Nat. Prod. Rep. 2006, 23, 256–320. 
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Inspired by these biosynthetic pathways, chemists have long been wondering 
biomimetic approaches based on the use of thioesters as equivalent of oxoesters with 
enhanced reactivity, especially in catalytic settings. The rationale behind the unique 
behaviour of thioesters is their increased α-acidity as compared with parent esters. 
Bordwell has quantified this difference in about 2 pKa units176. In addition, thioesters are 
also rather reactive acyl-transfer agents177, so thioesters-based reaction has turned out 
to be an interesting alternative to methods involving oxo-esters giving access to a much 
wider array of compounds (Figure 28). 
 
Figure 28. The effect in the acidity and transformations allowed with thioesters. 
However, only a few classes of thioesters have been successfully employed so far in 
catalytic asymmetric carbon-carbon bond forming reactions. The most representative 
cases are described below. 
3.1.1.1. Malonic acid derivatives as nucleophiles 
Decarboxylative Claisen condensation with malonic acid half thioester (MAHTs) is a key 
step in the biosynthesis of polyketides and fatty acids (Scheme 38, a). This 
transformation, which involves a decarboxylative enolate generation followed by a C-C 
bond forming reaction, has served as inspiration to scientists for the development of the 
first catalytic asymmetric nucleophilic additions of thioester compounds (Scheme 38, b). 
                                                     
176
 Bordwell, F. G.; Fried, H. E. J. Org. Chem. 1991, 13, 4218–4223. 
177
 Miyazaki, T.; Han-ja, X.; Tokuyama, H.; Fukuyama, T. Synlett 2004, 477–480. 
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Scheme 38. Decarboxylative Claisen condensation with malonic acid half thioesters and its 
implementation into asymmetric C-C bond technologies. 
Based on this approach catalytic asymmetric aldol,178 Michael,179 and Mannich180 
reactions involving addition of MAHTs, including organocatalytic methods, have been 
developed (Table 22). However, the low reactivity of the thioester enolate precursors 
typically forces the use of relatively large amounts of the catalyst (up to 30 mol%) and 
long reaction time. 
  
                                                     
178
 a) Orlandi, S.; Benaglia, M.; Cozzi, F. Tetrahedron Lett. 2004, 45, 1747–1749. b) Magdziak, D.; Lalic, G.; 
Lee, H. M.; Fortner, K. C.; Aloise, A. D.; Shair, M. D. J. Am. Chem. Soc. 2005, 127, 7284–7285. c) Bae, H. Y.; 
Sim, J. H.; Lee, J.-W.; List, B.; Song, C. E. Angew. Chem. Int. Ed. 2013, 52, 12143-12147. 
179
 Lubkoll, J.; Wennemers, H. Angew. Chem. Int. Ed. 2007, 46, 6841–6844. 
180
 a) Ricci, A.; Pettersen, D.; Bernardi, L.; Fini, F.; Fochi, M.; Herrera, R. P.; Sgarzani, V. Adv. Synth. Catal. 
2007, 349, 1037–1040. b) Pan, Y.; Kee, C. W.; Jiang, Z.; Ma, T.; Zhao, Y.; Yang, Y.; Xue, H.; Tan, C.-H. Chem. 
Eur. J. 2011, 17, 8363–8370. c) Hara, N.; Nakamura, S.; Sano, M.; Tamura, R.; Funahashi, Y.; Shibata, N. 
Chem. Eur. J. 2012, 18, 9276–9280. d) Zhong, F.; Jiang, C.; Yao, W.; Xu, L.-W.; Lu, Y. Tetrahedron Lett. 2013, 
54, 4333–4336. 
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Table 22. Representative catalytic asymmetric addition of MAHTs. 
  
 Electrophile Cat.* Product Results Ref. 
1 
 
 
(13 mol%) 
Cu(OTf)2 (10 mol%) 
 
59-83% 
2.2:1-36:1 dr 
89-96% ee 
178b 
2 
 
(30 mol%) 
 
 
R1=H/R3=Ar 
61-96% 
89-96% ee 
178c 
R1 = 
Me/R3=Ar 
31%, 5:1 dr 
97% ee 
R3 ≠ Ar 
16-32% 
73-91% ee 
3  
 
(20 mol%) 
 
23-93% 
61-90% ee 
179 
4 
 
 
(20 mol%)  
47-84% 
51-79% ee 
(R3=o-
BrC6H4: 
21-38% ee) 
180a 
5 
 
(10 or 20 mol%) 
 
R1 = H 
43-85% 
>20:1 dr 
85-97% ee 
180b 
R1 ≠ H 
37-70% 
 1:1-7:3 dr 
90-98% ee 
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More recently, the use of mono thiomalonates (MTMs) as thioester (or thioesters 
enolate precursor) equivalents has emerged. In these cases, the decarboxylation step is 
obviated and lower catalyst loadings are needed. Following this strategy, MTMs have 
been employed in catalytic asymmetric Michael181 and Mannich182 reactions giving rise 
products containing a α-quaternary stereocenter in several instances (Table 23). 
Table 23. Representative catalytic asymmetric addition of MTMs. 
 
 Electrophile Cat.* Product Results Ref. 
1 
 
 
(<5 mol%) 
(R3 = Alk: 20 mol%) 
 
82-98% 
91-99% ee 
181a 
2 
 
70-87% 
3:1-10:1 dr 
92-99% ee 
181c 
3 
 
 
(<5 mol%) 
 
R1 = H 
62-93% 
90-99% ee 
182a 
 
R1 = Alk 
51-99% 
6:1->20:1 
dr 
90-99% ee 
4 
 
 
42-96% 
4:1->20:1 
dr 
73-99% ee 
182b 
 
                                                     
181
 a) Clerici, P.; Wennemers, H. Org. Biomol. Chem. 2012, 10, 110–113. b) Kolarovic, A.; Käslin, A.; 
Wennemers, H. Org. Lett. 2014, 16, 4236–4239. c) Arakawa, Y.; Fritz, S. P.; Wennemers, H. J. Org. Chem. 
2014, 79, 3937–3945. d) Eng, O. D.; Fritz, S. P.; Käsling, A.; Wennemers, H. Org. Lett. 2014, 16, 5454–5457. 
182
 a) Bahlinger, A.; Fritz, S. P.; Wennemers, H. Angew. Chem. Int. Ed. 2014, 53, 8779–8783. b) Engl, O. D.; 
Fritz, S. P.; Wennemers, H. Angew. Chem. Int. Ed. 2015, 54, 8193–8197. c) Cosimi, E.; Engl, O. D.; Saadi, J.; 
Elbert, M.-O.; Wennemers, H. Angew. Chem. Int. Ed. 2016, 55, 13127–13131. 
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3.1.1.2. Arylacetic derivatives as nucleophiles 
With the aim of developing more atom economical method that does not require waste-
producing decarboxylation as a driving force or an additional activating group at the α-
position of the thioester, it aroused the idea of using arylacetic thioesters (Table 24). 
These reagents could be applied as donors in asymmetric Michael additions involving 
α,β-unsaturated aldehydes183 and in Mannich additions involving sulphonyl imines184. 
For example, the Michael reaction of benzothiophen-2-one and enals, proceeded 
through via iminium ion activation affording a double Michael addition, followed by 
intramolecular aldol reaction, giving rise to spirocyclic compounds (entry 2). Later, the 
reaction was expanded to 3-substituted benzothiophen-2-ones.183e The reaction could 
also be carried out with α-alkyl-substituted thioesters using enolsilanes as starting 
material in a Mukaiyama-Michael variant via enamine intermediate (entry 3). 
 
Table 24. Representative catalytic asymmetric addition of arylacetic thioesters. 
 
 Nucleophile Cat.* Product Results Ref. 
1 
 
 
(10 mol%)/ 
PhCO2H (10 mol%) 
 
46-88% 
57:43-81:19 dr 
66-98% ee 
(R = Me, 54% 
ee) 
183a 
2 
 
 
(20 mol%)/ 
Acid (20 mol%) 
 
42-77% 
>20:1 dr 
99% ee 
(R = H, 60% ee) 
183c 
                                                     
183
 a) Alonso, D. A.; Kitagaki, S.; Utsumi, N.; Barbas III, C. F. Angew. Chem. Int. Ed. 2008, 47, 4588–4591. b) 
Duce, S.; Jorge, M.; Alonso, I.; Ruano, J. L. G.; Cid, M. B. Eur. J. Org. Chem. 2013, 7067–7075. c) Géant, P.-
Y.; Urban, M.; Remes, M; Císarova, I.; Veselý, J. Eur. J. Org. Chem. 2013, 7979–7988. d) Claraz, A.; Sahoo, 
G.; Berta, D.; Madarász, A.; Pápai, I.; Pikho, P. M. Angew. Chem. Int. Ed. 2016, 55, 669–673. e) Li, S.; Zhang, 
E.; Feng, J.; Li, X. Org. Chem. Front. 2017, 4, 2301–2305. 
184
 a) Kohler, M. C.; Yost, J. M.; Garnsey, M. R.; Caltart, D. M. Org. Lett. 2010, 12, 3376–3379. b) Guang, J.; 
Larson, A. J.; Zhao, J. C.-G. Adv. Synth. Catal. 2015, 357, 523–529. 
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 Nucleophile Cat.* Product Results Ref. 
3 
 (20 mol%)/ 
4-nitrobenzoic acid 
(20 mol%) 
 
60-76% 
88-96% ee 
183d 
4 
 
 
(10 mol%) 
 
82-97% 
19:9-98:2 dr 
90-98% ee 
184b 
 
3.1.1.3. β,γ-Unsaturated carboxylic acid derivatives as nucleophiles 
Reactions involving dienolate (or equivalent dienamine) intermediates constitute a 
particular case owing to bidentate nature of these nucleophiles (Scheme 39).185 While 
these transformations thus require additional control over the α- vs. γ-competitive 
reaction pathways, the resulting adducts are of great synthetic versatility. Enamine 
catalysis (dienamine/trienamine) and metal catalysis have been employed recently to 
some extent, typically leanding to γ-addition compounds. The alternative α-reaction 
pathway implies the disruption of the π-conjugation at some point along the reaction, 
and hence, the regioselective formation of α-addition product is less favorable.  
 
Scheme 39. Reaction pathways of β,γ-unsaturated carboxylic acid nucleophiles additions. 
                                                     
185
 For reviews on vinylogous addition reactions, see: a) Casiraghi, G.; Battistini, L.; Curti, C; Rassu, G.; 
Zanardi, F. Chem. Rev. 2011, 111, 3076–3154. b) Schneider, C.; Abels, F. Org. Biomol. Chem. 2014, 12, 
3531–3543. c) Denmark, S. E.; Heemstra, J. R.; Beuter, G. L. Angew. Chem. Int. Ed. 2005, 44, 4682–4698. 
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In this context, Brønsted base catalyzed α-site functionalization of vinylogous enolates 
remains little explored, and in general the reported examples featured moderated 
enantioselectivities or were restricted to specific substrates. There are only few 
examples where in Brønsted base catalyzed α-functionalization of β,γ-unsaturated 
carbonyl compounds with three potentially reactive sites (α, β and α´) has proceeded in 
a stereocontrolled manner.186 Our group accomplished the asymmetric α-addition of a 
β,γ-unsaturated esters and equivalents to nitrostyrene and could be demonstrated that 
thioesters are more reactive and regioselective to α-addition compounds than the 
parent esters (Scheme 40).186b In the study previously carried out by Tan and 
collaborators, the asymmetric addition of β,γ-unsaturated thioester to azodicarboxylate 
compounds was γ-selective.187  
 
Scheme 40. Asymmetric addition of β,γ-unsaturated thioester to nitrostyrene. 
In consequence, the use of thioesters as activated ester equivalents has enabled to 
expand the inherently difficult α-reactivity of the parent ester.  
3.1.2. Isocyanothioacetates in asymmetric synthesis 
Until the starting of this thesis, a single precedent was known involving 
isocyanothioacetates as reagents in the synthesis of chiral compounds. Rotstein et al. 
reported a reactions secuence between isocyanoacetates and other enantiopure 
starting materials for the synthesis of chiral macrocycles (Scheme 41).188  
                                                     
186
 a) Frias, M.; Mas-Ballesté, R.; Arias, S.; Alvarado, C.; Alemán, J. J. Am. Chem. Soc. 2017, 139, 672–679. b) 
Iriarte, I.; Olaizola, O.; Vera, S.; Gamboa, I.; Oiarbide, M.; Palomo, C. Angew. Chem. Int. Ed. 2017, 56, 
8860–8864. 
187
 Wang, J.; Chen, J.; Kee, C. W.; Tan, C.-H. Angew. Chem. Int. Ed. 2012, 51, 2382–2386. 
188
 Rotstein, B. H.; Winternheimer, D. J.; Yin, L. M.; Deber, C. M.; Yudin, A. K. Chem. Commun. 2012, 48, 
3775–3777. 
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Scheme 41. Isocyanothioacetates in chiral macrocycles synthesis. 
More recently and during the progress of our investigations, Li et. all carried out a 
diastereoselective α-addition of glycine-thioester isonitrile to chiral aldehydes, as a key 
step for the synthesis of pseudaminic acid (Pse) saccharide and its functionalized 
derivatives from L-threonine (Scheme 42). 189 The diastereoselectivity of the aldol 
addition under this condition could be rationalized by the lithium cation chelation 
stabilized Felkin-Anh model, which resulted in the formation of a cis-oxazoline that was 
hydrolyzed one-pot to give the desired aldol products. Finally, the aldol products could 
be transformed in Pse glycosyl donors, which were used for the synthesis of biologically 
active Pseudomonas aeruginosa 1244 pilin trisaccharide. 
 
Scheme 42.  The synthesis of Pseudomonas aeruginosa 1244 pilin through diastereoselective aldol 
reaction involving glycine-thioester isonitrile. 
Therefore, to the best our knowledge, thioester-isocyanides had never been used as 
nucleophiles in catalytic asymmetric reactions; their used in asymmetric synthesis have 
been limited to substrate-controlled reactions involving quiral starting materials. 
                                                     
189
 Liu, H.; Zhang, Y.; Wei, R.; Andolina, G.; Li, X. J. Am. Chem. Soc. 2017, 139, 13420–13428. 
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3.2. Working hypothesis 
As explained before, isocyanoacetates have aroused a great interest among synthetic 
chemists due to the structural richness they provide in such a small portion of the 
molecule (see Chapter 1, Figure 18, page 46). The carboxyl group in the α-position of the 
molecule and the unique reactivity of the isocyano group open a wide range of 
possibilities that no other amino acid equivalent offers. However, to date, their use as 
nucleophiles in the branch of asymmetric organocatalysis has been very limited, in part 
because the low acidity of Cα, as demonstrated in our results with α-alkyl 
isocyanoacetates (see Chapter 2, section 2.4, page 75). Thus, it would be interesting to 
find more active isocyanoacetate equivalents that may serve to considerably expand its 
use in synthesis. 
Our rationale was that employing thioesters-isocyanides as activated 
isocyanoacetate equivalents could expand their use to reactions difficult to perform with 
the parent esters. So, we decided to explore thioester-isocyanides in catalytic 
asymmetric nucleophilic additions, particularly the α-alkyl substituted ones. α-Alkyl 
substituents, compromise reactivity in part because of stereic stress and also because a 
lowering of the Cα acidity.  
Ultimatelly, finding suitable conditions to carry out Brønsted base catalyzed 
enantioselective additions of thioester-isocyanides is not only challenge, but also would 
constitute a new approach for the synthesis of α-quaternary amino acids from the most 
active isocyanide containing AA-derivative nucleophiles found to date. If successful, the 
eventually formed Michael adduct would allow a divergent route to Δ4- and Δ5-
Dehydroprolines with a quaternary α-alkyl stereocenter (Scheme 43). Finally, to 
demonstrate thioester isocyanides generality and synthetic utility, several electrophiles, 
such as vinyl sulphones and imines with different reactivity would be studied. 
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Scheme 43. Synthetic plan for α-alkyl quaternary Δ
4
- and Δ
5
-dehydroprolines asymmetric synthesis. 
The intrinsic nature of these new nucleophiles can be very similar to conventional 
isocyanoacetates, so the new squaramide family (C20-C26) designed and essayed 
successfully in the previous setion were the first BB catalyst candidates to evaluate. 
 
3.3. Synthesis of isocyanothioacetates 
We first focused our efforts in the development of an efficient and robust methology to 
prepare a variety of isocyanothioacetates. 
3.3.1. Isocyano phenyl-thioacetates 
The synthetic route to reach these compounds is different from that used with 
conventional isocyanoacetates because the amine must be protected prior to the 
formation of the thioester. According to the literature, thiol esters could be prepared 
using classical peptidic coupling conditions from Boc-protected amino acids in excellent 
yields.190 Hence, we started with the preparation of thiophenylester-isocyanides 
following the reactions sequence shown in Scheme 44 for the thioester formation. These 
steps were developed with good overall yields (65-97%), but the steps from amine 
hydrochloride to isocyanide required a deeper study. 
                                                     
190
 Garnier-Amblard, E. C.; Mays, S. G.; Arrendale, R. F.; Baillie, M. T.; Bushnev, A. S.; Culver, D. G.; Evers, T. 
J.; Holt, J. J.; Howard, R. B.; Liebeskind, L. S. Med. Chem. Lett. 2011, 2, 438–443. 
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Scheme 44. Reactions sequence for (phenyl)thioesters formation. 
After releasing the amine from the amine hydrochloride, it was attempted to perform 
the formylation under the same conditions as with isocyanoacetates 1 (Table 25, entry 
1), but in all cases (except when Alk= iPr, yield 90%) autocondensation byproduct was 
observed harming the yields of the reaction. Therefore, a variety of reaction conditions 
were studied taking as reference the formylation of amine hydrochloride with R= Me. 
Under conditions of entry 2 and 3 desired product was hardly observed. Nevertheless, 
under conditions of entry 4 the reaction was effective, without formation of the 
byproduct and giving the fomyl-thioesters in 85% isolated yield. These reaction 
conditions could also be used successfully for the formylation of α-Bn and α-iBu amino 
thioesters (yields of 85-94%). 
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Table 25. Conditions for the formylation step.  
 
Entry R Formylation conditions 
Yield of formyl 
products (%) 
Byproduct 
1 Me 
1. NaHCO3 sat. 
2. HCO2Et, 6 h ,reflux 
16% Yes 
2 Me 
1. NaHCO3 sat. 
2. HCO2H, I2, 6 h ,reflux
191 
Messy Yes 
3 Me 
HCO2H, Si(OEt)4, Et3N 
CH3CN, r.t.
 192 
Messy Yes 
4 
Me 
1. HCO2H/EDCI, CH2Cl2 
2. NMM, 5 °C, 16 h193 
85 No 
Bn 94 No 
iBu 85 No 
     
 
The subsequent dehydration step was also not effective under the conditions employed 
with isocyanoacetates, and very complex product mixtures were obtained instead (Table 
26, entry 1). Similar results were obtained with SO2Cl/DMAP system (entry 2). However, 
using triphosgene and N-methyl molpholine as dehydrating system the reaction was 
clean, allowing the formation of the desired isocyano product 27A-D in acceptable yields 
(60-75%). The isonitrile group of isocyanothioacetates 27 is easily detectable by infrared 
spectroscopy as in the case of isocyanoacetates 1. 
                                                     
191
 Kim, J.-G.; Jang, D. O. Synlett 2010, 14, 2093–2096. 
192
 Nishikawa, Y.; Nakamura, H.; Ukai, N.; Adachi, W.; Hara, O. Tetrahedron Lett. 2017, 58, 860–863. 
193
 Chem, F. M. F.; Benoitton, N. L. Synthesis 1979, 9, 709–710. 
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Table 26. Conditions for the dehydration step.  
 
Entry Alk Conditions Product Yield (%) 
1 Bn 
POCl3, DIPA 
CH2Cl2, –30 °C, 2 h
194 
27A Messy 
2 Bn 
SO2Cl, DMAP 
CH2Cl2, –30 °C, 2 h
195 
27A Messy 
3 
Bn 
Triphosgene/NMM 
–78 °C, 2 h196 
27A 60 
Me 27B 62 
iBu 27C 75 
iPr 27D 71 
 
3.3.2.  Isocyano aryl- or benzyl-thioacetates (2nd generation route) 
For reasons that will be commented later, isocyanothioacetates with benzyl or aryl 
thioesters group other than phenyl were required as well. With this objective, we 
prepared several isocyanothioesters containing ortho- or elsewhere substituted aryl 
groups. However, the formation of these thioesters was not possible by applying the 
previous methodology, probably because the N-Boc is too bulky and prevents the attack 
of thiol to the carbonyl group. So, we designed another route starting from N-formyl α-
amino acids instead (Figure 29). 
 
Figure 29. Strategy for the formation of the thioester group.  
                                                     
194
 Buyck, T.; Wang, Q.; Zhu, J. Angew. Chem. Int. Ed. 2013, 52, 12714–12718. 
195
 Arrieta, A.; García, T.; Palomo, C. Synth. Commun. 1982, 12, 1139–1146. 
196
 Zhu, J.; Wu, X.; Danishefsky, S. J. Tetrahedron Lett., 2009, 50, 577–579. 
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Following the reactions sequence shown in Scheme 45 the synthesis of desired 
isocyanothioacetates have been possible with moderate overall yields and in fewer 
steps than in the previous methology. Once the formamides were obtained following a 
simple procedure197, the thioesterification with an array of aryl and benzyl thiols could 
be carried out effectively by employing dicyclohexylcarbodiimide and dimethylamino 
pyridine as coupling activation reagents.198 Finally, the dehydration step was 
accomplished under the same conditions as before. In general, yields of isolated 
compounds over the three steps were good, with the exception of isocyanothioacetates 
bearing 2,6-dichlorophenyl thioester; the final product 31 was hardly observed in any of 
the conditions tested for the last step. 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 45. Synthetic route for α-substituted aryl isocyano thioacetates. 
Eventually it was found that this route was also applicable to α-benzyl phenylthioester-
isocyanide (27A), which could be obtained from DL-phenylalanine in total 3 steps and a 
global 44% isolated yield (methodology 1: global 23% isolated yield). It should be noted 
                                                     
197
 Aizpurua, J. M.; Palomo, C. Synth. Commun. 1983, 13, 745–752. 
198
 See ref. 184, page 98. 
R Product 
Overall Yields 
(%) 
Ph 27 44 
1-Naphth 28 33-37 
2,6-Me2C6H3 29 43-64 
2,6-ClMeC6H3 30 40 
2,6-Cl2C6H3 31 12-22 
3,5-(CF3)2C6H3 32 30 
2,4,6-iPr3C6H2 33 50 
2-OMeC6H4 34 46 
Bn 35 33 
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that compounds 27-35 are stable enough to be stored at low temperature (–30 °C) for 
months. 
3.4. Michael reaction with enones: synthesis of α-alkyl α-
quaternary dehydroprolines 
3.4.1. Synthetic plan 
As can be seen in the introduction, the nucleophilic conjugate additions of α-substituted 
isocyanoacetates to Michael acceptors involve most often very reactive olefins or 
require the presence of a metal complex to catalyze the reaction (see Chapter 1, Table 8, 
page 41). In addition, in these instances, the initially formed Michael adduct tends to 
cyclisize intramolecularly to exclusively lead to α-quaternary Δ4-dehydroprolines. 
However, as shown in the previous chapter the linear Michael adducts of this reaction 
offer a greater synthetic diversity, allowing the synthesis of proline derivatives of 
different nature (Scheme 46). Nevertheless, as it reflected experimentally in the Chapter 
2 of this thesis, the low reativity of isocyanoacetates is accentuated in α-alkyl 
isocyanoacetates, and thus, the stereocontrolled additions that involve them suppose a 
greater challenge.  
 
Scheme 46. Summary of the study carried out in chapter 2 
Therefore, we set out to explore the catalytic asymmetric Michael addition of α-alkyl 
isocyanothioacetates to vinyl ketones. It was our expectation that the α-isonitrile 
thioacetate esters would be more acidic and so deprotonation by Brønsted-base catalyst 
to form reactive enolate intermediate would be more effective. In addition, also in this 
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way (absence of metal) the intramolecular cyclization step would be less likely to occur 
(Scheme 47).  
It should be noted that there was a single example in which α-substituted 
isocyanoacetates are used as nucleophiles in the catalytic asymmetric conjugate 
addition to vinyl selenones, which act as the equivalent of vinyl sulfone (see Chapter 2, 
Table 9, page 60, entry 2). However, although vinyl selenones are more active than vinyl 
sulfones, the reaction is limited only to α-aryl isocyanoacetates. Hence, once the 
appropriate conditions for the previous reaction were found, α-alkyl 
isocyanothioacetates would be applied in the conjugate addition to vinylsulfones, an 
unexplored reaction to date.  
 
Scheme 47. Synthetic plan for catalytic asymmetric Michael addition of.α-akyl isocyanothioacetates 
If successful, the overall Michael addition of α-substituted isocyano(thio)acetates would 
allow the enantioselective synthesis of a great variety of α-akyl and α-aryl substituted 
quaternary amino acids. 
 
Figure 30. α-Akyl and α-aryl substituted quaternary amino acids. 
3.4.2. Catalytic Michael reaction with enones 
The initial study was carried out using the isocyanothio(phenyl)acetate 27A and methyl 
vinyl ketone 2a (Scheme 48). We observed that the squaramide C5 could catalyze the 
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reaction giving Michael adduct 36Aa with low yield and moderate enantiocontrol. 
Besides desired adduct 36Aa, the formation of several by-products was observed, which 
could be isolated and indentified as the oxazole 37A and the thio-Michael adduct 38. 
Palusible routes to both byproducts via intermediate enolate are shown in Scheme 48. In 
order to improve the yield of the desired product 36Aa it was convenient to find a way 
to avoid these undesired reaction pathways. 
 
Scheme 48. Catalytic asymmetric Michael addition of 27A to methyl vinyl ketone 2a.  
In subsequent experiments it was observed that the reaction of 27A with aryl vinyl 
ketones 2c/2d in the presence of catalyst C26 effectively provided Michael adducts 36Ac 
and 36Ad with moderate yields and excellent enantiocontrol (Scheme 49). In these 
instances by products analogs to 37A and 38 were not observed. Instead, a new by-
product 39 was isolated. The divergent behaviour of aryl enones as compared with alkyl 
enones might be explained base on the: 1) higher reactivity of the former 2) additional 
stabilization of both the Michael adduct enolate and the enol lactone by-product. In 
addition, the carbonyl group in thioesters is more susceptible to a nucleophilic attack 
than in a parent oxoester, making possible the formation of the corresponding lactone 
39 for the first time. Thus, to avoid the formation of the lactone was essential to 
improve the yield of the desired Michael adducts (40-60%). 
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Scheme 49. Catalytic asymmetric Michael addition of 27A to aryl vinyl ketones 2c-d.  
3.4.2.1. Substrate optimization 
We set out to explore the most appropriate conditions to improve the yield of the 
reaction towards the acyclic Michael addition product. To that end, some precursors of 
α-isocyanothioesters, such as α-formamido 40 and N-Boc α-amido thioester 42, were 
also evaluated for their reactions with enones, but these attempts were completely 
unsuccessful and unreacted starting material was recovered (Scheme 50). 
 
Scheme 50. Catalytic asymmetric Michael addition involving precursors of α-isocyanothioesters. 
Our next focus was on the nature of the thioesters and how the nature of the S-
subtituent may affect the course of the reaction. In this respect we envisaged bulky 
thioester groups could probably prevent formation of these by-products (Scheme 51).  
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Scheme 51. Strategy to avoid the formation of by-products. 
For that purpose, α-akylisocyanothioacetates with more sterically demanding thiols, 
namely 1-naphthyl, 2,6-Me2C6H3 and Bn groups, were prepared and evaluated (Table 
27). The reaction of 28B with methyl vinyl ketone (2a) in the presence of 10 mol% C26 
did not produce even traces of product 44 (entry 2). On the contrary, both 
isocyanoacetates 29 and 35 reacted cleanly to produce the corresponding adducts 45 
and 46 essentially as sole reaction product (entry 3, 4 and 5). Within these isocyano 
thioester compounds, the one containing ortho-dimethyl-substituted aryl group (29) was 
better in enantioselectivity terms (entry 3: 88% ee, entry 4: 91% ee), and thus, it was 
selected to continue with the study. We could also observe the effectiveness of the new 
catalyst C26 in stereochemical terms compared to the common squaramide C5 (entry 5). 
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Table 27. Substrate optimization for the Michael addition to methyl vinyl ketone 2a.
a
 
 
 
Isocyanothioacetate 
Products 
Products 
ratio 
Yield 
(%)b 
ee (%) 
R2  
1 
 
27A 36Aa:37A:38 38:24:38 30 68b 
2 
 
28B 44Ba:47B:48 0:57:43 -- -- 
3 
 
35B 46Ba 100:0:0 62 88 
4 
 
29B 45Ba 100:0:0 90 91 
5 29A 45Aa 100:0:0 74 92/80c 
[a] Reaction conduced on a 0.1 mmol scale in 0.4 mL CH2Cl2 (molar ratio isocyanothioacetate/2/catalyst 
1:2:0.1). The enantioselectivity determined by chiral HPLC. [b] Yields of isolated Michael adducts after 
complete conversion. [c] Reaction carried out using C5 (10 mol%). 
To see the generality of this reaction, the Michael addition of isocyano thioacetates 27 
and 29 to aryl vinyl ketones 2c-d (Table 28) was evaluated. Whereas in the reactions 
with 27 the formation of the corresponding lactone 39 was always observed (entry 1-5), 
with 29 only the desired product 45 was observed (entry 6-7). However, the reactivity 
decreased considerably especially with p-methylaryl enone partner (2d), hence, we used 
3 equivalents of enone 2d (entry 7).  
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Table 28. Substrate optimization for the Michael addition to aryl vinyl ketones 2c-d.
a
 
 
 
Isocyanothioacetate Vinyl 
ketone 
Products 
Products 
ratio 
Yield 
(%)b 
ee 
(%) 
R2  
1 
 
27A 2c 36Ac:39Ac 75:25 40 90 
2 27A 2d 36Ad:39Ad 85:15 60 94 
3 27B 2d 36Bd:39Bd 75:25 41 93 
4 27C 2c 36Cc:39Cc 80:20 52 96 
5 27D 2c 36Dc:39Dc 90:10 74 98 
6 
 
29A 2c 45Ac 100:0 77 94 
7 29A 2d 45Ad 100:0 70 92 c 
[a] Reaction conduced on a 0.1 mmol scale in 0.4 mL CH2Cl2 (molar ratio isocyanothioacetate/2/catalyst 
1:2:0.1). The enantioselectivity determined by chiral HPLC. [b] Yields of isolated Michael adducts after 
complete conversion. [c] Reaction run for 2 days and using 3 equiv. of 2d. 
3.4.2.2. Scope of the reaction 
With the o,o-dimethylphenyl thioesters isocyanide selected as optimum, the substrate 
scope of the catalytic reaction was studied (Table 29). This reactivity pattern was general 
for an array of vinyl ketones, including the α´-hydroxy enone 6a.  Regarding the α-alkyl 
isocyanide, isocyanoacetates 29 bearing short, medium, longer and branched α-alkyl 
chains, all provided the Michael acyclic adducts in good yields and excellent 
enantioselectivities and without any detectable main by-product. Furthermore, as the 
production of compound 45Fe illustrates, the reaction can be run at 3 mmol scale 
without any detriment in yield or stereoselectivity. 
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Table 29. Reaction scope of α-alkyl isocyanothioacetates asymmetric Michael addition to vinyl ketone.
a
 
[a] Reaction conduced on a 0.1 mmol scale in 0.4 mL CH2Cl2 (molar ratio 1/2/catalyst 1:2:0.1). Yields of 
isolated product after column chromatography. The enantioselectivity determined by chiral HPLC. [b] 
Reaction run at 3 mmol scale using 1.3 equiv. of 2e.  
We next considered applying the α-aryl substituted thioesters series as well, which 
would be of great interest to increase the reactivity as, for example, of ortho-substituted 
aryl isocyanoacetates (see Chapter 2, Table 17, page 79, compounds 9Fa and 9Ga). 
However, as shown in Scheme 52, reaction between 29G and 2c in the presence of C5 
failed, and instead of Michael adduct 45Gc, product 50 coming from intramolecular oxo-
cyclization was exclusively formed, even cooling the experiment at –20 °C. Therefore, 
the use of thioesters as active oxoester surrogates, a priori, does not seem possible in 
the case of α-aryl isocyanides. 
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Scheme 52.  
Concluding, the substitution of the ester group in isocyanoacetates by a thioester 
allowed to perform the catalytic asymmetric Michael addition of α-alkyl 
isocyano(thio)acetates to vinyl ketones, providing acyclic Michael adducts bearing α-
alkyl quaternary stereocenters with good isolated yields and excellent 
enantioselectivities.199 
 
3.4.3. Elaboration of adducts 
The Michael adduct 45Be was submitted to several transformations to demonstrate the 
synthetic potential of these adducts. In each case the corresponding Δ4-dehydroproline 
and Δ5-dehydroproline were formed, thus paralleling the results obtained with the 
isocyanoacetate adducts (see Chapter 2, section 2.5, page 81-113). 
For example, when the isocyano ketone 45B was subjected to hydrolysis in 
hydrochloric acid solution for two hours the corresponding Δ5-dehydroproline 51 was 
obtained in good yield (Scheme 53). 
                                                     
199
 This reactivity pattern appears to be independent of the acceptor. For example, although N-phenyl 
maleimide hardly reacts with α-benzyl and α-methyl isocyanoacetate methyl ester through Brønsted base 
catalysis (Chaper 2, Table 9, entry 1, page 60), the reaction with isocyanothioacetate 29A proceeded 
smoothly (10 mol% C26, r.t., overnight) to produce the correspondig adduct in 70% isolated yield, albeit as 
a mixture of diastereomers (dr= 70:30, 68%/80% ee). 
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Scheme 53. Synthesis of α-alkyl quaternary Δ
5
-dehydroproline 51. 
On the other hand, treatment of 45Be to silver(I) fluoride and DBU, afforded the 
corresponding Δ4-dehydroproline 52. In this instance, at some point in the reaction 
course or during aqueous workup, the thioester gets also hydrolized to give the free 
carboxylic acid. 
 
Scheme 54. Synthesis of α-alkyl quaternary Δ
4
-dehydroproline 52. 
 
3.4.4. Reaction with vinyl sulfones as acceptor 
Vinyl sulfones have demonstrated their value as building blocks in organic chemistry 
involving very different reactions,200 including asymmetric versions.201 They have been 
used mainly in Michael addition reactions, being the desulfonilation the most common 
aftermath transformation. Accordingly, the Michael addition of α-amino acid derivatives 
to vinyl sulfones gives access to interesting α-alkyl substituted amino acids. Likewise, by 
using α-alkyl amino acid derivatives as nucleophiles α,α-dialkyl amino acids would be 
obtained (Scheme 55). As alternative routes to enantiopure α,α-dialkyl amino acids, the 
                                                     
200
 a) Simpkins, N. S. Tetrahedron 1990, 46, 6951–6984. b) Simpkins, N. S. Sulphones in Organic Synthesis 
(Pergamon, Oxford) 1993. c) Forristal, I. J. Sulfur Chem. 2005, 26, 163–195. d) El-Awa, A.; Noshi, M. N.; du 
Jourdin, X. M.; Fuchs, P. L. Chem. Rev. 2009, 109, 2315–2349. d) Alba, A.-N. R.; Compayó, X.; Rios, R. Chem. 
Soc. Rev. 2010, 39, 2018–2033. 
201
 Carretero, J. C.; Arrayás, R. G.; Adrio, J. Organosulfur Chemistry in Asymmetric Synthesis, Toru, B., Bolm, 
C., Eds.; Wiley, 2008; pp 291.  
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catalytic alkylation of α-alkyl amino acid derivatives (or glycine)202 and the Strecker 
reaction involving ketimines203 are the most commonly employed.  
 
Scheme 55. Synthesis of α,α-dialkyl AAs through the Michael addition to vinyl sulfones. 
Nevertheless, in the presence of a metal to catalyze the asymmetric Michael addition of 
α-alkyl AA derivatives to vinyl sulfones, the intramolecular cyclization of the Michael 
adduct occurs spontaneously in most instaces resulting in cycloaddition products.204 
Studies describing isolation of the respective acyclic Michael adducts have been limited, 
and usually involve organocatalytic methods. Deng and co-workers developed the first 
highly enantioselective catalytic conjugate addition to vinyl sulfones, involving the use of 
O-phenantrenyl quinine as a monofunctional Brønsted base catalyst and using α-
substituted cyanoacetates as nucleophiles (Scheme 56).205 Nevertheless, the 
transformation of the nitrile group into amine is not direct, so the adduts were 
elaborated through a 3 steps sequence providing α-amino acids with modest overall 
yield. 
                                                     
202
 a)  Maruoka, K.; Ooi, T. Chem. Rev. 2003, 8, 3013–3028. b) see Chapter 1, ref 103b, page 59. 
203
 For selected articles, see: a) Vachal, P.; Jacobsen, E. N. J. Am. Chem. Soc. 2002, 124, 10012–10014. b) 
Masumoto, S.; Usuda, H.; Suzuki, M.; Kanai, M.; Shibasaki, M. J. Am. Chem. Soc. 2003, 125, 5634–5635. c) 
Wang, J.; Wang, W.; Li, W.; Hu, X.; Shen, K.; Tan, C.; Liu, X.; Feng, X. Chem. Eur. J. 2009, 15, 11642–11659. 
204
 See Chapter 2, ref. 90, page 26. 
205
 a) Li, H.; Song, J.; Liu, X.; Deng, L. J. Am. Chem. Soc. 2005, 127, 8948–8949. For more recent examples, 
see: b) Liu, T. Y.; Long, J.; Li, B.; Jiang, L.; Li, R.; Wu, Y.; Ding, L. S.; Chen, Y.-C. Org. Biomol. Chem. 2006, 4, 
2097–2099. c) Li, H.; Song, J.; Deng, L. Tetrahedron 2009, 65, 3139–3148.  
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Scheme 56. Enantioselective catalytic conjugate addition of α-substituted cyanoacetates to vinyl sulfones. 
More recently, azlactones were used as α-AA surrogates in their reaction with vinyl bis-
sulfones206 in the presence of a thiourea catalyst. α,α-Dialkyl amino acid derivatives 
were obtained upon hydrolysis and subsequent double desulfonation of adducts, which 
makes the method hardly atom economic. 
 
Scheme 57. Enantioselective catalytic conjugate addition of α-alkyl azlactones to vinyl sulfones. 
It is remarkably that no study is known regarding the catalytic asymmetric Michael 
addition of α-substituted isocyanoacetates to vinyl sulfones. As mentioned earlier (see 
                                                     
206
 Alba, A.-N. R.; Compayó, X.; Valero, G.; Moyano, A.; Rios, R. Chem. Eur. J. 2010, 16, 5354–5361. 
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Chapter 2, Table 9, page 60),207 a single example is known of catalytic addition of 
isocyanoacetates to vinyl selenones acting as vinyl sulfone equivalents; but even vinyl 
selenones are proven more active olefins than vinyl sulfones, the α-alkyl 
isocyanoacetates still turn out to be too little reactive to give the conjugate addition.  
In view of this gap in the use of α-isocyanoacetates, the catalytic asymmetric 
Michael addition of α-alkyl isocyano thioesters to vinyl sulfones was considered for 
study. At the outset, both reactivity as well as stereocontrol during formation of 
quaternary stereocenters remained considerable challenges.  
3.4.4.1. Study of the catalytic reaction 
A series of selected vinyl sulfones were tested against their reaction with 
isocyanothioacetate 29A under the catalytic conditions previously optimized for the 
enones (Table 30). Phenylsulfonylethylene was initially selected as model acceptor,208 
but it displayed very low reactivity (entry 1). Then the comparatively more reactive 
geminal bis-sulfone group was tested,209 but under this reaction conditions messy 
reaction crude was obtained even at –20 °C (entry 2). Recently, heteroaryl vinyl sulfones 
have been used as acceptor olefins with increased reactivity.210 Specifically, it has been 
demonstrated that sulfones with a phenyltetrazole ring at the sulfur atom are more 
reactive and show interesting sythetic possibilities, 211 so we decided to test them. We 
found that this vinyl sulfone reacted with the isocyano(thio)acetate 29A using the 
gem,gem-(bis)diaryl C26 as catalyst (entry 3), without formation of undesired 
byproducts. Nevertheless, the enantioselectivity of the reaction was low and the 
reaction proceeded too slowly, so further study of the reaction conditions and catalyst 
was undertaken. We reproduced the reaction of entry 3 using toluene as solvent, which 
led to product 58 with an increased enantioselectivity (from 30% to 44% ee). 
                                                     
207
 See: a) ref 153b, page 60. For recently reported transformations of phenylselenonyl group, see: b) 
Buyck, T.; Wang, Q; Zhu, J. J. Am. Chem. Soc. 2014, 136, 11524–11528. c) Torres-Ochoa, R. O.; Buyck, T.; 
Wang, Q.; Zhu, J. Angew. Chem. Int. Ed. 2018, 57, 5679–5683. 
208
 See ref. 200, page 117. 
209
 For some representative examples, see: a) Mossé, S.; Alexakis, A. Org. Let. 2005, 7, 4361–4364. b) Zhu, 
Q.; Cheng, L. L.; Lu, Y. Chemm. Commun. 2008, 44, 6315–6317. c) Zhu, Q.; Lu, Y. Org. Lett. 2009, 11, 1721–
1724. d) Zhu, Q.; Lu, Y. Angew. Chem. Int. Ed. 2010, 49, 7753–7756. e) Quitard, A.; Alexakis, A. Chem. 
Commun. 2011, 47, 7212–7214. For articles involving amino acid derivatives as nucleophiles, see: f) see 
ref. 205b, page 118. g) see ref. 206, page 119. 
210
 a) Mauleón, P.; Alonso, I.; Rivero, M. R.; Carretero, J. C. J. Org. Chem. 2007, 72, 9924–9935. b) 
Desrosiers, J.-N.; Bechara, W. S.; Charette, A. B. Org. Lett. 2008, 10, 2315–2318.  
211
 a) Rodrigo, E.; Morales, S.; Duce, S.; Ruano, J. L. G.; Cid, M. B. Chem. Commun. 2011, 47, 11267–11269. 
b) Uraguchi, D.; Nakamura, S.; Sasaki, H.; Konakade, Y.; Ooi, T. Chem. Commun. 2014, 50, 3491–3493. c) 
Simlandy, A. K.; Mukherjee, S. Org. Biomol. Chem. 2016, 14, 5659–5664. d) Rodrigo, E.; Alonso, I.; Ruano, J. 
L. G.; Cid, M. B. J. Org. Chem. 2016, 81, 10887–10899. 
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Accordingly, toluene was adopted as the solvent of choice for the remaining 
experiments which include variation of the nature of the thioester group.  
Table 30. Screening of vinyl sulfones.
a
 
 
Entry Vinyl sulfone Conditions Product Results 
1 
 
r.t., 16 h 56 No reaction 
2 
 
–20 °C, 2 h 57 Messy crude 
3 
 
r.t., 48 h 58 
70% conversion 
47%, 30% ee (44% ee)b 
 [a] Reaction conduced on a 0.2 mmol scale in 0.4 mL CH2Cl2 (molar ratio 1/2/catalyst 1:2:0.1). Yields of 
isolated product after column chromatography. The enantioselectivity determined by chiral HPLC. [b] 
Reaction carried out using toluene as solvent. 
Knowing that Michael reaction to vinyl ketones was closely conditioned by the thioester 
nature, we performed a screening of thioester groups in the reaction with vinyl sulfone 
55 (Table 31, reaction a). We wanted to see the effect of the incorporation of halide 
groups in the thioesters using 31A. As expected, the reaction was much faster, with a full 
conversion at 16h, and also it showed a positive effect in the stereoselectivity of the 
reaction (62% ee, entry 2). In its turn, the thioester 30A, a kind of hybrid of 29 and 31, 
behaved similar to 31A in terms of reactivity (entry 3), with the advantage that the 
isocyanoacetate 30A could be synthesized more effectively than 31A. The thioesters 
28A, 32A and 35A were also tested, but whilst the reactions proceeded equally well, the 
stereocontrol diminished considerably (entry 4-5), and with the new nucleophile 32A 
stereoselectivity was neglectable (entry 6). In all experiments carried out with these 
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nucleophiles, the reactions were clean and only traces of intramolecular oxo-cyclization 
byproduct could be observed (<5%). Finally, the reaction did not work well using a 
relatively active oxoester 62 (Table 31, reaction b), so the thioester group at the 
nucleophile resulted essential.  
Table 31. Screening of the (thio)ester group.
a
 
 
Entry Nucleophile R t (h) Product Yield (%) ee (%) 
1 29A 
 
48 56 47 (70)b 44 
2 31A 
 
16 57 90 62 
3 30A 
 
16 58 60 65 
4 28A 
 
16 59 61 40 
5 35A 
 
48 60 43 28 
6 32A 
 
16 61 50 0 
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[a] Reaction conduced on a 0.1 mmol scale in 0.4 mL toluene (molar ratio 1/2/catalyst 1:2:0.1). Yields of 
isolated product after column chromatography. The enantioselectivity determined by chiral HPLC. [b] The 
results in parentheses indicate the conversion value when the total conversion was not achieved.  
Once the suitable nucleophile was selected, other types of bifunctional Brønsted base 
catalysts were tested (Table 32). In all cases the conversion was total upon 16 h of 
reaction, but with lower levels of stereocontrol (essentially 0% ee with thiourea C3). The 
Rawal´s squaramide C9 also gave a low enantiomeric excess compared to the gem,gem-
(bis)diaryl squaramide catalyst C26. However, surprisingly the catalyst C27, analogous to 
C26 which contained (–)-dihydroquinine as a Brønsted base, improved the enantiomeric 
excess, providing the product 58 in moderated yield and enantioselectivity (64%, 74% 
ee). 
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Table 32. Screening of catalysts. 
 
[a] Reaction conduced on a 0.2 mmol scale in 0.4 mL CH2Cl2 (molar ratio 1/2/catalyst 1:2:0.1). Yields of 
isolated product after column chromatography. The enantioselectivity determined by chiral HPLC. [b] 
Reaction carried out using toluene as solvent. 
During this preliminary study it was demonstrated that the isocyanothioesters work 
correctly in the Michael addition with vinylsulfones, giving solution for the first time to 
the reactivity problem shown by the α-alkyl isocyanoesters in similar reactions. It has 
also been possible to see the compatibility of the new squaramide catalysts with these 
AA-derivative nucleophiles to give several conjugate additions in a stereocontrolled 
fashion. However, we eventually decided to stop here the study with vinyl sulfones, and 
we moved to study a different class of acceptor reagents. 
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3.5. Mannich reaction: synthesis of α-alkyl α-quaternary 
imidazolines 
In this section, our purpose was to expand the application of α-alkyl 
isocyanothioacetates to asymmetric Mannich reactions using the newly designed 
bifunctional Brønsted base catalysts. 
The Mannich reaction is one of the most powerful methods for the preparation 
of chiral nitrogen containing molecules with concominant formation of a new C-C 
bond.212 Along the process, imines work as electrophilic reagents and β-amino carbonyl 
compound with up to two new stereogenic centers can be generated (Figure 31).  
 
Figure 31. General Mannich reaction. 
Many approaches have been developed to afford asymmetric Mannich reactions. Some 
of them are based on the use of chiral auxiliaries,213 but in the last decades catalytic 
asymmetric Mannich methodologies have been developed based on the use of metal 
catalysts214 or organocatalysts, particularly enamine mediated methods using aldehydes 
and ketones as donor carbonyl components.215,216  
                                                     
212
 For general reviews on the asymmetric Mannich reaction, see: a) Arend, M.; Westermann, B.; Risch, N. 
Angew. Chem. Int. Ed. 1998, 37, 1044–1070. b) Syamala, M. Org. Prep. Procc. Int. 2009, 41, 1–68. c) Greco, 
S. J.; Lacerda, V.; Bezerra dos Santos, R. Aldrichimica Acta 2011, 44, 15–23. d) Bhadury, P. S.; Song, B.-A. 
Curr. Org. Chem. 2010, 14, 1989–2006. e) Xiao-Hua, C.; Hui, G.; Bing, X. Eur. J. Chem. 2012, 3, 258–266. 
213
 For some pioneer stereoselective Mannich reaction using chiral auxiliaries, see: a) Broandley, K.; 
Davies, S. G. Tetrahedron Lett. 1984, 25, 1743–1744. b) Hart, D. J.; Lee, C.-S. J. Am. Chem. Soc. 1986, 108, 
6054–6056. c) Gennari, C.; Venturini, I.; Gilson, G.; Shimperna, G. Tetrahedron Lett. 1987, 28, 227–230. For 
more recent representative examples, see: a) Oppolzer, W.; Moretti, R.; Thomi, S. Tetrahedron Lett. 1989, 
308, 5603–5606. b) Evans, D. A.; Urpi, F.; Somers, T. C.; Clark, J. S.; Bilodeau, M. T. J. Am. Chem. Soc. 1990, 
112, 8215–8216. c) Enders, D.; Ward, D.; Adam, J.; Raabe, G. Angew. Chem. Int. Ed. Engl. 1996, 35, 981–
984. d) Palomo, C.; Oiarbide, M; González-Rego, M. C.; Sharma, A. K.; García, J. M.; Landa, C.; Linden, A. 
Angew. Chem. Int. Ed. 2000, 39, 1063–1065. 
214
 For selected reviews on metallocatalyzed approaches, see: a) Shibasaki, M.; Matsunaga, S. J. 
Organomet. Chem. 2006, 691, 2089–2100. b) Kazmaier, U. Angew. Chem. Int. Ed. 2009, 48, 5790–5792. c) 
Tsubogo, T.; Yamashita, Y.; Kobayashi, S. Top. Organomet. Chem. 2013, 45, 243–270. d) Karimi, B.; Enders, 
D.; Jafari, E. Synthesis 2013, 2769–2812. 
215
 For selected reviews on organocatalyzed approaches, see: a) Notz, W.; Tanaka, F.; Watanabe, S.; 
Chowdari, N. S.; Turner, J. M.; Thayumanavan, R.; Barbas III, C. F. J. Org. Chem. 2003, 68, 9624–9634. b) 
Marques, M. M. B. Angew. Chem. Int. Ed. 2006, 45, 348–352. c) Ting, A.; Schaus, S. E. Eur. J. Org. Chem. 
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The Mannich reaction involving α-amino acid equivalents constitutes one of the 
most practical routes towards the preparation of α,β-diamino acids stereoselectively,217 
important structural motifs that are contained in many biologically active compounds 
(see Chapter 1, section 1.4, page 42). The common approach consists on the catalytic 
asymmetric direct Mannich reaction between a prochiral α-amino acid derivative and an 
imine, which results in the construction of a C-C bond and the two neighbouring 
nitrogen containing stereocenters simultaneously in a single step (Scheme 58). Several 
α-AA surrogates (particularly α-carboxy azomethine ylides,218 α-nitroesters,219 
azlactones,220 and isothiocyanates221) have been employed in this context, with methods 
employing α-isocyanoacetates being underdeveloped to date. The Mannich reaction 
between α-carboxy azomethine ylides and imines is perhaps the most thoroughly 
investigated approach. 
                                                                                                                                                              
2007, 5797–5815. d) Verkade, J. M. M.; van Hemert, L. J. C.; Quaedflieg, P. J. L. M.; Rutjes, P. P. J. T. Chem. 
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Hazell, R. G.; Jørgensen, K. A. J. Org. Chem. 2003, 68, 2583–2591. b) Ooi, T.; Kameda, M.; Fujii, J.-I.; 
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Hou, X.-L.; Wu, Y.-D.  J. Am. Chem. Soc. 2008, 130, 14362–14363. h) Shang, D.; Liu, Y.; Zhou, X.; Liu, X.; 
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2013, 135, 11799–11802. 
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Scheme 58. Mannich addition of α-amino acid precursors on route to α,β- diamino acids products. 
 
3.5.1. Isocyanoacetates in catalytic asymmetric Mannich reactions 
An attractive route to enantiopure α,β-diamino acids starting from isocyanates proceeds 
via 2-imidazoline formation and subsequent standard hydrolytic or reductive 
manipulation.222 2-Imidazolines may be formed by catalytic asymmetric Mannich 
addition/cyclization reactions between isocyanoacetates and imines (Scheme 59).  
 
Scheme 59. General approach for α, β-diamino acids synthesis based on catalytic asymmetric Mannich 
reaction of isocyanoacetates. 
On the other hand, substituted imidazolines are structural subunits of biologically active 
compounds223 and they are useful for the synthesis of cyclopalladated complexes, chiral 
catalysts and chiral solvating agents as well.224 Due to these practical interests, chemists 
                                                     
222
 a) Sang-Hun, J.; Harold, K. Tetrahedron Lett. 1984, 25, 399–402. b) Meyer, R.; Schöllkopf, U.; Bohme, P. 
Liebigs Ann. Chem. 1977, 1183–1193. 
223
 For example, see: a) Betschart, C.; Hegedus, L. S. J. Am. Chem. Soc. 1992, 114, 5010–5017. b) Rondu, F.; 
Le Bihan, G.; Wang, X.; Lamouri, A.; Touboul, E.; Dive, G.; Bellahsene, T.; Pfeiffer, B.; Renard, P.; Guardiola-
Lamaitre, B.; Manechez, D.; Penicaud, L.; Ktorza, A.; Godfroid, J. J. J. Med. Chem. 1997, 40, 3793 –3803. c) 
Hsiao, Y.; Hegedus, L. S. J. Org. Chem. 1997, 62, 3586–3591. 
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729. b) Liu, H.; Du, D.-M. Adv. Synth. Catal. 2009, 351, 489–519. c) Liu, H.; Du, D.-M. Adv. Synth. Catal. 
2010, 352, 1113–1118. 
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have made great efforts in developing methodologies for their enantioselective 
synthesis. 
The racemic Mannich-type reaction of isocyanoacetates with imines was first 
reported by Schöllkoptf et al. in 1977.225 In 1996 Hayashi et al. reported the Au(I)-
catalyzed cis-diastereoselective Mannich reaction of isocyanoacetates with N-
sulfonylimines226 and the following studies showed that the diastereoselectivity depends 
closely on the catalyst used.227 As far as the enantioselective Mannich versions of these 
substrates are concerned, the majority of the methods are based on combined use of 
chiral ligands and metal; the transition metal is assumed to coordinate to isocyano 
group during activation.  
Metal-catalyzed methods reported to date are collected in Table 33.228 In 1999, 
Lin et al. found that the reaction between ethyl isocyanoacetate and N-Tosyl aldimines 
can be catalyzed by Me2SAuCl and ferrocene-derived diphosphine ligand (entry 1). Later, 
it was found that the same reaction could be promoted by chiral palladium-pincer 
complex catalyst with similar levels of selectivity (entry 2). Ulterior studies 
demonstrated that Ag, Cu and Ni salts in combination with multi(three)dentate 
cinchona-alkaloid-derived ligands are able to promote the reaction between 
isocyanoacetates and several imines (entry 3-7), such as phosphinoyl ketimines (entry 4-
7), even using α-alkyl substituted isocyanoacetates (entry 6-7). However, in all these 
examples activated imines, bearing activating groups attached at N, C or both were 
employed. 
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Dai, L.-X.; Sun, J.; Xia, L.-J.; Tang, M.-H. J. Org. Chem. 1999, 64, 1331–1334. b) Zhou, X.-T.; Lin, Y.-R.; Dai, L.-
X. Tetrahedron: Asymmetry 1999, 10, 855–862. c) Aydin, J.; Rydén, A.; Szabó, J. Tetrahedron: Asymmetry 
2008, 19, 1867–1870. d) Ortín, I.; Dixon, D. J. Angew. Chem. Int. Ed. 2014, 53, 3462–3465. e) Shao, P.-L.; 
Liao, J.-Y.; Ho, Y. A.; Zhao, Y. Angew. Chem. Int. Ed. 2014, 53, 5435–5439. f) Hayashi, M.; Iwanaga, M.; 
Shiomi, N.; Nakane, D.; Masuda, H.; Nakamura, S. Angew. Chem. Int. Ed. 2014, 53, 8411–8415. g) 
Nakamura, S.; Yamaji, R.; Iwanaga, M. Chem. Commun. 2016, 52, 7462–7465. h) de la Campa, R.; 
Yamagata, A. D. G.; Ortín, I.; Franchino, A.; Thompson, A. L.; Odell, B.; Dixon, D. J. Chem. Commun. 2016, 
52, 10632–10635. 
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Table 33. Asymmetric Mannich reactions of isocyanoacetates with imines promoted by metal catalysts. 
 
 
 Electrophile Cat.* Product Results Ref 
1 
 
 
(0.5 mol%)/ 
Me2SAuCl (0.5 mol%) 
 
79-91% 
85:15-96:4 
dr 
46-88% ee 
228a 
2 
(1 mol%) 
 
98% 
1:4 dr 
75% ee 
228c 
3 
  
(20 mol%)/ 
Ag2O (10 mol%) 
 
84-92% 
20:1 dr 
93-91% ee 
228e 
4 
 
  
(20 mol%)/ 
Ag2O (5 mol%) 
 
70-98% 
73:27-99:1 
dr 
90-99% ee 
228d 
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The asymmetric Mannich reaction of isocyanoacetates in the absence of metals still 
remains a scarcely explored area. As far as we are aware, only the works shown in the 
Table 34 are known,229 all involving aldimines with N-activating groups such as sulfonyl 
(entries 1 and 2) or tert-butoxycarbonyl (entry 4), or specially reactive ketimines, such as 
isatin-derived cyclic ketimines showed in entry 3. Furthermore, while α-aryl substituted 
isocyanoacetates have been applied in several reactions (entry 2-4), those with an α-
alkyl substituent still remain a challenge due to their attenuated reactivity. The only 
                                                     
229
 For organocatalyzed asymmetric Mannich reactions of isocyanoacetates, see: a) Zhang, Z.-W.; Lu, G.; 
Chen, M.-M.; Lin, N; Li, Y.-B.; Hayashi, T.; Chan, A. S. C. Tetrahedron: Asymmetry 2010, 21, 1715–1721. b) 
Nakamira, S.; Maeno, Y.; Ohara, M.; Yamamura, A.; Funahashi, Y.; Shibata, N. Org. Lett. 2012, 14, 2960–
2963. c) Zhao, M.-X.; Jing, L.; Zhou, H.; Shi, M. RSC Adv. 2015, 5, 75648–75652. d) Ji, X.; Cao, W.-G.; Zhao, 
G. Tetrahedron 2017, 73, 5983–5992. 
 Electrophile Cat.* Product Results Ref 
5 
 
 
(10 mol%)/ 
Cu(OTf)2 (10 mol%)/ 
Cs2CO3 (20 mol%) 
syn 
R: Ar (syn) 
44-68% 
81:19-92:8 
dr 
91-99% ee 
228f 
R: Alk (anti) 
54-78% 
40:60-28:72 
dr 
93-95% ee 
6 
 
(10 mol%)/ 
NiCl2 (10 mol%)/ 
Cs2CO3 (20 mol%) 
R= Alk, Ar 
68-99% 
85:15-99:1 
dr 
80--92% ee 
228g 
7 
 
(10 mol%)/ 
AgOAc (5 mol%) 
R= Ar, CH2CH2Ph 
48-90% 
98:2 dr 
87-95% ee 
228h 
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example by Nakamura, Shibata et al. using N-azaarenesulfonyl imines is remarkable 
although it failed with the bulky α-isopropyl group (entry 2).  
Table 34. Asymmetric Mannich reactions of isocyanoacetates with imines promoted by organocatalysts. 
 
 Electrophile Cat.* Product Results Ref. 
1 
 
  
(10 mol%) 
 
 
34-79% 
91:9-99:1 dr 
5-70% ee 
229a 
2 
 
 
(10 mol%) 
 
R= Alk, Ar 
R= Ar 
71-99% 
81:19-99:1 dr 
74-96% ee 
229b R= Alk 
73:27-99:1 dr 
78-88 % ee 
(R= iPr: no 
reaction) 
3 
 
 
R1= Ar 
55-90% 
20:1 dr 
69-98% ee 
 
R1= Bn, 2-
BrC6H4: no 
reaction 
229c 
4 
 
1) Mannich reaction: 
 
(0.5 mol%)/ 
Methyl acrylate (0.5 mol%) 
2) Cyclization:  
AgOAc (10 mol%)/ 
PPh2Me (20 mol%) 
 
 
85-98% 
1.1:1-9:1 dr 
50-93% ee 
229d 
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In summary, the organocatalytic asymmetric synthesis of α-quaternary 2-imidazolines, 
particularly those containing α-alkyl quaternary stereocenters, remains underdeveloped 
as yet. The low reactivity of the α-alkyl isocyanoacetates compared to α-aryl analogs is 
one of the major obstacles. 
3.5.2. Objetive 
In view of the good results obtained with gem,gem-(bis)diaryl squaramide catalysts C26-
C27 in various Michael addition reactions of α-alkyl isocyano(thio)acetates, our goal was 
to explore that catalytic system in the context of the Mannich reactions. The attenuated 
reactivity of isocyanoacetates has limited their use in organocatalytic Mannich reactions, 
and to date, squaramide catalysts have never been successfully employed in this type of 
reaction. 
At the beginning the reaction of α-alkyl isocyano(thio)acetates to activated 
aldimines was explored, and then the study was extended to other less activated 
aldimines (Scheme 60). 
 
 
Scheme 60. Synthetic plan. 
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3.5.3. Reaction of α-alkyl isocyano(thio)acetates with activated (N-nosyl) 
aldimines 
The study was initiated by comparing the behavior of several isocyanothioacetates in 
the reaction with the N-nosyl imine 64, using 10 mol% of catalyst C26 and 
dichloromethane as solvent (Table 35). The reaction with 29A as nuclephile proceeded 
in a stereocontrolled manner (entry 1). However, the reaction was too slow and before 
total consumption of the nucleophile the imine hydrolyzed extensively, so the product 
was obtained in a low yield. In addition, although the diastereocontrol of the reaction 
was good, the enantiocontrol was poor (36% ee). We decided to test thioesters 33A and 
30A which exhibit clearly congested sterics and electron-poor character respectively, 
adding molecular sieve at the reaction to avoid the hydrolysis of the imine. The reaction 
with 33A did not go at room temperature and it was necessary to heat up to 50 °C to 
give the product in good yield but low stereocontrol (entry 2). In its turn, the 
isocyanothioacetate 30A gave product 67 with total conversion in 3 h at room 
temperature, and with improved stereocontrol (entry 3). Thus, 30A, bearing ortho-
chloro-ortho-methylphenyl thioester group, was selected for further optimization of the 
reaction conditions. 
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Table 35. Substrate optimization for the Mannich reaction with N-p-Nosyl aldimines.
a
 
 
Entry R 
T 
(°C) 
t (h) Product Yield (%) dr ee (%) 
1 
 
r.t. 16 65 47 90:10 36 
2b 
 
r.t. 16 
66 
n.r. -- -- 
50 16 82 70:30 10 
3b 
 
r.t. 3 67 75 90:10 56 
[a] Reaction conduced on a 0.1 mmol scale in 0.2 mL CH2Cl2 (molar ratio isocyanothioacetate/64/catalyst 
1:1.5:0.1). Yields of isolated product after column chromatography. The diastereoselectivity and the 
enantioselectivity of the major diastereomer determined by chiral HPLC. [b] MS 4 Å was added. 
Next we analyzed the best conditions for the reaction with 30A, varying the catalyst, 
solvent and temperature (Table 36). The Mannich reaction with catalyst C26 in toluene 
as solvent (97:3 dr and 70% ee) was superior as compared with the reaction in CH2Cl2 
(entry 3). On the other hand, the (–)-dihydroquinine catalyst C27 promoted the reaction 
in toluene faster that catalyst C26 yielding essentially a single diastereomer of 
compound 67 at 0 °C with a 72% ee (entry 4). However, catalyst 28 containing two 
tertiary alcohol groups provided product 67 with very poor enantiocontrol (entry 5, 10% 
ee) as in case of the commonly known squaramides (C5, C9 and C29).  
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Table 36. Study of reaction conditions for the addition of 30A to 64. 
[a] Reaction conduced on a 0.1 mmol scale in 0.2 mL CH2Cl2 or toluene (molar ratio 30A/64/catalyst 
1:1.5:0.1) at room temperature. The diastereo- and enantioselectivity determined by chiral HPLC.  
Unfortunately, the bulkier α-iPr isocyanothioacetate 27D resulted inactive under the 
present catalytic conditions (Scheme 61), even heating at 50 °C.  
Entry C Solvent T (°C) t (h) 
Conversion 
(%) 
dr ee (%) 
1 5 CH2Cl2 r.t. 3 100 85:15 3 
2 9 CH2Cl2 0 16 100 85:15 10 
3 26 
CH2Cl2 r.t. 3 100 90:10 56 
Toluene r.t. 16 90 97:3 70 
4 27 Toluene 
r.t. 3 100 97:3 74 
0 3 100 100:0 72 
5 28 CH2Cl2 
r.t. 24 90 85:15 10 
0 16 0 -- -- 
6 29 Toluene r.t. 16 98 80:20 32 
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Scheme 61.  
In summary, the asymmetric Mannich reaction of isocyano(thio)acetates has been 
promoted by a squaramide catalyst for the first time, giving access to α-alkyl quaternary 
N-(p-Nosyl) imidazolines with excellent diastereoselectivity and moderate 
enantioselectivity.  
3.5.4. α-Alkyl isocyano(thio)acetates with unactivated (N-aryl) aldimines 
As far as non-activated imines are concerned (Figure 32), to date they have never been 
used in asymmetric Mannich reactions with α-isocyanoacetates, and imines with N- or C-
activating groups are generally required even in the reactions promoted by metal 
catalysts (see Table 33, page 129 and Table 34, page 131).  
 
Figure 32. Classification of aldimines according to their electrophilicity/reactivity. 
N-aryl propargylic imines are a particular type of non-activated imines with great 
synthetic versatility: the alkynyl moiety in the Mannich adducts may participate in 
several intramolecular cyclization processes,230 or alternatively can be partially or totally 
                                                     
230
 a) Zhang, X.; Larock, R. C. J. Am. Chem. Soc. 2005, 127, 12230–12231. b) Lee, E.-S.; Yeom, H.-S.; Hwang, 
J.-H.; Shin, S. Eur. J. Org. Chem. 2007, 3503–3507. c) Patil, N. T.; Yamamoto, Y. Chem. Rev. 2008, 108, 
3395–3442. c) Gudoi, B.; Schumacher, R. F.; Zeni, G. Chem. Rev. 2011, 111, 2937–2980. d) Gómez-Bengoa, 
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reduced, providing adducts formally derived from recalcitrant imines (little reactive and 
enolizable).230b In addition, the removal of the N-aryl group if desired, can be carried out 
easily in some instances to produce the NH amine by a simple oxidative procedure.231  
These features make the resulting propargylamine adducts potentially versatile building-
blocks in the synthesis of natural products,232 drugs233 and pesticides,234 as well as a 
number of bioactive compounds.235  
Enamine-mediated Mannich methodology involving propargylic imines has been 
previously developed in our laboratory using a new type of α,α-dialkylprolinol catalysts 
(Scheme 62).230d  
 
Scheme 62.   Precedent of our group related to the use of propargylic imines as Mannich acceptor. 
The aim was now to explore the asymmetric Mannich addition of α-alkyl 
isocyanothioacetates to N-aryl propargylic imines using our newly developed gem,gem-
(bis)diaryl squaramide catalyst C27 (Scheme 63).  
  
                                                                                                                                                              
E.; Jiménez, J.; Lapuerta, I.; Mielgo, A.; Oiarbide, M.; Otazo, I.; Velilla, I.; Vera, S.; Palomo, C. Chem. Sci. 
2012, 3, 2949–2957. 
231
 a) Porter, J. R.; Traverse, J. F.; Hoveyda, A. H.; Snapper, M. L. J. Am. Chem. Soc. 2001, 123, 10409–
10410. b) Josephsohn, N. S.; Snapper, M. L.; Hoveyda, A. H. J. Am. Chem. Soc. 2004, 126, 3734–3735. 
232
 a) Yoon, T.; Shair, M.D.; Danishefsky, S. J.; Shulte, G. K. J. Org. Chem. 1994, 59, 3752–3754. b) Jiang, B.; 
Xu, M. Angew. Chem. Int. Ed. 2004, 43, 2543–2546. c) Fleming, J.; Du Bois, J. J. Am. Chem. Soc. 2006, 128, 
3926–3927. 
233
 For selected examples, see: a) Shibasaki, M.; Ishida, Y.; Iwasaki, G.; Limori, T. J. Org. Chem. 1987, 52, 
3488–3489. b) Miyachi, N.; Kanda, F.; Shibasaki, M. J. Org. Chem. 1989, 54, 3511–3513. c) Hoepping, A.; 
Johnson George, K. M.; Flippen-Anderson, J.; Kozikowski, A. P. J. Med. Chem. 2000, 43, 2064–2071. 
234
 Swithenbank, C.; McNulty, P. J.; Viste, K. L. Agric. Food. Chem. 1971, 19, 417–423. 
235
 For selected examples, see: a) Gupta, P.; Qiu, Y.; Adjei, A. Int. J. Pharm. 1997, 147, 207–218. b) Aungst, 
B. J.; Nguyen, N. H.; Taylor, N. J.; Bindra, D. S. J. Pharm. Sci. 2002, 91, 1390–1395. c) Suzuki, T.; Fujii, A.; 
Ohya, J.; Amano, Y.; Kitano, Y.; Abe, D.; Nakamura, H. Cancer Sci. 2007, 98, 1977–1984. 
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Scheme 63. Asymmetric Mannich reaction between α-alkyl isocyanothioacetates and N-aryl propargylic 
imines. 
3.5.4.1. Study of reaction conditions and scope 
The reaction study began testing different propargylic N-aryl imines with the aim to 
assess the impact of the N-aryl group on the reaction outcome (Table 37). The reaction 
of isocyanothioacetate 30A with the N-phenyl or para-nitrile substituted N-aryl imines 
(69a and 69b) in the presence of gem,gem-(bis)diaryl squaramide C27 as catalyst gave 
no imidazoline (entry 1 and 2) and only byproduct 71 was observed in both cases. This 
byproduct, which is analogue to the previously identify 37A (see Scheme 48, page 110), 
derived from the intramolecular hydroalkoxylation of the isonitrile group. 
Table 37. Screenig of propargylic N-aryl imines.
a
 
 
 
Entry Imine t (h) Products 
Products 
ratio 
Yield of 70 
(%) 
dr ee (%) 
1 69a 20 71 0:100 -- -- -- 
2 69b 20 71 0:100 -- -- -- 
3 69c 16 70Ac:71 40:60 20 40:60 20/20 
4 69d 48 70Ad:71 60:40 54 40:60 54/0 
[5] 69e 20 messy -- -- 45:55 4/3 
[a] Reaction conduced on a 0.1 mmol scale in 0.2 mL CH2Cl2 (molar ratio 30A/imine/catalyst 1:1.5:0.1) at 
room temperature. The diastereo- and enantioselectivity determined by chiral HPLC on the reaction 
crude. The compound with the entry in brackets cannot be isolated and characterized.. 
  CHAPTER 3 
 
139 
 
Imine 69c, bearing an ortho-OH group, demonstrated to be more reactive and led to the 
formation of the desired imidazoline product (entry 3). However, the stereoselectivity of 
the reaction and the yield of imidazoline 70Ac were low. It should be noted that imine 
69c is of limited solubility in CH2Cl2, a circumstance that can justify the poor results. The 
higher reactivity of imine 69c as compared to both 69a and 69b might be explained by 
assuming an intramolecular H-bond activation as depicted in Figure 33, model a. On the 
other hand, the corresponding methyl ether analog 69d participated well in the Mannich 
reaction, affording adduct 70Ad in higher yield and with lower amount of byproduct 71 
formed (entry 4). This behaviour indicates that the methoxy group at the ortho position 
can also participate during the reaction probably by facilitating the substrate quelation 
through H-bonding (postulated in section b of the Figure 33). It should be noted that this 
imine was soluble in CH2Cl2 thus facilitating the reaction. Finally, the corresponding 
ortho-ethoxy imine 69e was tested and although 71 was not observed, the 
stereoselectivity of the reaction crude was very bad and the reaction turned out to be 
very dirty (entry 5). Hence, the imines 69c and 69d were selected as the best to continue 
with the study. 
 
Figure 33. Speculative models to justify the increase of reactivity in 69c and 69d imines. 
Subsequent attempts to improve the Mannich reaction outcome by varying the nature 
of the thioesters group as before were unsuccellful. Thus, as results in Table 38 show, 
while the phenyl oxoester isocyanide 62 gave no reaction and starting materials were 
recovered (entry 3), with the rest of the thioesters isocyanides the reactions were dirty 
(entry 4-9), besides that in most cases, the formation of by-product 71 was observed. 
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Table 38. Screenig of the thioester group. 
 
 
Entry 
Isocyano 
thioacetate 
Imine C t (h) 70:71 
Yield of 
70 (%) 
dr ee (%) 
1 
 
69c 27 16 60:40 20 40:60 20/20 
2 69d 27 48 40:60 56 40:60 54/0 
3 
-OPh 
62 
69d 27 72 
Starting 
materials 
-- -- -- 
4 
-SPh 
27A 
69d 27 4 0:100 -- -- -- 
5 
 
69c 
27 16 
Messy + 
71 traces 
-- -- -- 
6 5 16 
Messy + 
71 traces 
-- -- -- 
7 
 
69d 27 16 
Messy + 
71 traces 
-- -- -- 
8 
 
69c 5 72 
Messy + 
72Ac traces 
-- -- -- 
9 69d 27 72 
Messy + 
72Ad traces 
-- -- -- 
[a] Reaction conduced on a 0.1 mmol scale in 0.2 mL CH2Cl2 (molar ratio 
isocyanothioacetate/imine/catalyst 1:1.5:0.1) at room temperature. The diastereo- and enantioselectivity 
determined by chiral HPLC on the reaction crude. The compound with the entry in brackets cannot be 
isolated and characterized. 
Then, a brief survey of reaction conditions and solvent was carried out for the reaction 
between 30A and 69d catalyzed by 27(Table 39). Surprisingly, we could observe by 1H-
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NMR that changing the solvent from CH2Cl2 to toluene the diastereoselectivity was 
reversed (entry 1 vs entry 2). On the other hand, employing toluene as solvent better 
enantiomeric excess was obtained for the major diastereomer (85% ee) but more 
byproduct was formed, probably because the reaction was slower (entry 2). To decrease 
the formation of byproduct, we concentrated the reaction (entry 3); and although under 
these conditions less amount of byproduct is observed at the end of the reaction, the 
stereochemical results were worse both diastereoselectively (65:35 dr) and 
enantioselectively (70% ee for the major diastereomer). Thus, we decided to carry out 
the reaction employing the imine as limiting reagent. In this way, we could obviate the 
formation of 71 and achieve a total consumption of 69b to give the desired product. As 
observed in entry 4, following this strategy 70Ad was obtained with the best results to 
date: 58% yield, moderated diastereoselectivity (82:18) and good enantiomeric excess 
(80%) for the major diastereomer. In all cases using toluene as solvent, the enantiopurity 
of the major diastereomer was much better than that for the minor isomer.  
Table 39.  Study of reaction conditions for the addition of 30A to 69d. 
 
 
Entry 
30A 
equiv. 
69d 
equiv. 
Solvent 
(mL/mmoL) 
t 
(h) 
70Ad:71 
Yied of 
70Ad (%) 
dr ee (%) 
1 1 1.5 CH2Cl2 (2) 48 60:40 54 40:60 54/0 
2 1 1.5 Tol. (2) 20 15:85 15 85:15 85/15 
3 1 2 Tol. (1) 16 45:55 36 65:35 70/0 
4 2 1 Tol. (2) 72 -- 58 82:18 80/14 
[a] Reaction conduced on a 0.1 mmol scale at room temperature. The diastereo- and enantioselectivity 
determined by chiral HPLC on the reaction crude. 
Eventually, during the purification of the reaction crudes by column chromatography we 
observed that the resulting Mannich adducts were not completely stable to silica gel 
conditions. Indeed adduct 72Ac with the bulky tris-isopropylphenyl group was the only 
fully stable congener (Figure 34). According to this observation, we believe that the low 
chemical stability of adducts may be one of the causes of the unsatisfactory yields.  
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Figure 34.  
Then, the reaction was extended to the corresponding α-aryl isocyanoacetates (Table 
40). The tert-butyl ester isocyanide 1A was not sufficiently reactive (entry 1) and a 
phenylester group (more electron-withdrawing) was required for the reaction to 
proceed (entry 2). In addition, with 73 no oxo-cyclization byproducts were produced, 
although other uncharacterized byproducts were observed in small quantities, which 
caused the yields to be moderated. As it happened with the thioester analogues, the 
selectivity towards one or another diastereomer varied depending on the solvent used 
(entry 2 and 3). In addition, toluene turned out to be better than dichloromethane in 
enantioselectivity terms, at least as regards the major diastereoisomer (entry 2: 10% ee 
vs entry 3: 56% ee). In this instance, product 74 was perfectly stable to regular silica-gel 
column purification and in the reaction medium. 
Table 40. Reaction conditions for the corresponding Mannich addition of α-aryl isocyanoacetates. 
 
 
 
Entry Isocyanoacetate 
Cat. 
(mol%) 
Solvent 
(mL/mmoL) 
Yied 74 (%) dr ee (%) 
1 1A 5 DCM (2) -- -- -- 
2 73 5 DCM (2) 57 70:30 10:10 
3 73 27 Tol. (2) 51 40:60 0:56 
[a] Reaction conduced on a 0.1 mmol scale in 0.2 mL of solvent (molar ratio 
isocyanoacetate/imine/catalyst 1:1.5:0.1) at room temperature. The diastereo- and enantioselectivity 
determined by chiral HPLC on the reaction crude. 
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The absolute configuration of compound 74 was established by a single crystal X-ray 
analysis (Figure 35) and that for the remaining adducts including those derived from α-
akyl isocyanothioacetates (70 and 72) was assumed based on a uniform mechanism. 
 
Figure 35. ORTEP diagram of compound 74. 
In summary, preliminary results indicate that these new squaramide catalysts can 
catalyze the Mannich reaction between α-aryl and α-alkyl isocyano(thio)acetates and 
propargyl N-aryl imines although with yet unsatisfactory stereoselectivities. There is 
additional room for further reaction optimization as the variability of the thioester or 
the N-aryl group. 
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4. Conclusions 
A divergent method for the asymmetric synthesis of α-quaternary prolines and 
derivatives has been developed starting from isocyano(thio)acetates as key reaction 
partners and under bifunctional Brønsted base/H-bond catalysis activation. The key step 
for the formation of the chiral common intermediate has been the enantioselective 
Michael addition of isocyano(thio)acetates to vinyl ketones, for which a new 
squaramide/tertiary amine catalyst has been designed, more effective than those known 
to date.  
The lack of reactivity shown by α-alkyl isocyanoacetates in this Michael addition 
reaction has been solved by employing thioesters-isocyanides as activated 
isocyanoacetates equivalents. Following this strategy, the Michael adducts containing α-
aryl and α-alkyl quaternary stereocenters have been obtained with excellent results. 
Isocyanothioacetates had never been used as nucleophiles in catalytic 
asymmetric reaction; hence, their reaction with vinyl sulfones and imines with different 
reactivity has been described for the first time. Preliminary experiments show their 
generality and synthetic utility to expand the inherently difficult α-reactivity of the 
parent oxoester. 
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5. Experimental section 
5.1. Material and Techniques 
5.1.1. Reagents and solvents 
Reagents were purchased from common commercial suppliers such as Aldrich, Across, 
Alfa Aesar, Fluka, TCI, Merck, Fluorochem, etc., stored as specified by the manufacturer 
and used without previous purification unless otherwise stated.  
Triethylamine, DBU, DIPA and DIPEA were purified by distillation. Liquid 
aldehydes were purified by distillation before usage and stored in the fridge at –30 °C 
under nitrogen.  
Anhydrous solvents were dried following established procedures.236 
Dichloromethane was dried over CaH2, diethyl ether and tetrahydrofuran were dried by 
filtration through activated alumina (powder 150 mesh, pore size 58 Å, basic Sigma 
Aldrich) columns. 
5.1.2. General experimental 
All non-aqueous reactions were performed under inert atmosphere using oven-dried 
glassware and were magnetically stirred. Yields refer to chromatographically purified 
and spectroscopically pure compounds, unless otherwise stated. 
Heat requiring reactions were performed using a hotplate with a sand bath and a 
condenser. Reactions requiring low temperatures were performed using cooling bath 
circulators Huber T100E and acetone or isopropanol baths. 
Organic layers washed with aqueous phases were dried over MgSO4 or Na2SO4 
and filtered through cotton. 
Organic solvents were evaporated under reduced pressure using rotavapors 
Büchi R-100, R-200 and R-210, the latter equipped with a Büchi V-700 vacuum pump and 
a Büchi V-850 vacuum controller. For the complete removal of solvents vacuum pump 
Telstar Top-3 (P ≈ 0.5 mmHg) was employed. 
                                                     
236
 Armanego, W. L. F.; Perrin, D. D. Purification of laboratory Chemicals, 3
rd
 Edition Butterworth-
Heinemann, Oxford, 1988. 
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5.1.3. Chromatography 
Reactions and flash chromatographic columns were monitored by thin layer 
chromatography (TLC) using Merck silica gel 60 F254 plates and visualized by 
fluorescence quenching under UV light, Fisher Biolock lamp VL-4LC, λ = 254 and 365 nm. 
In addition, TLC plates were stained with a dipping solution of potassium permanganate 
(1g) in 100 ml of water (limited lifetime), followed by heating. 
Purification by column chromatography was performed on Merck ROCC 60 silica 
gel 40-63 µm as stationary phase and a suitable mixture of solvents (typically hexane: 
ethyl acetate, pentane: diethyl ether or dichloromethane: methanol) as eluent. 
5.1.4. Optical rotation 
Optical rotations were recorded using a Jasco P-2000 polarimeter; specific rotation (SR) 
([α]D) are reported in 10
-1 deg.cm2.g-1; concentrations (c) are quoted in g/100 mL; D 
refers to the D-line of sodium (589 nm); temperatures (T) are given in degree Celsius 
(°C). 
5.1.5. Melting points 
Melting points were determined in open capillaries in a Stuart SHP3 melting point 
apparatus and microscope and were uncorrected. 
5.1.6. NMR spectra 
NMR spectra were recorded using a Bruker Avance 300 (300 MHz for 1H, 75 MHz for 13C) 
spectrometer, Bruker 400 spectrometer (400 MHz for 1H, 100 MHz for 13C) Varian 400 
MR (400 MHz for 1H, 100 MHz for 13C) or Bruker AV-500 spectrometer (500 MHz for 1H, 
125 MHz for 13C). Chemical shifts (δ) are quoted in parts per million referenced to the 
residual solvent peak, usually CDCl3, 
1H (δ = 7.26) and 13C (δ = 77.0). The multiplicity of 
each signal is designated using the following abbreviations: s, singlet; d, doublet; t, 
triplet; q, quartet; m, multiplet; brs, broad singlet. Coupling constants (J) are reported in 
Hertz (HZ).  
MestrReNova Mnova 8.1 program was used to process and edit the registered 
spectra. 
CHAPTER 5 
 
157 
 
5.1.7. Mass spectra 
Ms spectra were recorded on an ESI-ion trap Mass spectrometer (Agilent 1100 series 
LC/MSD, SL model) on a UPLC-DAD-QTOF, Ultra High Performance Liquid 
Chromatography-Mass spectrometer, Waters UPLC ACQUITY, Waters PDA detector, 
Waters Sunapt G2 or on an Agilent Thermoquest LCT spectrometer. Mass spectrometry 
analyses were performed in the General Research Service (SGIker) of the University of 
the Basque Country (UPV/EHU). 
5.1.8. Infrared spectra 
Infrared spectra were recorded on a Bruker Alpha FT-IR spectrometer as a thin film. 
5.1.9. X-Ray diffraction analysis 
The X-ray diffraction analysis experiments were conducted in the General Research 
Service (SGIker) of the University of the Basque Country (UPV/EHU) using difractometers 
for monocrystals. 
 
5.2. Preparation of catalysts 
(DHQ)2Pyr (C1) was purchased from Sigma Aldrich, quinine (C2) was purchased 
from Alfa Aesar and catalysts C3,237 C4,238 C5,239 C6,240 C7,241 C9,242 C10,243 C11,243 C12244 
and C13244 were prepared following the procedures described in the literature. Catalyst 
C8 was prepared starting from (S)-(−)-3-aminoquinuclidine dihydrochloride and the 
corresponding squaric amide-ester. Catalysts C14-C26 were prepared starting from 
                                                     
237
 Vakulya, B.; Varga, S.; Csámpai, A.; Soós, T. Org. Lett. 2005, 7, 1967–1969. 
238
 Adapted from: a) Diosdado, S.; Etxabe, J.; Izquierdo, J.; Landa, A.; Mielgo, A.; Olaizola, I.; López, R.; 
Palomo, C. Angew. Chem. Int. Ed. 2013, 52, 11846–11851. b) Diosdado, S. Adición de Fosfonoacetatos, 
Malonatos y Sulfonilacetonitrilos a Iminas. Desarrollo de Bases de Brønsted Bifuncionales, Ureidopétido-
Cinchona EHU/UPV; Doctoral thesis; 2013; pp 186–201. 
239
 Yang, W.; Du, D. M. Org. Lett. 2010, 12, 5450–5453. 
240
 Hu, K.; Lu, A.; Wang, Y.; Zhou, Z.; Tang, C. Tetrahedron: Asymmetry 2013, 24, 953–957. 
241
 Yang, W.; Du, D.-M. Adv. Synth. Catal. 2011, 353, 1241–1246. 
242
 See ref. 41, Chapter 1, page 13. 
243
 a) See ref. 156, Chapter 2, page 65. b) Izquierdo, J. New Approaches to Optically Active 2-tert-Alkyl 
Azaaryl Compounds and 5,5-Disubstituted Hydantoyns EHU/UPV; Doctoral thesis; 2018; pp 149–156. 
244
 a) See ref. 157a, Chapter 2, page 65. b) Etxabe, J. Catalytic Asymmetric Synthesis of α,α-Disubtituted α-
Thio and α-Amino Acid Derivatives EHU/UPV; Doctoral thesis; 2016; pp 259–261. 
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(R,R)-9-deoxy-9-epiaminoquinine or (R,R)-9-amino-(9-deoxy)epihydroquinine and the 
corresponding squaric amide-ester. 
Preparation of 9-amino-(9-deoxy)epiquinine245 
 
1st step:246 A mixture of quinine (1 equiv., 16.2 g, 50 mmol) and triethylamine 
(3.6 equiv., 25.1 mL, 180 mmol) in dry THF (250 mL) was cooled to 0 °C and then 
methanesulfonyl chloride (1.8 equiv., 7.0 mL, 90 mmol) was added dropwise. The 
mixture was stirred overnight at room temperature. The reaction was quenched with 
water (40 mL) and then THF was removed under vacuum. The residue was dissolved in 
dichloromethane (40 mL) and washed with water (30 mL) and saturated sodium 
bicarbonate (30 mL). The organic layer was dried over MgSO4, filtered and concentred 
under vacuum to afford crude mesylated product with 96% yield, which was used in the 
next step without further purification. 
2nd step:247 The crude mesylated product (1 equiv., 19.3 g, 48 mmol) was 
dissolved in DMF (150 mL). The solution was cooled to 0 °C and NaN3 (2 equiv., 6.2 g, 96 
mmol) was added portionwise. The mixture was stirred at 70 °C for 16 h and after this 
time the reaction was quenched with water (80 mL) and then ethyl acetate (150 mL) was 
added. The organic layer was separated and washed with saturated NaCl thoroughly (5 x 
60 mL), dried over MgSO4, filtered and evaporated under reduced pressure to obtain the 
                                                     
245
 Adapted from: Brunner, H.; Büegler, J.; Nuber, B. Tetrahedron: Asymmetry, 1995, 6, 1699–1702. 
246
 Adapted from: Zielinska-Blajet, M.; Kucharska, M.; Skarzewski, J.  Synthesis, 2006, 7, 4383–4387. 
247
 Adapted from: Sudermeier, U.; Döbler, C.; Mehltretter, G. M.; Baumann, W.; Beller, M. Chirality, 2003, 
15, 127–134. 
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crude azide derived product in quantitative yield which was used in the next step 
without further purification. 
3rd step:247 The azide derived crude product was dissolved in THF (250 mL) and 
PPh3 (1 equiv., 12.6 g, 48 mmol) was added. The reaction mixture was heated to 40 °C 
and stirred until the gas evolution ceased (~5 h). Then H2O (8 mL) was added and the 
mixture was stirred overnight at 40 °C. The solvent was removed under vacuum and the 
residue was dissolved in dichloromethane (150 mL). HCl 6M (250 mL) was added and the 
aqueous phase was separated and washed with dichloromethane (2 x 100 mL). Then the 
aqueous layer was cooled to 0 °C and basified until pH > 10 with NaOH 40%. The 
aqueous phase was then extracted with dichloromethane (3 x 150 mL), dried over 
MgSO4 and concentrated under reduced pressure to afford 9-amino-(9-deoxy)epiquinine 
as a yellow viscous oil. Yield: 56% (8.7 g, 26.9 mmol). All data were consistent with those 
previously reported. 1H NMR (300 MHz, CDCl3), δ: 8.75 (d, J = 4.6 Hz, 1H), 7.36–8.05 (m, 
4H), 5.79 (m, 1H), 4.97 (m, 2H), 4.57 (d, J = 10.4 Hz, 1H), 3.97 (s, 3H), 3.02–3.34 (m, 3H), 
2.77 (m, 2H), 2.27 (m, 1H), 2.08 (s, 2H), 1.26–1.63 (m, 4H), 0.80 (m, 1H). 
Preparation of 9-amino-(9-deoxy)epihydroquinine248 
 
10% Palladium on carbon (10% w/w, 0.32 g) was added to a solution of 9-amino-
(9-deoxy)epiquinine (1 equiv., 3.2 g, 10 mmol) in methanol (10 mL). The reaction mixture 
was stirred overnight under H2 atmosphere, and then was filtered over celite and 
concentrated under reduced pressure to afford 9-amino-(9-deoxy)epihydroquinine as a 
yellow viscous oil. Yield: 92% (3.0 g, 9.2 mmol). All data were consistent with those 
previously reported. 1H NMR (300 MHz, CD3OD), δ: 8.69 (d, J = 4.7 Hz, 1H), 7.97 (d, J = 
9.3 Hz, 1H), 7.69 (brs, 1H), 7.61 (d, J = 4.7 Hz, 1H,), 7.45 (dd, J = 9.3, 2.6 Hz, 1H), 4.72 (d, J 
= 11.0 Hz, 1H), 4.00 (s, 3H), 3.36–3.24 (m, 1H), 3.28 (dd, J = 13.6, 9.9 Hz, 1H), 3.16 (q, J = 
10.7 Hz, 1H), 2.79 (ddd, J = 15.6, 13.8, 4.9 Hz, 1H), 2.56 (ddd, J = 13.6, 4.7, 2.3 Hz, 1H), 
1.62–1.58 (m, 1H), 1.60 (dd, J = 13.3, 10.4 Hz, 1H), 1.58–1.47 (m, 4H), 1.37–1.34 (m, 2H), 
0.85 (t, J = 7.3 Hz, 3H). 
                                                     
248
 Adapted from: Vakulya, B.; Varga, S.; Csámpai, A. Soós, T. Org. Lett. 2005, 7, 1967–1969. 
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5.2.1. Preparation of catalyst C8 
Catalyst C8 was prepared according to the following procedure: 
 
1st step:249 To a solution of 3,4-dimethoxy-3-cyclobutane-1,2-dione (1 equiv., 
1.42 g, 10 mmol) in MeOH (20 mL) was added 3,5-bis(trifluoromethyl)aniline (1 equiv., 
1.56 mL, 10 mmol). The reaction mixture was stirred at room temperature for 48 h. The 
formed precipitate was filtered and dried under vacuum to give title compound as a 
white solid. Yield: 66% (2.25 g, 6.6 mmol). M.p. = 179–181 °C. All data were consistent 
with those previously reported. 1H NMR (300 MHz, DMSO), δ: 11.18 (s, 1H), 8.04 (s, 2H), 
7.78 (s, 1H), 4.41 (s, 3H). 
2nd step: To a suspension of the corresponding squaric ester monoamide 
prepared above (3.6 mmol, 1.2 equiv.) in CH2Cl2 (6 mL) was added (S)-(−)-3-
aminoquinuclidine dihydrochloride (597 mg, 3.0 mmol, 1 equiv.) and triethylamine (0.3 
mL, 6.6 mmol, 2.2 equiv.). The reaction mixture was stirred for 16 h at room 
temperature. Then, CH2Cl2 (15 mL) was added and the mixture was washed with water 
(3 x 10 mL), dried with anhydrous MgSO4 and the solvent was evaporated under reduced 
pressure. The product was submitted to purification by silica gel column 
chromatography (CH2Cl2/MeOH, 95:5), affording the catalyst C8 as white solid (936 mg, 
2.16 mmol, 72%). 1H NMR (300 MHz, MeOD) δ 8.09 (s, 2H), 7.51 (s, 1H), 4.47 – 4.30 (m, 
1H), 3.51 (ddd, J = 14.3, 9.6, 2.1 Hz, 1H), 3.14 – 2.77 (m, 5H), 2.17 – 2.10 (m, 1H), 2.10 – 
1.96 (m, 1H), 1.95 – 1.76 (m, 2H), 1.76 – 1.61 (m, 1H). 13C NMR (75 MHz, MeOD) δ 185.5, 
182.3, 171.1, 164.6, 142.6, 133.8 (q), 124.3 (q), 119.2, 116.4, 55.9, 52.3, 47.9, 47.1, 28.6, 
25.4, 19.6. 
                                                     
249
 Yang, W.; Du, D. M. Org. Lett., 2010, 12, 5450–5453. 
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5.2.2. Preparation of catalysts C14-C19 
Amide group-bearing squaramide-based catalysts C14-C19 were prepared for the 
first time adapting the previously described procedure for C12-C13.250 
 
1st step: METHOD A:251 1-Methylimidazole (2.2 mL, 27.6 mmol, 2.5 equiv.) was added to 
the 3-nitrobenzoic acid (3 g, 11 mmol, 1 equiv.) in CH2Cl2 (25 mL) at 0 °C, and the 
mixture was stirred for 10 min. MsCl (1.3 mL, 16.5 mmol, 1.5 equiv) in CH2Cl2 (1 mL) was 
added to the mixture under –5 °C. After the mixture was stirred under that temperature 
for 20 min, the corresponding aniline derivative (11 mmol, 1 equiv) was added. Then the 
mixture was stirred at room temperature for 2 h. The solvent was removed under 
reduced pressure, H2O (100 mL) was added to the mixture and a solid precipitated, 
which was solved with ethyl acetate (100 mL). The organic layer was washed with brine 
(3 × 50 mL) and dried with anhydrous MgSO4. The solvent was evaporated under 
reduced pressure and the crude was crushed with diethyl ether to afford the title 
product. 
                                                     
250
 See ref. 244, page 157. 
251
 Adapted from: Mao, L.; Wang, Z.; Li, Y.; Han, X.; Zhou, W. Synlett 2011, 1, 129–133. 
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METHOD B: Oxalyl chloride (0.52 mL, 6 mmol, 1.2 equiv.) was added to a 
suspension of the corresponding 3-nitrobenzoic acid (836 mg, 5 mmol, 1 equiv.) in 
CH2Cl2 (5 mL) at 0 °C under nitrogen atmosphere. DMF (1 drop) was then added and the 
mixture was allowed to stir at room temperature for 2 h, observing the complete 
dissolution of the solid. The resulting crude was concentrated under reduced pressure 
and slowly added to a solution of the corresponding aniline derivative (10 mmol, 2 
equiv.) and triethylamine (0.84 mL, 6 mmol, 1.2 equiv.) in dichloromethane (2.5 mL) at 0 
°C under nitrogen atmosphere. The reaction mixture was stirred at room temperature 
overnight and CH2Cl2 (30 mL) was added. The organic phase was washed with aqueous 
HCl (1 M) (2 × 30 mL) and brine (30 mL), dried over MgSO4 and the solvent was 
eliminated under reduced pressure affording the desired amide. 
N-(2-(Trifluoromethyl)phenyl)-3-nitrobenzamide 
Yield: 56% (method A).1H NMR (300 MHz, DMSO-d6) δ 10.13 (s, 1H), 
8.33 (t, J = 2.0 Hz, 1H), 8.02 (ddd, J = 8.3, 2.4, 1.0 Hz, 1H), 7.93 (dt, J = 
7.8, 1.4 Hz, 1H), 7.48 – 7.27 (m, 3H), 7.13 (t, J = 7.1 Hz, 2H).  
 
 
N-(2,4-bis(Trifluoromethyl)phenyl)-3-nitrobenzamide 
Yield: 50% (method B).1H NMR (300 MHz, CDCl3) δ 8.76 (t, J = 2.0 Hz, 
1H), 8.67 (d, J = 8.6 Hz, 1H), 8.54 – 8.46 (m, 1H), 8.36 (s, 1H), 8.19 (ddd, 
J = 7.8, 1.8, 1.0 Hz, 1H), 7.98 – 7.88 (m, 2H), 7.78 (t, J = 8.0 Hz, 1H).  
 
 
N-(2-Chlorophenyl)-3-nitrobenzamide 
Yield: Quantit (method B). 1H NMR (300 MHz, CDCl3) δ 8.78 (t, J = 2.0 Hz, 
1H), 8.54 – 8.49 (m, 1H), 8.48 – 8.42 (m, 2H), 8.26 (dt, J = 7.8, 1.3 Hz, 1H), 
7.75 (t, J = 8.0 Hz, 1H), 7.46 (dd, J = 8.0, 1.5 Hz, 1H), 7.38 (td, J = 8.4, 7.9, 
1.5 Hz, 1H), 7.15 (td, J = 7.8, 1.6 Hz, 1H).  
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N-(2-Methoxyphenyl)-3-nitrobenzamide 
Yield: 70% (method A). 1H NMR (300 MHz, CDCl3) δ 8.73 (t, J = 2.0 Hz, 
1H), 8.57 (s, 1H), 8.49 (dd, J = 8.0, 1.7 Hz, 1H), 8.41 (ddd, J = 8.2, 2.2, 1.1 
Hz, 1H), 8.25 (ddd, J = 7.8, 1.8, 1.1 Hz, 1H), 7.71 (t, J = 8.0 Hz, 1H), 7.14 
(td, J = 7.8, 1.7 Hz, 1H), 7.05 (td, J = 7.8, 1.5 Hz, 1H), 6.96 (dd, J = 8.0, 
1.5 Hz, 1H), 3.96 (s, 3H).  
3-Nitro-N-(o-tolyl)benzamide 
Yield: Quantit (method B). 1H NMR (300 MHz, CDCl3) δ 8.75 (t, J = 2.0 Hz, 
1H), 8.46 (ddd, J = 8.2, 2.2, 1.1 Hz, 1H), 8.29 (d, J = 7.8 Hz, 1H), 7.88 (d, J = 
7.8 Hz, 1H), 7.80 – 7.69 (m, 2H), 7.36 – 7.30 (m, 2H), 7.27 – 7.17 (m, 1H), 
2.40 (s, 3H).  
 
N-(2-Hydroxyphenyl)-3-nitrobenzamide 
Yield: 40% (method B). 1H NMR (300 MHz, DMSO-d6) δ 8.83 – 8.70 (m, 
1H), 8.48 – 8.34 (m, 2H), 7.82 (t, J = 8.0 Hz, 1H), 7.59 (dd, J = 8.1, 1.6 Hz, 
1H), 7.06 (td, J = 7.7, 1.7 Hz, 1H), 6.93 (dd, J = 7.9, 1.5 Hz, 1H), 6.88 – 6.76 
(m, 1H).  
 
 
N-(2-(Allyloxy)phenyl)-3-nitrobenzamide 
 
 To a solution of nitrobenzamide (516 mg, 2 mmol, 1 equiv.) and K2CO3 (836 mg, 
6 mmol, 3 equiv.) in DMF (5 mL) was added allyl bromide (0.44 mL, 5 mmol, 2.5 equiv.). 
After 4 h at room temperature, the reaction mixture was filtered over celita, and EtOAc 
(10 mL) was added. The organic phase was washed with brine (10 × 5 mL), dried over 
MgSO4 and the solvent was eliminated under reduced pressure affording the desired 
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product. Yield: 84%. 1H NMR (300 MHz, DMSO-d6) δ 9.98 (s, 1H), 8.76 (t, J = 2.1 Hz, 1H), 
8.49 – 8.33 (m, 2H), 7.84 (t, J = 8.0 Hz, 1H), 7.64 (dd, J = 7.8, 1.7 Hz, 1H), 7.22 (ddd, J = 
8.7, 7.4, 1.7 Hz, 1H), 7.11 (dd, J = 8.2, 1.4 Hz, 1H), 6.99 (td, J = 7.6, 1.4 Hz, 1H), 6.14 – 
5.97 (m, 1H), 5.42 (dd, J = 17.3, 1.8 Hz, 1H), 5.23 (dq, J = 10.6, 1.6 Hz, 1H), 4.64 (dt, J = 
5.0, 1.7 Hz, 2H). 
 
2nd step: 
 
METHOD A: To a solution of the previous 3-nitrobenzamide (5 mmol) in EtOAc 
(15 mL) under inert atmosphere, Pd/C was added (Pd 10% in activated carbon, 10% in 
weight). In the cases that benzamide was insoluble, DMF was added until complete 
dissolution of the solid. The reaction mixture was stirred under H2 atmosphere (1 atm) at 
room temperature for 20 h. After that the mixture was filtered over celite and the 
filtrate was concentrated under reduced pressure to afford the hydrogenated product, 
which was used for the preparation of the corresponding squaric ester monoamide 
without further purification. 
METHOD B: To a solution of the previous 3-nitrobenzamide (1 mmol) in EtOH (2 
mL) SnCl2×H2O (1.13 g, 5 mmol, 5 equiv.) was added, and the reaction mixture was 
refluxed for 6 h. After cooling to room temperature, a saturated solution of sodium 
bicarbonate (5 mL) was added. The aqueous layer was extracted with ethyl acetate (3 × 
5 mL), the combined organic layer was dried over MgSO4 and the solvent was 
evaporated under reduced pressure to afford the hydrogenated product, which was 
used for the preparation of the corresponding squaric ester monoamide without further 
purification.  
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3-Amino-N-(2-(trifluoromethyl)phenyl)benzamide 
Yield: 75% (method A). 1H NMR (300 MHz, CDCl3) δ 8.43 (d, J = 8.3 Hz, 
1H), 8.19 (s, 1H), 7.74 – 7.54 (m, 2H), 7.32 – 7.26 (m, 2H), 7.24 – 7.20 (m, 
1H), 7.16 (ddt, J = 7.6, 1.5, 0.8 Hz, 1H), 6.87 (ddt, J = 7.9, 2.4, 0.8 Hz, 1H), 
3.88 (brs, 2H). 
 
3-Amino-N-(2,4-bis(trifluoromethyl)phenyl)benzamide 
Yield: 56% (method A).1H NMR (300 MHz, CDCl3) δ 8.75 (d, J = 8.7 Hz, 
1H), 8.36 (s, 1H), 7.93 – 7.81 (m, 2H), 7.30 (t, J = 7.8 Hz, 1H), 7.21 (t, J = 
2.1 Hz, 1H), 7.15 (ddd, J = 7.7, 1.8, 0.9 Hz, 1H), 6.90 (ddd, J = 8.0, 2.4, 0.9 
Hz, 1H), 3.90 (brs, 2H). 
 
 
3-Amino-N-(2-chlorophenyl)benzamide 
Yield: 88% (method B). 1H NMR (300 MHz, CDCl3) δ 8.56 (dd, J = 8.3, 1.6 
Hz, 1H), 8.40 (s, 1H), 7.41 (dd, J = 8.0, 1.5 Hz, 1H), 7.37 – 7.27 (m, 2H), 7.26 
– 7.20 (m, 2H), 7.07 (ddd, J = 8.0, 7.4, 1.6 Hz, 1H), 6.87 (ddd, J = 7.7, 2.4, 
1.3 Hz, 1H), 3.87 (brs, 2H).  
 
3-Amino-N-(2-methoxyphenyl)benzamide 
Yield: Quantit (method A). 1H NMR (300 MHz, CDCl3) δ 8.52 (dd, J = 7.9, 
2.0 Hz, 2H), 7.28 – 7.17 (m, 3H), 7.13 – 6.97 (m, 2H), 6.92 (dd, J = 7.9, 1.7 
Hz, 1H), 6.84 (ddd, J = 7.6, 2.4, 1.2 Hz, 1H), 3.92 (s, 3H), 3.84 (brs, 2H). 
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3-Amino-N-(o-tolyl)benzamide 
Yield: 93% (method B). 1H NMR (300 MHz, CDCl3) δ 8.03 – 7.95 (m, 1H), 
7.67 (s, 1H), 7.36 – 7.10 (m, 6H), 6.88 (ddd, J = 7.8, 2.5, 1.1 Hz, 1H), 3.88 
(brs, 2H), 2.37 (s, 3H).  
 
 
3-Amino-N-(2-butoxyphenyl)benzamide 
Yield: Quantit. (method A).  1H NMR (300 MHz, CDCl3) δ 8.61 (s, 1H), 
8.53 (dd, J = 7.7, 2.0 Hz, 1H), 7.30 – 7.22 (m, 2H), 7.20 – 7.13 (m, 1H), 
7.09 – 6.96 (m, 2H), 6.90 (dd, J = 7.7, 1.9 Hz, 1H), 6.84 (ddd, J = 7.9, 2.4, 
1.0 Hz, 1H), 4.04 (t, J = 6.5 Hz, 2H), 3.83 (brs, 2H), 1.89 (m, 2H), 1.09 (t, J 
= 7.4 Hz, 3H). 
 
3rd step : 
 
To a solution of 3,4-dimethoxy-3-cyclobutane-1,2-dione (308 mg, 2.2 mmol, 1.1 
equiv.) in MeOH (8 mL) was added the corresponding amine (2.0 mmol, 1 equiv.) and 
the reaction mixture was stirred at room temperature until the amine is consumed. The 
formed precipitate was filtered and in few cases, the solid was submitted to purification 
by silica gel column chromatography (CH2Cl2/MeOH, 95:5), affording the the squaric 
ester monoamide as pale yellow solid. 
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3-((2-Methoxy-3,4-dioxocyclobut-1-en-1-yl)amino)-N-(2-(trifluoromethyl)phenyl) 
benzamide 
Yield: 80%. 1H NMR (300 MHz, Acetone-d6) δ 9.78 (s, 1H), 9.07 (s, 
1H), 8.05 (t, J = 2.0 Hz, 1H), 7.94 – 7.87 (m, 1H), 7.83 – 7.70 (m, 
4H), 7.57 (t, J = 7.9 Hz, 1H), 7.50 (t, J = 7.7 Hz, 1H), 4.47 (s, 3H). 
 
 
N-(2,4-bis(Trifluoromethyl)phenyl)-3-((2-methoxy-3,4-dioxocyclobut-1-en-1-yl)amino) 
benzamide 
Yield: 82%. 1H NMR (300 MHz, DMSO-d6) δ 10.95 (s, 1H), 10.35 (s, 
1H), 8.20 – 8.10 (m, 2H), 7.91 – 7.82 (m, 2H), 7.70 (dt, J = 7.3, 1.5 
Hz, 1H), 7.65 – 7.59 (m, 1H), 7.58 – 7.51 (m, 1H), 4.39 (s, 3H). 
 
 
 
N-(2-Chlorophenyl)-3-((2-methoxy-3,4-dioxocyclobut-1-en-1-yl)amino)benzamide 
Yield: 73%. 1H NMR (300 MHz, Acetone-d6) δ 9.78 (s, 1H), 9.02 (s, 
1H), 8.25 (dd, J = 8.2, 1.6 Hz, 1H), 8.17 – 8.10 (m, 1H), 7.82 (ddd, J 
= 7.7, 1.7, 1.0 Hz, 1H), 7.75 (ddd, J = 8.2, 2.4, 1.0 Hz, 1H), 7.64 – 
7.51 (m, 2H), 7.42 (td, J = 7.7, 1.6 Hz, 1H), 7.30 – 7.19 (m, 1H), 
4.50 (s, 3H). 
 
3-((2-Methoxy-3,4-dioxocyclobut-1-en-1-yl)amino)-N-(2-methoxyphenyl)benzamide 
Yield: 72%. 1H NMR (300 MHz, DMSO-d6) δ 10.91 (s, 1H), 9.34 (s, 
1H), 7.91 (t, J = 1.8 Hz, 1H), 7.85 (dd, J = 8.0, 1.6 Hz, 1H), 7.69 (dt, 
J = 7.3, 1.6 Hz, 1H), 7.56 (d, J = 8.8 Hz, 1H), 7.54 – 7.46 (m, 1H), 
7.18 (ddd, J = 8.2, 7.3, 1.6 Hz, 1H), 7.10 (dd, J = 8.3, 1.5 Hz, 1H), 
7.02 – 6.94 (m, 1H), 4.40 (s, 3H), 3.85 (s, 3H). 
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3-((2-Methoxy-3,4-dioxocyclobut-1-en-1-yl)amino)-N-(o-tolyl)benzamide 
Yield: 70%. 1H NMR (300 MHz, Acetone-d6) δ 9.72 (s, 1H), 8.95 (s, 
1H), 8.14 – 8.07 (m, 1H), 7.78 (dt, J = 7.8, 1.3 Hz, 1H), 7.69 (ddd, J 
= 8.0, 2.3, 1.1 Hz, 2H), 7.53 (t, J = 7.9 Hz, 1H), 7.32 – 7.18 (m, 2H), 
7.14 (td, J = 7.4, 1.5 Hz, 1H), 4.47 (s, 3H), 2.37 (s, 3H). 
 
3-((2-Methoxy-3,4-dioxocyclobut-1-en-1-yl)amino)-N-(2-propoxyphenyl)benzamide 
Yield: 76%. 1H NMR (300 MHz, DMSO-d6) δ 10.91 (s, 1H), 9.28 (s, 
1H), 7.89 (t, J = 1.9 Hz, 1H), 7.86 (s, 1H), 7.66 (dt, J = 7.0, 1.7 Hz, 
1H), 7.61 – 7.46 (m, 2H), 7.22 – 7.05 (m, 2H), 6.96 (td, J = 7.5, 1.6 
Hz, 1H), 4.39 (s, 3H), 4.01 (t, J = 6.5 Hz, 2H), 1.86 – 1.67 (m, 2H), 
0.96 (t, J = 7.4 Hz, 3H). 
 
4rd step : 
 
To a suspension of the corresponding squaric ester monoamide prepared above 
(1.0 mmol, 1 equiv.) in CH2Cl2 (8 mL) was added 9-amino-(9-deoxy)epiquinine (323 mg, 
1.0 mmol, 1 equiv.) and the reaction mixture was stirred for 48 h at room temperature. 
Then, the solvent was evaporated, and the product submitted to purification by silica gel 
column chromatography (CH2Cl2/MeOH, 95:5), affording the corresponding squaramide 
product. 
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3-((2-(((S)-(6-Methoxyquinolin-4-yl)((1S,2S,4S,5R)-5-vinylquinuclidin-2-yl)methyl) 
amino)-3,4-dioxocyclobut-1-en-1-yl)amino)-N-(2-(trifluoromethyl)phenyl)benzamide 
(C14) 
White solid (532 mg, 0.78 mmol, 78%). M.p.= 180-
190 °C. 1H NMR (300 MHz, Acetone-d6) δ 9.02 (s, 1H), 8.74 
(d, J = 4.5 Hz, 1H), 7.99 (d, J = 9.2 Hz, 1H), 7.92 (td, J = 6.1, 
3.5 Hz, 2H), 7.82 – 7.75 (m, 1H), 7.71 (dd, J = 7.9, 2.6 Hz, 
2H), 7.68 – 7.60 (m, 2H), 7.49 (td, J = 7.8, 2.3 Hz, 2H), 7.41 
(dd, J = 9.2, 2.7 Hz, 1H), 6.25 (s, 1H), 5.93 (ddd, J = 17.6, 
10.3, 7.7 Hz, 1H), 5.09 – 4.89 (m, 2H), 4.03 (s, 3H), 3.70 – 
3.43 (m, 2H), 3.28 (dd, J = 13.6, 10.0 Hz, 1H), 2.81 – 2.68 
(m, 2H), 2.44 – 2.29 (m, 1H), 1.74 – 1.52 (m, 4H), 0.94 – 0.78 (m, 1H). 13C NMR (101 MHz, 
DMSO) δ 184.2, 179.7, 168.2, 165.9, 163.6, 157.9, 147.8, 144.3, 143.1, 142.1, 139.1, 
135.6, 135.2, 133.1, 131.5, 131.1, 129.5, 127.4, 126.5, 126.1, 124.9, 122.2, 121.9, 121.5, 
121.3, 119.5, 117.4, 114.3, 101.5, 58.9, 55.7, 55.6, 53.6, 39.0, 38.9, 27.3, 27.0, 26.0. 
UPLC-DAD-QTOF: C38H35N5O4F3 [M+H]
+ calcd.: 682.2641, found: 682.2658. 
N-(2,4-bis(Trifluoromethyl)phenyl)-3-((2-(((S)-(6-methoxyquinolin-4-yl)((1S,2S,4S,5R)-
5-vinylquinuclidin-2-yl)methyl)amino)-3,4-dioxocyclobut-1-en-1-yl)amino)benzamide 
(C15) 
White solid (532 mg, 0.71 mmol, 71%). M.p.= 195-
197 °C 1H NMR (300 MHz, CD2Cl2) δ 8.65 (d, J = 4.5 Hz, 1H), 
8.37 (d, J = 8.7 Hz, 1H), 7.96 (d, J = 9.2 Hz, 1H), 7.87 (t, J = 
3.4 Hz, 1H), 7.84 – 7.72 (m, 3H), 7.59 – 7.50 (m, 1H), 7.36 
(dd, J = 9.1, 2.6 Hz, 1H), 7.33 – 7.21 (m, 2H), 7.21 – 7.09 
(m, 1H), 6.25 (s, 1H), 5.94 – 5.69 (m, 1H), 5.18 – 4.92 (m, 
2H), 3.98 (s, 3H), 3.93 – 3.73 (m, 1H), 3.76 – 3.53 (m, 1H), 
3.44 – 3.17 (m, 1H), 3.09 – 2.72 (m, 2H), 2.42 (s, 1H), 1.94 
– 1.49 (m, 4H), 0.99 – 0.79 (m, 1H). 13C NMR (75 MHz, 
CD2Cl2) δ 184.3, 181.6, 168.9, 165.2, 164.3, 159.0, 147.8, 145.1, 142.7, 140.1, 139.5, 
138.9, 134.8, 131.9, 130.1, 130.0, 128.0, 126.7 (q), 125.4, 125.2, 124.0, 123.9, 122.8, 
122.7, 121.8, 121.4, 118.0, 115.7, 101.5, 60.5, 56.3, 55.60, 4.38, 38.8, 27.5, 26.8, 25.6. 
UPLC-DAD-QTOF: C39H34N5O4F6 [M+H]
+ calcd.: 750.2515, found: 750.2518. 
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N-(2-Chlorophenyl)-3-((2-(((S)-(6-methoxyquinolin-4-yl)((1S,2S,4S,5R)-5-vinyl 
quinuclidin-2-yl)methyl)amino)-3,4-dioxocyclobut-1-en-1-yl)amino)benzamide (C16) 
Yellow solid (305 mg, 0.47 mmol, 47%). M.p.= 183-
189 °C. 1H NMR (300 MHz, DMSO-d6) δ 8.99 (s, 1H), 8.74 
(d, J = 4.5 Hz, 1H), 8.22 (dt, J = 8.2, 2.5 Hz, 1H), 8.07 – 7.91 
(m, 2H), 7.65 (q, J = 4.1 Hz, 3H), 7.55 – 7.33 (m, 3H), 7.21 
(td, J = 7.7, 1.6 Hz, 1H), 5.94 (ddd, J = 17.6, 10.2, 7.4 Hz, 
1H), 5.13 – 4.92 (m, 2H), 4.03 (s, 3H), 3.83 – 3.67 (m, 1H), 
3.58 (d, J = 12.1 Hz, 1H), 3.46 – 3.24 (m, 1H), 2.96 – 2.74 
(m, 1H),  2.41 (s, 1H), 1.83 – 1.57 (m, 4H), 0.96 – 0.83 (m, 
2H). 13C NMR (75 MHz, DMSO-d6) δ 184.3, 179.7, 168.2, 165.1, 163.8, 157.8, 147.8, 
144.2, 143.3, 141.8, 139.4, 135.1, 134.9, 131.5, 129.5, 129.3, 128.8, 127.7, 127.4, 127.2, 
121.9, 121.5, 121.4, 120.2, 117.6, 114.4, 101.4, 58.9, 55.7, 55.4, 54.8, 39.1, 38.7, 29.6, 
27.2, 27.1, 25.8. UPLC-DAD-QTOF: C37H35N5O4Cl [M+H]
+ calcd.: 648.2378, found: 
648,2380. 
N-(2-Methoxyphenyl)-3-((2-(((S)-(6-methoxyquinolin-4-yl)((1S,2S,4S,5R)-5-vinyl 
quinuclidin-2-yl)methyl)amino)-3,4-dioxocyclobut-1-en-1-yl)amino)benzamide (C17) 
Yellow solid (412 mg, 0.64 mmol, 64%). M.p.= 
188-198 °C 1H NMR (400 MHz, DMSO-d6) δ 10.03 – 9.90 
(m, 1H), 9.30 (s, 1H), 8.80 (d, J = 4.5 Hz, 1H), 8.39 – 8.27 
(m, 1H), 7.98 (d, J = 9.1 Hz, 1H), 7.85 (d, J = 8.7 Hz, 2H), 
7.77 (s, 1H), 7.72 – 7.63 (m, 2H), 7.58 (d, J = 7.6 Hz, 1H), 
7.51 – 7.40 (m, 2H), 7.19 – 7.12 (m, 1H), 7.07 (d, J = 8.2 
Hz, 1H), 6.95 (t, J = 7.7 Hz, 1H), 5.99 (tt, J = 17.4, 9.3 Hz, 
2H), 5.01 (dd, J = 22.3, 13.7 Hz, 2H), 3.95 (s, 3H), 3.82 (s, 
3H), 3.55 (s, 2H), 3.60 – 3.39 (m, 2H), 3.29 – 3.11 (m, 1H), 2.83 – 2.60 (m, 3H), 2.30 (d, J = 
10.4 Hz, 1H), 1.70 – 1.40 (m, 4H), 0.75 – 0.59 (m, 1H). 13C NMR (101 MHz, DMSO-d6) δ 
184.1, 179.9, 168.1, 164.4, 163.6, 157.9, 150.8, 147.8, 144.3, 143.0, 142.0, 139.0, 135.7, 
131.5, 129.6, 127.4, 126.8, 125.4, 123.2, 121.9, 121.5, 121.0, 120.2, 117.1, 114.4, 111.3, 
101.5, 58.9, 55.7, 55.7, 55.5, 53.1, 38.9, 38.9, 27.2, 25.9. UPLC-DAD-QTOF: C38H38N5O5 
[M+H]+ calcd.: 644.2873, found: 644.2888. 
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3-((2-(((S)-(6-Methoxyquinolin-4-yl)((1S,2S,4S,5R)-5-vinylquinuclidin-2-yl)methyl) 
amino)-3,4-dioxocyclobut-1-en-1-yl)amino)-N-(o-tolyl)benzamide (C18) 
Pale yellow solid (389 mg, 0.62 mmol, 62%). M.p.= 
185-200 °C. 1H NMR (300 MHz, Acetone-d6) δ 8.93 (s, 1H), 
8.73 (d, J = 4.6 Hz, 1H), 8.08 – 8.03 (m, 1H), 7.99 (dd, J = 
9.2, 1.9 Hz, 1H), 7.93 (d, J = 2.7 Hz, 1H), 7.76 – 7.68 (m, 
1H), 7.69 – 7.63 (m, 2H), 7.63 (s, 1H), 7.46 – 7.38 (m, 2H), 
7.30 – 7.16 (m, 2H), 7.16 – 7.09 (m, 1H), 6.29 (d, J = 10.8 
Hz, 1H), 5.92 (ddd, J = 17.5, 10.3, 7.6 Hz, 1H), 5.12 – 4.90 
(m, 2H), 4.03 (s, 3H), 3.80 – 3.62 (m, 1H), 3.62 – 3.47 (m, 
1H), 3.31 (dd, J = 13.6, 10.0 Hz, 1H), 2.79 – 2.68 (m, 2H), 2.45 – 2.36 (m, 1H), 2.35 (s, 3H), 
1.78 – 1.53 (m, 3H), 0.96 – 0.81 (m, 1H). 13C NMR (75 MHz, DMSO-d6) δ 184.1, 179.8, 
168.1, 164.9, 163.6, 157.8, 147.7, 144.3, 143.0, 142.0, 138.9, 136.3, 135.8, 133.4, 131.5, 
130.3, 129.5, 127.4, 126.3, 126.0, 121.9, 121.6, 120.9, 119.7, 117.5, 114.4, 101.5, 59.7, 
58.9, 55.7, 55.6, 54.9, 27.2, 26.0, 20.7, 17.8, 14.1. UPLC-DAD-QTOF: C42H22NO3F24 [M+H]
+ 
calcd.: 628.2924, found: 628.2919. 
3-((2-(((S)-(6-Methoxyquinolin-4-yl)((1S,2S,4S,5R)-5-vinylquinuclidin-2-yl)methyl) 
amino)-3,4-dioxocyclobut-1-en-1-yl)amino)-N-(2-propoxyphenyl)benzamide(C19) 
Orange solid (417 mg, 0.62 mmol, 62%). M.p.= 166-
172 °C. 1H NMR (300 MHz, DMSO-d6) δ 9.95 (s, 1H), 9.22 
(s, 1H), 8.81 (d, J = 4.5 Hz, 1H), 8.36 – 8.21 (m, 1H), 7.99 (d, 
J = 9.2 Hz, 1H), 7.94 – 7.82 (m, 2H), 7.82 – 7.75 (m, 1H), 
7.71 – 7.61 (m, 2H), 7.59 – 7.53 (m, 1H), 7.52 – 7.41 (m, 
2H), 7.13 (td, J = 7.7, 7.3, 1.7 Hz, 1H), 7.05 (dd, J = 8.3, 1.5 
Hz, 1H), 6.94 (td, J = 7.6, 1.5 Hz, 1H), 6.18 – 5.89 (m, 2H), 
5.12 – 4.93 (m, 2H), 4.05 – 3.92 (m, 6H), 3.60 – 3.48 (m, 
1H), 3.29 – 3.14 (m, 1H), 2.82 – 2.62 (m, 2H), 2.39 – 2.21 (m, 1H), 1.72 (h, J = 7.1 Hz, 3H), 
1.65 – 1.45 (m, 4H), 0.91 (t, J = 7.4 Hz, 3H), 0.78 – 0.61 (m, 1H). 13C NMR (75 MHz, 
DMSO-d6) δ 184.1, 179.9, 168.1, 164.3, 163.6, 157.9, 150.1, 147.8, 144.3, 143.0, 142.0, 
139.0, 135.8, 131.5, 129.7, 127.4, 127.0, 125.4, 123.1, 121.9, 121.3, 121.1, 120.2, 117.1, 
114.4, 112.2, 101.5, 69.7, 58.9, 55.7, 55.5, 53.4, 38.7, 38.2, 27.3, 27.3, 26.0, 21.9, 10.3. 
UPLC-DAD-QTOF: C40H42N5O5 [M+H]
+ calcd.: 672.3115, found: 672.3108. 
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5.2.3. Preparation of catalysts C20-C27 
New catalysts C20-C27 were synthesised as follows: 
5.2.3.1. Preparation of catalyst C20 
 
1st step:  To a solution 3-aminobenzoic acid (1.37 g, 10 mmol, 1.0 equiv.) in MeOH (10 
mL) was added concentrated H2SO4 (1.5 mL, 40 mmol, 4.0 equiv.). The reaction mixture 
was stirred for 16 h and then, the solvent was removed under reduced pressure. NaOH 
2M was added at 0 °C to reach pH 7 and the product was extracted with ethyl acetate (3 
× 40 mL). The combined organic phases were dried over magnesium sulphate, filtered 
and concentrated under reduced pressure. The product was obtained as yellow solid 
(1.18 g, 7.80 mmol, 78 %). 1H NMR (400 MHz, CDCl3) δ 7.48 (d, J = 7.6 Hz, 1H), 7.41 (s, 
1H), 7.27 (t, J = 7.9 Hz, 1H), 6.91 (d, J = 7.0 Hz, 1H), 3.95 (s, 3H), 3.83 (bs, 2H). 
2nd step:252 To a solution of the obtained aniline (1.51 g, 10 mmol) and Et3N (1.40 mL, 10 
mmol) in CH2Cl2 (50 mL) acetyl chloride (0.757 mL, 10.5 mmol) was added dropwise at 0 
°C. After 7 h at room temperature, the reaction mixture was washed with water and 
brine, dried over MgSO4 and concentrated to provide the title compound as white solid 
(1.70 g, 8.8 mmol, 80%) which was used in the next step without further purification. 1H-
                                                     
252
 Adapted from: Yang, H.; Zhou, L.; Wang, P. Photochem. Photobiol. Sci.2012, 11, 514–517. 
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RMN (300 MHz, CDCl3) δ 7.88 (d, J = 6.7 Hz, 1H), 7.67 (s, 1H), 7.34 (t, J = 5.8 Hz, 1H), 7.15 
(d, J = 7.0 Hz, 1H), 3.92 (s, 3H), 2.03 (s, 3H). 
3rd step: 252 A solution of the acetylated ester (966 mg, 5 mmol, 1 equiv.) in THF (25 mL) 
was treated with MeMgBr (10 mL, 2 M in THF, 4 equiv.) dropwise at 0 °C under argon 
atmosphere. The reaction was stirred overnight at room temperature, quenched by 
NH4Cl saturated solution and the solvent was evaporated under reduced pressure. The 
mixture was extracted with dichloromethane (3 × 10 mL), dried over MgSO4 and 
concentrated under reduced pressure. After recrystallization from petroleum ether and 
CH2Cl2 the trityl alcohol was obtained as a brown solid (754 mg, 3.9 mmol, 78%). 
1H NMR 
(300 MHz, CDCl3) δ 7.56 (t, J = 2.0 Hz, 1H), 7.47 (d, J = 7.8 Hz, 1H), 7.33 – 7.27 (m, 1H), 
7.21 (d, J = 8.1 Hz, 1H), 2.18 (s, 3H), 1.57 (s, 6H). 
4th step: A solution of the obtained trityl alcohol (580 g, 3 mmol, 1 equiv.) was treated 
with NaOH (2.4 g, 60 mmol, 20 equiv.) in methanol (17 mL) and water (2.4 mL) and 
heated at 85 °C for 3 d. The reaction mixture was neutralized with HCl 1M until pH 7, 
extracted with DCM (3 × 10 mL), dried over MgSO4 and the solvent was evaporated 
under reduced pressure to obtain the title compound as a white solid (334 mg, 2.21 
mmol, 74%). 1H NMR (300 MHz, CDCl3) δ 7.17 – 7.09 (m, 1H), 6.88 – 6.82 (m, 2H), 6.61 – 
6.54 (m, 1H), 1.55 (s, 6H). 
5th step: To a solution of 3,4-dimethoxy-3-cyclobutane-1,2-dione (170 mg, 1.2 mmol, 1 
equiv.) in MeOH (4.8 mL) was added the free aniline (181 mg, 1.2 mmol, 1 equiv.) at 
room temperature. The mixture was stirred at room temperature for 14 h. The solvent 
was evaporated under reduced pressure and the crude material was purified by flash 
column chromatography on silica gel (eluting with DCM/MeOH 98/2) to give the title 
compound as a yellow solid (201 mg, 0.92 mmol, 77%). 1H NMR (300 MHz, CDCl3) δ 7.49 
– 7.43 (m, 1H), 7.35 (t, J = 7.8 Hz, 1H), 7.29 (t, J = 1.4 Hz, 1H), 7.15 (d, J = 7.6 Hz, 1H), 4.51 
(s, 3H), 1.59 (s, 6H). 
6th step: To a suspension of the squarate (130 mg, 0.5 mmol, 1 equiv.) in CH2Cl2 (2 mL) 
was added (R,R)-9-deoxy-9-epiaminoquinine (162 mg, 0.5 mmol, 1 equiv.) at room 
temperature. The reaction mixture was stirred vigorously at room temperature for 2 
days. The reaction mixture was evaporated and purified by silica column 
chromatography (DCM/MeOH, 98/2) to give pure C20 as a yellow solid (235 mg, 0.43 
mmol, 85%). 1H NMR (300 MHz, CDCl3) δ 8.57 (d, J = 4.5 Hz, 1H), 7.96 (d, J = 9.2 Hz, 1H), 
7.77 (s, 1H), 7.51 (d, J = 4.5 Hz, 2H), 7.34 (dd, J = 9.3, 2.3 Hz, 1H), 6.98 – 6.74 (m, 3H), 
6.41 – 6.18 (m, 1H), 5.87 – 5.66 (m, 1H), 5.12 – 4.91 (m, 2H), 3.96 (s, 3H), 3.85 – 3.48 (m, 
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2H), 3.31 – 3.13 (m, 1H), 3.08 – 2.70 (m, 2H), 2.48 – 2.28 (m, 1H), 1.63 (d, J = 40.5 Hz, 
5H), 1.36 (d, J = 13.5 Hz, 6H), 0.90 – 0.69 (m, 1H). 13C NMR (75 MHz, CDCl3) δ 182.8, 
181.6, 168.9, 163.9, 158.9, 150.9, 147.7, 144.7, 142.8, 140.1, 137.9, 131.7, 129.0, 127.8, 
122.7, 120.1, 119.3, 117.2, 115.7, 115.5, 101.2, 77.4, 72.2, 60.4, 56.2, 55.5, 53.5, 41.2, 
38.8, 31.8, 31.3, 27.4, 27.0, 25.7. UPLC-DAD-QTOF: C33H37N4O4 [M+H]
+ calcd.: 553.2815, 
found: 553.2813. 
5.2.3.2. Preparation of catalysts C21-C22 and C24-C25 
Preparation of methyl 3-acetamido-5-(trifluoromethyl)benzoate (common 
intermediate) 
 
 
1st step: To a solution of 3-trifluoromethylbenzoic acid (2 g, 10 mmol) in concentrated 
sulfuric acid (10 mL) was added nitric acid (2 mL) at 0 ºC over 15 min. The mixture was 
stirred at 35 °C for 3 h, and slowly poured onto ice. The precipitate was filtrated with 
water (100 mL), and dissolved in ethyl acetate (50 mL). The ethyl acetate solution was 
washed with water, and dried, and the solvent was evaporated under reduced pressure 
to give 3-nitro-5-(trifluoromethyl) benzoic acid. Yield: 91 % (2.14 g, 9.12 mmol). 1H NMR 
(300 MHz, CDCl3) δ 9.10 (s, 1H), 8.74 (s, 1H), 8.69 (s, 1H).  
2nd step: To a solution of nitro compound (1.31 g, 5.6 mmol) in MeOH (20 mL) under 
inert atmosphere, Pd/C was added (Pd 10% in activated carbon, 10% in weight). The 
reaction mixture was stirred under H2 atmosphere (1 atm) at room temperature for 16 
h. After that the mixture was filtered over celite and the filtrate was concentrated under 
reduced pressure to afford the hydrogenated product as a white solid (1.18 g, 5.4 mmol, 
97%). 1H NMR (CDCl3, 300 MHz): δ 7.72 (s, 1H), 7.54 (s, 1H), 7.11 (s, 1H). 
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3rd step: To a solution 3-amino-5-(trifluoromethyl)benzoic acid (1.17 g, 5.74 mmol, 1.0 
equiv.) in MeOH (8.0 mL) was added concentrated H2SO4 (1.24 mL, 23.0 mmol, 4.0 
equiv.). The reaction mixture was stirred for 24 h and then, the solvent was removed 
under reduced pressure. NaOH 2M was added at 0 °C to reach pH 7 and the product was 
extracted with ethyl acetate (3 × 20 mL). The combined organic phases were dried over 
magnesium sulphate, filtered and concentrated under reduced pressure. The product 
was obtained as yellow solid (1.14 g, 5.20 mmol, 91 %). 1H-RMN (300 MHz, CDCl3) δ  7.65 
(dd, J = 1.5, 0.8 Hz, 1H), 7.49 (t, J = 1.9 Hz, 1H), 7.05 (dt, J = 1.7, 0.9 Hz, 1H), 3.98 (s, 2H), 
3.92 (s, 3H). 
 
4th step: To a solution of the obtained aniline (2.192 g, 10 mmol) and Et3N (1.40 mL, 10 
mmol) in CH2Cl2 (50 mL) acetyl chloride (0.757 mL, 10.5 mmol) was added dropwise at 0 
°C. After 7 h at room temperature, the reaction mixture was washed with water and 
brine, dried over MgSO4 and concentrated to provide the title compound as white solid 
(2.534 g, 9.7 mmol, 97%) which was used in the next step without further purification. 
1H-RMN (300 MHz, CDCl3) δ 8.20 (d, J = 5.4 Hz, 2H), 8.03 (s, 1H), 7.44 (s, 1H), 3.95 (s, 3H), 
2.23 (s, 3H). 
 
Preparation of catalyst C21 
 
1st step: A solution of the crude material of the previous reaction (5.0 mmol, 1.31 g) in 
THF (10 mL) was added dropwise at 0 °C to a solution of phenyl magnesium bromide 
(0.5M in THF, 15 mmol). The mixture was stirred at room temperature overnight. The 
reaction was quenched with NH4Cl saturated solution, the solvent was evaporated under 
reduced pressure and diluted with water (20 mL). The mixture was extracted with CH2Cl2 
(3 × 10 mL), the combined organic layers was dried over MgSO4 and concentrated under 
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reduced pressure. The crude material was purified by flash column chromatography on 
silica gel (eluting with hexane/ ethyl acetate 7/3) to give the title compound as a yellow 
solid (1.67 g, 4.3 mmol, 86%). 1H-RMN (300 MHz, CDCl3) δ 8.00 (s, 1H), 7.39 (d, J = 1.8 Hz, 
2H), 7.36 – 7.30 (m, 5H), 7.27 – 7.21 (m, 5H), 2.87 (s, 1H), 2.13 (s, 3H). 
 
2nd step: To a solution of the acetamide obtained above (770 mg, 2.0 mmol) was added 
in MeOH (15 mL) and water (2 mL) NaOH (1.60 g, 40 mmol, 20 equiv.) and the mixture 
was heated at 85 °C for 3 d. The reaction mixture was neutralized with HCl 1M until pH 
7, extracted with CH2Cl2 (3 × 10 mL), the combined organic layers were dried over 
MgSO4 and the solvent was evaporated under reduced pressure to give the title 
compound as a yellow solid (651 mg, 1.9 mmol, 95%). 1H-RMN (300 MHz, CDCl3) δ δ 7.35 
– 7.23 (m, 10H), 6.97 (dd, J = 1.6, 0.8 Hz, 1H), 6.81 (s, 1H), 6.76 (s, 1H), 3.87 (s, 3H). 
3rd step: To a solution of 3,4-dimethoxy-3-cyclobutane-1,2-dione (142 mg, 1.0 mmol, 1 
equiv.) in MeOH (4 mL) was added the free aniline obtained above (343 mg, 1.0 mmol, 1 
equiv.) and the mixture was stirred at room temperature for 14 h. The solvent was 
evaporated under reduced pressure and the crude material was purified by flash column 
chromatography on silica gel (eluting with Hexane/ ethyl acetate 7/3) to give the title 
compound as a yellow solid (316 mg, 0.7 mmol, 70%). M.p.= 100-110 °C. 1H-RMN (300 
MHz, CDCl3) δ 7.53 (s, 1H), 7.48 (s, 2H), 7.39 – 7.32 (m, 5H), 7.27 – 7.23 (m, 5H), 4.37 (s, 
3H), 2.89 (s, 1H). UPLC-DAD-QTOF: C25H19NO4F3 [M+H]
+ calcd.: 454.1266, found: 
454.1260. 
4th step: To a suspension of the hemisquaramide obtained above (227 mg, 0.5 mmol, 1 
equiv.) in CH2Cl2 (2 mL) was added (R,R)-9-deoxy-9-epiaminoquinine (162 mg, 0.5 mmol, 
1 equiv.) and the reaction mixture was stirred at room temperature for 2 days. The 
solvent was evaporated in the rotary evaporator and the oil residue was submitted to 
purification by silica column chromatography (CH2Cl2/MeOH, 98/2) to give the pure C21 
catalyst as a yellow solid (253 mg, 0.34 mmol, 68%). M.p.= 185-198 °C. 1H NMR (300 
MHz, MeOD) δ 8.63 (d, J = 4.7 Hz, 1H), 7.94 – 7.82 (m, 2H), 7.82 – 7.71 (m, 1H), 7.51 (d, J 
= 4.8 Hz, 1H), 7.41 – 7.29 (m, 2H), 7.29 – 7.10 (m, 10H), 6.20 (d, J = 11.1 Hz, 1H), 5.84 
(ddd, J = 17.4, 10.3, 7.3 Hz, 1H), 5.09 – 4.93 (m, 2H), 3.93 (s, 3H), 3.54 (ddd, J = 21.8, 
17.1, 8.7 Hz, 2H), 3.29 – 3.26 (m, 1H), 3.26 – 3.19 (m, 1H), 2.91 – 2.67 (m, 2H), 2.43 – 
2.26 (m, 1H), 1.71 – 1.50 (m, 4H), 0.77 – 0.63 (m, 1H). 13C NMR (75 MHz, MeOD) δ 185.3, 
181.9, 169.6, 165.5, 160.4, 152.1, 148.3, 147.8, 145.4, 145.0, 141.9, 140.1, 131.7, 129.3, 
129.1, 128.9, 128.3, 124.4, 122.8, 120.4, 120.3, 115.5, 114.9, 102.0, 82.3, 61.1, 56.7, 
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54.7, 41.8, 40.2, 28.6, 27.9, 27.0. UPLC-DAD-QTOF: C44H40N4O4F3 [M+H]
+ calcd.: 
745.3002, found: 745.2998. 
Preparation of catalysts C22 
 
1st step: A solution of the crude material of the previous reaction (5.0 mmol, 1.31 g) in 
THF (10 mL) was added dropwise at 0 °C to a solution of 3,5-bis(trifluoromethyl)-phenyl 
magnesium bromide (0.5M in THF, 15 mmol). The mixture was stirred at reflux 
overnight. The reaction was quenched with NH4Cl saturated solution, the solvent was 
evaporated under reduced pressure and diluted wit water (20 mL). The mixture was 
extracted with CH2Cl2 (3 × 10 mL), the combined organic layers was dried over MgSO4 
and concentrated under reduced pressure. The crude material was purified by flash 
column chromatography on silica gel (eluting with hexane/ ethyl acetate 7/3) to give the 
title compound as a brown solid (2.70 g, 4.1 mmol, 82%). M.p.= 190-198 °C. 1H NMR 
(300 MHz, MeOD) δ 8.08 – 8.04 (m, 1H), 8.01 – 7.96 (m, 2H), 7.91 – 7.85 (m, 4H), 7.63 (t, 
J = 1.8 Hz, 1H), 7.40 – 7.35 (m, 1H), 2.09 (s, 3H). 13C NMR (75 MHz, MeOD) δ 172.1, 
150.0, 148.2, 141.2, 133.2, 129.2, 126.4, 123.4, 123.0, 120.2, 120.2, 117.0, 117.0, 81.3, 
23.9. UPLC-DAD-QTOF: C26H15NO2F15 [M+H]
+ calcd.: 658.0863, found: 658.0859. 
 
2nd step: To a solution of the acetamide obtained above (1.31 g, 2.0 mmol) was added in 
MeOH (15 mL) and water (2 mL) NaOH (1.60 g, 40 mmol, 20 equiv.) and the mixture was 
heated at 85 °C for 3 d. The reaction mixture was neutralized with HCl 1M until pH 7, 
extracted with CH2Cl2 (3 × 10 mL), the combined organic layers were dried over MgSO4 
and the solvent was evaporated under reduced pressure. The crude material was 
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purified by flash column chromatography on silica gel (eluting with CH2Cl2/MeOH 98:2) 
to give the title compound as a brown solid (1.14 g, 1.9 mmol, 93%).1H NMR (300 MHz, 
CDCl3) δ 7.92 – 7.85 (m, 2H), 7.85 – 7.78 (m, 4H), 6.92 (t, J = 1.8 Hz, 1H), 6.78 (td, J = 1.6, 
0.8 Hz, 1H), 6.53 (t, J = 1.9 Hz, 1H), 3.98 (s, 2H), 2.96 (s, 1H). 
3rd step: To a solution of 3,4-dimethoxy-3-cyclobutane-1,2-dione (142 mg, 1.0 mmol, 1 
equiv.) in MeOH (4 mL) was added the free aniline obtained above (615 mg, 1.0 mmol, 1 
equiv.) and the mixture was stirred at room temperature for 14 h. The solvent was 
evaporated under reduced pressure and the crude material was purified by flash column 
chromatography on silica gel (eluting with Hexane/ ethyl acetate 7/3) to give the title 
compound as a yellow solid (616 mg, 0.85 mmol, 85%).1H NMR (300 MHz, CDCl3) δ 7.92 
(s, 2H), 7.80 (s, 4H), 7.55 (s, 2H), 7.22 (s, 1H), 4.42 (s, 3H), 4.02 (s, 1H).   
4th step: To a suspension of the hemisquaramide obtained above (363 mg, 0.5 mmol, 1 
equiv.) in CH2Cl2 (2 mL) was added (R,R)-9-deoxy-9-epiaminoquinine (162 mg, 0.5 mmol, 
1 equiv.) and the reaction mixture was stirred at room temperature for 2 days. The 
solvent was evaporated in the rotary evaporator and the oil residue was submitted to 
purification by silica column chromatography (CH2Cl2/MeOH, 98/2) to give the pure C22 
catalyst as a yellow solid (346 mg, 0.34 mmol, 68%). M.p.= 175-183 °C. 1H NMR (300 
MHz, DMSO-d6) δ 10.14 – 9.71 (m, 1H), 8.78 (d, J = 4.5 Hz, 1H), 8.13 – 8.03 (m, 2H), 8.03 
– 7.89 (m, 5H), 7.79 (s, 1H), 7.74 – 7.65 (m, 2H), 7.62 (d, J = 4.6 Hz, 1H), 7.50 – 7.38 (m, 
2H), 7.33 (s, 1H), 6.03 – 5.88 (m, 1H), 5.11 – 4.88 (m, 2H), 3.90 (s, 3H), 3.23 – 3.10 (m, 
2H), 2.75 – 2.54 (m, 2H), 2.36 – 2.19 (m, 1H), 1.65 – 1.39 (m, 4H), 0.63 (d, J = 14.3 Hz, 
1H). 13C NMR (75 MHz, DMSO-d6) δ 184.4, 179.6, 168.3, 163.0, 157.9, 148.3, 147.7, 
147.4, 144.3, 142.9, 142.1, 139.7, 131.5, 130.3 (q), 128.6, 128.2, 127.4, 125.5, 124.9, 
121.9, 121.3, 120.8, 117.7, 117.6, 114.4, 114.1, 101.4, 79.5, 64.9, 58.8, 55.6, 38.5, 38.2, 
27.3, 26.0. UPLC-DAD-QTOF: C48H36N4O4F15 [M+H]
+ calcd.: 1017.2497, found: 1017.2518. 
Preparation of catalyst C24 
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To a suspension of catalyst C22 (102 mg, 0.1 mmol, 1 equiv.) and DMAP (20 mg, 
0.15 mmol, 1.5 equiv.) in CH2Cl2 (0.2 mL) was added dropwise chlorotrimethylsilane (20 
μL, 0.15 mmol, 1.5 equiv.) and the reaction mixture was stirred for 14 h at r.t. Then, 
CH2Cl2 (2 mL) was added and the organic layer was washed twice with water and HCl 
1M, dried over MgSO4 and the solvent was evaporated. The product was purified by 
column chromatography on silica gel (Hexane/EtOAc, 70:30) to give pure catalyst C24 as 
a yellow solid (93.6 mg, 0.086 mmol, 86%). M.p.= 160-165 °C. 1H NMR (300 MHz, MeOD) 
δ 8.74 (d, J = 4.6 Hz, 1H), 8.07 (t, J = 1.8 Hz, 1H), 8.00 (s, 6H), 7.98 – 7.92 (m, 2H), 7.76 (d, 
J = 2.6 Hz, 1H), 7.71 – 7.63 (m, 2H), 7.41 (dd, J = 9.3, 2.5 Hz, 1H), 7.32 (s, 1H), 6.34 (d, J = 
11.4 Hz, 1H), 5.96 (ddd, J = 17.4, 10.4, 7.2 Hz, 1H), 5.27 – 5.06 (m, 2H), 4.04 (d, J = 10.3 
Hz, 1H), 3.97 (s, 3H), 3.82 – 3.67 (m, 1H), 3.52 (dd, J = 13.4, 10.2 Hz, 1H), 3.25 – 2.98 (m, 
2H), 2.71 – 2.57 (m, 1H), 1.37 – 1.11 (m, 2H), 1.02 – 0.87 (m, 1H), -0.12 (s, 9H). 13C NMR 
(75 MHz, MeOD) δ 185.8, 181.3, 169.5, 166.0, 160.7, 149.1, 148.4, 145.5, 143.8, 141.6, 
140.7, 133.1 (q), 132.8, 131.8, 129.4, 129.1, 126.3, 124.6, 123.3, 122.7, 122.3, 120.4, 
119.6, 119.1, 116.4, 115.9, 115.9, 101.7, 84.6, 61.2, 56.7, 56.1, 54.4, 42.2, 39.4, 28.4, 
26.8, 26.3, 1.4. UPLC-DAD-QTOF: C51H44N4O4F15Si [M+H]
+ calcd.: 1089.2876, found: 
1089.2873. 
 
Preparation of catalyst C25 
 
To a suspension of catalyst C22 (102 mg, 0.1 mmol, 1 equiv.) and DIPEA (26 mg, 
0.2 mmol, 2 equiv.) in DMF (0.2 mL) was added dropwise triisopropylsilyl 
trifluoromethanesulfonate (46 mg, 0.15 mmol, 1.5 equiv.) and the reaction mixture was 
stirred for 14 h at r.t.. Then, EtOAc (5 mL) was added and the organic layer was washed 
with HCl 1M (2 x 5 mL) and brine (10 x 5 mL), dried over MgSO4 and the solvent was 
evaporated. The product was purified by column chromatography on silica gel 
(Hexane/EtOAc, 70:30) to give pure catalyst C25 as a white solid (91.5 mg, 0.078 mmol, 
78%). M.p.= 145-152 °C. 1H NMR (300 MHz, CDCl3) δ 8.78 (d, J = 4.5 Hz, 1H), 8.04 (d, J = 
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9.2 Hz, 1H), 7.95 – 7.87 (m, 3H), 7.83 (d, J = 5.3 Hz, 4H), 7.73 – 7.57 (m, 3H), 7.55 (s, 1H), 
7.42 (dd, J = 9.3, 2.4 Hz, 1H), 6.38 (s, 1H), 5.54 (dt, J = 17.1, 8.7 Hz, 1H), 5.17 – 4.95 (m, 
2H), 4.30 (d, J = 11.3 Hz, 1H), 4.00 (s, 3H), 3.95 – 3.84 (m, 1H), 3.68 – 3.51 (m, 2H), 3.37 – 
3.10 (m, 2H), 2.69 (d, J = 10.5 Hz, 1H), 2.12 (d, J = 8.6 Hz, 1H), 2.04 (s, 2H), 1.82 (t, J = 
12.9 Hz, 1H), 0.89 (d, J = 8.2 Hz, 18H), 0.84 – 0.73 (m, 4H). 13C NMR (75 MHz, CDCl3) δ 
184.7, 180.1, 167.2, 166.2, 159.5, 147.9, 147.7, 147.6, 145.2, 139.9, 135.8, 132.5, 132.4, 
131.8 (q), 128.6, 127.2, 125.3, 125.0, 124.9, 123.4, 122.4, 121.7, 121.4, 121.3, 121.2, 
118.7, 118.2, 114.8, 100.3, 83.9, 60.7, 56.4, 54.4, 41.9, 36.3, 29.8, 26.4, 24.2, 24.0, 18.4, 
13.7. UPLC-DAD-QTOF: C57H56N4O4F15Si [M+H]
+ calcd.: 1173.3840, found: 1173.3844.. 
 
5.2.3.3. Preparation of catalysts C23, C26 ad C27 
Preparation of the squaric ester monoamide intermediate 
 
1st step: To a solution 5-aminoisophthalic acid (1.81 g, 10 mmol, 1.0 equiv.) in MeOH (20 
mL) was added concentrated H2SO4 (4.32 mL, 80 mmol, 8 equiv.). The reaction mixture 
was stirred for 24 h at 90 °C. After allowing the mixture to reach r.t. the solvent was 
removed under reduced pressure. Then, water (10 mL) and NaOH 2M was added until 
neutral pH and the mixture was extracted with ethyl acetate (3 × 30 mL). The combined 
organic phases were dried over MgSO4, filtered and concentrated under reduced 
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pressure. The product was obtained as white solid and used without further purification 
(1.54 g, 6.84 mmol, 68 %). 1H NMR (300 MHz, CDCl3) δ 8.05 (t, J = 1.5 Hz, 1H), 7.52 (d, J = 
1.5 Hz, 2H), 3.92 (s, 6H). 
2nd step: To a solution of the crude dimethyl 3-aminophtalate (1.54 g, 6.84 mmol) and 
Et3N (1.0 mL, 6.84 mmol) in CH2Cl2 (33 mL) was added dropwise at 0 °C acetyl chloride 
(0.54 mL, 7.52 mmol, 1.1 equiv.). After stirring for 7 h at room temperature, the reaction 
mixture was filtrated and the solid was washed with cool CH2Cl2 (2 × 10 mL) to provide 
the title compound as white solid (1.55 g, 6.16 mmol, 90%) which was used without 
further purification. 1H NMR (300 MHz, DMSO-d6) δ 10.39 (s, 1H), 8.46 (d, J = 1.4 Hz, 2H), 
8.21 – 8.10 (m, 1H), 3.89 (s, 6H), 2.08 (s, 3H). 
3rd step: A solution of the acetamide ester product obtained above (2.0 mmol, 522 mg) 
in THF (5 mL) was added dropwise at 0 °C to a solution of 3,5-bis(trifluoromethyl)phenyl 
magnesium bromide (0.5M in THF, 8 equiv., 32mL). The mixture was stirred at 90 °C 16 
h. The reaction was cooled to room temperature, quenched with NH4Cl saturated 
solution and solvent evaporated under reduced pressure. The resulting residue was 
extracted with CH2Cl2 (3 × 5.0 mL), and the combined organic layers were dried over 
MgSO4 and concentrated under reduced pressure. The crude material was purified by 
flash column chromatography on silica gel (eluting with hexane/ ethyl acetate 7/3) to 
give the title compound as a brown solid (1.03 g, 1.57 mmol, 79%). M.p.= 195-205 °C. 1H 
NMR (300 MHz, CDCl3) δ 7.86 – 7.78 (m, 4H), 7.64 (d, J = 1.7 Hz, 8H), 7.44 (d, J = 1.7 Hz, 
2H), 7.34 (s, 1H), 2.03 (s, 3H). UPLC-DAD-QTOF: C42H22NO3F24 [M+H]
+ calcd.: 1044,1216, 
found: 1044,1239. 
4th step: To a solution of the acetamide product obtained above (522 mg, 0.5 mmol) in 
MeOH (4.0 mL) and water (0.5 mL) was added NaOH (400 mg, 10 mmol, 20 equiv.) and 
the mixture was heated at 85 °C for 3 d. The reaction mixture was neutralized by adding 
dropwise HCl 1M until pH 7, and then, extracted with CH2Cl2 (3 × 10 mL). The combined 
organic layers were ried over MgSO4, filtered and the solvent was evaporated under 
reduced pressure to give the title compound as a brown solid (431 mg, 0.43 mmol, 
85%).1H NMR (300 MHz, CDCl3) δ 7.88 – 7.78 (m, 4H), 7.68 (d, J = 1.7 Hz, 8H), 6.52 (d, J = 
1.6 Hz, 2H), 6.08 (t, J = 1.7 Hz, 1H). 
5th step: To a solution of 3,4-dimethoxy-3-cyclobutene-1,2-dione (64 mg, 0.45 mmol, 
1.05 equiv.) in MeOH (3 mL) was added the free aniline product obtained above (431 
mg, 0.43 mmol, 1 equiv.) and the mixture was stirred at room temperature for 48 h. 
Then, the solvent was evaporated under reduced pressure and the oil residue was 
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purified by flash column chromatography on silica gel (eluting with hexane/ ethyl 
acetate, 7:3) to give the title compound as a yellow solid (410 mg, 0.37 mmol, 82%). 1H 
NMR (300 MHz, MeOD) δ 8.02 – 7.89 (m, 4H), 7.76 (d, J = 1.8 Hz, 8H), 7.49 (t, J = 2.4 Hz, 
2H), 6.68 (s, 1H), 4.27 (s, 3H).  
Preparation of the catalysts C23, C26 and C27  
 
1st step: To a solution of the squaric ester monoamide prepared above (218 mg, 0.20 
mmol) in CH2Cl2 (1 mL) was added the corresponding amine (0.20 mmol) and the 
reaction mixture was stirred for 48 h at room temperature. The resulting precipitate was 
filtered and washed with cold CH2Cl2 to give C23 to use as catalyst, or the crude product 
was subsequently used in the second step without further purification.  
2nd step: To a suspension of the previously prepared diol-squaramide (0.20 mmol, 1 
equiv.) and DMAP (80 mg, 0.60 mmol, 3 equiv.) in CH2Cl2 (0.8 mL) was added dropwise 
chlorotrimethylsilane (80 μL, 0.60 mmol, 3 equiv.) and the reaction mixture was stirred 
for 14 h at room temperature. Then, additional CH2Cl2 (4 mL) was added and the mixture 
was washed with water (2 × 4 mL) and HCl 1 M (2 × 4 mL). The organic layer was dried 
over MgSO4 and the solvent was evaporated. The resulting residue was subjected to 
purification by flash column chromatography on silica gel (CH2Cl2/MeOH 98:2) affording 
the pure catalyst. 
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3-((3,5-bis(bis(3,5-bis(Trifluoromethyl)phenyl)(hydroxy)methyl)phenyl)amino)-4-(((S)-
(6-methoxyquinolin-4-yl)((1S,2S,4S,5R)-5-vinylquinuclidin-2-yl)methyl)amino)cyclobut-
3-ene-1,2-dione (C23) 
White solid (253 mg, 0.18 mmol, 
60%). M.p.= 180-188 °C. 1H NMR (300 MHz, 
MeOD) δ 8.63 (d, J = 4.7 Hz, 1H), 7.92 – 7.80 
(m, 5H), 7.80 – 7.68 (m, 9H), 7.55 – 7.41 (m, 
3H), 7.31 (dd, J = 9.3, 2.5 Hz, 1H), 6.69 (t, J = 
1.5 Hz, 1H), 6.16 (d, J = 10.9 Hz, 1H), 5.85 
(ddd, J = 17.5, 10.3, 7.4 Hz, 1H), 5.06 – 4.91 
(m, 2H), 3.91 (s, 3H), 3.43 (td, J = 9.6, 5.4 Hz, 
2H), 3.29 – 3.15 (m, 2H), 2.87 – 2.61 (m, 2H), 
2.40 – 2.25 (m, 1H), 1.69 – 1.43 (m, 4H), 0.72 – 0.56 (m, 1H). 13C NMR (75 MHz, MeOD) δ 
185.6, 181.3, 169.6, 165.6, 160.5, 150.1, 150.1, 148.2, 148.2, 145.4, 145.4, 142.4, 141.0, 
132.8 (q) , 131.5, 129.9, 129.4, 129.1, 126.3, 124.4, 122.9, 122.7, 118.7, 115.2, 102.0, 
81.4, 61.1, 56.9, 56.7, 54.8, 41.7, 40.6, 28.8, 28.3, 27.3. UPLC-DAD-QTOF: C64H43N4O5F24 
[M+H]+ calcd.: 1403.2850, found: 1403.2844.  
3-(3,5-bis[bis(3,5-bis(Trifluoromethyl)phenyl)(trimethylsilyloxy)methyl]phenyl)amino)-
4-(((S)-(6-methoxyquinolin-4-yl)((1S,2S,4S,5R)-5-vinylquinuclidin-2-
yl)methyl)amino)cyclobut-3-ene-1,2-dione (C26) 
Yellow solid. Yield after 2 steps: 47% 
(145 mg, 0.094 mmol). M.p.= 160–168 ºC. 
1H NMR (300 MHz, CDCl3) δ 8.47 (d, J = 4.6 
Hz, 1H), 7.82 (d, J = 7.8 Hz, 13H), 7.71 (s, 
1H), 7.65 – 7.37 (m, 2H), 7.40 – 7.24 (m, 
1H), 7.24 – 7.12 (m, 1H), 7.12 – 7.03 (m, 
1H), 6.14 (s, 1H), 5.85 – 5.61 (m, 1H), 5.11 – 
4.92 (m, 2H), 3.95 (s, 3H), 3.43 – 3.03 (m, 
3H), 2.43 – 2.27 (m, 1H), 1.79 – 1.58 (m, 
3H), 1.49 (t, J = 12.0 Hz, 1H), 1.37 – 1.21 (m, 1H), 0.78 (td, J = 17.3, 13.8, 6.5 Hz, 1H), -
0.28 (s, 18H). 13C NMR (75 MHz, CDCl3) δ 185.1, 180.5, 168.1, 164.9, 159.7, 148.2, 147.4, 
147.0, 145.1, 140.8, 140.6, 132.5 (q), 132.4, 129.4, 129.0, 128.7, 125.4, 124.0, 122.7, 
121.8, 118.2, 118.1, 115.9, 101.6, 84.0, 60.7, 59.4, 56.7, 56.3, 41.3, 39.2, 31.6, 30.4, 27.6, 
26.5, 1.7. UPLC-DAD-QTOF: C70H59N4O5F24Si2 [M+H]
+ calcd.: 1547.3641, found: 
1547.3595.  
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3-((3,5-bis(bis(3,5-bis(Trifluoromethyl)phenyl)((trimethylsilyl)oxy)methyl)phenyl) 
amino)-4-(((S)-((1S,2S,4S,5R)-5-ethylquinuclidin-2-yl)(6-methoxyquinolin-4-
yl)methyl)amino)cyclobut-3-ene-1,2-dione (C27) 
Yellow solid. Yield after 2 steps: 65% 
(202 mg, 0.13 mmol). M.p.= 155–160 ºC. 
1H-NMR (300 MHz, DMSO-d6) δ 8.73 (d, J = 
4.6 Hz, 1H), 8.21 (s, 1H), 7.96 (d, J = 3.9 Hz, 
4H), 7.93 (s, 1H), 7.89 (d, J = 4.9 Hz, 8H), 
7.72 – 7.63 (m, 1H), 7.59 – 7.54 (m, 1H), 
7.46 (s, 2H), 7.36 (dd, J = 9.2, 2.5 Hz, 1H), 
6.85 (s, 1H), 5.96 (s, 1H), 3.88 (s, 3H), 3.53 – 
3.45 (m, 1H), 3.27 – 3.06 (m, 2H), 2.62 – 
2.53 (m, 1H), 2.39 (d, J = 13.4 Hz, 1H), 1.61 – 1.17 (m, 8H), 0.90 – 0.75 (m, 3H), 0.62 (s, 
1H), -0.33 (s, 18H). 13C NMR (75 MHz, DMSO) δ 183.9, 179.2, 168.1, 162.9, 157.8, 147.5, 
147.5, 145.4, 144.3, 142.9, 140.1, 131.5, 130.7 (q), 128.2, 127.8, 124.6, 121.9, 120.9, 
120.3, 117.3, 117.2, 101.1, 82.9, 78.4, 72.0, 70.0, 60.3, 57.2, 55.4, 36.7, 26.8, 25.8, 24.9, 
11.8, 0.6. UPLC-DAD-QTOF: C70H61N4O5F24Si2 [M+H]
+ calcd.: 1549.3797, found: 
1549.3822. 
 
5.3. Experimental section of chapter 2 
5.3.1. Synthesis of isocyanoacetates 1 
5.3.1.1. Synthesis of isocyanoacetates 1A and 1E 
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1st step:253 To a solution of the aminoacid (30 mmol, 1 equiv.) in tert-butyl acetate (70 
mL) at 0 °C, was added slowly HClO4 (70% in water , 3.9 mL, 45 mmol, 1.5 equiv.) and the 
reaction mixture was stirred at room temperature for 12 h. Then, the mixture was 
washed with H2O (100 mL) and hydrochloric acid 1M (50 mL). The resulting combined 
aqueous solution was adjusted to pH 9 by addition of sat. K2CO3 solution, and then 
extracted with CH2Cl2 (3 x 30 mL). The combined organic phases were dried with 
anhydrous MgSO4, filtered and concentrated to give an oil which was subjected to 
purification by flash chromatography on silica gel (ethyl acetate/hexane, 1:1) to give the 
pure tert-butyl aminoester. 
tert-Butyl 2-amino-2-phenylacetate  
Yield: 81%. 1H NMR (300 MHz, CDCl3) δ 7.43 – 7.27 (m, 5H), 4.48 (s, 
1H), 1.84 (brs, 2H), 1.39 (s, 9H).  
 
tert-Butyl 2-isocyano-3-phenylpropanoate 
Yield: 93%. 1H NMR (300 MHz, CDCl3) δ 7.41 – 7.18 (m, 5H), 3.64 
(dd, J = 7.8, 5.6 Hz, 1H), 3.07 (dd, J = 13.5, 5.6 Hz, 1H), 2.87 (dd, J = 
13.5, 7.7 Hz, 1H), 1.46 (s, 9H).  
2nd step: A solution of tert-butyl phenylglycine (2.07 g, 10 mmol) in ethyl formate (30 
mL) was heated at 70 °C for 2 h and then, the reaction was concentrated under reduced 
pressure to afford formamide product in quantitative yield. The crude material was used 
in the next step without purification. 
3rd step:254 To a solution of previously obtained formamide (10 mmol, 1 equiv.) in CH2Cl2 
(30 mL) was added DIPA (5.19 mL, 37 mmol, 3.7 equiv.) and the mixture was cooled to 
-30 °C. POCl3 (1.12 mL, 12 mmol, 1.2 equiv.) was added and the solution was stirred at 
-30 °C with TLC monitoring (around 1.5 h). A saturated aqueous solution of Na2CO3 (10 
mL) was added and the resulting mixture was extracted with CH2Cl2 (2 × 10 mL). The 
combined organic phases were washed with brine (2 × 20 mL), HCl 1M (2 × 20 mL), dried 
over MgSO4 and was concentrated under reduced pressure. The crude was purified by 
flash column chromatography on silica gel (eluent ethyl acetate/hexane, 5:95) to give 
the isocyanide. Isonitrile NC band at IR: 2145 cm-1. 
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 tert-Butyl 2-isocyano-2-phenylacetate (1A) 
The isocyanoacetate 1A was obtained following the general 
procedure. Yellow oil. Yield (last step): 87 % (1.89 g, 8.7 mmol). 1H 
NMR (300 MHz, CDCl3) δ 7.54 – 7.35 (m, 5H), 5.23 (s, 1H), 1.42 (s, 9H).
 13C NMR (75 MHz, 
CDCl3) δ 164.4, 160.7, 132.4, 129.2, 129.0, 126.5, 84.1, 61.1, 27.6. UPLC-DAD-QTOF: 
calcd for C13H16NO2 [M+H]
+, 218.1181; found, 218.1184.  
tert-Butyl 2-isocyano-3-phenylpropanoate (1E) 
The isocyanoacetate 1E was obtained following the general 
procedure. Colourless oil. Yield (last step): 76 % (1.76 g, 7.6 mmol).1H 
NMR (300 MHz, CDCl3) δ 7.40 – 7.24 (m, 5H), 4.34 (dd, J = 8.1, 5.3 Hz, 
1H), 3.29 – 3.06 (m, 2H), 1.45 (s, 9H). 13C NMR (75 MHz, CDCl3) δ 
165.0, 160.2, 134.8, 129.4, 128.7, 127.7, 83.9, 58.6, 38.9, 27.7. UPLC-DAD-QTOF: calcd 
for C14H17NO2 [M+H]
+, 232.3035; found, 232.3031. 
5.3.1.2. Synthesis of  isocyanoacetate 1A´ 
 
1st step:255 A mixture of phenylglycine (3.0 g, 20 mmol), p-toluene sulfonic acid 
monohydrate (4.14 g, 22 mmol) and benzyl alcohol (8.0 ml, 77 mmol) was refluxed in 30 
ml toluene overnight. The solution was then cooled to room temperature and the 
resulting crystals filtered to yield a white solid. Those crystals was dissolved in 
dichloromethane (20 mL), washed with a saturated sodium bicarbonate solution (3 × 20 
mL) and the organic layer was dried over magnesium sulphate and concentrated under 
reduced pressure. The crude was purified by flash column chromatography on silica gel. 
Yield: 80%. 1H NMR (300 MHz, Chloroform-d) δ 7.42 – 7.17 (m, 10H), 5.14 (dd, J = 12.4 
Hz, 2H), 4.66 (s, 1H), 1.84 (s, 2H).  
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2nd step: A solution of amine in ethyl formate (3 mL/mmol) was heated at 70ºC for 2h 
and the reaction was concentrated under reduced pressure to afford pure formamide in 
quantitative yield. The crude was used in the next step without purification. 
3rd step:256 To a solution of previously obtained formamide (10 mmol, 1 equiv.) in CH2Cl2 
(30 mL) was added DIPA (5.19 mL, 37 mmol, 3.7 equiv.) and the mixture was cooled to 
-30 °C. POCl3 (1.12 mL, 12 mmol, 1.2 equiv.) was added and the solution was stirred at 
-30 °C with TLC monitoring (around 1.5 h). A saturated aqueous solution of Na2CO3 (10 
mL) was added and the resulting mixture was extracted with CH2Cl2 (2 × 10 mL). The 
combined organic phases were washed with brine (2 × 20 mL), HCl 1M (2 × 20 mL), dried 
over MgSO4 and was concentrated under reduced pressure. The crude was purified by 
flash column chromatography on silica gel (eluent ethyl acetate/hexane, 5:95) to give 
the isocyanide 1A´. Isonitrile NC band at IR: 2145 cm-1. Yellow oil. Yield (last step): 74 % 
(1.86 g, 7.4 mmol). 1H NMR (300 MHz, CDCl3) δ 7.50 – 7.37 (m, 5H), 7.37 – 7.29 (m, 3H), 
7.29 – 7.20 (m, 2H), 5.39 (s, 1H), 5.27 – 5.13 (m, 2H). 13C NMR (75 MHz, CDCl3) δ 165.1, 
161.2, 134.1, 131.4, 129.2, 128.8, 128.4, 128.3, 127.8, 126.4, 68.1, 60.0. UPLC-DAD-
QTOF: calcd for C16H14NO2 [M+H]
+, 252.0913; found, 222.0918. 
5.3.1.3. Synthesis of isocyanoacetates 1B-D and 1F-G 
 
1st step: A solution of amine (10 mmol) in ethyl formate (30 mL) was heated at 70 °C for 
2 h and then, the reaction was concentrated under reduced pressure to afford 
formamide product in quantitative yield. The crude material was used in the next step 
without purification. 
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2nd step:257 To a solution of previously obtained formamide (10 mmol, 1 equiv.) in CH2Cl2 
(30 mL) was added DIPA (5.19 mL, 37 mmol, 3.7 equiv.) and the mixture was cooled to 
-30 °C. POCl3 (1.12 mL, 12 mmol, 1.2 equiv.) was added and the solution was stirred at 
-30 °C with TLC monitoring (around 1.5 h). A saturated aqueous solution of Na2CO3 (10 
mL) was added and the resulting mixture was extracted with CH2Cl2 (2 × 10 mL). The 
combined organic phases were washed with brine (2 × 20 mL), HCl 1M (2 × 20 mL), dried 
over MgSO4 and was concentrated under reduced pressure at 0 °C. The crude was 
purified immediately by flash column chromatography on silica gel due to the instability 
of the products. NC band in IR: 2137-2147 cm-1. 
1-(Isocyanomethyl)-4-methylbenzene 
Yield (2 steps): 80%. 1H NMR (300 MHz, CDCl3) δ 7.27 – 7.18 (m, 4H), 
4.60 (s, 2H), 2.37 (s, 3H). 
1-(Isocyanomethyl)-4-methoxybenzene  
Yield (2 steps): 89%. 1H NMR (300 MHz, CDCl3) δ 7.29 – 7.24 (m, 
2H), 6.95 – 6.89 (m, 2H), 4.57 (s, 2H), 3.82 (s, 3H). 
1-Bromo-3-(isocyanomethyl)benzene   
Yield (2 steps): 83%. 1H NMR (300 MHz, CDCl3) δ 7.56 – 7.44 (m, 2H), 
7.33 – 7.23 (m, 2H), 4.63 (s, 2H). 
1-(Isocyanomethyl)-2-methylbenzene  
Yield (2 steps): 66%. 1H NMR (300 MHz, CDCl3) δ 7.39 (dd, J = 6.6, 2.4 Hz, 
1H), 7.33 – 7.17 (m, 3H), 4.59 (s, 2H), 2.34 (s, 3H). 
1-Chloro-2-(isocyanomethyl)benzene  
Yield (2 steps): 63%. 1H NMR (300 MHz, CDCl3) δ 7.59 – 7.54 (m, 1H), 7.43 
– 7.29 (m, 3H), 4.75 (s, 2H). 
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3rd step:258 A solution of isonitrile (10 mmol) in THF (10 mL) was added dropwise to a 
cooled solution of LDA (25 mmol, 2.5 eq) in THF (30mL). The reac on mixture was 
allowed to s r at   78 °C for 45 min and then at room temperature for additional 45 min. 
The reaction mixture was cooled to   78 °C and a solution of di-tert-butyl dicarbonate 
(2.62 g, 12 mmol, 1.2 equiv.) in THF (10 mL) was added via syringe. The reaction mixture 
was stirred at    78 °C for another 2 h. The reaction mixture was quenched with 
saturated NH4Cl (20 mL) and extracted with diethyl ether (3 x 50 mL). The combined 
organic layers were washed with 1M HCl (30 mL), brine (30 mL) and dried over MgSO4. 
The solvent was removed under reduced pressure and the resulting crude material was 
purified by flash column chromatography on silica gel (eluent, hexane/ethyl acetate, 9:1) 
to yield the desired product. Isonitrile NC band at IR: 2137-2147 cm-1. 
tert-Butyl 2-isocyano-2-(p-tolyl)acetate (1B)  
The isocyanoacetate 1B was obtained following the general 
procedure. Yellow oil. Yield (last step): 80 % (1.85 g, 8.0 mmol). 
1H NMR (300 MHz, CDCl3) δ 7.37 – 7.30 (m, 2H), 7.24 – 7.18 (m, 2H), 5.18 (s, 1H), 2.37 (s, 
3H), 1.42 (s, 9H). 13C NMR (75 MHz, CDCl3) δ 164.6, 160.3, 139.2, 129.6, 129.4, 126.4, 
84.0, 60.9, 27.6, 21.1. UPLC-DAD-QTOF: calcd for C14H18NO2 [M+H]
+, 232.1338; found, 
232.1332.  
tert-Butyl 2-isocyano-2-(4-methoxyphenyl)acetate (1C)  
The isocyanoacetate 1C was obtained following the general 
procedure. White solid. Yield (last step): 65 % (1.61 g, 6.5 
mmol).1H NMR (300 MHz, CDCl3) δ 7.41 – 7.33 (m, 2H), 6.97 – 6.89 (m, 2H), 5.16 (s, 1H), 
3.83 (s, 3H), 1.42 (s, 9H). 13C NMR (75 MHz, CDCl3) δ 164.7, 160.4, 160.2, 127.9, 124.5, 
114.4, 84.0, 60.6, 55.3, 27.6. UPLC-DAD-QTOF: calcd for C14H18NO3 [M+H]
+, 248.1287; 
found, 248.1282. 
tert-Butyl 2-(3-bromophenyl)-2-isocyanoacetate (1D)  
The isocyanoacetate 1D was obtained following the general 
procedure. Yellow oil. Yield (last step): 80 % (2.37 g, 8.0 mmol). 1H 
NMR (300 MHz, CDCl3) δ 7.62 (t, J = 1.8 Hz, 1H), 7.57 – 7.51 (m, 1H), 
7.44 – 7.38 (m, 1H), 7.30 (t, J = 7.9 Hz, 1H), 5.20 (s, 1H), 1.44 (s, 9H). 13C NMR (75 MHz, 
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CDCl3) δ 163.8, 161.7, 134.3, 132.5, 130.6, 129.7, 125.2, 122.9, 84.8, 60.4, 27.7. UPLC-
DAD-QTOF: calcd for C13H15NO2Br [M+H]
+, 296.0286; found, 296.0287. 
tert-Butyl 2-isocyano-2-(o-tolyl)acetate (1F) 
The isocyanoacetate 1F was obtained following the general 
procedure. Yellow oil. Yield (last step): 85 % (1.97 g, 8.5 mmol). 1H 
NMR (300 MHz, CDCl3) δ 7.50 – 7.43 (m, 1H), 7.32 – 7.25 (m, 2H), 7.24 
– 7.18 (m, 1H), 5.43 (s, 1H), 2.42 (s, 3H), 1.42 (s, 9H). UPLC-DAD-QTOF: calcd for 
C14H17NO2 [M+H]
+, 232.3076; found, 232.3080. 
tert-Butyl 2-(2-chlorophenyl)-2-isocyanoacetate (1G)  
The isocyanoacetate 1G was obtained following the general 
procedure. Yellow oil. Yield (last step): 87 % (2.19 g, 8.7 mmol). 1H 
NMR (300 MHz, CDCl3) δ 7.61 – 7.54 (m, 1H), 7.47 – 7.41 (m, 1H), 7.39 
– 7.32 (m, 2H), 5.72 (s, 1H), 1.44 (s, 9H). 13C NMR (75 MHz, CDCl3) δ 163.7, 160.8, 133.1, 
131.0, 130.7, 130.0, 128.4, 127.7, 84.6, 58.1, 27.7. UPLC-DAD-QTOF: calcd for 
C13H15NO2Cl [M+H]
+, 252.0791; found, 252.0799. 
 
5.3.2. Synthesis of vinyl ketones 2 and 6a 
Compounds 2a and 2b are commercially available. Compounds 2c-f and 6a were 
prepared according the following procedure: 
5.3.2.1. Synthesis of 2c-f 259 
 
 
 
 To a solution of the corresponding acetophenone (10 mmol) and paraformaldehyde 
(600 mg, 20 mmol, 2 equiv.) in dry THF (10 mL) were succesively added 
diisopropylammonium trifluoroacetate (2.15 g, 10 mmol, 1 equiv.) and trifluoroacetic 
acid (0.8 mL, 10 mmol, 1 equiv.). The reaction mixture was stirred at reflux for 2 h, then 
cooled down to room temperature and a second addition of paraformaldehyde (20 
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mmol) and ammonium salt (10 mmol) was performed. Next, the reaction mixture was 
stirred at reflux overnight. Then cooled down and the solvent was removed under 
reduced pressure. The crude material was dissolved in Et2O and washed with HCl 1M, 
NaOH 1M and brine. The resulting organic solution was dried over MgSO4 and 
concentrated under vacuum. The crude product was purified by silica gel column 
chromatography (eluent hexane/ethyl acetate, 9:1). The spectroscopic data of thus 
obtained compounds were identical to those reported in the literature.260 
1-Phenylprop-2-en-1-one (2c) 
Colorless oil. Yield: 70%. 1H NMR (CDCl3, 300 MHz) δ 7.93 (2H, d, J= 9.2 
Hz), 7.53-7.55 (1H, m), 7.43-7.47 (2H, m), 7.15 (1H, dd, J= 17.2, 10.8 Hz), 
6.42 (1H, d, J= 17.2 Hz), 5.90 (1H, d, J= 10.8Hz). 
1-(p-Tolyl)prop-2-en-1-one (2d) 
Colorless oil. Yield: 78%. 1H NMR (CDCl3, 300 MHz) δ 7.84 (2H, d, J= 
8.0 Hz), 7.23 (2H, d, J= 8.0 Hz), 7.15 (1H, dd, J= 17.2, 10.4 Hz), 6.39 - 
6.44 (1H, m), 5.84 - 5.87 (1H, m), 2.37 (3H, s). 
1-(4-Chlorophenyl)prop-2-en-1-one (2e) 
Colorless oil. Yield: 68%. 1H NMR (CDCl3, 300 MHz) δ 7.87 (2H, d, J= 
8.4Hz), 7.43 (2H, d, J= 8.4 Hz), 7.12 (1H, dd, J= 16.8, 10.4 Hz), 6.42 - 
6.46 (1H, m), 5.92 - 5.95 (1H, m). 
1-(4-Methoxyphenyl)prop-2-en-1-one (2f) 
Colorless oil. Yield: 75%. 1H NMR (CDCl3, 300 MHz) δ 7.96 (2H, d, J= 
8.8 Hz), 7.18 (1H, dd, J= 16.8, 10.4 Hz), 6.95 (2H, d, J= 8.8 Hz), 6.42 
(1H, d, J= 16.8Hz), 5.87 (1H, d, J= 10.4Hz), 3.86 (3H, s). 
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5.3.2.2. Synthesis of α’-hydroxy enone 6a.261 
 
To a solution of methoxypropadiene (3.50 g, 50 mmol, 1 equiv.) in dry Et2O (100 
mL) at ‒40 °C, nBuLi (2.5 M in hexanes, 22 mL, 55 mmol) was added under nitrogen and 
the reaction was stirred at ‒40 °C for 10 min. Then, acetone (4.04 mL, 55 mmol, 1.1 
equiv.) in dry Et2O (55 mL) was added within 5 min. The reaction was stirred at the same 
temperature for 0.5 h and quenched with H2O (100 mL). The resulting mixture was 
allowed to warm to room temperature and extracted with Et2O (3 × 100 mL). The 
combined organic extracts were dried over Na2SO4 and concentrated under reduced 
pressure to afford 2-methyl-3-methoxy-3,4-pentadien-2-ol as a yellow liquid (5.65 g, 41 
mmol, 82%) that was employed in the next step without further purification. 
The material from previous step (2-methyl-3-methoxy-3,4-pentadien-2-ol, 5.65 g, 
44 mmol) was added dropwise to 5% aq. H2SO4 (110 mL) at 0 °C and the mixture was 
stirred for 1.5 h. After this time the reaction was allowed to warm to room temperature 
and the solution was saturated with solid NaCl. The mixture was extracted with Et2O (5 × 
60 mL) and the combined extracts were washed with brine and dried over Na2SO4. The 
solvent was removed to give a yellow oil which upon distillation afforded the enone as a 
colorless liquid (4.42 g) (88%). 1H NMR (CDCl3) δ: 6.73 (1H, dd, J= 9.5 Hz, J’= 16.8 Hz), 
6.50 (1H, dd, J= 2.2 Hz, J’= 16.8 Hz), 5.82 (1H, dd, J= 2.2 Hz, J’= 10.3 Hz), 1.38 (s, 6H). 13C 
NMR (CDCl3) δ: 202.3, 131.1, 128.8, 75.4, 26.1. IR (neat, cm
-1) 3445 (OH), 1693 (C=O). 
5.3.3. General Procedure for the conjugate addition of isocyanoacetates 1 to 
vinyl ketones. 
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Catalyst C26 (5 mol%) was added to a solution of the corresponding 
isocyanoacetate 1 (0.2 mmol, 1 equiv.) and vinyl ketone 2 or 6a (1  2 equiv.) in CH2Cl2 
(0.4 mL) at room temperature and the resulting mixture was stirred at the same 
temperature until the reaction was completed (monitored by TLC). The solvent was 
removed under reduced pressure and the product was purified by column 
chromatography. 
tert-Butyl (R)-2-isocyano-5-oxo-2-phenylhexanoate (3Aa) 
Prepared according to the general procedure starting from 
isocyanoacetate 1A (43.4 mg, 0.2 mmol) and vinyl ketone 2a (28 
mg, 0.4 mmol). The title compound was obtained as a 97.5:2.5 
mixture of enantiomers. The crude material was purified by flash 
column chromatography on silica gel (eluting with hexane/ ethyl acetate 9/1 to 8/2) to 
give the title compound as a colorless oil. Yield: 85% (48.9 mg). [α]D 
22    7.22° (c=1, 95% 
ee, CH2Cl2).  
1H NMR (300 MHz, CDCl3) δ 7.54 – 7.48 (m, 2H), 7.44 – 7.34 (m, 3H), 2.68 – 2.39 
(m, 4H), 2.13 (s, 3H), 1.40 (s, 9H).  13C NMR (75 MHz, CDCl3) δ 206.2, 166.1, 160.9, 135.1, 
129.0,129.0, 125.1, 84.4, 70.8, 38.6, 33.2, 30.1, 27.6. UPLC-DAD-QTOF: calcd for 
C17H22NO3 [M+H]
+, 288.1600; found, 288.1597. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
AYH, hexane:ethanol, 99:1; flux= 1 mL/min; retention times: 12.4 min (minor), 16.1 min 
(major)). 
tert-Butyl (R)-2-isocyano-5-oxo-2-phenylheptanoate (3Ab) 
Prepared according to the general procedure starting 
from isocyanoacetate 1A (43.4 mg, 0.2 mmol) and vinyl ketone 
2b (34 mg, 0.4 mmol). The title compound was obtained as a 
97.5:2.5 mixture of enantiomers. The crude material was 
purified by flash column chromatography on silica gel (eluting with hexane/ ethyl 
acetate 9/1 to 8/2) to give the title compound as a yellow oil. Yield: 95% (57.3 mg). [α]D 
22    9.16° (c=1.95, 95% ee, CH2Cl2). 
1H NMR (300 MHz, CDCl3) δ 7.55 – 7.48 (m, 2H), 7.43 – 7.34 (m, 3H), 2.68 – 2.34 
(m, 6H), 1.40 (s, 9H), 1.02 (t, J = 7.3 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 209.1, 166.2, 
160.8, 135.1, 129.0, 129.0, 125.1, 84.4, 70.9, 37.2, 36.2, 33.3, 27.6, 7.8. UPLC-DAD-QTOF: 
calcd for C18H24NO3 [M+H]
+, 302.1756; found, 302.1769. 
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The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
AYH, hexane:ethanol, 99:1; flux= 1 mL/min; retention times: 11.2 min (minor), 14.9 min 
(major)). 
tert-Butyl (R)-2-isocyano-2-(4-methoxyphenyl)-5-oxohexanoate (3Ca) 
 
Prepared according to the general procedure starting 
from isocyanoacetate 1C (49.5 mg, 0.2 mmol) and vinyl ketone 
2a (28 mg, 0.4 mmol). The title compound was obtained as a 
99:1 mixture of enantiomers. The crude material was purified by flash column 
chromatography on silica gel (eluting with hexane/ ethyl acetate 9/1 to 8/2) to give the 
title compound as a yellow oil. Yield: 90% (57.1 mg). [α]D 
22     6.43° (c=0.85, 98% ee, 
CH2Cl2).  
1H NMR (300 MHz, CDCl3) δ 7.42 (d, J = 9.0 Hz, 2H), 6.90 (d, J = 8.9 Hz, 2H), 3.80 
(s, 3H), 2.65 – 2.35 (m, 4H), 2.12 (s, 3H), 1.40 (s, 9H).13C NMR (75 MHz, CDCl3) δ 206.4, 
166.3, 160.5, 160.0, 127.0, 126.5, 114.2, 84.3, 70.4, 55.4, 38.6, 33.0, 30.2, 27.7. UPLC-
DAD-QTOF: calcd for C18H23NO4Na [M+H]
+, 340.1525; found, 340.1536. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
ODH, hexane:isopropanol, 99:1; flux= 0.5 mL/min; retention times: 23.2 min (major), 
29.2 min (minor)). 
tert-Butyl (R)-2-isocyano-5-oxo-2,5-diphenylpentanoate (3Ac) 
 
Prepared according to the general procedure starting 
from isocyanoacetate 1A (43.4 mg, 0.2 mmol) and vinyl 
ketone 2c (26.4 mg, 0.2 mmol). The title compound was 
obtained as a 97:3 mixture of enantiomers. The crude 
material was purified by flash column chromatography on silica gel (eluting with hexane/ 
ethyl acetate 9/1) to give the title compound as a yellow oil. Yield: 77% (53.8 mg). [α]D 
22    10.90° (c= 3.4, 94% ee, CH2Cl2). 
1H NMR (300 MHz, CDCl3) δ 7.96 – 7.88 (m, 2H), 7.62 – 7.51 (m, 3H), 7.49 – 7.36 
(m, 5H), 3.24 – 2.95 (m, 2H), 2.86 – 2.73 (m, 1H), 2.73 – 2.58 (m, 1H), 1.43 (s, 9H). 13C 
NMR (75 MHz, CDCl3) δ 197.8, 166.0, 160.9, 136.4, 135.0, 133.3, 128.9, 128.9, 128.6, 
128.0, 125.0, 84.3, 70.9, 33.6, 33.6, 27.5. UPLC-DAD-QTOF: calcd for C22H24NO3 [M+H]
+, 
350.1756; found, 350.1764. 
CHAPTER 5 
 
195 
 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
AYH, hexane:ethanol, 99:1; flux= 1 mL/min; retention times: 17.3 min (minor), 24.6 min 
(major)). 
tert-Butyl (R)-2-isocyano-5-oxo-2-phenyl-5-(p-tolyl)pentanoate (3Ad) 
Prepared according to the general procedure 
starting from isocyanoacetate 1A (43.4 mg, 0.2 mmol) 
and vinyl ketone 2d (29.2 mg, 0.2 mmol). The title 
compound was obtained as a 98:2 mixture of 
enantiomers. The crude material was purified by flash column chromatography on silica 
gel (eluting with hexane/ ethyl acetate 9/1) to give the title compound as a yellow oil. 
Yield: 70% (50.9 mg). [α]D 
22     8.44° (c=1.5, 96% ee, CH2Cl2).  
1H NMR (300 MHz, CDCl3) δ 7.85 – 7.78 (m, 2H), 7.62 – 7.55 (m, 2H), 7.47 – 7.34 
(m, 3H), 7.28 – 7.20 (m, 2H), 3.20 – 2.92 (m, 2H), 2.86 – 2.72 (m, 1H), 2.70 – 2.56 (m, 1H), 
2.40 (s, 3H), 1.43 (s, 9H). 13C NMR (75 MHz, CDCl3) δ 197.4, 166.0, 160.8, 144.1, 135.0, 
133.9, 129.3, 128.8, 128.5, 128.1, 125.1, 84.3, 70.9, 33.7, 33.5, 27.5, 21.6. UPLC-DAD-
QTOF: calcd for C23H26NO3 [M+H]
+, 364.1913; found, 364.1910. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
ADH, hexane:ethanol, 99:1; flux= 1 mL/min; retention times: 19.3 min (minor), 45.6 min 
(major)). 
tert-Butyl (R)-5-(4-chlorophenyl)-2-isocyano-5-oxo-2-phenylpentanoate (3Ae) 
 
Prepared according to the general procedure 
starting from isocyanoacetate 1A (43.4 mg, 0.2 mmol) and 
vinyl ketone 2e (33.3 mg, 0.2 mmol). The title compound 
was obtained as a 97:3 mixture of enantiomers. The crude material was purified by flash 
column chromatography on silica gel (eluting with hexane/ ethyl acetate 9/1) to give the 
title compound as a yellow oil. Yield: 70% (53.7 mg). [α]D 
22     5.27° (c=1.45, 94% ee, 
CH2Cl2).  
1H NMR (300 MHz, CDCl3) δ 7.89 – 7.82 (m, 2H), 7.60 – 7.54 (m, 2H), 7.48 – 7.35 
(m, 5H), 3.19 – 2.91 (m, 2H), 2.86 – 2.71 (m, 1H), 2.70 – 2.56 (m, 1H), 1.43 (s, 9H). 13C 
NMR (75 MHz, CDCl3) δ 197.0, 166.4, 161.4, 140.2, 135.3, 135.1, 129.8, 129.4, 129.4, 
129.4, 125.4, 84.8, 71.3, 34.0, 34.0, 27.9. UPLC-DAD-QTOF: calcd for C22H23NO3Cl [M+H]
+, 
384.1366; found,384.1354. 
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The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
AYH, hexane:ethanol, 97:3; flux= 1 mL/min; retention times: 9.6 min (minor), 14.6 min 
(major)). 
tert-Butyl (R)-2-isocyano-5-(4-methoxyphenyl)-5-oxo-2-phenylpentanoate (3Af) 
 
Prepared according to the general procedure 
starting from isocyanoacetate 1A (43.4 mg, 0.2 mmol) 
and vinyl ketone 2f (32.4 mg, 0.2 mmol). The title 
compound was obtained as a 99:1 mixture of enantiomers. The crude material was 
purified by flash column chromatography on silica gel (eluting with hexane/ ethyl 
acetate 9/1) to give the title compound as colourless oil. Yield: 80% (60.7 mg). [α]D 
22     
18.48° (c=0.6, 98% ee, CH2Cl2).  
1H NMR (300 MHz, CDCl3) δ 7.95 – 7.87 (m, 2H), 7.63 – 7.55 (m, 2H), 7.48 – 7.35 
(m, 3H), 6.98 – 6.88 (m, 2H), 3.86 (s, 3H), 3.19 – 2.90 (m, 2H), 2.86 – 2.71 (m, 1H), 2.71 – 
2.56 (m, 1H), 1.43 (s, 9H). 13C NMR (75 MHz, CDCl3) δ 196.5, 166.2, 163.8, 160.9, 135.2, 
130.7, 130.4, 129.6, 129.0, 125.2, 113.9, 84.4, 71.1, 55.6, 33.9, 33.4, 27.7. UPLC-DAD-
QTOF: calcd for C23H26NO4 [M+H]
+, 380.1862; found, 380.1856. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
AYH, hexane:ethanol, 90:10; flux= 1 mL/min; retention times: 12.1 min (minor), 17.6 min 
(major)). 
tert-Butyl (R)-2-isocyano-2-(4-methoxyphenyl)-5-oxo-5-(p-tolyl)pentanoate (3Cd) 
 
Prepared according to the general procedure 
starting from isocyanoacetate 1C (49.5 mg, 0.2 mmol) 
and vinyl ketone 2d (29.2 mg, 0.2 mmol). The title 
compound was obtained as a 99.5:0.5 mixture of enantiomers. The crude material was 
purified by flash column chromatography on silica gel (eluting with hexane/ ethyl 
acetate 9/1) to give the title compound as colourless oil. Yield: 80% (63.0 mg). [α]D 
22     
1.79° (c=3, 99% ee, CH2Cl2). 
1H NMR (300 MHz, CDCl3) δ 7.82 (d, J = 8.1 Hz, 2H), 7.49 (d, J = 8.9 Hz, 2H), 7.24 
(d, J = 8.1 Hz, 2H), 6.92 (d, J = 8.9 Hz, 2H), 3.81 (s, 3H), 3.19 – 2.93 (m, 2H), 2.84 – 2.67 
(m, 1H), 2.69 – 2.54 (m, 1H), 2.39 (s, 3H), 1.43 (s, 9H). 13C NMR (75 MHz, CDCl3) δ 197.6, 
166.4, 160.6, 160.0, 144.2, 134.1, 129.4, 128.2, 127.1, 126.6, 114.3, 84.2, 70.6, 55.4, 
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33.7, 33.6, 27.7, 21.7. UPLC-DAD-QTOF: calcd for C24H28NO4 [M+H]
+, 394.2018; found, 
394.2026. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
AYH, hexane:ethanol, 95:5; flux= 1 mL/min; retention times: 15.0 min (minor), 25.1 min 
(major)). 
tert-Butyl (R)-5-(4-chlorophenyl)-2-isocyano-5-oxo-2-(p-tolyl)pentanoate (3Be) 
Prepared according to the general procedure 
starting from isocyanoacetate 1B (46.3 mg, 0.2 mmol) 
and vinyl ketone 2e (33.3 mg, 0.2 mmol). The title 
compound was obtained as a 98.5:1.5 mixture of 
enantiomers. The crude material was purified by flash column chromatography on silica 
gel (eluting with hexane/ ethyl acetate 9/1) to give the title compound as yellow oil. 
Yield: 80% (63.7 mg). [α]D 
22     6.89° (c=2.05, 97% ee, CH2Cl2).  
1H NMR (300 MHz, CDCl3) δ 7.85 (d, 2H), 7.48 – 7.38 (m, 4H), 7.21 (d, J = 8.1 Hz, 
2H), 3.18 – 2.90 (m, 2H), 2.82 – 2.69 (m, 1H), 2.69 – 2.54 (m, 1H), 2.36 (s, 3H), 1.42 (s, 
9H). 13C NMR (75 MHz, CDCl3) δ 196.8, 166.3, 160.8, 139.9, 139.0, 134.9, 132.1, 129.7, 
129.6, 129.1, 125.1, 84.4, 70.8, 33.8, 33.7, 27.7, 21.1. UPLC-DAD-QTOF: calcd for 
C23H25NO3Cl [M+H]
+, 398.1523; found, 398.1527. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
AYH, hexane:ethanol, 95:5; flux= 1 mL/min; retention times: 8.3 min (minor), 10.2 min 
(major)). 
tert-Butyl (R)-2-(3-bromophenyl)-2-isocyano-5-oxo-5-(p-tolyl)pentanoate (3Dd) 
Prepared according to the general procedure 
starting from isocyanoacetate 1D (59.2 mg, 0.2 mmol) 
and vinyl ketone 2d (29.2 mg, 0.2 mmol). The title 
compound was obtained as a 98:2 mixture of 
enantiomers. The crude material was purified by flash 
column chromatography on silica gel (eluting with hexane/ ethyl acetate 9/1) to give the 
title compound as a brown oil. Yield: 86% (76.1 mg). [α]D 
22     3.00° (c=2.55, 96% ee, 
CH2Cl2). 
1H NMR (300 MHz, CDCl3) δ 7.82 (d, J = 8.2 Hz, 2H), 7.75 (t, J = 1.8 Hz, 1H), 7.52 
(dd, J = 7.9, 1.9 Hz, 2H), 7.34 – 7.26 (m, 1H), 7.25 (d, J = 8.1 Hz, 2H), 3.21 – 2.91 (m, 2H), 
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2.86 – 2.69 (m, 1H), 2.59 (dd, J = 19.0, 11.2 Hz, 1H), 2.40 (s, 3H), 1.44 (s, 9H). 13C NMR (75 
MHz, CDCl3) δ 197.3, 165.6, 161.8, 144.4, 137.4, 134.0, 132.3, 130.5, 129.5, 128.5, 128.2, 
124.0, 123.2, 85.0, 70.6, 34.0, 33.5, 27.7, 21.7. UPLC-DAD-QTOF: calcd for C23H25NO3Br 
[M+H]+, 442.1018; found, 442.1021. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
AYH, hexane:ethanol, 98:2; flux= 1 mL/min; retention times: 12.6 min (minor), 23.4 min 
(major)). 
tert-Butyl (R)-6-hydroxy-2-isocyano-6-methyl-5-oxo-2-phenylheptanoate (9Aa) 
Prepared according to the general procedure starting 
from isocyanoacetate 1A (43.4 mg, 0.2 mmol) and vinyl 
ketone 6a (45.7 mg, 0.4 mmol). The title compound was 
obtained as a 99:1 mixture of enantiomers. The crude 
material was purified by flash column chromatography on silica gel (eluting with hexane/ 
ethyl acetate 9/1 to 7/3) to give the title compound as a yellow oil. Yield: 70% (46.4 mg). 
[α]D 
22    3.54° (c= 1, 98% ee, CH2Cl2). 
1H NMR (300 MHz, CDCl3) δ 7.56 (dd, J = 8.2, 1.6 Hz, 2H), 7.49 – 7.39 (m, 3H), 3.52 
(s, 1H), 2.87 – 2.60 (m, 3H), 2.52 (m, 1H), 1.44 (s, 9H), 1.39 (s, 3H), 1.34 (s, 3H). 13C NMR 
(75 MHz, CDCl3) δ 213.1, 166.4, 161.5, 135.4, 129.5, 129.5, 125.5, 85.0, 76.9, 71.3, 33.9, 
31.4, 28.1, 27.1, 27.0. UPLC-DAD-QTOF: calcd for C19H26NO4 [M+H]
+,332.1862; found, 
332.1863. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
IA, hexane:ethanol, 98:2; flux= 1 mL/min; retention times: 13.2 min (minor), 16.7 min 
(major)). 
Benzyl (R)-6-hydroxy-2-isocyano-6-methyl-5-oxo-2-phenylheptanoate (9A´g) 
Prepared according to the general procedure starting 
from isocyanoacetate 1A´ (50.2 mg, 0.2 mmol) and vinyl 
ketone 6a (45.7 mg, 0.4 mmol). The title compound was 
obtained as a 96:4 mixture of enantiomers. The crude material 
was purified by flash column chromatography on silica gel (eluting with hexane/ ethyl 
acetate 9/1 to 7/3) to give the title compound as yellow oil. Yield: 74% (54.1 mg). [α]D 
22     10.60° (c= 2.11, 92% ee, CH2Cl2). 
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1H NMR (300 MHz, CDCl3) δ 7.57 – 7.49 (m, 2H), 7.45 – 7.37 (m, 3H), 7.36 – 7.28 
(m, 3H), 7.28 – 7.20 (m, 2H), 5.20 (s, 2H), 3.42 (s, 1H), 2.81 – 2.47 (m, 4H), 1.30 (s, 3H), 
1.28 (s, 3H).13C NMR (75 MHz, CDCl3) δ 212.5, 167.1, 162.0, 134.6, 134.4, 129.4, 129.2, 
128.7, 128.7, 128.1, 125.2, 76.5, 70.4, 68.7, 33.6, 30.9, 26.6. UPLC-DAD-QTOF: calcd for 
C22H24NO4 [M+H]
+, 366.1605; found, 366.1606. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
AYH, hexane:ethanol, 98:2; flux= 1 mL/min; retention times: 58.9 min (minor), 63.8 min 
(major)). 
tert-Butyl (R)-6-hydroxy-2-isocyano-6-methyl-5-oxo-2-(p-tolyl)heptanoate (9Ba) 
Prepared according to the general procedure starting 
from isocyanoacetate 1B (46.3 mg, 0.2 mmol) and vinyl 
ketone 6a (45.7 mg, 0.4 mmol). The title compound was 
obtained as a 99.5:0.5 mixture of enantiomers. The crude 
material was purified by flash column chromatography on 
silica gel (eluting with hexane/ ethyl acetate 9/1 to 7/3) to give the title compound as 
colourless oil. Yield: 70% (48.4 mg). [α]D 
22     2.88° (c= 1.65, 99% ee, CH2Cl2). 
1H NMR (300 MHz, CDCl3) δ 7.39 (d, J = 8.4 Hz, 2H), 7.20 (d, J = 8.1 Hz, 2H), 3.50 
(s, 1H), 2.78 – 2.43 (m, 4H), 2.35 (s, 3H), 1.41 (s, 9H), 1.35 (s, 3H), 1.30 (s, 3H). 13C NMR 
(75 MHz, CDCl3) δ 212.8, 166.2, 160.8, 139.1, 132.0, 129.7, 125.0, 84.4, 76.5, 70.7, 33.4, 
31.0, 27.7, 26.7, 26.6, 21.1. UPLC-DAD-QTOF: calcd for C20H28NO4 [M+H]
+, 346.2018; 
found, 346.2023. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
IA, hexane:ethanol, 98:2; flux= 1 mL/min; retention times: 26.1 min (major), 29.0 min 
(minor)). 
 
tert-Butyl (R)-6-hydroxy-2-isocyano-2-(4-methoxyphenyl)-6-methyl-5-oxoheptanoate 
(9Ca) 
Prepared according to the general procedure 
starting from isocyanoacetate 1C (49.5 mg, 0.2 mmol) and 
vinyl ketone 6a (45.7 mg, 0.4 mmol). The title compound 
was obtained as a 99:1 mixture of enantiomers. The crude 
material was purified by flash column chromatography on silica gel (eluting with hexane/ 
ethyl acetate 9/1 to 7/3) to give the title compound as a yellow oil. Yield: 72% (52.2 mg). 
[α]D 
22     4.84° (c=2.65, 98% ee, CH2Cl2). 
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1H NMR (300 MHz, CDCl3) δ 7.47 – 7.41 (m, 2H), 6.96 – 6.88 (m, 2H), 3.81 (s, 3H), 
3.49 (s, 1H), 2.77 – 2.43 (m, 4H), 1.41 (s, 9H), 1.36 (s, 3H), 1.31 (s, 3H). 13C NMR (75 MHz, 
CDCl3) δ 212.8, 166.3, 160.8, 160.1, 126.9, 126.5, 114.3, 84.4, 76.5, 70.5, 55.5, 33.4, 31.0, 
27.7, 26.7, 26.6. UPLC-DAD-QTOF: calcd for C20H28NO5 [M+H]
+, 362.1961; found, 
394.2018. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
IA, hexane:ethanol, 98:2; flux= 1 mL/min; retention times: 21.3 min (minor), 31.8 min 
(major)). 
tert-Butyl (R)-2-(3-bromophenyl)-6-hydroxy-2-isocyano-6-methyl-5-oxoheptanoate 
(9Da) 
Prepared according to the general procedure starting 
from isocyanoacetate 1D (59.2 mg, 0.2 mmol) and vinyl ketone 
6a (45.7 mg, 0.4 mmol). The title compound was obtained as a 
98:2 mixture of enantiomers. The crude material was purified 
by flash column chromatography on silica gel (eluting with 
hexane/ ethyl acetate 9/1 to 7/3) to give the title compound as colourless oil. Yield: 86% 
(70.6 mg). [α]D 
22     4.63° (c=3.15, 96% ee, CH2Cl2). 
1H NMR (300 MHz, CDCl3) δ 7.68 (t, J = 1.6 Hz, 1H), 7.55 – 7.42 (m, 2H), 7.30 (d, J 
= 7.9 Hz, 1H), 3.44 (s, 1H), 2.80 – 2.53 (m, 3H), 2.54 – 2.37 (m, 1H), 1.42 (s, 9H), 1.36 (s, 
3H), 1.32 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 212.5, 165.4, 161.9, 137.2, 132.3, 130.6, 
128.4, 123.8, 123.2, 85.1, 76.6, 70.3, 33.6, 30.9, 27.6, 26.7, 26.7. UPLC-DAD-QTOF: calcd 
for C19H25NO4Br [M+H]
+, 410.0967; found, 410.0970. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
IA, hexane:ethanol, 98:2; flux= 1 mL/min; retention times: 11.5 min (minor), 16.4 min 
(major)). 
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5.3.4. Elaboration of adducts  
5.3.4.1. Synthesis of Δ5-dehydroprolines 10-13 and corresponding derivatives 
14-18 
Δ5-Dehydroprolines 10-13 were prepared according to the following 
procedure:262 
 
Concentrated HCl solution (0.5 mL) was dropwise added to a solution of the 
corresponding α-isonitrile ketone (1.0 mmol) in ethanol (10 mL). The mixture was stirred 
for 1 hour at room temperature. Then, the solvent was removed by reduced pressure. 
Water (10 mL) was added and the mixture was basified with NH4OH (pH 9-10). The 
aqueous phase was extracted with dichloromethane (3 × 15 mL) and the combined 
organic layer was washed with water and sat. brine. The organic phase was dried over 
MgSO4 and the solvent was evaporated to give Δ
5-dehydroprolines 10-13 which were 
submitted to the next hydrogenation step without further purification. 
tert-Butyl (R)-5-methyl-2-phenyl-3,4-dihydro-2H-pyrrole-2-carboxylate (10) 
Prepared according to the general procedure starting from 
adduct 3Aa (287 mg, 1 mmol). The title compound was isolated as 
white foam. Yield: 80% (207 mg, 0.8 mmol). 1H NMR (300 MHz, 
CDCl3) δ 7.50 – 7.40 (m, 2H), 7.40 – 7.19 (m, 3H), 2.92 – 2.76 (m, 1H), 2.77 – 2.59 (m, 
1H), 2.61 – 2.44 (m, 1H), 2.18 (s, 3H), 2.20 – 2.05 (m, 1H), 1.38 (s, 9H). 
tert-Butyl (R)-5-ethyl-2-phenyl-3,4-dihydro-2H-pyrrole-2-carboxylate (11) 
Prepared according to the general procedure starting from 
adduct 3Ab (301 mg, 1 mmol). The title compound was isolated as 
colourless oil. Yield: 83% (227 mg, 0.81 mmol).1H NMR (300 MHz, 
CDCl3) δ 7.50 – 7.40 (m, 2H), 7.37 – 7.20 (m, 3H), 2.88 – 2.76 (m, 1H), 2.75 – 2.61 (m, 
                                                     
262
 Adapted from: Zhao, M.; Zhu, H.; Dai, T.; Shi, M. J. Org. Chem 2015, 80, 11330-11338. 
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1H), 2.60 – 2.55 (m, 1H), 2.50 (q, J = 7.5 Hz, 2H), 2.16 – 2.03 (m, 1H), 1.38 (s, 9H), 1.22 (t, 
J = 7.5 Hz, 3H). 
tert-Butyl (R)-2-phenyl-5-(p-tolyl)-3,4-dihydro-2H-pyrrole-2-carboxylate (12) 
Prepared according to the general procedure starting 
from adduct 3Ad (363 mg, 1 mmol). The title compound was 
isolated as white solid. m.p.= 120-125°C. Yield: 80% (268 mg, 
0.8 mmol). 1H NMR (300 MHz, CDCl3) δ 7.94 – 7.85 (m, 2H), 7.58 – 7.50 (m, 2H), 7.38 – 
7.28 (m, 2H), 7.25 – 7.21 (m, 3H), 3.19 – 2.91 (m, 3H), 2.40 (s, 3H), 2.32 – 2.19 (m, 1H), 
1.40 (s, 9H). 
tert-Butyl (R)-5-(4-methoxyphenyl)-2-phenyl-3,4-dihydro-2H-pyrrole-2-carboxylate 
(13) 
Prepared according to the general procedure 
starting from adduct 3Af (379 mg, 1 mmol). The title 
compound was isolated as yellow foam. Yield: Quantit. 
(351 mg, 1.0 mmol). 1H NMR (300 MHz, CDCl3) δ 8.02 – 7.93 (m, 2H), 7.60 – 7.49 (m, 2H), 
7.40 – 7.31 (m, 2H), 7.32 – 7.24 (m, 1H), 7.00 – 6.93 (m, 2H), 3.88 (s, 3H), 3.21 – 2.91 (m, 
3H), 2.38 – 2.16 (m, 1H), 1.42 (s, 9H). 
 
Diastereoselective synthesis of α-quaternary proline esters 14 and 15 
 
 
 
The corresponding dihydropyrrol 10/11 (0.5 mmol) was dissolved in ethanol (2.0 
mL). Pd/C (50 mg) was added to this solution, and the resulting mixture was stirred 
under hydrogen atmosphere (balloon) for 16 h at room temperature. The reaction 
mixture was then passed through celite to remove Pd/C, the solvent was removed under 
reduced pressure and the crude was purified by flash column chromatography on silica 
(hexane/EtOAc 90/10) to give pyrrolidines 14 and 15. 
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tert-Butyl (2R,5S)-5-methyl-2-phenylpyrrolidine-2-carboxylate (14) 
Prepared according to the general procedure starting from 
the dihydropyrrol 10 (129.7 mg, 0.5 mmol). The title compound 
was isolated as a white foam. dr > 20:1. Yield: 80% (104.5 mg, 0.4 
mmol). [α]D 
22= – 5.6° (c=0.55, 98% ee, CH2Cl2). 
1H NMR (300 MHz, CDCl3) δ 7.57 – 7.48 (m, 2H), 7.34 – 7.16 (m, 3H), 3.38 – 3.24 
(m, 1H), 2.74 (ddd, J = 12.5, 7.2, 2.9 Hz, 1H), 2.57 (s, 1H), 2.15 – 2.04 (m, 1H), 2.01 – 1.88 
(m, 1H), 1.36 (s, 9H), 1.34 – 1.27 (m, 1H), 1.25 (d, J = 6.2 Hz, 3H). 13C NMR (75 MHz, 
CDCl3) δ 175.3, 144.2, 128.0, 126.9, 126.4, 81.5, 72.9, 54.4, 38.1, 34.5, 27.9, 21.9. UPLC-
DAD-QTOF: calcd for C16H24NO2 [M+H]
+, 262.1807; found, 262.1810. 
tert-Butyl (2R,5S)-5-ethyl-2-phenylpyrrolidine-2-carboxylate (15) 
Prepared according to the general procedure starting from 
the dihydropyrrol 11 (136.7 mg, 0.5 mmol). The title compound 
was isolated as a white foam. dr > 20:1. Yield: 75% (103.3 mg, 
0.38 mmol). [α]D 
22= – 6.23° (c=1, 94% ee, CH2Cl2). 
1H NMR (300 MHz, CDCl3) δ 7.61 – 7.54 (m, 2H), 7.38 – 7.21 (m, 3H), 3.23 – 3.10 
(m, 1H), 2.83 – 2.71 (m, 1H), 2.62 (s, 1H), 2.11 (ddd, J = 12.3, 10.5, 7.1 Hz, 1H), 2.04 – 
1.93 (m, 1H), 1.71 (m, 1H), 1.57 – 1.43 (m, 1H), 1.40 (s, 9H), 1.39 – 1.27 (m, 1H), 1.00 (t, J 
= 7.4 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 175.3, 144.2, 128.0, 126.9, 126.3, 81.4, 72.5, 
60.6, 37.5, 32.0, 29.7, 27.8, 11.5. UPLC-DAD-QTOF: calcd for C17H26NO2 [M+H]
+, 
276.1964; found, 276.1970. 
 
Derivatization of the quaternary proline esters 14 to 16 for X-ray analysis  
 
To a solution of pyrrolidine 14 (52 mg, 0.2 mmoL, 1 equiv.) and Et3N (42 μL, 0.3 
mmol, 1.5 equiv.) in 2mL of dichloromethane was added 4-nitrobenzoyl chloride (56 mg, 
0.3 mmoL, 1.5 equiv.) dropwise and the reaction was stirred at room temperature for 
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4h. After dilution with 5 mL dichloromethane, the mixture was washed with DCM (3 × 3 
mL). The resulting solution was dried over MgSO4, concentrated under reduced pressure 
and the crude was purified by flash column chromatography on silica (hexane/EtOAc 
90/10). The title compound 16 was isolated as a white solid. m.p.= 200-204°C. Yield: 95% 
(78.0 mg, 0.19 mmol). 1H NMR (300 MHz, CDCl3) δ 8.33 (d, J = 8.2 Hz, 2H), 7.75 (d, J = 8.3 
Hz, 2H), 7.46 (d, J = 7.7 Hz, 2H), 7.42 – 7.23 (m, 3H), 4.39 – 4.29 (m, 1H), 2.74 (td, J = 
12.4, 6.2 Hz, 1H), 2.43 – 2.29 (m, 1H), 2.13 – 1.95 (m, 1H), 1.71 – 1.60 (m, 1H), 1.55 (s, 
9H), 1.05 (d, J = 6.4 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 170.3, 167.3, 148.5, 143.6, 138.3, 
127.8, 127.8, 127.5, 127.4, 124.0, 81.9, 73.9, 56.4, 39.1, 31.4, 28.1, 20.9. 
 
Synthesis of α,α-disubtituted α-amino esters 17 and 18 
 
The corresponding dihydropyrrol 12/13 (0.5 mmol) was dissolved in ethanol (2.0 
mL). Pd/C (50 mg) was added to this solution, and the resulting mixture was stirred 
under hydrogen atmosphere (balloon) for 16 h at room temperature. The reaction 
mixture was then passed through celite to remove Pd/C, the solvent was removed under 
reduced pressure and the crude was purified by flash column chromatography on silica 
(hexane/EtOAc 90/10) to give amino esters 17 and 18. 
tert-Butyl (R)-2-amino-2-phenyl-5-(p-tolyl)pentanoate (17) 
Prepared according to the general procedure 
starting from the dihydropyrrol 12 (167.7 mg, 0.5 mmol). 
The title compound was isolated as a white solid. m.p.= 
45°C.  Yield: 82% (139.2 mg, 0.41 mmol). [α]D 
22= – 22.46° 
(c=0.65, 96% ee, CH2Cl2).  
1H NMR (300 MHz, CDCl3) δ 7.54 – 7.44 (m, 2H), 7.36 – 7.22 (m, 3H), 7.12 – 7.00 
(m, 3H), 2.58 (t, J = 7.6 Hz, 2H), 2.30 (s, 3H), 2.22 – 2.07 (m, 1H), 2.04 – 1.91 (m, 1H), 1.85 
(s, 1H), 1.69 – 1.52 (m, 2H), 1.39 (s, 9H). 13C NMR (75 MHz, CDCl3) δ 174.9, 143.9, 139.1, 
135.3, 129.1, 128.4, 128.3, 127.2, 125.5, 81.5, 64.1, 39.5, 35.8, 28.0, 26.3, 21.1. UPLC-
DAD-QTOF: calcd for C22H30NO2 [M+H]
+, 340.2277; found, 340.2281. 
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tert-Butyl (R)-2-amino-4-(4-methoxyphenyl)-2-phenylpentanoate (18) 
Prepared according to the general procedure 
starting from the dihydropyrrol 13 (176 mg, 0.5 mmol). 
The title compound was isolated as a yellow oil. Yield: 
80% (142.2 mg, 0.4 mmol). [α]D 
22= – 10.34° (c=1.65, 96% 
ee, CH2Cl2).  
1H NMR (300 MHz, CDCl3) δ 7.54 – 7.44 (m, 2H), 7.37 – 7.22 (m, 3H), 7.09 – 7.02 
(m, 2H), 6.85 – 6.76 (m, 2H), 3.78 (s, 3H), 2.57 (t, J = 7.5 Hz, 2H), 2.19 – 2.07 (m, 1H), 2.03 
– 1.95 (m, 1H), 1.92 (brs, 2H), 1.67 – 1.51 (m, 2H), 1.39 (s, 9H). 13C NMR (75 MHz, CDCl3) 
δ 175.4, 158.4, 144.4, 134.8, 129.9, 128.9, 127.7, 126.0,  114.4, 82.1, 64.6, 55.9, 40.0, 
35.9, 28.5, 26.9. UPLC-DAD-QTOF: calcd for C22H30NO2 [M+H]
+, 356.2115; found, 
356.2124. 
 
5.3.4.2. Synthesis of Δ4-dehydroprolines 19-23 
Δ4-Dehydroprolines 19-23 were prepared according to the following procedure: 
 
 
 
 
The corresponding adduct 3 (0.2 mmol) was dissolved in dichloromethane (0.4 
ml), and AgF (2.5 mg, 0.1 equiv.) and DBU (3 mg, 0.1 equiv.) was added. The reaction 
mixture was stirred for 5 h at room temperature. Then, the reaction mixture was diluted 
in dichloromethane (2 mL), washed with HCl 1M and saturated NH4Cl and the organic 
layer was dried with MgSO4. The solvent was remove under reduced pressure to give the 
desired dehydroproline adduct.  A rapid filtration through silica-gel pad (hexane/EtOAc 
50/15) was sufficient to remove traces of impurities and excess reactants. These 
products were thermally instables unless at low temperature (–40 °C). 
 
 
Experimental section 
206 
 
tert-Butyl (R) 2-(3-bromophenyl)-4-(4-methylbenzoyl)-2,3-dihydro-1H-pyrrole-2-
carboxylate (19) 
Prepared according to the general procedure 
starting from 3Dd (88.5 mg, 0.2 mmol). The title 
compound was isolated as a yellow foam. Yield: 92% 
(81.4 mg, 0.18 mmol). 
1H NMR (300 MHz, CDCl3) δ 7.59 (t, J = 1.8 Hz, 1H), 7.47 (d, J = 8.1 Hz, 2H), 7.43 – 
7.33 (m,2H), 7.17 (dd, J = 15.3, 7.7 Hz, 3H), 7.09 (d, J = 3.0 Hz, 1H), 6.25 (d, J = 2.6 Hz, 
1H), 3.86 (dd, J = 15.9, 0.9 Hz, 1H), 3.14 (d, J = 16.0 Hz, 1H), 2.35 (s, 3H), 1.41 (s, 9H). 13C 
NMR (75 MHz, CDCl3) δ 190.0, 171.9, 149.7, 144.5, 140.8, 137.8, 130.9, 130.2, 128.8, 
128.6, 128.0, 124.0, 122.8, 113.5, 83.5, 73.5, 40.4, 27.8, 21.5. UPLC-DAD-QTOF: calcd for 
C23H25NO3Br [M+H]
+, 442.0101; found, 442.0105. 
tert-Butyl (R) 4-(4-methylbenzoyl)-2-phenyl-2,3-dihydro-1H-pyrrole-2-carboxylate (20) 
Prepared according to the general procedure 
starting from 3Ad (72.7 mg, 0.2 mmol). The title compound 
was isolated as a white foam. Yield: 85% (61.8 mg, 0.17 
mmol).  
1H NMR (300 MHz, CDCl3) δ 7.49 (d, J = 8.1 Hz, 2H), 
7.44 (dd, J = 8.3, 1.4 Hz, 2H), 7.41 – 7.22 (m, 3H), 7.17 (d, J = 7.8 Hz, 2H), 7.12 (d, J = 3.1 
Hz, 1H), 5.96 (d, J = 2.5 Hz, 1H), 3.94 – 3.85 (m, 1H), 3.22 (d, J = 15.9 Hz, 1H), 2.37 (s, 3H), 
1.42 (s, 9H). 13C NMR (75 MHz, CDCl3) δ 190.2, 172.7, 149.7, 142.1, 140.8, 138.0, 128.9, 
128.7, 128.1, 127.9, 125.3, 113.8, 83.2, 74.0, 40.0, 27.9, 21.5. UPLC-DAD-QTOF: calcd for 
C23H26NO3 [M+H]
+, 364.1913; found, 364.1913. 
tert-Butyl (R) 4-acetyl-2-(4-methoxyphenyl)-2,3-dihydro-1H-pyrrole-2-carboxylate (21) 
Prepared according to the general procedure starting 
from 3Ca (63.5 mg, 0.2 mmol). The title compound was isolated 
as a white foam. Yield: 88% (55.9 mg, 0.18 mmol).  
1H NMR (300 MHz, CDCl3) δ 7.34 – 7.25 (m, 2H), 7.26 (d, J 
= 2.7 Hz, 1H), 6.90 – 6.79 (m, 2H), 5.74 (s, 1H), 3.78 (s, 3H), 3.67 
(d, J = 15.8 Hz, 1H), 2.99 (d, J = 15.9 Hz, 1H), 2.15 (s, 3H), 1.39 (s, 9H). 13C NMR (75 MHz, 
CDCl3) δ 192.4, 173.2, 159.5, 147.5, 134.4, 126.8, 115.4, 114.3, 83.3, 74.0, 55.6, 39.5, 
28.1, 25.7. UPLC-DAD-QTOF: calcd for C18H24NO4 [M+H]
+, 318.1705; found, 318.1711. 
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tert-Butyl (R) 4-acetyl-2-phenyl-2,3-dihydro-1H-pyrrole-2-carboxylate (22) 
 
Prepared according to the general procedure starting from 
3Aa (57.5 mg, 0.2 mmol). The title compound was isolated as a 
yellow foam. Yield: 85% (48.9 mg, 0.17 mmol).  
1H NMR (300 MHz, CDCl3) δ 7.46 – 7.23 (m, 6H), 5.74 (s, 1H), 
3.72 (d, J = 15.1 Hz, 1H), 3.01 (d, J = 15.8 Hz, 1H), 2.16 (s, 3H), 1.39 
(s, 9H). 13C NMR (75 MHz, CDCl3) δ 192.0, 172.6, 147.1, 141.9, 128.5, 127.7, 125.1, 115.0, 
83.0, 74.1, 53.4, 39.1, 27.7, 25.3. UPLC-DAD-QTOF: calcd for C17H21NO3 [M+H]
+, 
288.1600; found, 288.1598. 
tert-Butyl (R) 2-phenyl-4-propionyl-2,3-dihydro-1H-pyrrole-2-carboxylate (23) 
Prepared according to the general procedure starting from 
3Ab (60.3 mg, 0.2 mmol). The title compound was isolated as a 
white foam. Yield: 78% (47.0 mg, 0.16 mmol).  
1H NMR (300 MHz, CDCl3) δ 7.43 (d, J = 1.8 Hz, 1H), 7.38 – 
7.25 (m, 5H), 5.48 (s, 1H), 3.74 (dd, J = 15.8, 1.0 Hz, 1H), 3.02 (d, J 
= 15.8 Hz, 1H), 2.50 (q, J = 7.5 Hz, 2H), 1.41 (s, 9H), 1.11 (t, J = 7.5 Hz, 3H). 13C NMR (75 
MHz, CDCl3) δ 195.9, 172.9, 146.1, 142.2, 128.7, 127.9, 125.3, 114.4, 83.1, 74.0, 39.4, 
31.2, 27.9, 9.8. UPLC-DAD-QTOF: calcd for C18H24NO3 [M+H]
+, 302.1756; found, 
302.1760. 
 
5.3.4.3. Synthesis of  pyroglutamate 26 
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1st step: 263 A suspension of sodium periodate NaIO4 (535 mg, 2.5 mmol, 5 equiv.) in 
water (1.5 mL) was added to a solution of the corresponding α-hydroxy ketone 9Aa (166 
mg, 0.5 mmol, 1 equiv.) in methanol (2.5 mL). The mixture was stirred at room 
temperature until the reaction was complete (monitored by TLC). Then the solvent was 
removed under reduced pressure. Water (7 mL) was added to the crude product, the 
resulting mixture was extracted with Et2O (3 × 7 mL) and washed with water. The 
organic phase was dried over MgSO4, filtered and the solvent was evaporated to afford 
the corresponding carboxylic acid as white solid. The crude product was used 
inmediately in the next step without further purification because its instability. 1H NMR 
(300 MHz, CDCl3) δ 7.57 – 7.49 (m, 2H), 7.46 – 7.37 (m, 3H), 2.72 – 2.61 (m, 1H), 2.58 – 
2.38 (m, 3H), 1.42 (s, 9H). 
2nd step : (Trimethylsilyl)diazomethane (2M in hexane, 1.25 mL, 5 equiv.) was slowly 
added to a solution of the crude acid (0.5 mmol) in methanol (3.5 mL). The mixture was 
stirred at room temperature until the reaction was complete (about 2 h). The mixture 
was evaporated and purify by flash column chromatography on silica gel (eluting with 
hexane/ethyl acetate 20/1) to give the compound 25 as colourless oil. Overall yield (step 
1 and 2): 62% (94.0 mg, 0.31 mmol). 1H NMR (300 MHz, CDCl3) δ 7.53 (dd, J = 8.2, 1.6 Hz, 
2H), 7.48 – 7.33 (m, 3H), 3.66 (s, 3H), 2.76 – 2.58 (m, 1H), 2.59 – 2.31 (m, 3H), 1.42 (s, 
9H).  
3rd step: Concentrated HCl solution (0.1 mL) was dropwise added to a solution of the 
ester 25 (60.7 mg, 0.2 mmol) in ethanol (2 mL). The mixture was stirred for 1 hour at 
room temperature. Then, the solvent was removed by reduced pressure. Water (2 mL) 
was added and basify with NH4OH (pH 9-10). The aqueous phase was extracted with 
CH2Cl2 (3 × 3 mL) and the combined organic layer was washed with water and sat. brine. 
The organic phase was dried over MgSO4, the solvent was evaporated and the crude was 
purify by flash column chromatography on silica gel (eluting hexane/ethyl acetate 8/2) 
to give the product 26. Yield: 90% (54.5 mg, 0.18 mmol) [α]D 
22= +84.04° (c=0.55, 97% ee, 
CH2Cl2).
 1H NMR (300 MHz, CDCl3) δ 7.47 – 7.26 (m, 5H), 6.55 (s, 1H), 3.04 – 2.88 (m, 1H), 
2.43 – 2.33 (m, 2H), 2.33 – 2.21 (m, 1H), 1.41 (s, 9H). 13C NMR (75 MHz, CDCl3) δ 176.9, 
170.6, 140.7, 128.4, 127.7, 124.2, 82.5, 68.5, 33.1, 29.6, 27.4. UPLC-DAD-QTOF: calcd for 
C15H20NO3 [M+H]
+, 262.1443; found, 262.1445.  
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 Adapted from: Badiola, E.; Fiser, B.; Gomez-Bengoa, E.; Mielgo, A.; Olaizola, I.; Urruzuno, I.; García, J. 
M.; Odriozola, J. M.; Razkin, J.; Oiarbide, M.; Palomo C. J. Am. Chem. Soc. 2014, 136, 17869-17881. 
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5.4. Experimental section of chapter 3 
5.4.1. Synthesis of isocyano(thio)acetates 27-35, 62 and 73 
5.4.1.1. Synthesis of  isocyanothioacetates 27A-D 
The isocyanothioacetates 27A-D were prepared according to the following 
procedure: 
 
1st step: To a solution of the amino acid (10 mmol, 1 equiv.) in dioxane (40 mL) and 
water (20 mL) was added NaOH 1M (20 mL). The mixture was cooled to 0 °C, Boc2O (2.4 
g, 11 mmol, 1.1 equiv.) was slowly added and the reaction was stirred 6 h at room 
temperature. Then, the reaction mixture was diluted with ethyl acetate (20 mL), cooled 
in an ice-bath and acidified to pH 2-3 with KHSO4 1M. The layers were separated and the 
aqueous fraction was extracted with ethyl acetate (2 × 20 mL). Finally, the combined 
organic phases was dried over MgSO4 and was concentrated under reduced pressure. 
The crude material was used in the next step without purification. 
(tert-Butoxycarbonyl)phenylalanine 
Yield: Quantit. 1H NMR (300 MHz, CDCl3) δ 7.36 – 7.23 (m, 3H), 
7.22 – 7.14 (m, 2H), δ 4.94 (d, J = 8.1 Hz, 1H), 4.67 – 4.53 (m, 1H), 3.20 
(dd, J = 13.9, 5.5 Hz, 1H), 3.14 – 3.01 (m, 1H), 1.42 (s, 9H). 
(tert-Butoxycarbonyl)alanine 
Yield: 93%. 1H NMR (300 MHz, CDCl3) δ 5.06 (s, 1H), 4.48 – 4.30 
(m, 1H), 1.55 – 1.45 (m, 12H). 
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(tert-Butoxycarbonyl)leucine 
Yield: Quantit. 1H NMR (300 MHz, CDCl3) δ 4.95 – 4.77 (m, 1H), 
4.40 – 4.23 (m, 1H), 1.84 – 1.61 (m, 2H), 1.60 – 1.49 (m, 1H), 1.45 (s, 
9H), 0.96 (d, J = 6.2 Hz, 6H). 
2nd step:264 To a solution of Boc-aminoacid (5 mmol, 1 equiv.) and 1-
hydroxibenzotriazole HOBt (676 mg, 5 mmol, 1.0 equiv.) in dry ethyl acetate (50 mL) 
under argon, at 0 °C, was added the corresponding thiol (10 mmol, 2 equiv.). After 5 
min, 1,3-dicyclohexylcarbodiimide DCC (1.08 g, 5.5 mmol, 1.1 equiv.) was added by 
portions. After stirring overnight, a 50% solution of acetic acid in ethyl acetate (2 mL) 
was added. The reaction mixture was filtered through a pad of celite and solvent was 
removed under vacuum. The crude product was purified by column chromatography on 
silica gel. 
S-Phenyl 2-((tert-butoxycarbonyl)amino)-3-phenylpropanethioate 
Yield: 82%. 1H NMR (300 MHz, CDCl3) δ 7.53 – 7.19 (m, 10H), 
5.09 – 4.95 (m, 1H), 4.80 (q, J = 7.5, 7.1 Hz, 1H), 3.19 (t, J = 6.0 Hz, 2H), 
1.48 (d, J = 2.3 Hz, 9H). 
S-Phenyl 2-((tert-butoxycarbonyl)amino)propanethioate 
Yield: 89%. 1H NMR (300 MHz, CDCl3) δ 7.41 (s, 5H), 5.06 – 4.95 
(m, 1H), 4.59 – 4.45 (m, 1H), 1.49 (s, 9H), 1.44 (d, J = 7.2 Hz, 3H). 
S-Phenyl 2-((tert-butoxycarbonyl)amino)-4-methylpentanethioate 
Yield: 74%. 1H NMR (300 MHz, CDCl3) δ 7.51 – 7.35 (m, 5H), 
4.94 (d, J = 8.8 Hz, 1H), 4.53 (td, J = 9.5, 3.9 Hz, 1H), 1.88 – 1.70 (m, 
2H), 1.64 – 1.56 (m, 1H), 1.53 (s, 9H), 1.00 (dd, J = 6.3, 5.0 Hz, 6H). 
S-Phenyl 2-((tert-butoxycarbonyl)amino)-3-methylbutanethioate 
Yield: 97%. 1H NMR (300 MHz, CDCl3) δ 7.44 (d, J = 1.3 Hz, 5H), 
5.06 (d, J = 9.6 Hz, 1H), 4.45 (dd, J = 9.4, 4.6 Hz, 1H), 2.36 (dt, J = 13.1, 
6.8 Hz, 1H), 1.53 (s, 9H), 1.07 (d, J = 6.8 Hz, 3H), 0.97 (d, J = 6.9 Hz, 3H). 
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 Adapted from: a) Garnier-Amblard, E.-C.; Mays, S. G.; Arrendale, R. F.; Baillie, M. T.; Bushnev, A. S.; 
Culver, D. G.; Evers, T. J.; Holt, J. J.; Howard, R. B.; Liebeskind, L. S.; Menaldin, D. S.; Natchus, M. G.; Petros, 
G. A.; Ramaraju, H.; Reddy, G. P.; Liotta, D. C. Med. Chem. Lett. 2011, 2, 438-443. b) Rostein, B. H.; 
Winternheimer, D. J.; Yin, L. M.; Deber, C. M.; Yudin, A. K. Chem. Commun. 2012, 48, 3775–3777. 
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3rd step: To a solution of HCl 4M in dioxano (10 mL) Boc-protected aminothioester (4 
mmol) was added and the mixture was stirred 2h. Then, the solvent was removed under 
reduced pressure, the solid was triturated with Et2O and filtered. The title compound 
was obtained as a white solid.  
S-Phenyl 2-aminopropanethioate hydrochloride 
Yield: Quantit. 1H NMR (300 MHz, CDCl3) δ 8.65 (s, 3H), 7.53 – 
7.36 (m, 5H), 4.31 (q, J = 7.2 Hz, 1H), 1.65 (d, J = 7.2 Hz, 3H). 
S-Phenyl 2-amino-4-methylpentanethioate hydrochloride 
Yield: 88%. 1H NMR (300 MHz, CDCl3) δ 8.85 (s, 3H), 7.49 – 
7.31 (m, 5H), 4.28 – 4.15 (m, 1H), 2.10 – 1.88 (m, 2H), 1.87 – 1.71 (m, 
1H), 0.91 (t, J = 5.8 Hz, 6H). 
S-Phenyl 2-amino-3-methylbutanethioate hydrochloride 
Yield: Quantit. 1H NMR (300 MHz, CDCl3) δ 8.90 (s, 3H), 7.53 – 
7.37 (m, 5H), 4.16 (d, J = 4.5 Hz, 1H), 2.59 – 2.43 (m, 1H), 1.17 (dd, J = 
9.4, 6.9 Hz, 6H). 
4th step: METHOD A: The amine hydrochloride (5 mmol) was dissolved in CH2Cl2 (20 mL) 
and the solution was washed with saturated NaHCO3 (3 × 20 mL), dried over MgSO4 and 
concentrated under reduced pressure. To the residue obtained above was added ethyl 
formate (15 mL) and the mixture was heated at 90 °C for 14 h, and then the reaction was 
concentrated under reduced pressure. The crude was purified by flash column 
chromatography on silica gel. 
METHOD B265: To a solution of formic acid (9.3 mL, 8 mmol, 4 equiv.) in CH2Cl2 (15 mL) at 
0 °C was added EDCI carbodiimide (766 mg, 4 mmol, 2 equiv.). After 15 min, a solution 
containing substrate (2 mmol, 1 equiv.) and N-methylmorpholine (0.44 mL, 4 mmol, 2 
equiv.) in CH2Cl2 (15 mL) at 0 °C was added. The mixture was stirred at 5 °C for 20 h, 
washed successively twice with HCl 1M (20 mL), saturated NaHCO3 (20 mL). The solution 
was dried with anhydrous MgSO4, filtered and the solvent was evaporated under 
reduced pressure. The crude was purified by flash column chromatography on silica gel 
giving the formamide compound. 
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 Adapted from: Chem, F. M. F.; Benoitton, N. L. Synthesis, 1979, 9, 709-710. 
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S-Phenyl 2-formamido-3-phenylpropanethioate 
Yield: 94% (method B). 1H NMR (300 MHz, CDCl3) δ 8.26 (s, 
1H), 7.53 – 7.16 (m, 10H), 6.01 (d, J = 8.6 Hz, 1H), 5.31 – 5.19 (m, 1H), 
3.25 (d, J = 6.3 Hz, 2H). 
S-Phenyl 2-formamidopropanethioate 
Yield: 85% (method B). 1H NMR (300 MHz, CDCl3) δ 8.27 – 8.22 
(m, 1H), 7.49 – 7.37 (m, 5H), 6.13 (s, 1H), 5.04 – 4.90 (m, 1H), 1.53 (d, J = 
7.1 Hz, 3H). 
S-Phenyl 2-formamido-4-methylpentanethioate 
Yield: 94% (method B). 1H NMR (300 MHz, CDCl3) δ 8.32 – 8.23 
(m, 1H), 7.48 – 7.33 (m, 5H), 5.99 (d, J = 8.9 Hz, 1H), 5.07 – 4.89 (m, 
1H), 1.88 – 1.69 (m, 2H), 1.68 – 1.52 (m, 1H), 0.98 (dd, J = 6.3, 4.2 Hz, 
6H).  
S-Phenyl 2-formamido-3-methylbutanethioate 
Yield: 90% (method A). 1H NMR (300 MHz, CDCl3) δ 8.43 – 8.33 
(m, 1H), 7.54 – 7.38 (m, 5H), 6.08 (s, 1H), 4.95 (ddd, J = 9.4, 4.8, 0.8 Hz, 
1H), 2.50 – 2.32 (m, 1H), 1.10 (dd, J = 6.8, 1.9 Hz, 3H), 1.00 (m, 3H). 
 
5th step:266 To the corresponding N-formyl thioester (2 mmol, 1 equiv.) in CH2Cl2 (20 mL) 
was added N-methylmorpholine (0.44 mL, 4 mmol, 2 equiv.) and the mixture was cooled 
to –78 °C. Triphosgene (207 mg, 0.7 mmol, 0.35 equiv.) was added in one portion and 
the reaction mixture was stirred at -78 °C with TLC monitoring (around 2 h). The reaction 
was quenched by slow addition of water, quickly extracted with CH2Cl2 (2 × 20 mL), dried 
over MgSO4 and the solvent was evaporated under reduced pressure (Keep bath temp 
below 23 °C). The reaction crude was purified by flash column chromatography on silica 
gel. The product exhibited the characteristic isonitrile NC band at IR: 2135-2137 cm-1. 
S-Phenyl 2-isocyano-3-phenylpropanethioate (27A) 
The isocyanothioate 4B was obtained following the general 
procedure. Yellow oil. Yield (last step): 60 % (321 mg, 1.2 mmol). 1H 
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 Adapted from: Zhu, J.; Wu, X.; Danishefsky, S. J. Tetrahedron Lett., 2009, 50, 577-579. 
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NMR (300 MHz, CDCl3) δ 7.51 – 7.43 (m, 3H), 7.43 – 7.33 (m, 4H), 7.33 – 7.25 (m, 3H), 
4.56 (dd, J = 8.4, 4.7 Hz, 1H), 3.32 (dd, J = 13.9, 4.7 Hz, 1H), 3.19 (dd, J = 13.9, 8.4 Hz, 1H). 
13C NMR (75 MHz, CDCl3) δ 191.7, 164.0, 134.5, 133.9, 130.1, 129.5, 129.5, 128.7, 127.8, 
125.6, 64.2, 39.3. UPLC-DAD-QTOF: C16H14NOS [M+H]
+ calcd.: 268.0796, found: 
268.0795. 
S-Phenyl 2-isocyanopropanethioate (27B) 
The isocyanothioate 4A was obtained following the general 
procedure. Yellow oil. Yield (last step): 62 % (237 mg, 1.24 mmol). 1H 
NMR (300 MHz, CDCl3) δ 7.55 – 7.35 (m, 5H), 4.46 (q, J = 7.1 Hz, 1H), 1.72 
(d, J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 192.5, 162.5, 134.6, 130.1, 129.5, 125.6, 
58.2, 20.0. UPLC-DAD-QTOF: C10H10NOS [M+H]
+ calcd.: 192.0483, found: 192.0486. 
S-Phenyl 2-isocyano-4-methylpentanethioate (27C) 
The isocyanothioate 4C was obtained following the general 
procedure. Yellow oil. Yield (last step): 75 % (350 mg, 1.5 mmol). 1H 
NMR (300 MHz, CDCl3) δ 7.56 – 7.40 (m, 5H), 4.45 (dd, J = 9.9, 4.5 Hz, 
1H), 2.09 – 1.91 (m, 2H), 1.87 – 1.73 (m, 1H), 1.05 (dd, J = 12.5, 6.4 Hz, 6H). 13C NMR (75 
MHz, CDCl3) δ 192.5, 163.2, 134.6, 130.1, 129.5, 125.7, 61.8, 42.0, 24.9, 22.8, 20.9. UPLC-
DAD-QTOF: C13H16NOS [M+H]
+ calcd.: 234.0953, found: 234.0953. 
S-Phenyl 2-isocyano-3-methylbutanethioate (27D) 
The isocyanothioate 4D was obtained following the general 
procedure. Colourless oil. Yield (last step): 71 % (311 mg, 1.42 mmol). 1H 
NMR (300 MHz, CDCl3) δ 7.50 – 7.39 (m, 5H), 4.31 (d, J = 4.1 Hz, 1H), 2.55 – 2.37 (m, 1H), 
1.15 (d, J = 6.8 Hz, 3H), 1.09 (d, J = 6.7 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 191.7, 163.2, 
134.2, 129.7, 129.1, 125.4, 68.9, 31.4, 19.0, 15.8. UPLC-DAD-QTOF: C12H14NOS [M+H]
+ 
calcd.: 220.0796, found: 220.0800. 
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5.4.1.2.  Synthesis of  isocyano(thio)acetates 28-35, 62 and 73 
 
1st step:267 A mixture of formic acid (0.96 mL, 26 mmol, 1.7 equiv.), N,N-
dimethylformamide (5 mL) and the corresponding amino acid (10 mmol, 1 equiv.) was 
heated to reflux with good stirring. The starting amino acids got slowly dissolved as the 
reaction progress (about 1 h). Evaporation of the solvent gave the expected formamide. 
N-Formylphenyl alanine 
Yield: 87%. 1H NMR (400 MHz, DMSO-d6) δ 8.38 (dd, J = 8.4, 1.8 Hz, 
1H), 8.02 – 7.93 (m, 1H), 7.34 – 7.10 (m, 5H), 4.52 (td, J = 8.8, 4.9 Hz, 1H), 
3.08 (dd, J = 13.9, 4.9 Hz, 1H), 2.87 (dd, J = 13.9, 9.2 Hz, 1H). 
N-Formyl alanine 
Yield: 96%. 1H NMR (300 MHz, DMSO-d6) δ 8.34 (d, J = 7.6 Hz, 1H), 
8.01 – 7.98 (m, 1H), 4.26 (td, J = 7.4, 0.9 Hz, 1H), 1.26 (d, J = 7.3 Hz, 3H). 
 
N-Formyl leucine 
Yield: 85%. 1H NMR (300 MHz, DMSO-d6) δ 8.32 (d, J = 8.1 Hz, 
1H), 8.04 – 8.01 (m, 1H), 4.34 – 4.21 (m, 1H), 1.69 – 1.55 (m, 1H), 1.53 
– 1.46 (m, 2H), 0.87 (dd, J = 12.0, 6.4 Hz, 6H). 
2-Formamidopent-4-enoic acid 
Yield: 92%. 1H NMR (400 MHz, DMSO-d6) δ 8.25 (d, J = 8.0 Hz, 
1H), 8.01 (d, J = 1.6 Hz, 1H), 5.81 – 5.63 (m, 1H), 5.17 – 4.95 (m, 2H), 
4.29 (td, J = 8.0, 5.1 Hz, 1H), 2.48 – 2.42 (m, 1H), 2.39 – 2.26 (m, 1H). 
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 Aizpurua, J. M.; Palomo, C. Synth. Commun., 1983, 13, 745-752. 
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2-Formamidooctanoic acid 
Yield: 88%. 1H NMR (300 MHz, DMSO-d6) δ 8.32 (d, J = 7.9 Hz, 1H), 
8.02 (s, 1H), 4.23 (td, J = 8.3, 4.9 Hz, 1H), 1.79 – 1.47 (m, 2H), 1.34 – 1.16 
(m, 8H), 0.91 – 0.79 (m, 3H). 
2-Formamido-2-phenylacetic acid 
Yield: 95%. 1H NMR (300 MHz, DMSO-d6)
 δ 8.88 (d, J = 7.6 Hz, 1H), 
8.12 – 8.03 (m, 1H), 7.47 – 7.27 (m, 5H), 5.44 – 5.33 (m, 1H). 
 
2nd step:268 To a solution of N-formyl amino acid (5 mmol, 1 equiv.) in CH2Cl2 (25 mL)  at 
0 °C was added the corresponding thiol (1.1 equiv.) followed by DMAP (122 mg, 1 mmol, 
0.2 equiv.) and DCC (1.23 g, 6 mmol, 1.2 equiv.). The reaction mixture was allowed to 
reach room temperature and was stirred overnight. The precipitate is filtered off and the 
filtrate is concentrated under reduced pressure to an oil. The residue was purified by 
flash column chromatography on silica gel. 
S-(Naphthalen-1-yl) 2-formamido-3-phenylpropanethioate 
Yield: 62%. 1H NMR (300 MHz, CDCl3) δ 8.30 (s, 1H), 8.03 – 
7.96 (m, 2H), 7.96 – 7.88 (m, 1H), 7.65 (dd, J = 7.1, 1.3 Hz, 1H), 
7.63 – 7.50 (m, 3H), 7.44 – 7.33 (m, 3H), 7.28 – 7.23 (m, 2H), 6.07 
(d, J = 8.8 Hz, 1H), 5.40 – 5.25 (m, 1H), 3.35 – 3.22 (m, 2H). 
S-(Naphth-1-yl) 2-formamidopropanethioate 
Yield: 65%.1H NMR (300 MHz, CDCl3) δ 8.25 (s, 1H), 8.18 – 
8.08 (m, 1H), 8.04 – 7.96 (m, 1H), 7.91 (dd, J = 6.9, 2.6 Hz, 1H), 
7.71 (dd, J = 7.2, 1.3 Hz, 1H), 7.63 – 7.47 (m, 3H), 6.32 (d, J = 7.7 
Hz, 1H), 5.06 (m, 1H), 1.60 (d, J = 7.2 Hz, 3H). 
S-(2,6-Dimethylphenyl) 2-formamido-3-phenylpropanethioate 
Yield: 92%. 1H NMR (400 MHz, CDCl3) δ 8.24 (s, 1H), 7.40 – 
7.22 (m, 6H), 7.18 (d, J = 7.6 Hz, 2H), 6.11 (d, J = 8.3 Hz, 1H), 5.25 (dt, 
J = 8.6, 6.6 Hz, 1H), 3.32 – 3.15 (m, 2H), 2.31 (s, 6H). 
                                                     
268
 Adapted from: Claraz, A.; Sahoo, G.; Berta, D.; Madarász, A.; Pápai, I.; Pihko, P. M. Angew. Chem. Int. 
Ed. 2016, 55, 669-673. 
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S-(2,6-Dimethylphenyl) 2-formamidopropanethioate 
Yield: 84%. 1H NMR (300 MHz, CDCl3) δ 8.26 (s, 1H), 7.32 – 
7.23 (m, 1H), 7.23 – 7.14 (m, 1H), 6.34 – 6.07 (m, 1H), 5.09 – 4.89 
(m, 1H), 2.36 (s, 6H), 1.57 (d, J = 7.2 Hz, 3H). 
 
S-(2,6-Dimethylphenyl) 2-formamido-4-methylpentanethioate 
Yield: 91%.1H NMR (300 MHz, CDCl3) δ 8.32 – 8.23 (m, 1H), 
7.26 – 7.20 (m, 1H), 7.20 – 7.11 (m, 2H), 5.97 (d, J = 8.8 Hz, 1H), 
5.05 – 4.90 (m, 1H), 2.33 (s, 6H), 1.84 – 1.71 (m, 2H), 1.61 – 1.55 
(m, 1H), 1.00 (dd, J = 6.2, 2.9 Hz, 6H). 
S-(2,6-Dimethylphenyl) 2-formamidopent-4-enethioate 
Yield: 60%. 1H NMR (300 MHz, CDCl3) δ 8.23 (s, 1H), 7.35 – 
7.10 (m, 3H), 6.71 (d, J = 8.2 Hz, 1H), 5.87 – 5.65 (m, 1H), 5.28 – 
5.13 (m, 2H), 5.05 – 4.90 (m, 1H), 2.81 – 2.52 (m, 2H), 2.33 (s, 6H). 
 
S-(2,6-Dimethylphenyl) 2-formamidooctanethioate 
Yield: 71%. 1H NMR (300 MHz, CDCl3) δ 8.34 – 8.25 (m, 1H), 
7.28 – 7.24 (m, 1H), 7.22 – 7.16 (m, 2H), 6.09 (d, J = 8.4 Hz, 1H), 
5.05 – 4.91 (m, 1H), 2.36 (s, 6H), 2.11 – 1.95 (m, 1H), 1.78 (dq, J = 
14.7, 7.4 Hz, 1H), 1.52 – 1.21 (m, 8H), 0.98 – 0.85 (m, 3H). 
S-(2,6-Dimethylphenyl) 2-formamido-2-phenylethanethioate 
Yield: 85%.1H NMR (300 MHz, CDCl3) δ 8.28 – 8.23 (m, 1H), 
7.44 – 7.36 (m, 5H), 7.24 – 7.19 (m, 1H), 7.12 (d, J = 7.5 Hz, 2H), 6.64 
(d, J = 5.8 Hz, 1H), 5.91 (dd, J = 7.3, 0.9 Hz, 1H), 2.18 (bs, 6H). 
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S-(2-Chloro-6-methylphenyl) 2-formamido-3-phenylpropanethioate 
Yield: 73%. 1H NMR (300 MHz, CDCl3) δ 8.25 (s, 1H), 7.45 – 
7.15 (m, 8H), 6.11 (d, J = 8.5 Hz, 1H), 5.24 (dt, J = 8.6, 6.5 Hz, 1H), 
3.31 – 3.21 (m, 2H), 2.36 (s, 3H). 
 
S-(2,6-Dichlorophenyl) 2-formamido-3-phenylpropanethioate 
Yield: 72%. 1H NMR (400 MHz, CDCl3) δ 8.28 (s, 1H), 7.49 (d, J 
= 7.9 Hz, 2H), 7.43 – 7.20 (m, 6H), 6.02 (d, J = 8.8 Hz, 1H), 5.35 – 5.25 
(m, 1H), 3.36 – 3.23 (m, 2H). 
 
S-(2,6-Dichlorophenyl) 2-formamidopropanethioate 
Yield: 64%. 1H NMR (300 MHz, CDCl3) δ 8.31 – 8.26 (m, 1H), 
7.51 – 7.42 (m, 2H), 7.32 (dd, J = 8.9, 7.2 Hz, 1H), 6.13 (s, 1H), 5.09 – 
4.95 (m, 1H), 1.57 (d, J = 7.1 Hz, 3H). 
 
S-(3,5-bis(Trifluoromethyl)phenyl) 2-formamido-3-phenylpropanethioate 
Yield: 60%. 1H NMR (300 MHz, CDCl3) δ 8.30 – 8.24 (m, 
1H), 7.95 – 7.92 (m, 1H), 7.80 (dd, J = 1.7, 0.9 Hz, 2H), 7.45 – 
7.29 (m, 3H), 7.26 – 7.18 (m, 2H), 6.35 (s, 1H), 5.28 – 5.11 (m, 
1H), 3.30 – 3.15 (m, 2H). 
 
S-(2,4,6-Triisopropylphenyl) 2-formamido-3-phenylpropanethioate 
Yield: 89%. 1H NMR (300 MHz, CDCl3) δ 8.28 – 8.22 (m, 
1H), 7.42 – 7.21 (m, 7H), 6.08 (d, J = 8.7 Hz, 1H), 5.37 – 5.23 (m, 
1H), 3.31 – 3.16 (m, 4H), 2.93 (m, J = 6.9 Hz, 1H), 1.34 – 1.25 (m, 
6H), 1.16 (d, J = 7.5 Hz, 12H). 
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S-(2-Methoxyphenyl) 2-formamido-3-phenylpropanethioate 
Yield: 72%. 1H NMR (400 MHz, CDCl3) δ 8.24 (s, 1H), 7.40 – 
7.22 (m, 6H), 7.18 (d, J = 7.6 Hz, 3H), 6.11 (d, J = 8.3 Hz, 1H), 4.96 
(dt, J = 8.6, 6.6 Hz, 1H), 3.79 (s, 3H), 3.36 – 3.22 (m, 2H).  
 
S-Benzyl 2-formamido-3-phenylpropanethioate 
Yield: 80%. 1H NMR (300 MHz, CDCl3) δ 8.16 (s, 1H), 7.39 – 
7.17 (m, 8H), 7.15 – 7.04 (m, 2H), 6.21 – 6.06 (m, 1H), 5.11 (dt, J = 
8.6, 6.2 Hz, 1H), 4.15 (d, J = 2.2 Hz, 2H), 3.16 (dd, J = 6.2, 4.2 Hz, 2H). 
 
S-Benzyl 2-formamidopropanethioate 
Yield: 56%. 1H NMR (400 MHz, CDCl3) δ 8.22 (s, 1H), 7.41 – 
7.22 (m, 3H), 6.35 (d, J = 35.0 Hz, 1H), 4.95 – 4.78 (m, 1H), 4.17 (s, 
2H), 1.46 (dd, J = 7.3, 2.4 Hz, 2H). 
 
Phenyl formylphenylalaninate 
Yield: 54%. 1H NMR (300 MHz, CDCl3) δ 8.27 (s, 1H), 7.50 – 
7.20 (m, 8H), 7.04 (dt, J = 8.0, 1.0 Hz, 2H), 6.14 (d, J = 6.0 Hz, 1H), 
5.24 (dtd, J = 7.8, 5.9, 0.7 Hz, 1H), 3.35 (dd, J = 5.9, 1.6 Hz, 2H). 
 
Phenyl 2-formamido-2-phenylacetate 
Yield: Quantit. 1H NMR (300 MHz, CDCl3) δ 8.29 (t, J = 1.2 Hz, 
1H), 7.54 – 7.31 (m, 7H), 7.26 – 7.19 (m, 1H), 7.03 – 6.97 (m, 2H), 
6.69 (d, J = 7.2 Hz, 1H), 5.91 (d, J = 7.4 Hz, 1H). 
 
3rd step:269 To the corresponding N-formyl thioester (2 mmol, 1 equiv.) in CH2Cl2 (20 mL) 
was added N-methylmorpholine (0.44 mL, 4 mmol, 2 equiv.) and the mixture was cooled 
                                                     
269
 See ref. 266, page 212. 
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to –78 °C. Triphosgene (207 mg, 0.7 mmol, 0.35 equiv.) was added in one portion and 
the reaction mixture was stirred at –78 °C with TLC monitoring. The reaction was 
quenched by slow addition of water, quickly extracted with CH2Cl2 (2 × 20 mL), dried 
over MgSO4 and the solvent was evaporated under reduced pressure (Keep bath temp 
below 23 °C). The reaction crude was purified by flash column chromatography on silica 
gel. The product exhibited the characteristic isonitrile NC band at IR: 2135-2137 cm-1. 
S-(Naphthalen-1-yl) 2-isocyano-3-phenylpropanethioate (28A) 
The isocyanothioester 28A was obtained following the 
general procedure. Yellow oil. Yield (last step): 62 % (393 mg, 
1.24 mmol). 1H NMR (400 MHz, CDCl3) δ 8.07 – 8.02 (m, 1H), 8.00 
– 7.92 (m, 2H), 7.71 (dd, J = 7.2, 1.2 Hz, 1H), 7.64 – 7.59 (m, 2H), 
7.58 – 7.54 (m, 1H), 7.46 (ddd, J = 4.8, 2.0, 0.9 Hz, 3H), 7.40 – 7.32 (m, 2H), 4.69 (dd, J = 
7.8, 5.0 Hz, 1H), 3.34 (qd, J = 13.9, 6.4 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 192.1, 164.7, 
154.1, 135.8, 134.8, 134.5, 132.2, 130.2, 129.4, 129.3, 128.5, 128.1, 127.3, 127.1, 126.2, 
125.4, 64.8, 40.0. UPLC-DAD-QTOF: C20H16NOS [M+H]
+ calcd.: 318.0897, found: 
318.0901. 
S-(Naphth-1-yl) 2-isocyanopropanethioate (28B) 
The isocyanothioester 28B was obtained following the 
general procedure. Orange foam. Yield (last step): 60 % (290 mg, 
1.2 mmol). 1H NMR (300 MHz, CDCl3) δ 8.19 – 8.11 (m, 1H), 8.07 – 
7.99 (m, 1H), 7.95 (dd, J = 7.9, 1.6 Hz, 1H), 7.75 (dd, J = 7.2, 1.3 Hz, 
1H), 7.68 – 7.49 (m, 3H), 4.55 (q, J = 7.1 Hz, 1H), 1.78 (d, J = 7.1 Hz, 3H). 13C NMR (75 
MHz, CDCl3) δ 193.2, 163.8, 136.4, 135.3, 135.0, 132.9, 129.9, 128.6, 127.7, 126.7, 125.7, 
123.9, 59.3, 21.1. UPLC-DAD-QTOF: C14H12NOS [M+H]
+ calcd.: 242.0640, found: 
242.0649. 
S-(2,6-Dimethylphenyl) 2-isocyano-3-phenylpropanethioate (29A) 
The isocyanothioester 29A was obtained following the general 
procedure. Yellow oil. Yield (last step): 80 % (473 mg, 1.6 mmol). 1H 
NMR (400 MHz, CDCl3) δ 7.42 – 7.22 (m, 6H), 7.17 (d, J = 7.6 Hz, 2H), 
4.58 (dd, J = 8.4, 4.8 Hz, 1H), 3.32 (dd, J = 13.9, 4.8 Hz, 1H), 3.20 (dd, J 
= 13.9, 8.4 Hz, 1H), 2.29 (s, 6H). 13C NMR (75 MHz, CDCl3) δ 191.2, 164.3, 143.5, 134.7, 
131.5, 130.2, 129.5, 129.2, 128.5, 125.6, 64.9, 40.0, 22.1. UPLC-DAD-QTOF: C18H18NOS 
[M+H]+ calcd.: 296.1109, found: 296.1117. 
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S-(2,6-Dimethylphenyl) 2-isocyanopropanethioate (29B) 
The isocyanothioester 29B was obtained following the general 
procedure. Colourless oil. Yield (last step): 66 % (289 mg, 1.32 mmol). 
1H NMR (300 MHz, CDCl3) δ 7.34 – 7.26 (m, 1H), 7.25 – 7.17 (m, 2H), 
4.49 (q, J = 7.1 Hz, 1H), 2.38 (s, 6H), 1.75 (d, J = 7.1 Hz, 3H). 13C NMR 
(75 MHz, CDCl3) δ 191.1, 162.1, 142.7, 130.3, 128.4, 124.9, 58.1, 21.4, 20.0. UPLC-DAD-
QTOF: C12H14NOS [M+H]
+ calcd.: 220.0796, found: 220.0803. 
S-(2,6-Dimethylphenyl) 2-isocyano-4-methylpentanethioate (29C) 
 
The isocyanothioester 29C was obtained following the 
general procedure. Yellow oil. Yield (last step): 55 % (288 mg, 1.1 
mmol). 1H NMR (300 MHz, CDCl3) δ 7.34 – 7.26 (m, 1H), 7.24 – 7.17 
(m, 2H), 4.43 (dd, J = 10.0, 4.6 Hz, 1H), 2.38 (s, 6H), 2.06 – 1.90 (m, 
2H), 1.85 – 1.71 (m, 1H), 1.04 (dd, J = 12.2, 6.4 Hz, 6H). 13C NMR (75 MHz, CDCl3) δ 191.9, 
163.4, 143.5, 131.1, 129.2, 125.7, 62.4, 42.6, 25.5, 23.4, 22.1, 21.5. UPLC-DAD-QTOF: 
C15H20NOS [M+H]
+ calcd.: 262.1266, found: 262.1273. 
S-(2,6-Dimethylphenyl) 2-isocyanopent-4-enethioate (29E) 
The isocyanothioester 29E was obtained following the 
general procedure. Orange oil. Yield (last step): 62 % (304 mg, 1.24 
mmol). 1H NMR (300 MHz, CDCl3) δ 7.35 – 7.25 (m, 1H), 7.20 (d, J = 
7.5 Hz, 2H), 5.98 – 5.78 (m, 1H), 5.41 – 5.27 (m, 2H), 4.46 (t, J = 6.3 
Hz, 1H), 2.84 – 2.71 (m, 2H), 2.37 (s, 6H). 13C NMR (75 MHz, CDCl3) δ 191.1, 163.7, 143.4, 
131.1, 130.6, 129.1, 125.6, 121.5, 63.2, 38.3, 22.2. UPLC-DAD-QTOF: C12H14NOS [M+H]
+ 
calcd.: 246.0953, found: 246.0959. 
S-(2,6-Dimethylphenyl) 2-isocyanooctanethioate (29F) 
 The isocyanothioester 29F was obtained following the general 
procedure. Orange oil. Yield (last step): 73 % (420 mg, 1.45 mmol). 1H 
NMR (300 MHz, CDCl3) δ 7.31 (dd, J = 8.5, 6.4 Hz, 1H), 7.25 – 7.18 (m, 
2H), 4.43 (t, J = 6.5 Hz, 1H), 2.40 (s, 6H), 2.03 (q, J = 7.2 Hz, 2H), 1.70 – 
1.52 (m, 2H), 1.49 – 1.27 (m, 6H), 1.02 – 0.87 (m, 3H). 13C NMR (75 MHz, CDCl3) δ 191.7, 
163.3, 143.4, 131.0, 129.1, 125.7, 63.8, 34.1, 32.0, 28.9, 25.6, 23.0, 22.1, 14.6. UPLC-
DAD-QTOF: C17H24NOS [M+H]
+ calcd.: 290.1679, found: 290.1589. 
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S-(2,6-Dimethylphenyl) 2-isocyano-2-phenylethanethioate (29G) 
The isocyanothiester 29G was obtained following the general 
procedure. Brown oil. Yield (last step): 54 % (303 mg, 1.08 mmol). 1H 
NMR (300 MHz, CDCl3) δ 7.58 – 7.52 (m, 1H), 7.47 – 7.45 (m, 2H), 
7.16 – 7.07 (m, 5H), 5.49 (s, 1H), 2.18 (s, 6H). UPLC-DAD-QTOF: C17H16NOS [M-H]
- calcd.: 
282.0960, found: 282.0967. 
S-(2-Chloro-6-methylphenyl) 2-isocyano-3-phenylpropanethioate (30A) 
The isocyanothioester 30A was obtained following the 
general procedure. Yellow foam. Yield (last step): 60 % (378 mg, 1.2 
mmol). 1H NMR (400 MHz, CDCl3) δ 7.50 – 7.22 (m, 8H), 4.63 (dd, J = 
8.5, 4.7 Hz, 1H), 3.38 (dd, J = 13.9, 4.7 Hz, 1H), 3.24 (dd, J = 13.9, 8.6 
Hz, 1H), 2.38 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 189.7, 164.4, 145.3, 139.9, 134.2, 131.7, 
129.7, 129.4, 129.0, 128.2, 128.0, 125.1, 64.6, 39.5, 22.2. UPLC-DAD-QTOF: C17H15NOSCl 
[M+H]+ calcd.: 316.0563, found: 316.0574. 
S-(2,6-Dichlorophenyl) 2-isocyano-3-phenylpropanethioate (31A) 
The isocyanothioester 31A was obtained following the 
general procedure. Yellow oil. Yield (last step): 18 % (121 mg, 0.36 
mmol). 1H NMR (400 MHz, CDCl3) δ 7.55 – 7.49 (m, 2H), 7.46 – 7.31 
(m, 6H), 4.63 (dd, J = 8.9, 4.5 Hz, 1H), 3.38 (dd, J = 14.0, 4.5 Hz, 1H), 
3.24 (dd, J = 14.0, 8.9 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ 188.6, 164.8, 141.0, 133.9, 
132.3, 129.6, 128.9, 128.0, 64.5, 39.4. UPLC-DAD-QTOF: C16H12NOSCl2 [M+H]
+ calcd.: 
337.9908, found: 337.9915. 
S-(2,6-Dichlorophenyl) 2-isocyanopropanethioate (31B) 
The isocyanothioester 31B was obtained following the 
general procedure. Yellow oil. Yield (last step): 36 % (187 mg, 0.72 
mmol). 1H NMR (300 MHz, CDCl3) δ 7.54 – 7.43 (m, 2H), 7.42 – 7.32 
(m, 1H), 4.50 (q, J = 7.1 Hz, 1H), 1.75 (d, J = 7.0 Hz, 3H). 13C NMR (75 
MHz, CDCl3) δ 189.0, 163.0, 140.6, 131.9, 128.5, 128.5, 57.9, 19.7. UPLC-DAD-QTOF: 
C10H8NOSCl2 [M+H]
+ calcd.: 259.9611, found: 259.6904. 
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S-(3,5-bis(Trifluoromethyl)phenyl) 2-isocyano-3-phenylpropanethioate (32A) 
The isocyanothioester 32A was obtained following the 
general procedure. Brown oil. Yield (last step): 54 % (435 mg, 
1.1 mmol). 1H NMR (400 MHz, CDCl3) δ 7.98 (s, 1H), 7.80 (s, 2H), 
7.40 (d, J = 7.2 Hz, 3H), 7.35 – 7.25 (m, 2H), 4.65 (dd, J = 7.9, 4.7 
Hz, 1H), 3.35 (dd, J = 13.9, 4.7 Hz, 1H), 3.24 (dd, J = 13.9, 7.9 Hz, 
1H). 13C NMR (75 MHz, CDCl3) δ 191.7, 166.6, 135.8, 135.8, 134.5, 134.1, 133.6, 130.7, 
130.1, 130.0, 129.3, 125.1 (q), 65.4, 40.6. UPLC-DAD-QTOF: C18H12NOSF6 [M+H]
+ calcd.: 
404.0544, found: 404.0551. 
S-(2,4,6-Triisopropylphenyl) 2-isocyano-3-phenylpropanethioate (33A) 
The isocyanothioester 33A was obtained following the 
general procedure. White foam. Yield (last step): 64 % (503 mg, 
1.28 mmol). 1H NMR (300 MHz, CDCl3) δ 7.45 – 7.30 (m, 5H), 7.12 (s, 
2H), 3.35 (dd, J = 13.9, 5.2 Hz, 1H), 3.30 – 3.16 (m, 3H), 3.03 – 2.86 
(m, 1H), 1.29 (d, J = 6.9 Hz, 6H), 1.18 (d, J = 6.8 Hz, 12H). 13C NMR 
(75 MHz, CDCl3) δ 191.9, 163.6, 152.6, 151.9, 134.2, 129.5, 128.8, 127.8, 122.4, 119.5, 
64.2, 39.3, 34.4, 32.0, 24.4, 23.9, 23.6. UPLC-DAD-QTOF: C25H32NOS [M+H]
+ calcd.: 
394.2205, found: 394.2213. 
S-(2-Methoxyphenyl) 2-isocyano-3-phenylpropanethioate (34A) 
The isocyanothioester 34A was obtained following the 
general procedure. Orange oil. Yield (last step): 74 % (440 mg, 1.48 
mmol). 1H NMR (300 MHz, CDCl3) δ 7.50 – 7.22 (m, 8H), 4.63 (dd, J 
= 8.5, 4.7 Hz, 1H), 3.38 (dd, J = 13.9, 4.7 Hz, 1H), 3.24 (dd, J = 13.9, 
8.6 Hz, 1H), 2.38 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 189.7, 164.4, 145.3, 139.9, 134.2, 
131.7, 129.7, 129.4, 129.0, 128.2, 128.0, 125.1, 64.6, 39.5, 22.2. UPLC-DAD-QTOF: 
C17H16NO2S [M+H]
+ calcd.: 298.0902, found: 298.0916. 
S-Benzyl 2-isocyano-3-phenylpropanethioate (35A) 
The isocyanothioester 35A was obtained following the general 
procedure. Colourless oil. Yield (last step): 60 % (337 mg, 1.2 mmol). 
1H NMR (400 MHz, CDCl3) δ 7.39 – 7.27 (m, 7H), 7.27 – 7.20 (m, 3H), 
4.50 (dd, J = 8.5, 4.6 Hz, 1H), 4.20 (s, 2H), 3.30 (dd, J = 13.9, 4.6 Hz, 1H), 3.14 (dd, J = 
13.9, 8.5 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ 193.5, 164.4, 136.7, 134.6, 130.0, 129.6, 
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129.4, 129.4, 128.4, 128.3, 65.1, 40.1, 34.5. UPLC-DAD-QTOF: C17H16NOS [M+H]
+ calcd.: 
282.0934, found: 382.0929. 
S-Benzyl 2-isocyanopropanethioate (35B) 
The isocyanothiester 35B was obtained following the general 
procedure. Yellow oil. Yield (last step): 82 % (337 mg, 1.64 mmol). 1H 
NMR (300 MHz, CDCl3) δ 7.40 – 7.26 (m, 3H), 4.38 (q, J = 7.2 Hz, 1H), 
4.21 (s, 2H), 1.66 (d, J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 193.6, 162.1, 136.1, 
128.9, 128.7, 127.7, 58.3, 33.7, 20.0. UPLC-DAD-QTOF: C11H12NOS [M+H]
+ calcd.: 
206.0640, found: 206.0646. 
Phenyl 2-isocyano-3-phenylpropanoate (62) 
The isocyanothioester 62 was obtained following the general 
procedure. Yellow oil. Yield (last step): 40 % (201 mg, 0.8 mmol). 1H 
NMR (300 MHz, CDCl3) δ 7.48 – 7.22 (m, 8H), 7.10 – 6.97 (m, 2H), 4.72 
(dd, J = 7.7, 5.4 Hz, 1H), 3.38 (qd, J = 13.9, 6.5 Hz, 2H). 13C NMR (75 
MHz, CDCl3) δ 165.3, 162.4, 150.6, 134.6, 130.3, 130.1, 129.6, 128.7, 127.3, 121.6, 58.6, 
39.6. UPLC-DAD-QTOF: C16H12NO2 [M-H]
- calcd.: 250.0868, found: 250.0875. 
Phenyl 2-isocyano-2-phenylacetate (73) 
The isocyanothioester 73 was obtained following the general 
procedure. Yellow oil. Yield (last step): 56 % (265 mg, 1.12 mmol). 1H 
NMR (300 MHz, CDCl3) δ 7.67 – 7.60 (m, 2H), 7.54 – 7.47 (m, 3H), 7.42 
– 7.36 (m, 2H), 7.31 – 7.27 (m, 1H), 7.09 – 7.03 (m, 2H), 5.64 (s, 1H). 
13C NMR (75 MHz, CDCl3) δ 165.2, 163.0, 151.1, 130.8, 130.6, 130.4, 127.8, 127.6, 121.8, 
116.3, 61.3. UPLC-DAD-QTOF: C15H12NO2 [M-H]
- calcd.: 238.0840, found: 238.0833. 
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5.4.2. General Procedure for the conjugate addition of 
isocyanothioacetates 27, 29 and 35 to vinyl ketones 2 and 6a.  
 
Catalyst C26 (15 mg, 10 mol%) was added to a solution of the corresponding α-
alkyl isocyanothioacetate (0.1 mmol, 1 equiv.) and vinyl ketone (1  2 equiv.) in CH2Cl2 
(0.2 mL) at room temperature and the resulting mixture was stirred at the same 
temperature until the reaction was completed (monitored by TLC). The solvent was 
removed under reduced pressure and the product was purified by column 
chromatography. 
S-Phenyl (R)-2-benzyl-2-isocyano-5-oxohexanethioate (36Aa) 
Prepared according to the general procedure starting from 
isocyanothioacetate 27A (27 mg, 0.1 mmol) and vinyl ketone 2a 
(14 mg, 0.2 mmol) using catalyst C5 (7 mg, 10 mol%) instead. The 
title compound was obtained as a 84:16 mixture of enantiomers. The crude material was 
purified by flash column chromatography on silica gel (eluting with hexane/ ethyl 
acetate 98/2 to 95/5) to give the title compound as a colorless oil. Yield: 30% (10 mg). 
[α]D 
22= +14.04° (c=1.3, 68% ee, CH2Cl2). 
1H NMR (300 MHz, CDCl3) δ 7.52 – 7.42 (m, 3H), 7.42 – 7.35 (m, 3H), 7.34 – 7.24 
(m, 4H), 3.31 (d, J = 13.5 Hz, 1H), 3.06 (d, J = 13.6 Hz, 1H), 2.81 (ddd, J = 17.9, 10.8, 4.8 
Hz, 1H), 2.61 (ddd, J = 17.9, 11.0, 5.0 Hz, 1H), 2.40 (ddd, J = 15.4, 10.7, 4.8 Hz, 1H), 2.22 
(s, 3H), 2.20 – 2.12 (m, 1H). 13C NMR (75 MHz, CDCl3) δ 205.8, 196.0, 165.3, 134.7, 132.9, 
130.7, 130.3, 129.6, 128.6, 128.2, 126.3, 77.4, 45.6, 38.1, 33.0, 30.2. UPLC-DAD-QTOF: 
C20H20NO2S [M+H]
+ calcd.: 338.1215, found: 338.1218. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
AYH, hexane:ethanol, 90:10; flux= 1 mL/min; retention times: 9.5 min (major), 11.9 min 
(minor)). 
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S-Phenyl (R)-2-benzyl-2-isocyano-5-oxo-5-phenylpentanethioate (36Ac) 
Prepared according to the general procedure starting 
from isocyanothioacetate 27A (27 mg, 0.1 mmol) and vinyl 
ketone 2c (26 mg, 0.2 mmol). The title compound was obtained 
as a 95:5 mixture of enantiomers. The crude material was purified by flash column 
chromatography on silica gel (eluting with hexane/ ethyl acetate 98/2 to 95/5) to give 
the title compound as a colorless oil. Yield: 40% (16 mg). [α]D 
22= +5.72° (c=0.60, 90% ee, 
CH2Cl2).  
1H NMR (300 MHz, CDCl3) δ 8.05 – 7.91 (m, 2H), 7.67 – 7.55 (m, 1H), 7.55 – 7.22 
(m, 13H), 3.44 – 3.23 (m, 2H), 3.22 – 3.04 (m, 2H), 2.67 – 2.51 (m, 1H), 2.35 (ddd, J = 
14.4, 11.1, 4.8 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ 197.5, 196.0, 165.3, 136.5, 134.7, 
133.6, 133.0, 130.8, 130.3, 129.6, 128.9, 128.7, 128.2, 128.2, 126.3, 74.6, 45.6, 33.6, 
33.3. UPLC-DAD-QTOF: C25H22NO2S [M+H]
+ calcd.: 400.1371, found: 400.1364. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
AYH, hexane:ethanol, 98:2; flux= 1 mL/min; retention times: 22.1 min (major), 24.8 min 
(minor)). 
S-Phenyl (S)-2-isocyano-2-methyl-5-oxo-5-(p-tolyl)pentanethioate (36Bd) 
Prepared according to the general procedure 
starting from isocyanothioacetate 27B (19 mg, 0.1 mmol) 
and vinyl ketone 2d (44 mg, 0.3 mmol). The title compound 
was obtained as a 96.5:3.5 mixture of enantiomers. The crude material was purified by 
flash column chromatography on silica gel (eluting with hexane/ ethyl acetate 98/2 to 
95/5) to give the title compound as a colorless oil. Yield: 41% (14 mg). [α]D 
22=   50.49° 
(c=0.55, 93% ee, CH2Cl2).  
1H NMR (300 MHz, CDCl3) δ 7.93 – 7.81 (m, 2H), 7.51 – 7.38 (m, 5H), 7.34 – 7.23 
(m, 2H), 3.26 (ddd, J = 17.4, 10.6, 5.1 Hz, 1H), 3.11 (ddd, J = 17.4, 10.7, 5.1 Hz, 1H), 2.50 
(ddd, J = 15.9, 10.8, 5.4 Hz, 1H), 2.42 (s, 3H), 2.31 (ddd, J = 14.4, 10.8, 5.1 Hz, 1H), 1.77 (s, 
3H).  13C NMR (75 MHz, CDCl3) δ 197.2, 195.9, 163.4, 144.5, 134.8, 134.0, 130.2, 129.6, 
129.5, 128.3, 126.2, 69.7, 34.3, 33.3, 27.2, 21.8. UPLC-DAD-QTOF: C20H20NO2S [M+H]
+ 
calcd.: 338.1128, found: 338.1121. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
AYH, hexane:ethanol, 98:2; flux= 1 mL/min; retention times: 21.2 min (minor), 23.1 min 
(major)). 
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S-Phenyl (R)-2-isobutyl-2-isocyano-5-oxo-5-phenylpentanethioate (36Cc) 
Prepared according to the general procedure starting 
from isocyanothioacetate 27C (23 mg, 0.1 mmol) and vinyl 
ketone 2c (26 mg, 0.2 mmol). The title compound was 
obtained as a 98:2 mixture of enantiomers. The crude 
material was purified by flash column chromatography on silica gel (eluting with hexane/ 
ethyl acetate 98/2 to 95/5) to give the title compound as a yellow oil. Yield: 52% (19 
mg). [α]D 
22     36.07° (c=1.11, 96% ee, CH2Cl2).  
1H NMR (300 MHz, CDCl3) δ 8.07 – 7.96 (m, 2H), 7.68 – 7.59 (m, 1H), 7.58 – 7.37 
(m, 7H), 3.36 (ddd, J = 17.4, 10.8, 4.9 Hz, 1H), 3.16 (ddd, J = 17.4, 11.0, 5.1 Hz, 1H), 2.49 
(ddd, J = 15.5, 10.7, 5.1 Hz, 1H), 2.35 (ddd, J = 14.3, 11.0, 4.9 Hz, 1H), 2.15 – 2.00 (m, 2H), 
1.86 (q, J = 8.2 Hz, 1H), 1.13 (d, J = 6.2 Hz, 3H), 1.04 (d, J = 6.1 Hz, 3H). 13C NMR (75 MHz, 
CDCl3) δ 197.6, 196.1, 164.6, 136.5, 134.7, 133.6, 130.2, 129.7, 128.9, 128.2, 126.4, 73.3, 
47.7, 35.2, 33.1, 25.2, 24.0, 23.3. UPLC-DAD-QTOF: C22H24NO2S [M+H]
+ calcd.: 366.1528, 
found: 366.1528. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
AYH, hexane:ethanol, 98:2; flux= 1 mL/min; retention times: 12.2 min (minor), 19.4 min 
(major)). 
S-Phenyl (R)-2-isocyano-2-isopropyl-5-oxo-5-phenylpentanethioate (36Dc) 
Prepared according to the general procedure starting 
from isocyanothioacetate 27D (22 mg, 0.1 mmol) and vinyl 
ketone 2c (26 mg, 0.2 mmol). The title compound was 
obtained as a 99:1 mixture of enantiomers. The crude material was purified by flash 
column chromatography on silica gel (eluting with hexane/ ethyl acetate 98/2 to 95/5) 
to give the title compound as a colourless oil. Yield: 74% (26 mg). [α]D 
22    31.09° (c=1, 
98% ee, CH2Cl2).  
1H NMR (300 MHz, CDCl3) δ 8.07 – 7.95 (m, 2H), 7.69 – 7.58 (m, 1H), 7.59 – 7.38 
(m, 7H), 3.37 (ddd, J = 17.4, 10.7, 4.9 Hz, 1H), 3.10 (ddd, J = 17.3, 10.8, 5.5 Hz, 1H), 2.56 – 
2.29 (m, 3H), 1.18 (t, J = 6.6 Hz, 6H). 13C NMR (75 MHz, CDCl3) δ 198.1, 196.9, 164.7, 
137.0, 135.1, 134.0, 130.7, 130.1, 129.3, 128.6, 126.9, 78.8, 36.8, 33.8, 32.3, 18.3, 17.2. 
UPLC-DAD-QTOF: C22H24NO2S [M+H]
+ calcd.: 366.1528, found: 366.1526. 
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The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
ADH, hexane:ethanol, 98:2; flux= 1 mL/min; retention times: 13.7 min (minor), 18.5 min 
(major)). 
S-(2,6-Dimethylphenyl) (R)-2-benzyl-2-isocyano-5-oxohexanethioate (45Aa) 
Prepared according to the general procedure starting from 
isocyanothioacetate 29A (30 mg, 0.1 mmol) and vinyl ketone 2a 
(14 mg, 0.2 mmol). The title compound was obtained as a 96:4 
mixture of enantiomers. The crude material was purified by flash 
column chromatography on silica gel (eluting with hexane/ ethyl acetate 98/2 to 95/5) 
to give the title compound as a white foam. Yield: 74% (27 mg). [α]D 
22= +24.94° (c=1.4, 
92% ee, CH2Cl2).  
1H NMR (300 MHz, CDCl3) δ 7.34 (m, 5H), 7.27 (d, J = 7.6 Hz, 1H), 7.17 (d, J = 7.6 
Hz, 2H), 2.85 (ddd, J = 17.8, 10.9, 4.9 Hz, 1H), 2.65 (ddd, J = 17.8, 11.2, 4.8 Hz, 1H), 2.47 – 
2.28 (m, 4H), 2.22 (s, 3H), 2.21 – 2.14 (m, 1H), 2.14 – 1.97 (m, 3H). 13C NMR (75 MHz, 
CDCl3) δ 206.1, 194.9, 165.5, 143.4, 133.5, 131.2, 131.0, 129.1, 129.0, 128.5, 126.0, 74.6, 
45.3, 38.4, 33.6, 30.6, 22.0. UPLC-DAD-QTOF: C22H24NO2S [M+H]
+ calcd.: 366.1528, 
found: 366.1528. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
ODH, hexane:ethanol, 95:5; flux= 1 mL/min; retention times: 9.5 min (major), 10.8 min 
(minor)). 
S-(2,6-Dimethylphenyl) (R)-2-benzyl-2-isocyano-5-oxo-5-phenylpentanethioate (45Ac) 
Prepared according to the general procedure starting 
from isocyanothioacetate 29A (30 mg, 0.1 mmol) and vinyl 
ketone 2c (26 mg, 0.2 mmol). The title compound was obtained 
as a 97:3 mixture of enantiomers. The crude material was 
purified by flash column chromatography on silica gel (eluting with hexane/ ethyl 
acetate 98/2 to 95/5) to give the title compound as a colorless oil. Yield: 77% (33 mg). 
[α]D 
22    9.14° (c=1.35, 94% ee, CH2Cl2).  
1H NMR (300 MHz, CDCl3) δ 8.04 – 7.94 (m, 2H), 7.67 – 7.57 (m, 1H), 7.56 – 7.47 
(m, 2H), 7.43 – 7.33 (m, 5H), 7.28 (dd, J = 8.1, 7.0 Hz, 1H), 7.17 (d, J = 7.6 Hz, 2H), 3.47 – 
3.33 (m, 2H), 3.28 – 3.16 (m, 1H), 3.13 (d, J = 13.7 Hz, 1H), 2.65 – 2.50 (m, 1H), 2.47 – 
2.28 (m, 4H), 2.09 (brs, 3H). 13C NMR (75 MHz, CDCl3) δ 197.4, 194.6, 165.2, 136.5, 133.6, 
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133.1, 130.9, 130.6, 128.9, 128.8, 128.7, 128.7, 128.1, 128.1, 125.6, 74.4, 45.1, 33.9, 
33.3, 21.6. UPLC-DAD-QTOF: C27H26NO2S [M+H]
+ calcd.: 428.1684, found: 428.1684. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
IB, hexane:ethanol, 98:2; flux= 1 mL/min; retention times: 11.4 min (major), 13.2 min 
(minor)). 
S-(2,6-Dimethylphenyl) (R)-2-benzyl-2-isocyano-5-oxo-5-(p-tolyl)pentanethioate 
(45Ad) 
Prepared according to the general procedure 
starting from isocyanothioacetate 29A (30 mg, 0.1 mmol) 
and vinyl ketone 2d (44 mg, 0.3 mmol). The title 
compound was obtained as a 96:4 mixture of 
enantiomers. The crude material was purified by flash 
column chromatography on silica gel (eluting with hexane/ ethyl acetate 98/2 to 95/5) 
to give the title compound as a yellow oil. Yield: 60% (26 mg). [α]D 
22    8.42° (c=1.90, 
92% ee, CH2Cl2).  
1H NMR (300 MHz, CDCl3) δ 7.89 (dd, J = 8.8, 2.3 Hz, 2H), 7.42 – 7.34 (m, 5H), 7.34 
– 7.23 (m, 3H), 7.17 (d, J = 7.6 Hz, 2H), 3.46 – 3.29 (m, 2H), 3.28 – 3.07 (m, 2H), 2.65 – 
2.50 (m, 1H), 2.45 (s, 3H), 2.43 – 2.28 (m, 4H), 2.10 (brs, 3H). 13C NMR (75 MHz, CDCl3) δ 
197.0, 194.6, 165.1, 144.5, 134.0, 133.1, 130.8, 130.5, 129.6, 129.0, 128.7, 128.7, 128.2, 
128.1, 128.0, 125.6, 74.5, 45.1, 34.0, 33.1, 21.8, 21.6. UPLC-DAD-QTOF: C28H28NO2S 
[M+H]+ calcd.: 442.1845, found: 442.1841. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
ODH, hexane:ethanol, 95:5; flux= 1 mL/min; retention times: 10.4 min (major), 12.4 min 
(minor)). 
S-(2,6-Dimethylphenyl) (S)-2-isocyano-2-methyl-5-oxohexanethioate (45Ba) 
Prepared according to the general procedure starting 
from isocyanothioacetate 29B (22 mg, 0.1 mmol) and vinyl 
ketone 2a (14 mg, 0.2 mmol). The title compound was obtained 
as a 95.5:4.5 mixture of enantiomers. The crude material was 
purified by flash column chromatography on silica gel (eluting with hexane/ ethyl 
acetate 98/2 to 95/5) to give the title compound as a yellow oil. Yield: 90% (26 mg). [α]D 
22    13.90° (c=0.80, 91% ee, CH2Cl2).  
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1H NMR (300 MHz, CDCl3) δ 7.31 – 7.24 (m, 1H), 7.23 – 7.15 (m, 2H), 2.76 (ddd, J 
= 17.8, 10.8, 5.0 Hz, 1H), 2.57 (ddd, J = 17.8, 10.9, 4.9 Hz, 1H), 2.35 (s, 6H), 2.32 – 2.24 
(m, 1H), 2.20 (s, 3H), 2.19 – 2.08 (m, 1H), 1.71 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 206.3, 
195.2, 163.7, 143.4, 131.1, 129.3, 126.0, 69.9, 38.7, 34.0, 30.7, 27.6, 22.2. UPLC-DAD-
QTOF: C16H20NO2S [M+H]
+ calcd.: 290.1215, found: 290.1232. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
IC, hexane:ethanol, 95:5; flux= 0.5 mL/min; retention times: 29.4 min (minor), 31.5 min 
(major)). 
S-(2,6-Dimethylphenyl) (S)-2-isocyano-2-methyl-5-oxoheptanethioate (45Bb) 
Prepared according to the general procedure starting 
from isocyanothioacetate 29B (22 mg, 0.1 mmol) and vinyl 
ketone 2b (17 mg, 0.2 mmol). The title compound was 
obtained as a 98:2 mixture of enantiomers. The crude material 
was purified by flash column chromatography on silica gel (eluting with hexane/ ethyl 
acetate 98/2 to 95/5) to give the title compound as a orange oil. Yield: 82% (25 mg). [α]D 
22    20.63° (c=1.15, 96% ee, CH2Cl2).  
1H NMR (300 MHz, CDCl3) δ 7.34 – 7.24 (m, 1H), 7.24 – 7.16 (m, 2H), 2.76 (ddd, J 
= 17.5, 10.8, 5.1 Hz, 1H), 2.64 – 2.53 (m, 1H), 2.52 – 2.44 (m, 2H), 2.37 (s, 6H), 2.31 (dd, J 
= 10.7, 5.0 Hz, 1H), 2.18 (ddd, J = 14.3, 10.9, 5.1 Hz, 1H), 1.73 (s, 3H), 1.10 (t, J = 7.3 Hz, 
3H). 13C NMR (75 MHz, CDCl3) δ 209.6, 195.6, 164.1, 143.8, 131.5, 129.7, 126.5, 70.4, 
37.8, 37.2, 34.5, 28.0, 22.6, 8.9. UPLC-DAD-QTOF: C17H22NO2S [M+H]
+ calcd.: 304.1371, 
found: 304.1370. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
IC, hexane:ethanol, 98:2; flux= 0.5 mL/min; retention times: 23.2 min (minor), 25.2 min 
(major)). 
S-(2,6-Dimethylphenyl) (S)-2-isocyano-2-methyl-5-oxo-5-(p-tolyl)pentanethioate 
(45Bd) 
Prepared according to the general procedure 
starting from isocyanothioacetate 29B (22 mg, 0.1 mmol) 
and vinyl ketone 2d (44 mg, 0.3 mmol). The title 
compound was obtained as a 97:3 mixture of 
enantiomers. The crude material was purified by flash 
column chromatography on silica gel (eluting with hexane/ ethyl acetate 98/2 to 95/5) 
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to give the title compound as a yellow oil. Yield: 68% (25 mg). [α]D 
22    45.49° (c=1.15, 
94% ee, CH2Cl2).  
1H NMR (300 MHz, CDCl3) δ 7.94 – 7.84 (m, 2H), 7.36 – 7.25 (m, 3H), 7.20 (d, J = 
7.5 Hz, 2H), 3.31 (ddd, J = 17.3, 10.9, 4.9 Hz, 1H), 3.13 (ddd, J = 17.3, 11.1, 4.9 Hz, 1H), 
2.58 – 2.47 (m, 1H), 2.45 (s, 3H), 2.39 (s, 6H), 2.36 – 2.30 (m, 1H), 1.80 (s, 3H). 13C NMR 
(75 MHz, CDCl3) δ 197.1, 194.7, 163.2, 144.4, 142.9, 134.0, 130.6, 129.5, 128.7, 128.2, 
125.5, 69.7, 34.2, 33.3, 27.1, 21.8, 21.77. UPLC-DAD-QTOF: C22H24NO2S [M+H]
+ calcd.: 
366.1528, found: 366.1522. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
AYH, hexane:ethanol, 98:2; flux= 1 mL/min; retention times: 16.4 min (minor), 17.7 min 
(major)). 
S-(2,6-Dimethylphenyl) (S)-5-(4-chlorophenyl)-2-isocyano-2-methyl-5-
oxopentanethioate (45Be) 
Prepared according to the general procedure 
starting from isocyanothioacetate 29B (22 mg, 0.1 
mmol) and vinyl ketone 2e (33 mg, 0.2 mmol). The title 
compound was obtained as a 95:5 mixture of 
enantiomers. The crude material was purified by flash 
column chromatography on silica gel (eluting with hexane/ ethyl acetate 98/2 to 95/5) 
to give the title compound as a orange oil. Yield: 88% (34 mg). [α]D 
22    52.09° (c=1.40, 
90% ee, CH2Cl2).  
1H NMR (300 MHz, CDCl3) δ 8.02 – 7.86 (m, 2H), 7.57 – 7.40 (m, 2H), 7.35 – 7.25 
(m, 1H), 7.20 (d, J = 7.9 Hz, 2H), 3.29 (ddd, J = 17.5, 10.8, 4.9 Hz, 1H), 3.11 (ddd, J = 17.5, 
10.9, 4.9 Hz, 1H), 2.51 (ddd, J = 15.4, 10.9, 4.9 Hz, 1H), 2.38 (s, 6H), 2.35 – 2.27 (m, 1H), 
1.80 (s, 3H13C NMR (75 MHz, CDCl3) δ 196.6, 195.1, 163.8, 143.3, 140.5, 135.2, 131.0, 
129.9, 129.6, 129.2, 125.8, 69.9, 34.4, 33.8, 27.6, 22.1. UPLC-DAD-QTOF: C21H21NO2SCl 
[M+H]+ calcd.: 386.0982, found: 386.0984. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
IB, hexane:ethanol, 99:1; flux= 1 mL/min; retention times: 10.5 min (minor), 11.2 min 
(major)). 
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S-(2,6-Dimethylphenyl) (R)-2-isobutyl-2-isocyano-5-oxo-5-phenylpentanethioate (45Cc) 
Prepared according to the general procedure 
starting from isocyanothioacetate 29C (26 mg, 0.1 mmol) 
and vinyl ketone 2c (26 mg, 0.2 mmol). The title compound 
was obtained as a 99.5:0.5 mixture of enantiomers. The 
crude material was purified by flash column 
chromatography on silica gel (eluting with hexane/ ethyl acetate 98/2 to 95/5) to give 
the title compound as a yellow oil. Yield: 70% (28 mg). [α]D 
22    40.04° (c=1.45, 99% ee, 
CH2Cl2).  
1H NMR (300 MHz, CDCl3) δ 8.05 – 7.94 (m, 2H), 7.67 – 7.57 (m, 1H), 7.56 – 7.46 
(m, 2H), 7.36 – 7.25 (m, 1H), 7.20 (d, J = 7.5 Hz, 2H), 3.37 (ddd, J = 17.4, 10.7, 5.1 Hz, 1H), 
3.18 (ddd, J = 17.4, 10.9, 5.2 Hz, 1H), 2.55 – 2.43 (m, 1H), 2.40 (s, 6H), 2.39 – 2.32 (m, 
1H), 2.16 – 1.97 (m, 2H), 1.90 – 1.74 (m, 1H), 1.16 (d, J = 6.4 Hz, 3H), 1.03 (d, J = 6.3 Hz, 
3H). 13C NMR (75 MHz, CDCl3) δ 198.5, 195.8, 165.5, 143.9, 137.5, 134.6, 131.5, 129.8, 
129.7, 129.0, 126.7, 74.2, 48.2, 36.0, 34.2, 26.3, 24.8, 24.7, 22.7. UPLC-DAD-QTOF: 
C24H28NO2S [M+H]
+ calcd.: 394.4841, found: 394.4839. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
IB, hexane:ethanol, 98:2; flux= 0.5 mL/min; retention times: 14.1 min (major), 19.3 min 
(minor)). 
S-(2,6-Dimethylphenyl)(R)-5-(4-chlorophenyl)-2-isobutyl-2-isocyano-5-
oxopentanethioate (45Ce) 
Prepared according to the general procedure 
starting from isocyanothioacetate 29C (26 mg, 0.1 
mmol) and vinyl ketone 2e (34 mg, 0.2 mmol). The title 
compound was obtained as a 98.5:1.5 mixture of 
enantiomers. The crude material was purified by flash 
column chromatography on silica gel (eluting with hexane/ ethyl acetate 98/2 to 95/5) 
to give the title compound as a yellow oil. Yield: 86% (36 mg). [α]D 
22    47.69° (c=1.25, 
97% ee, CH2Cl2).  
1H NMR (300 MHz, CDCl3) δ 7.99 – 7.87 (m, 2H), 7.53 – 7.43 (m, 2H), 7.35 – 7.25 
(m, 1H), 7.24 – 7.15 (m, 2H), 3.32 (ddd, J = 17.5, 10.6, 5.1 Hz, 1H), 3.13 (ddd, J = 17.5, 
10.9, 5.1 Hz, 1H), 2.52 – 2.41 (m, 1H), 2.39 (s, 6H), 2.37 – 2.29 (m, 1H), 2.14 – 1.96 (m, 
2H), 1.89 – 1.74 (m, 1H), 1.16 (d, J = 6.4 Hz, 3H), 1.02 (d, J = 6.3 Hz, 3H). 13C NMR (75 
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MHz, CDCl3) δ 196.3, 194.8, 164.6, 142.9, 140.1, 134.8, 130.6, 129.5, 129.2, 128.8, 125.7, 
73.2, 47.3, 34.9, 33.2, 25.3, 23.8, 23.7, 21.8. UPLC-DAD-QTOF: C24H27NO2SCl [M+H]
+ 
calcd.: 428.1451, found: 428.1448. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
IA, hexane:ethanol, 98:2; flux= 0.5 mL/min; retention times: 13.7 min (minor), 16.6 min 
(major)). 
S-(2,6-Dimethylphenyl)(R)-2-(3-(4-chlorophenyl)-3-oxopropyl)-2-isocyanopent-4-
enethioate (45Ee) 
Prepared according to the general procedure 
starting from isocyanothioacetate 29E (25 mg, 0.1 mmol) 
and vinyl ketone 2e (34 mg, 0.2 mmol). The title 
compound was obtained as a 98.5:1.5 mixture of 
enantiomers. The crude material was purified by flash 
column chromatography on silica gel (eluting with hexane/ ethyl acetate 98/2 to 95/5) 
to give the title compound as a colourless oil. Yield: 63% (26 mg). [α]D 
22    53.24° 
(c=0.75, 97% ee, CH2Cl2).  
1H NMR (300 MHz, CDCl3) δ 7.99 – 7.85 (m, 2H), 7.55 – 7.41 (m, 2H), 7.36 – 7.25 
(m, 1H), 7.20 (d, J = 7.5 Hz, 2H), 6.05 – 5.85 (m, 1H), 5.42 – 5.26 (m, 2H), 3.33 (ddd, J = 
17.4, 10.8, 5.0 Hz, 1H), 3.11 (ddd, J = 17.4, 11.1, 5.0 Hz, 1H), 2.83 (dd, J = 13.9, 7.4 Hz, 
1H), 2.70 – 2.58 (m, 1H), 2.55 – 2.43 (m, 1H), 2.38 (s, 6H), 2.35 – 2.26 (m, 1H). 13C NMR 
(75 MHz, CDCl3) δ 197.1, 195.3, 165.3, 143.8, 141.1, 135.7, 131.6, 130.4, 130.3, 130.2, 
129.7, 126.5, 123.0, 74.3, 44.9, 34.2, 34.1, 22.8. UPLC-DAD-QTOF: C23H23ClNO2S [M+H]
+ 
calcd.: 412.1138, found: 412.1140. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
AYH, hexane:ethanol, 95:5; flux= 0.5 mL/min; retention times: 23.2 min (minor), 26.4 
min (major)). 
S-(2,6-Dimethylphenyl)(S)-2-(3-(4-chlorophenyl)-3-oxopropyl)-2-isocyanooctanethioate 
(45Fe) 
Prepared according to the general procedure 
starting from isocyanothioacetate 29F (29 mg, 0.1 
mmol) and vinyl ketone 2e (34 mg, 0.2 mmol). The title 
compound was obtained as a 99:1 mixture of 
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enantiomers. The crude material was purified by flash column chromatography on silica 
gel (eluting with hexane/ ethyl acetate 98/2 to 95/5) to give the title compound as a 
colourless oil. Yield: 86% (39 mg). [α]D 
22    34.09° (c=1.20, 98% ee, CH2Cl2).  
The reaction carried out at 3 mmol scale, using  isocyanothioacetate 4F (870 mg, 
3 mmol), vinyl ketone 2e (666 mg, 4 mmol) and catalyst C6 (464 mg, 0.3 mmol) provided 
the title compound as a 99:1 mixture of enantiomers. Yield: 96% (1.313 g). 
1H NMR (300 MHz, CDCl3) δ 7.96 – 7.87 (m, 2H), 7.53 – 7.44 (m, 2H), 7.35 – 7.24 
(m, 1H), 7.20 (d, J = 8.0 Hz, 2H), 3.32 (ddd, J = 17.4, 10.8, 4.9 Hz, 1H), 3.10 (ddd, J = 17.4, 
11.1, 4.9 Hz, 1H), 2.45 (dd, J = 12.7, 7.9 Hz, 1H), 2.39 (s, 6H), 2.37 – 2.28 (m, 1H), 2.19 – 
2.01 (m, 1H), 1.96 – 1.81 (m, 1H), 1.80 – 1.63 (m, 1H), 1.58 – 1.45 (m, 1H), 1.44 – 1.26 
(m, 6H), 0.97 – 0.87 (m, 3H). 13C NMR (75 MHz, CDCl3) δ 196.9, 195.3, 164.3, 140.6, 
135.3, 130.8, 130.0, 129.7, 129.6, 129.3, 126.2, 74.5, 40.4, 34.2, 33.8, 32.1, 29.5, 24.6, 
23.1, 22.3, 14.7. UPLC-DAD-QTOF: C26H31ClNO2S [M+H]
+ calcd.: 456.1765, found: 
456.1759. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
ODH, hexane:ethanol, 98:2; flux= 1 mL/min; retention times: 8.8 min (major), 12.7 min 
(minor)). 
S-Benzyl (S)-2-isocyano-2-methyl-5-oxohexanethioate (46Ba) 
Prepared according to the general procedure starting 
from the corresponding isocyanothioacetate 35B (21 mg, 0.1 
mmol) and vinyl ketone 2a (14 mg, 0.2 mmol). The title 
compound was obtained as a 94:6 mixture of enantiomers. The crude material was 
purified by flash column chromatography on silica gel (eluting with hexane/ ethyl 
acetate 98/2 to 95/5) to give the title compound as a colourless oil. Yield: 62% (19 mg). 
[α]D 
22    0.56° (c=1.40, 88% ee, CH2Cl2).  
1H NMR (300 MHz, CDCl3) δ 7.43 – 7.22 (m, 3H), 4.17 (s, 2H), 2.65 (ddd, J = 17.9, 
10.7, 5.0 Hz, 1H), 2.43 (ddd, J = 18.0, 10.8, 4.9 Hz, 1H), 2.33 – 2.18 (m, 1H), 2.15 (s, 3H), 
2.13 – 2.03 (m, 1H), 1.66 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 206.8, 197.7, 163.8, 137.2, 
130.0, 129.8, 128.8, 70.3, 39.0, 35.3, 34.7, 31.1, 27.9. UPLC-DAD-QTOF: C15H18NO2S 
[M+H]+ calcd.: 276.1058, found: 276.1072. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
IC, hexane:ethanol, 95:5; flux= 0.5 mL/min; retention times: 30.5 min (major), 32.4 min 
(minor)). 
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S-(2,6-Dimethylphenyl) (R)-2-benzyl-6-hydroxy-2-isocyano-6-methyl-5-
oxoheptanethioate (49Aa)  
Prepared according to the general procedure starting 
from isocyanothioacetate 29A (30 mg, 0.1 mmol) and vinyl 
ketone 6a (23 mg, 0.2 mmol). The title compound was 
obtained as a 98:2 mixture of enantiomers. The crude 
material was purified by flash column chromatography on silica gel (eluting with hexane/ 
ethyl acetate 98/2 to 95/5) to give the title compound as a yellow oil. Yield: 73% (30 
mg). [α]D 
22= +41.03° (c=1.35, 96% ee, CH2Cl2).  
1H NMR (300 MHz, CDCl3) δ 7.43 – 7.30 (m, 5H), 7.27 (d, J = 7.4 Hz, 1H), 7.17 (d, J 
= 7.5 Hz, 2H), 3.43 (s, 1H), 3.34 (d, J = 13.6 Hz, 1H), 3.08 (d, J = 13.6 Hz, 1H), 2.98 (ddd, J = 
18.0, 10.9, 4.9 Hz, 1H), 2.79 (ddd, J = 18.0, 11.2, 4.8 Hz, 1H), 2.49 – 2.30 (m, 4H), 2.24 
(ddd, J = 14.3, 11.2, 4.9 Hz, 1H), 2.17 – 1.97 (m, 3H), 1.42 (d, J = 7.3 Hz, 6H). 13C NMR (75 
MHz, CDCl3) δ 212.2, 194.5, 165.3, 142.9, 132.9, 130.8, 130.6, 128.7, 128.2, 125.5, 76.5, 
74.2, 45.1, 33.5, 30.6, 26.9, 26.7, 21.6. UPLC-DAD-QTOF: C22H24NO3S [M+H]
+ calcd.: 
382.1477, found: 382.1469. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
AYH, hexane:ethanol, 95:5; flux= 0.5 mL/min; retention times: 15.3 min (minor), 19.4 
min (major)). 
 
Selected isolated by-products 
4-Methyl-5-(naphth-1-ylthio)oxazole (47B) 
1H NMR (300 MHz, CDCl3) δ 8.45 (d, J = 9.0 Hz, 1H), 7.96 (s, 
1H), 7.84 (dd, J = 30.5, 8.0 Hz, 2H), 7.70 – 7.51 (m, 1H), 7.43 – 7.29 (m, 
2H), 2.36 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 154.2, 144.5, 138.8, 
135.1, 133.0, 132.6, 129.7, 129.2, 128.9, 127.9, 127.6, 126.8, 125.5, 
13.3. UPLC-DAD-QTOF: C14H12NOS [M+H]
+ calcd.: 242.0640, found: 242.0652. 
4-(Phenylthio)butan-2-one (38) 
1H NMR (300 MHz, CDCl3) δ 7.40 – 7.16 (m, 5H), 3.14 (t, J = 
7.3 Hz, 2H), 2.76 (t, J = 7.3 Hz, 2H), 2.14 (s, 3H). 13C NMR (75 MHz, 
CDCl3) δ 207.5, 136.7, 130.4, 130.0, 127.2, 44.0, 31.1, 28.4. UPLC-
DAD-QTOF: C10H12OS [M+H]
+ calcd.: 181.2712, found: 181.2706. 
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4-(Naphthalen-1-ylthio)butan-2-one (48) 
1H NMR (300 MHz, CDCl3) δ 8.46 – 8.38 (m, 1H), 7.93 – 
7.84 (m, 1H), 7.79 (d, J = 8.1, 1.1 Hz, 1H), 7.65 – 7.51 (m, 3H), 7.44 
(dd, J = 8.2, 7.2 Hz, 1H), 3.21 (t, J = 7.3 Hz, 2H), 2.77 (t, J = 7.3 Hz, 
2H), 2.14 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 207.3, 134.7, 133.9, 133.4, 129.6, 129.3, 
128.4, 127.2, 127.0, 126.2, 125.8, 43.8, 30.8, 28.8. UPLC-DAD-QTOF: C14H15OS [M+H]
+ 
calcd.: 231.0844, found: 231.0844. 
3-Isobutyl-3-isocyano-6-phenyl-3,4-dihydro-2H-pyran-2-one (39Cc) 
 1H NMR (300 MHz, CDCl3) δ 7.63 – 7.54 (m, 2H), 7.47 – 7.36 
(m, 3H), 3.08 (dd, J = 17.5, 3.1 Hz, 1H), 2.81 (dd, J = 17.5, 6.3 Hz, 1H), 
2.10 – 1.90 (m, 2H), 1.86 – 1.70 (m, 1H), 1.06 (d, J = 6.5 Hz, 3H), 0.99 
(d, J = 6.4 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 165.0, 162.2, 151.8, 
132.0, 130.8, 129.8, 125.6, 97.5, 61.6, 45.4, 35.2, 25.8, 25.1, 24.3. UPLC-DAD-QTOF: 
C16H21N2O2 [M+NH4]
+ calcd.: 273.1603, found: 273.1602. Isonitrile NC band at IR: 2139 
cm-1. 
5.4.3. Reaction of 29A with N-phenyl maleimide 
 
Catalyst C26 (15 mg, 10 mol%) was added to a solution of the α-alkyl 
isocyanothioacetate 29A (59 mg, 0.2 mmol, 1 equiv.) and N-phenyl maleimide (105 mg, 
0.4 mmol, 2 equiv.) in CH2Cl2 (0.4 mL) at room temperature and the resulting mixture 
was stirred at the same temperature until the reaction was completed (36 h). The 
solvent was removed under reduced pressure and the product was purified by column 
chromatography on silica (hexane/EtOAc 85/15). The title compound was obtained as 
70:30 mixture of diastereomers and 68% ee for the major diastereomer (minor diast.: 
80% ee). Yield (mixture of diastereoisomers): 70% (66.6 mg, 0.14 mmol). [α]D 
22 (major 
diastereomer)= –38.03° (c=1.1, 68% ee, CH2Cl2). 
Data of major diastereomer: 1H NMR (300 MHz, CDCl3) δ 7.58 – 7.43 (m, 3H), 7.40 
– 7.29 (m, 7H), 7.28 – 7.24 (m, 1H), 7.21 – 7.08 (m, 2H), 4.08 (d, J = 14.0 Hz, 1H), 3.64 
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(dd, J = 9.0, 5.3 Hz, 1H), 3.48 (d, J = 14.0 Hz, 1H), 3.24 – 2.99 (m, 2H), 2.31 (br s, 3H), 1.94 
(br s, 3H). 13C NMR (75 MHz, CDCl3) δ 193.5, 174.1, 173.6, 168.4, 143.4, 134.9, 133.3, 
131.5, 131.4, 129.9, 129.4, 129.3, 128.7, 127.4, 126.7, 75.7, 47.2, 43.5, 32.0, 22.3. UPLC-
DAD-QTOF: calcd for C28H25N2O3S [M+H]
+, 469.1556; found, 468.1550. 
The diastereomeric and enantiomeric purity were determined on crude material 
by chiral HPLC analysis (Daicel Chiralpak IC, hexane:ethanol, 90:10; flux= 0.5 mL/min; 
retention times: diast. A (minor enantiomer) 19.9 min, diast. A (major enantiomer) 22.14 
min, diast. B. 24.9 min, diast. B 35.0 min). 
 
5.4.4. Elaboration of adduct 45B 
5.4.4.1. Synthesis of Δ5-dehydroproline thioester 51270  
 
Concentrated HCl solution (0.5 mL) was dropwise added to a solution of 45Be 
(386 mg, 1.0 mmol) in ethanol (10 mL). The mixture was stirred for 2 hour at room 
temperature. Then, the solvent was removed under reduced pressure. Water (10 mL) 
was added and the mixture was basified with NH4OH (pH 9-10). The aqueous phase was 
extracted with DCM (3 × 15 mL) and the combined organic layer was washed with water 
and sat. brine. The organic phase was dried over MgSO4 and the solvent was evaporated 
to give Δ5-dehydroprolines 51 which was purified by flash column chromatography on 
silica (hexane/EtOAc 90/10). The pure compound 51 was isolated as colourless foam. 
Yield: 70% (250 mg, 0.7 mmol). [α]D 
22    160.41° (c=1, 90% ee, CH2Cl2). 
  
1H NMR (300 MHz, CDCl3) δ 7.97 – 7.87 (m, 2H), 7.50 – 7.40 (m, 2H), 7.28 – 7.17 
(m, 1H), 7.13 (d, J = 7.9 Hz, 2H), 3.20 – 2.96 (m, 2H), 2.52 – 2.42 (m, 1H), 2.42 – 2.18 (m, 
6H), 2.07 (ddd, J = 13.4, 9.2, 6.4 Hz, 1H), 1.63 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 202.5, 
174.8, 143.4, 138.0, 133.2, 130.2, 130.1, 129.5, 128.9, 128.2, 87.0, 35.7, 34.7, 26.3, 22.3. 
UPLC-DAD-QTOF: calcd for C20H21ClNOS [M+H]
+, 358.1032; found, 358.1057. 
                                                     
270
 Adapted from: Zhao, M; Zhu, H.; Dai, T.; Shi, M. J. Org. Chem 2015, 80, 11330-11338. 
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5.4.4.2. Synthesis of Δ4-dehydroproline 52 
 
The corresponding adduct 45Be (71.2 mg, 0.2 mmol) was dissolved in 
dichloromethane (0.4 ml), and AgF (2.5 mg, 0.1 equiv.) and DBU (3 mg, 0.1 equiv.) was 
added. The reaction mixture was stirred for 5 h at room temperature. Then, the reaction 
mixture was diluted with dichloromethane (2 mL), washed with HCl 1M and saturated 
NH4Cl and the organic layer was dried with MgSO4. The solvent was remove under 
reduced pressure to give compound 52 as essentially pure compound. Yield: 56% (29.8 
mg, 0.11 mmol). [α]D 
22    67.68° (c=0.22, 90% ee, CH2Cl2). 
1H NMR (300 MHz, CDCl3) δ 7.68 (dd, J = 8.6, 2.1 Hz, 2H), 7.56 – 7.39 (m, 3H), 3.50 
(dd, J = 16.8, 2.4 Hz, 1H), 3.06 (dd, J = 16.9, 1.1 Hz, 1H), 1.80 (s, 3H). 13C NMR (75 MHz, 
CDCl3) δ 190.0, 166.8, 139.1, 137.0, 136.5, 129.9, 129.2, 124.5, 68.0, 42.5, 26.5. UPLC-
DAD-QTOF: calcd for C13H13ClNO3 [M+H]
+, 266.0523; found, 266.0522. 
 
5.4.5. General Procedure for the conjugate addition of 
isocyanothioacetates to vinyl sulfone 55 
Vinyl sulfone 55 was prepared following the procedure described in the 
literature271 and the Michael reaction with isocyanothioacetates was performed 
according to the following procedure: 
 
                                                     
271
 See ref. 211, Chapter 3, page 120. 
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Catalyst C26 (10 mol%, 15mg) was added to a solution of the corresponding 
isocyanothioacetate (0.1 mmol, 1 equiv.) and vinyl sulfone 55 (2 equiv., 47.2 mg, 0.2 
mmol) in toluene (0.2 mL) at room temperature and the resulting mixture was stirred at 
the same temperature until the reaction was completed (monitored by TLC). The crude 
was directly purified by column chromatography. 
S-(2,6-dimethylphenyl)2-benzyl-2-isocyano-4-((1-phenyl-1H-tetrazol-5-yl) 
sulfonyl)butanethioate (56) 
Prepared according to the general procedure 
starting from isocyanothioacetate 29A (30 mg, 0.1 mmol). 
The title compound was obtained as a 72:28 mixture of 
enantiomers. The crude material was purified by flash 
column chromatography on silica gel (eluting with hexane/ ethyl acetate 9/1 to 8/2) to 
give the title compound as a colorless oil. Yield: 47% (25 mg). [α]D 
22=  +38.82° (c=0.85, 
44% ee, CH2Cl2). 
1H NMR (300 MHz, CDCl3) δ 7.78 – 7.58 (m, 5H), 7.44 – 7.25 (m, 6H), 7.18 (d, J = 
7.6 Hz, 2H), 4.16 – 3.86 (m, 2H), 3.40 (d, J = 13.7 Hz, 1H), 3.12 (d, J = 13.7 Hz, 1H), 2.79 
(ddd, J = 13.8, 12.0, 4.7 Hz, 1H), 2.58 (ddd, J = 13.7, 12.1, 4.4 Hz, 1H), 2.37 (brs, 3H), 2.08 
(brs, 3H). 13C NMR (75 MHz, CDCl3) δ 194.4, 168.1, 154.1, 143.9, 133.9, 133.2, 132.7, 
131.7, 130.9, 129.9, 129.7, 129.4, 126.0, 125.9, 73.8, 52.7, 45.7, 32.9, 22.7, 22.4. UPLC-
DAD-QTOF: C27H26N5O3S2 [M+H]
+ calcd.: 532.1477, found: 532.1484. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
AYH, hexane:ethanol, 90:10; flux= 1 mL/min; retention times: 22.4 min (minor), 42.4 min 
(major)). 
S-(2,6-Dichlorophenyl) 2-benzyl-2-isocyano-4-((1-phenyl-1H-tetrazol-5-yl)sulfonyl) 
butanethioate (57) 
 
Prepared according to the general procedure 
starting from isocyanothioacetate 31A (33.6 mg, 0.1 mmol). 
The title compound was obtained as a 81:19 mixture of 
enantiomers. The crude material was purified by flash 
column chromatography on silica gel (eluting with hexane/ ethyl acetate 9/1 to 8/2) to 
give the title compound as a yellow oil. Yield: 90% (51.5 mg). [α]D 
22=  +70.82° (c=1.2, 
62% ee, CH2Cl2). 
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1H NMR (300 MHz, CDCl3) δ 7.77 – 7.58 (m, 4H), 7.55 – 7.45 (m, 2H), 7.45 – 7.35 
(m, 4H), 7.35 – 7.26 (m, 3H), 4.13 – 3.97 (m, 2H), 3.45 (d, J = 13.7 Hz, 1H), 3.12 (d, J = 
13.7 Hz, 1H), 2.90 – 2.72 (m, 1H), 2.69 – 2.49 (m, 1H). 13C NMR (75 MHz, CDCl3) δ 192.1, 
168.0, 153.3, 141.2, 133.0, 132.7, 131.9, 131.9, 130.9, 130.1, 129.2, 129.1, 128.6, 125.2, 
73.1, 51.8, 45.0, 32.2. UPLC-DAD-QTOF: C25H20N5O3S2Cl2 [M+H]
+ calcd.: 572.0385, found: 
572.0385. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
AYH, hexane:ethanol, 80:20; flux= 0.5 mL/min; retention times: 32.3 min (minor), 43.3 
min (major)). 
S-(2-Chloro-6-methylphenyl)2-benzyl-2-isocyano-4-((1-phenyl-1H-tetrazol-5-
yl)sulfonyl)butanethioate (58) 
Prepared according to the general procedure 
starting from isocyanothioacetate 30A (31.5 mg, 0.1 mmol) 
using catalyst C27 (15 mg, 10 mol%) instead. The title 
compound was obtained as a 87:13 mixture of enantiomers. 
The crude material was purified by flash column 
chromatography on silica gel (eluting with hexane/ ethyl acetate 9/1 to 8/2) to give the 
title compound as white foam. Yield: 64% (33.1 mg). [α]D 
22=  +46.33° (c=1.5, 74% ee, 
CH2Cl2). 
1H NMR (300 MHz, CDCl3) δ 7.76 – 7.52 (m, 4H), 7.44 – 7.14 (m, 8H), 4.17 – 3.78 
(m, 2H), 3.37 (d, J = 13.7 Hz, 1H), 3.10 (d, J = 13.6 Hz, 1H), 2.89 – 2.70 (m, 1H), 2.70 – 
2.48 (m, 1H), 2.08 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 193.2, 168.1, 153.8, 145.7, 140.3, 
133.5, 132.8, 132.3, 131.3, 130.5, 130.0, 129.5, 129.0, 128.8, 125.7, 73.3, 52.3, 45.4, 
33.1, 22.5. UPLC-DAD-QTOF: C26H23N5O3S2Cl [M+H]
+ calcd.: 552.0931, found: 552.0924. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
AYH, hexane:ethanol, 90:10; flux= 1 mL/min; retention times: 27.2 min (minor), 44.5 min 
(major)). 
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S-(Naphthalen-1-yl)2-benzyl-2-isocyano-4-((1-phenyl-1H-tetrazol-5-yl)sulfonyl) 
butanethioate 
Prepared according to the general procedure 
starting from isocyanothioacetate 28A (31.7 mg, 0.1 
mmol). The title compound was obtained as a 70:30 
mixture of enantiomers. The crude material was 
purified by flash column chromatography on silica gel 
(eluting with hexane/ ethyl acetate 9/1 to 8/2) to give the title compound as yellow oil. 
Yield: 61% (33.8 mg). [α]D 
22=  +27.22° (c=1, 40% ee, CH2Cl2). 
1H NMR (300 MHz, CDCl3) δ 8.01 (d, J = 7.4 Hz, 1H), 7.91 (dd, J = 6.2, 3.2 Hz, 1H), 
7.85 – 7.75 (m, 1H), 7.74 – 7.51 (m, 9H), 7.51 – 7.39 (m, 3H), 7.39 – 7.28 (m, 2H), 4.09 
(td, J = 11.9, 5.4 Hz, 1H), 3.95 (dd, J = 13.2, 3.5 Hz, 1H), 3.39 (d, J = 13.5 Hz, 1H), 3.13 (d, J 
= 13.6 Hz, 1H), 2.78 (td, J = 13.0, 12.5, 4.7 Hz, 1H), 2.60 (td, J = 13.5, 13.0, 4.1 Hz, 1H). 13C 
NMR (75 MHz, CDCl3) δ 195.1, 168.0, 153.8, 135.9, 135.2, 134.9, 134.6, 132.7, 132.5, 
132.3, 131.4, 130.5, 129.5, 129.4, 129.1, 128.4, 127.4, 126.4, 125.8, 125.6, 125.4, 123.5, 
73.7, 52.3, 45.6, 32.6. UPLC-DAD-QTOF: C29H24N5O3S2 [M+H]
+ calcd.: 554.1321, found: 
554.1310. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
AYH, hexane:ethanol, 90:10; flux= 1 mL/min; retention times: 36.9 min (minor), 54.6 min 
(major)). 
S-Benzyl 2-benzyl-2-isocyano-4-((1-phenyl-1H-tetrazol-5-yl)sulfonyl)butanethioate (60) 
Prepared according to the general procedure 
starting from isocyanothioacetate 35A (28.1 mg, 0.1 
mmol). The title compound was obtained as a 64:36 
mixture of enantiomers. The crude material was purified by flash column 
chromatography on silica gel (eluting with hexane/ ethyl acetate 9/1 to 8/2) to give the 
title compound as yellow oil. Yield: 43% (22.3 mg). [α]D 
22    81.50° (c=0.6, 28% ee, 
CH2Cl2) 
1H NMR (300 MHz, CDCl3) δ 7.73 – 7.58 (m, 4H), 7.39 – 7.21 (m, 8H), 7.15 (dq, J = 
6.6, 2.3, 1.8 Hz, 3H), 4.25 – 4.07 (m, 2H), 3.90 (ddd, J = 14.5, 12.1, 4.3 Hz, 1H), 3.72 (ddd, 
J = 14.5, 12.2, 4.5 Hz, 1H), 3.34 (d, J = 13.6 Hz, 1H), 3.05 (d, J = 13.6 Hz, 1H), 2.77 (ddd, J = 
13.7, 12.1, 4.5 Hz, 1H), 2.51 (ddd, J = 13.7, 12.2, 4.3 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ 
196.2, 167.3, 153.7, 136.3, 133.5, 132.5, 132.3, 131.0, 130.5, 129.7, 129.4, 129.3, 128.9, 
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128.5, 125.7, 73.4, 52.2, 45.7, 35.3, 32.2. UPLC-DAD-QTOF: C26H24N5O3S2 [M+H]
+ calcd.: 
518.1321, found: 518.1309. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
AYH, hexane:ethanol, 80:20; flux= 0.5 mL/min; retention times: 40.5 min (minor), 53.5 
min (major)). 
S-(3,5-bis(Trifluoromethyl)phenyl) 2-benzyl-2-isocyano-4-((1-phenyl-1H-tetrazol-5-
yl)sulfonyl)butanethioate (61) 
Prepared according to the general procedure 
starting from isocyanothioacetate 32A (40.3 mg, 0.1 
mmol). The title compound was obtained as a 50:50 
mixture of enantiomers. The crude material was 
purified by flash column chromatography on silica gel 
(eluting with hexane/ ethyl acetate 9/1 to 8/2) to give the title compound as brown oil. 
Yield: 50% (32.0 mg).  
1H NMR (300 MHz, CDCl3) δ 8.04 – 7.95 (m, 1H), 7.75 – 7.59 (m, 6H), 7.50 – 7.37 
(m, 3H), 7.35 – 7.24 (m, 3H), 4.07 (ddd, J = 14.4, 11.6, 4.6 Hz, 1H), 3.90 (ddd, J = 14.5, 
11.8, 4.8 Hz, 1H), 3.35 (d, J = 13.6 Hz, 1H), 3.20 (d, J = 13.6 Hz, 1H), 2.85 (ddd, J = 13.9, 
11.6, 4.8 Hz, 1H), 2.67 (ddd, J = 13.9, 11.7, 4.6 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ 194.3, 
169.0, 153.6, 135.4, 133.8, 133.4, 133.3, 132.3, 132.2, 131.2, 130.5, 129.5, 129.4, 125.6, 
124.9 (q), 73.8, 52.1, 46.0, 32.3. UPLC-DAD-QTOF: C27H20N5O3S2F6 [M+H]
+ calcd.: 
640.0912, found: 640.0907. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
AYH, hexane:ethanol, 98:2; flux= 1 mL/min; retention times: 16.0 min, 19.3 min). 
 
5.4.6. General Procedure for the Mannich reaction of isocyanothioacetates 
with N-nosyl aldimine 64 
N-nosyl aldimine 64 was prepared following the procedure described in the 
literature272 and the Mannich reaction with isocyanothioacetates was performed 
according to the following procedure: 
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 Esquivias, J.; Gómez Arrayás, R.; Carretero, J. C. Angew. Chem. Int. Ed. 2006, 45, 629–633. 
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Catalyst C26 or C27 (10 mol%, 15mg) was added to a solution of the 
corresponding isocyanothioacetate (0.1 mmol, 1 equiv.), N-nosyl imine 64 (52 mg, 0.15 
mmol, 1.5 equiv.) and molecular sieves 4 Å (20 mg) in dried dichloromethane or toluene 
(0.2 mL) at room temperature and the resulting mixture was stirred at the same 
temperature until the reaction was completed (monitored by 1H-NMR). The crude was 
directly purified by column chromatography. 
Methyl 4-(4-benzyl-4-(((2,6-dimethylphenyl)thio)carbonyl)-1-((4-nitrophenyl) sulfonyl)-
4,5-dihydro-1H-imidazol-5-yl)benzoate (65) 
Prepared according to the general procedure 
starting from isocyanothioacetate 29A (30 mg, 0.1 mmol). 
The reaction was catalyzed by C26 (10 mol%) in 
dichloromethane. The title compound was obtained as a 
90:10 mixture of diastereomers (36% ee for the major 
diast.). The crude material was purified by flash column 
chromatography on silica gel (eluting with hexane/ ethyl 
acetate 9/1 to 8/2) to give the title compound as white 
foam. Yield: 47% (30 mg). [α]D 
22=  +8.25° (c=0.8, 36% ee, CH2Cl2). 
Data of major diastereomer: 1H NMR (300 MHz, CDCl3) δ 8.32 – 8.24 (m, 2H), 8.01 
(s, 1H), 7.93 – 7.85 (m, 2H), 7.81 (d, J = 8.0 Hz, 1H), 7.44 (d, J = 8.0 Hz, 1H), 7.30 (d, J = 7.7 
Hz, 1H), 7.25 – 7.16 (m, 4H), 7.16 – 7.03 (m, 5H), 5.08 (s, 1H), 3.94 (s, 3H), 2.45 (d, J = 5.9 
Hz, 2H), 1.91 (brs, 3H), 1.73 (brs, 3H). 13C NMR (75 MHz, CDCl3) δ 200.8, 166.2, 150.9, 
149.7, 142.4, 138.2, 134.4, 131.1, 131.0, 130.9, 130.2, 129.4, 129.2, 129.1, 128.4, 128.2, 
127.2, 124.7, 124.3, 89.2, 68.4, 52.5, 42.8, 21.1. UPLC-DAD-QTOF: C33H30N3O7S2 [M+H]
+ 
calcd.: 664.1525, found: 644.1533. 
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The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
IC, hexane:ethanol, 90:10; flux= 1 mL/min; retention times: diast. A (minor enantiomer) 
17.7 min, diast. B 22.1 min, diast. B 23.5 min, diast. A (major enantiomer) 31.9 min). 
Methyl-4-(4-benzyl-1-((4-nitrophenyl)sulfonyl)-4-(((2,4,6-triisopropylphenyl)thio) 
carbonyl)-4,5-dihydro-1H-imidazol-5-yl)benzoate (66) 
Prepared according to the general procedure 
starting from isocyanothioacetate 33A (41 mg, 0.1 
mmol). The reaction was catalyzed by C26 (10 mol%) 
in dichloromethane. The title compound was 
obtained as a 70:30 mixture of diastereomers (10% 
ee for the major diast.). The crude material was 
purified by flash column chromatography on silica gel 
(eluting with hexane/ ethyl acetate 9/1 to 8/2) to 
give the title compound as brown foam. Yield: 82% (61 mg). [α]D 
22=  +2.54° (c=1, 10% 
ee, CH2Cl2). 
Data of major diastereomer: 1H NMR (300 MHz, CDCl3) δ 8.25 – 8.12 (m, 2H), 8.01 
(d, J = 4.5 Hz, 1H), 7.83 – 7.73 (m, 2H), 7.57 (d, J = 8.1 Hz, 1H), 7.36 – 7.29 (m, 1H), 7.23 
(dp, J = 7.8, 2.7, 2.1 Hz, 3H), 7.14 (tt, J = 4.6, 2.3 Hz, 2H), 7.05 (d, J = 2.0 Hz, 1H), 7.00 (d, J 
= 1.9 Hz, 1H), 6.85 (d, J = 12.0 Hz, 1H), 5.24 (s, 1H), 3.90 (s, 3H), 3.15 (dp, J = 15.6, 7.1, 5.5 
Hz, 1H), 2.99 – 2.80 (m, 1H), 2.51 – 2.36 (m, 2H), 1.24 (dd, J = 7.0, 2.2 Hz, 6H), 1.17 (dd, J 
= 6.9, 1.3 Hz, 3H), 1.12 (d, J = 6.7 Hz, 3H), 1.07 – 0.94 (m, 3H), 0.82 (d, J = 6.7 Hz, 3H). 13C 
NMR (75 MHz, CDCl3) δ 202.1, 166.1, 152.9, 152.0, 151.4, 150.7, 149.5, 143.2, 137.7, 
134.6, 131.1, 130.7, 129.6, 129.0, 128.6, 128.2, 127.0, 124.4, 122.3, 89.3, 69.0, 52.5, 
42.3, 34.4, 32.1, 31.5, 24.9, 24.2, 23.9, 23.7, 23.3. UPLC-DAD-QTOF: C40H44N3O7S2 [M+H]
+ 
calcd.: 742.2621, found: 742.2623. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
IC, hexane:ethanol, 98:2; flux= 1 mL/min; retention times: diast. A (major enantiomer) 
29.7 min, diast. B 32.9 min, diast. B 37.7 min, diast. A (minor enantiomer) 78.6 min). 
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Methyl-4-(4-benzyl-4-(((2-chloro-6-methylphenyl)thio)carbonyl)-1-((4-nitrophenyl) 
sulfonyl)-4,5-dihydro-1H-imidazol-5-yl)benzoate (67) 
 
Prepared according to the general procedure 
starting from isocyanothioacetate 30A (32 mg, 0.1 mmol). 
The reaction was catalyzed by C27 (10 mol%) in toluene. 
The title compound was obtained as a 97:3 mixture of 
diastereomers (74 % ee for the major diast.). The crude 
material was purified by flash column chromatography on 
silica gel (eluting with hexane/ ethyl acetate 9/1 to 8/2) to 
give the title compound as a yellow oil. Yield: 75% (50 mg). [α]D 
22=  +17.90° (c=0.8, 74% 
ee, CH2Cl2). 
Data of major diastereomer: 1H NMR (300 MHz, CDCl3) δ 8.32 (d, J = 8.2 Hz, 2H), 
8.05 (s, 1H), 8.00 (s, 1H), 7.91 (d, J = 8.0 Hz, 2H), 7.50 – 7.31 (m, 2H), 7.30 – 7.13 (m, 6H), 
7.06 (t, J = 8.6 Hz, 3H), 5.02 (s, 1H), 3.92 (s, 3H), 2.41 (s, 2H), 1.79 (s, 3H). 13C NMR (75 
MHz, CDCl3) δ 199.7, 166.9, 151.5, 151.0, 145.6, 142.4, 139.7, 138.9, 134.9, 131.7, 131.5, 
131.4, 130.7, 130.0, 129.7, 129.1, 128.7, 128.2, 127.9, 127.7, 126.6, 125.4, 124.8, 89.6, 
68.6, 53.0, 43.3, 22.2. UPLC-DAD-QTOF: C32H27N3O7S2Cl [M+H]
+ calcd.: 664,0979 found: 
664.0974. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
IC, hexane:ethanol, 90:10; flux= 1 mL/min; retention times: diast. A (minor enantiomer) 
23.1 min, diast. B 27.3 min, diast. B 29.0 min, diast. A (major enantiomer) 41.2 min). 
 
5.4.7. Mannich reaction of isocyano(thio)acetates with N-aryl aldimines 
5.4.7.1. Preparation of the N-aryl aldimines273 
N-aryl aldimines 69c-e were prepared according to the following procedure: 
 
                                                     
273
 Adapted from: Gómez-Bengoa, E.; Jiménez, J.; Lapuerta, I.; Mielgo, A.; Oiarbide, M.; Otazo, I.; Velilla, I.; 
Vera, S.; Palomo, C. Chem. Sci. 2012, 3, 2949–2957. 
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A mixture of the corresponding aldehyde (5 mmol), amine (5 mmol), and MgSO4 (2g, 
400 mg/mmol) in dry CH2Cl2 (25 mL) was stirred at room temperature for 16 h. The mixture 
was filtered through celite and concentrated under reduced pressure. The resulting solid 
was disgregated with Et2O and filtered to give the corresponding imines. 
(E)-2-((3-Phenylprop-2-yn-1-ylidene)amino)phenol (69c) 
Yield: 55% (608 mg, 2.75 mmol). 1H NMR (300 MHz, CDCl3) δ 
8.12 (s, 1H), 7.65 – 7.53 (m, 2H), 7.51 – 7.35 (m, 3H), 7.33 – 7.16 (m, 
2H), 7.11 – 7.01 (m, 1H), 6.98 – 6.85 (m, 1H).  13C NMR (75 MHz, 
CDCl3) δ 152.5, 140.2, 135.5, 132.5, 130.4, 130.1, 128.7, 121.3, 
120.2, 115.8, 115.6, 96.2, 88.0. 
(E)-N-(2-Methoxyphenyl)-3-phenylprop-2-yn-1-imine (69d) 
Yield: 75% (881 mg, 3.75 mmol). 1H NMR (300 MHz, CDCl3) δ 
8.00 (s, 1H), 7.66 – 7.52 (m, 2H), 7.47 – 7.12 (m, 4H), 7.09 – 6.88 (m, 
3H), 3.89 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 152.6, 144.4, 142.9, 
132.5, 129.8, 128.6, 128.1, 126.7, 121.0, 120.3, 111.6, 94.8, 88.1, 
55.9. 
(E)-N-(2-Ethoxyphenyl)-3-phenylprop-2-yn-1-imine (69e) 
Yield: 62% (772 mg, 3.1 mmol).1H NMR (300 MHz, CDCl3) δ 
7.99 (s, 1H), 7.58 – 7.48 (m, 2H), 7.33 – 7.22 (m, 3H), 7.15 – 7.05 (m, 
1H), 6.98 (dd, J = 7.7, 1.8 Hz, 1H), 6.91 – 6.81 (m, 2H), 3.99 (q, J = 7.0 
Hz, 2H), 1.35 (t, J = 7.0 Hz, 3H).  13C NMR (75 MHz, CDCl3) δ 151.11, 
144.06, 142.31, 139.97, 131.81, 131.75, 129.20, 128.01, 127.95, 
127.37, 121.03, 120.37, 112.42, 93.95, 87.76, 63.69, 14.27. 
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5.4.7.2. Reaction of isocyanothioacetate 33A with 69c 
 
 Catalyst C27 (10 mol%, 15mg) was added to a solution of isocyanothioacetate 
33A (39 mg, 0.1 mmol, 1 equiv.) and N-aryl imine 69c (33 mg, 0.15 mmol, 1.5 equiv.) in 
dichloromethane (0.2 mL) at room temperature and the resulting mixture was stirred at 
the same temperature until the consumption of the starting material (monitored by 1H-
NMR). Only traces of product were observed. The crude was directly purified by flash 
column chromatography on silica gel (hexane/EtOAc 70/30). Yield: 5% (3.1 mg, 0.005 
mmol). Due to the low yield the enantiopurity of compound 72Ac was not determined. 
 Data of major diastereomer: 1H NMR (300 MHz, CDCl3) δ 7.57 – 7.49 (m, 2H), 
7.43 – 7.29 (m, 8H), 7.25 – 7.18 (m, 2H), 7.07 (s, 2H), 7.02 – 6.94 (m, 2H), 5.16 (s, 1H), 
3.59 (d, J = 1.8 Hz, 2H), 3.45 – 3.30 (m, 1H), 3.02 – 2.82 (m, 2H), 1.27 (d, J = 6.9 Hz, 6H), 
1.18 (dd, J = 6.9, 2.6 Hz, 6H), 1.12 (d, J = 6.8 Hz, 3H), 0.99 (d, J = 6.8 Hz, 3H). 13C NMR (75 
MHz, CDCl3) δ 202.5, 156.4, 152.9, 152.1, 152.0, 151.0, 135.9, 131.7, 131.0, 128.9, 128.8, 
128.3, 128.0, 126.8, 126.1, 125.8, 122.1, 122.0, 120.9, 116.6, 90.5, 86.3, 82.5, 62.5, 41.7, 
34.3, 32.0, 31.5, 31.0, 24.7, 24.2, 23.9, 23.6, 23.4. UPLC-DAD-QTOF: C40H43N2O2S [M+H]
+ 
calcd.: 615.3045, found: 615.3046.  
5.4.7.3. Reaction of isocyanothioacetate 30A with 69d 
 
Catalyst C27 (10 mol%, 15mg) was added to a solution of isocyanothioacetate 
30A (63 mg, 0.2 mmol, 2 equiv.) and N-aryl imine 69d (23 mg, 0.1 mmol, 1 equiv.) in 
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toluene (0.2 mL) at room temperature and the resulting mixture was stirred at the same 
temperature until the consumption of the imine (monitored by 1H-NMR). The crude was 
directly purified by flash column chromatography on silica (hexane/EtOAc 80/20).  The 
compound 70Ad was obtained as 82:18 mixture of diastereomers (80% ee for the major 
diast.). Yield: 58% (32 mg, 0.056 mmol).  
Data of major diastereomer: 1H NMR (300 MHz, CDCl3) δ 7.65 (d, J = 2.4 Hz, 1H), 
7.43 (d, J = 7.4 Hz, 2H), 7.38 – 7.07 (m, 13H), 7.07 – 6.92 (m, 2H), 5.50 (s, 1H), 3.88 (s, 
3H), 3.59 (d, J = 13.4 Hz, 1H), 3.40 (d, J = 13.5 Hz, 1H), 1.94 (s, 3H). 13C NMR (75 MHz, 
CDCl3) δ 203.1, 157.3, 156.9, 154.5, 146.2, 140.8, 137.3, 132.7, 132.2, 131.5, 129.8, 
129.7, 129.3, 129.1, 128.9, 128.6, 128.4, 128.0, 127.6, 125.6, 123.3, 122.0, 113.1, 90.6, 
86.6, 83.9, 61.9, 56.9, 43.4, 22.8. UPLC-DAD-QTOF: C33H28N2O2SCl [M+H]
+ calcd.: 
551.1560, found: 551.1564. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
IC, hexane:ethanol, 95:5; flux= 0.5 mL/min; retention times: diast. A (minor enantiomer) 
19.9 min, diast. A (major enantiomer) 24.0 min, diast. B 33.6 min, diast. B 36.5 min). 
 
Selected isolated by-product (71) 
1H NMR (300 MHz, CDCl3) δ 7.82 (s, 1H), 7.43 – 7.13 (m, 8H), 
4.05 (s, 2H), 2.65 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 153.2, 145.6, 
143.7, 140.1, 139.5, 139.0, 130.8, 130.0, 129.6, 129.4, 129.2, 128.8, 
127.1, 33.2, 23.3. UPLC-DAD-QTOF: C17H15NOSCl [M+H]
+ calcd.: 
316.0563, found: 316.0570. 
 
5.4.7.4. Reaction of isocyanoacetate 73 with 69d 
 
Catalyst C27 (10 mol%, 15mg) was added to a solution of isocyanoacetate 73 (24 
mg, 0.1 mmol, 1 equiv.) and N-aryl imine 69d (35 mg, 0.15 mmol, 1.5 equiv.) in toluene 
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(0.2 mL) at room temperature and the resulting mixture was stirred at the same 
temperature until the reaction was completed (monitored by 1H-NMR). The compound 
74 was obtained as 40:60 mixture of diastereomers (determined by 1H-NMR)  and 56 % 
ee for the major diastereomer. The crude was directly purified by flash column 
chromatography on silica gel (hexane/EtOAc 80/20). Yield: 51% (24 mg, 0.051 mmol).  
Data of major diastereomer: 1H NMR (300 MHz, CDCl3) δ 7.92 – 7.84 (m, 2H), 7.70 
(s, 1H), 7.52 – 7.35 (m, 3H), 7.35 – 7.21 (m, 8H), 7.22 – 7.07 (m, 3H), 7.06 – 6.95 (m, 2H), 
5.71 (s, 1H), 3.87 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 169.2, 155.1, 153.8, 151.6, 141.9, 
132.5, 129.8, 129.4, 129.1, 128.9, 128.9, 128.8, 127.4, 126.4, 124.7, 122.6, 122.2, 121.7, 
112.7, 89.5, 84.7, 84.5, 62.8, 56.5. UPLC-DAD-QTOF: C31H25N2O3 [M+H]
+ calcd.: 473.1865, 
found: 473.1876. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
IC, hexane:ethanol, 90:10; flux= 1 mL/min; retention times: diast. B 9.0 min, diast. A 
(minor enantiomer) 13.4 min, diast. A (major enantiomer) 19.7 min, diast. B 44.2 min). 
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5.5. Representative NMR spectra 
5.5.1. Catalysts 
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5.5.2. Chapter 2 
5.5.2.1. Isocyanoacetates 1 
 
 
 CHAPTER 5 
 
265 
 
 
 
Experimental section 
266 
 
 
 
 
 
 CHAPTER 5 
 
267 
 
 
 
Experimental section 
268 
 
 
 
 
 CHAPTER 5 
 
269 
 
 
 
 
Experimental section 
270 
 
 
 
 
 
 
 CHAPTER 5 
 
271 
 
5.5.2.2. Michael adducts 3 
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5.5.2.3. Michael adducts 9 
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5.5.2.4. Elaboration of adducts 
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5.5.3. Chapter 3 
5.5.3.1. Isocyano(thio)acetates 27-35, 62 and 73 
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5.5.3.2. Adducts of the Michael addition to vinyl ketones 
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5.5.3.3. Reaction of 29A with N-phenyl maleimide 
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5.5.3.4. Elaboration of adduct 45Be 
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5.5.3.5. Adducts of the Michael addition to vinyl sulfone 55 
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5.5.3.6. Adducts of the Mannich reaction with N-nosyl aldimine 64 
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5.5.3.7. N-Aryl propargylic aldimines 69c-e 
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5.5.3.8. Adducts of the Mannich reaction with N-aryl aldimines 
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5.5.3.9. Isolated by-products 
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5.6. HPLC chromatograms of representative compounds 
5.6.1. Chapter 2 
 
 
 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
AYH, hexane:ethanol, 99:1; flux= 1 mL/min). 
Rac-3Aa 
  
Retention Time % Area 
13,321 48,83 
18,048 51,17 
  
Scalemic-3Aa 
 
 
                                     95% ee 
 
AU
0,00
0,50
1,00
1,50
Minutes
10,00 12,00 14,00 16,00 18,00 20,00
13
,3
21
18
,0
48
A
U
0,00
0,50
1,00
1,50
2,00
Minutes
11,00 12,00 13,00 14,00 15,00 16,00 17,00 18,00 19,00 20,00 21,00
12
,4
30
16
,0
67
Retention Time % Area 
12,430 2,47 
16,067 97,53 
Experimental section 
362 
 
 
 
 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
AYH, hexane:ethanol, 99:1; flux= 1 mL/min). 
Rac-3Ab 
 
Retention Time % Area 
10,101 50,16 
13,826 49,84 
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The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
ODH, hexane:isopropanol, 99:1; flux= 0.5 mL/min). 
Rac-3Ca 
 
Retention Time % Area 
23.214 49.82 
28.532 50.18 
 
Scalemic-3Ca 
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The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
AYH, hexane:ethanol, 99:1; flux= 1 mL/min). 
Rac-3Ac 
 
Retention Time % Area 
16,930 50,07 
25,395 49,93 
 
Scalemic-3Ac 
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The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
ADH, hexane:ethanol, 99:1; flux= 1 mL/min). 
Rac-3Ad 
 
 
 
 
 
 
Scalemic-3Ad 
 
 Retention Time % Area 
1 19.022 1.72 
2 47.938 98.28 
 
    96% ee 
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The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
AYH, hexane:ethanol, 97:3; flux= 1 mL/min). 
Rac-3Ae 
 
 Retention Time % Area 
1 9.616 51.15 
2 14.569 48.85 
 
 
Scalemic-3Ae 
 
 
 Retention Time % Area 
1 9.547 2.74 
2 14.133 97.26 
 
 
       94% ee 
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The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
AYH, hexane:ethanol, 90:10; flux= 1 mL/min). 
Rac-3Af 
 
 Retention Time % Area 
1 12.177 50.52 
2 17.654 49.48 
 
 
Scalemic-3Af 
 
 Retention Time % Area 
1 12.271 1.17 
2 17.460 98.83 
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The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
AYH, hexane:ethanol, 95:5; flux= 1 mL/min). 
 Rac-3Cd
 
Retention Time % Area 
15,467 50,83 
25,859 49,17 
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The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
AYH, hexane:ethanol, 95:5; flux= 1 mL/min). 
Rac-3Be 
 
 Retention Time % Area 
1 8.315 50.30 
2 10.101 49.70 
 
 
Scalemic-3Be 
 
 Retention 
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% Area 
1 8.226 1.56 
2 9.860 98.44 
          97% ee 
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The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
AYH, hexane:ethanol, 98:2; flux= 1 mL/min). 
Rac-3Dd 
 
 Retention Time % Area 
1 12.646 50.85 
2 23.375 49.15 
 
Scalemic-3Dd 
 
 Retention Time % Area 
1 12.788 2.16 
2 23.878 97.84 
         96% ee 
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The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
IA, hexane:ethanol, 98:2; flux= 1 mL/min). 
Rac-9Aa 
 
Retention Time % Area 
13,313 50,47 
17,259 49,53 
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The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
AYH, hexane:ethanol, 98:2; flux= 1 mL/min). 
Rac-9A´a 
 
Retention Time % Area 
52,764 49,05 
59,541 50,95 
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The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak IA, 
hexane:ethanol, 98:2; flux= 1 mL/min). 
Rac-9Ba 
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The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
IA, hexane:ethanol, 98:2; flux= 1 mL/min). 
Rac-9Ca 
 
Retention Time % Area 
20.943 48.30 
33.427 51.70 
 
Scalemic-9Ca 
 
Retention Time % Area 
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The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak 
IA, hexane:ethanol, 98:2; flux= 1 mL/min). 
Rac-9Da 
 
Retention Time % Area 
11,503 48,80 
16,129 51,20 
 
Scalemic-9Da 
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5.6.2. Chapter 3 
5.6.2.1. Adducts of the Michael additions to vinyl ketones 
 
 
 
 
 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak AYH, 
hexane:ethanol, 90:10; flux= 1 mL/min). 
Rac-36Aa 
 
 
 Retention Time % Area 
1 9.559 49.86 
2 11.848 50.14 
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The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak AYH, 
hexane:ethanol, 98:2; flux= 1 mL/min). 
 
Rac-36Ac 
 
 
 
 Retention Time % Area 
1 24.197 50.38 
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The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak AYH, 
hexane:ethanol, 98:2; flux= 1 mL/min). 
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The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak AYH, 
hexane:ethanol, 98:2; flux= 1 mL/min). 
 
Rac-36Cc 
 
 
 Retention Time % Area 
1 11.659 50.11 
2 19.136 49.89 
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The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak ADH, 
hexane:ethanol, 98:2; flux= 1 mL/min). 
 
Rac-36Dc 
 
 
 Retention Time % Area 
1 13,766 49,74 
2 18,506 50,26 
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The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak ODH, 
hexane:ethanol, 95:5; flux= 1 mL/min).  
 
Rac-45Aa 
 
 
 Retention Time % Area 
1 9.515 49.52 
2 10.918 50.48 
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1 9.466 95.92 
2 10.881 4.08 
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The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak IB, 
hexane:ethanol, 98:2; flux= 1 mL/min). 
 
Rac-45Ac 
 
 
 Retention Time % Area 
1 11.434 49.81 
2 13.210 50.19 
 
Scalemic-45Ac 
 
 
 
 Retention Time % Area 
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2 13.206 2.95 
 
94% ee 
 
1
1
.4
3
4
1
3
.2
1
0
A
U
0.00
0.50
1.00
Minutes
9.00 10.00 11.00 12.00 13.00 14.00 15.00 16.00 17.00
1
1
.2
7
7
1
3
.2
0
6
A
U
0.00
0.20
0.40
0.60
0.80
Minutes
8.00 9.00 10.00 11.00 12.00 13.00 14.00 15.00 16.00 17.00
 CHAPTER 5 
 
383 
 
 
 
 
 
 
 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak ODH, 
hexane:ethanol, 95:5; flux= 1 mL/min). 
 
Rac-45Ad 
 
 
 Retention Time % Area 
1 10.439 50.88 
2 12.410 49.12 
 
 
Scalemic-45Ad 
 
 
 
 Retention Time % Area 
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2 12.347 3.94 
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The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak IC, 
hexane:ethanol, 95:5; flux= 0.5 mL/min). 
 
Rac-45Ba 
 
 
 
 Retention Time % Area 
1 29.892 49.07 
2 32.167 50.93 
 
 
Scalemic-45Ba 
 
 
 
 Retention Time % Area 
1 29.362 4.42 
2 31.529 95.58 
 
 
          91% ee 
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The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak IC, 
hexane:ethanol, 98:2; flux= 0.5 mL/min). 
 
Rac-45Bb 
 
 
 Retention Time % Area 
1 21.723 50.11 
2 24.111 49.89 
 
 
Scalemic-45Bb 
 
 
 
 
 
 
 
     96% ee 
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The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak AYH, 
hexane:ethanol, 98:2; flux= 1 mL/min). 
 
Rac-45Bd 
 
 
 Retention Time % Area 
1 16.650 50.04 
2 18.286 49.96 
 
Scalemic-45Bd 
 
 
 
 
 Retention Time % Area 
1 16.382 2.82 
2 17.716 97.18 
     94% ee 
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The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak IB, 
hexane:ethanol, 99:1; flux= 1 mL/min; retention times). 
 
Rac-45Be 
 
 
 
 
 
 
Scalemic-45Be 
 
 
 Retention Time % Area 
1 10,516 4,88 
2 11,105 95,12 
 
90% ee 
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The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak IB, 
hexane:ethanol, 98:2; flux= 0.5 mL/min). 
 
Rac-45Cc 
 
 
 Retention Time % Area 
1 14.115 51.03 
2 19.274 48.97 
 
 
Scalemic-45Cc 
 
 
 
 Retention Time % Area 
1 14.014 99.95 
2 19.524 0.05 
 
99% ee 
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The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak IA, 
hexane:ethanol, 98:2; flux= 0.5 mL/min). 
 
Rac-45Ce 
 
 
 
 Retention Time % Area 
1 13.648 48.46 
2 16.546 51.54 
 
Scalemic-45Ce 
 
 
 
 Retention Time % Area 
1 13.714 1.59 
2 16.649 98.41 
97% ee 
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The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak AYH, 
hexane:ethanol, 95:5; flux= 0.5 mL/min). 
 
Rac-45Ee 
 
 
 
 Retention Time % Area 
1 23.433 50.17 
2 27.109 49.83 
 
 
Scalemic-45Ee 
 
 
 
 Retention Time % Area 
1 23.176 1.68 
2 26.377 98.32 
 
 
97% ee 
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The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak ODH, 
hexane:ethanol, 98:2; flux= 1 mL/min). 
 
Rac-45Fe 
 
 
 
 
 
 
Scalemic-45Fe 
 
 
 
 Retention Time % Area 
1 8.811 98.98 
2 12.739 1.02 
 
 
98% ee 
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The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak IC, 
hexane:ethanol, 95:5; flux= 0.5 mL/min). 
 
Rac-346Ba 
 
 
 
 Retention Time % Area 
1 31.615 49.93 
2 33.391 50.07 
 
 
Scalemic-46Ba 
 
 
 
 Retention Time % Area 
1 30.560 93.95 
2 32.407 6.05 
 
 
 
88% ee 
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The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak AYH, 
hexane:ethanol, 95:5; flux= 0.5 mL/min). 
 
Rac-49Aa 
 
 
 
 Retention Time % Area 
1 14.649 50.16 
2 18.369 49.84 
 
Scalemic-49Aa 
 
 
 
 
 
 
96% ee 
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5.6.2.2. Adduct of the Michael addition to N-phenyl maleimide 
 
 
 
 
The diastereomeric and enantiomeric purity were determined on crude material by 
chiral HPLC analysis (Daicel Chiralpak IC, hexane:ethanol, 90:10; flux= 0.5 mL/min). 
Rac-XX 
 
 
 
 
Scalemic-XX 
 
 
 
dr= 70:30, 68% ee (minor: 80% ee)  
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5.6.2.3. Adducts of Michael addition to vinyl sulfone 55 
 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak AYH, 
hexane:ethanol, 90:10; flux= 1 mL/min). 
 
Rac-56 
 
 Retention Time % Area 
1 21.980 49.53 
2 42.380 50.47 
 
Scalemic-56 
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The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak AYH, 
hexane:ethanol, 80:20; flux= 0.5 mL/min). 
Rac-57 
 
 Retention Time % Area 
1 32.257 47.61 
2 43.440 52.39 
 
Scalemic-57 
 
 
 Retention Time % Area 
1 32.308 19.46 
2 43.306 80.54 
 
  62% ee 
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The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak AYH, 
hexane:ethanol, 90:10; flux= 1 mL/min). 
Rac-58 
 
 Retention Time % Area 
1 30.726 50.20 
2 47.796 49.80 
 
Scalemic-58 
 
 
 Retention Time % Area 
1 27.235 12.99 
2 44.481 87.01 
74% ee 
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The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak AYH, 
hexane:ethanol, 90:10; flux= 1 mL/min). 
Rac-59 
 
 Retention Time % Area 
1 36.726 49.42 
2 54.654 50.58 
 
Scalemic-59 
 
 
 
 
 
 40% ee 
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The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak AYH, 
hexane:ethanol, 80:20; flux= 0.5 mL/min). 
Rac-60 
 
 Retention Time % Area 
1 39.942 49.66 
2 52.840 50.34 
 
Scalemic-60 
 
 
 
 
 
   28% ee 
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5.6.2.4. Adducts of Mannich reaction with N-nosyl aldimine 64 
The enantiomeric purity was determined by chiral 
HPLC analysis (Daicel Chiralpak IC, hexane:ethanol, 90:10; 
flux= 1 mL/min). 
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Retention Time % Area 
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The enantiomeric purity was determined by chiral 
HPLC analysis (Daicel Chiralpak IC, hexane:ethanol, 
98:2; flux= 1 mL/min). 
 
 
Rac-66 
 
Retention Time % Area 
30,053 41,51 
33,230 8,92 
38,141 8,30 
79,001 41,27 
 
Scalemic-66 
 
Retention Time % Area 
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 The enantiomeric purity was determined by chiral 
HPLC analysis (Daicel Chiralpak IC, hexane:ethanol, 90:10; 
flux= 1 mL/min). 
 
Rac-67 
 
Retention Time % Area 
27,717 13,71 
32,576 34,80 
34,652 38,05 
50,445 13,44 
 
Scalemic-67 
                                                    MAJOR DIASTEREOISOMER 
Retention Time % Area 
23,083 13,10 
41,233 86,90 
dr 97:3     74% ee 
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5.6.2.5. Adducts of Mannich reaction with N-aryl aldimines 
The enantiomeric purity was determined by chiral 
HPLC analysis (Daicel Chiralpak IC, hexane:ethanol, 95:5; 
flux= 0.5 mL/min). 
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The enantiomeric purity was determined by chiral HPLC 
analysis (Daicel Chiralpak IC, hexane:ethanol, 95:5; flux= 0.5 
mL/min). 
 
 
Rac-70Ad 
 
Retention Time % Area 
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38.676 14.85 
 
Scalemic-70Ad 
 
   Major diastereomer                 dr 82:18  80% ee  
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The enantiomeric purity was determined by chiral HPLC 
analysis (Daicel Chiralpak IC, hexane:ethanol, 90:10; flux= 1 
mL/min). 
 
Rac-74 
 
 
 
Scalemic-70Ad (purified) 
 
                                                                       
Retention Time % Area 
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19.715 36.70    major in the crude 
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  56% ee 
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5.7. X-Ray analysis  
5.7.1. ORTEP diagram of catalyst C26  
CCDC-1555683 contains the supplementary crystallographic data for the 
structural analysis of C26. These data can be obtained free of charge from The 
Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
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5.7.2. ORTEP diagram of compound 16 
CCDC-1555684 contains the supplementary crystallographic data for the 
structural analysis of 16. These data can be obtained free of charge from The Cambridge 
Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
 
 
5.7.3. ORTEP diagram of compound 26 
CCDC-1555682 contains the supplementary crystallographic data for the 
structural analysis of 26. These data can be obtained free of charge from The Cambridge 
Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
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5.7.4. ORTEP diagram of compound 74 
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&Cycloaddition
Enantioselective Synthesis of Quaternary D4- and D5-
Dehydroprolines Based on a Two-Step Formal [3+2] Cycloaddition
of a-Aryl and a-Alkyl Isocyano(thio)acetates with Vinyl Ketones
Amaiur Odriozola, Mikel Oiarbide, and Claudio Palomo*[a]
Abstract: A divergent synthesis of optically active quater-
nary D4- and D5-dehydro prolines is developed based on
the first catalytic enantioselective conjugate addition of a-
substituted isocyano(thio)acetates to vinyl ketones that is
general for both a-aryl and a-alkyl isocyano(thio)acetates.
The new tetrasubstituted C@N stereocenter is formed
without the need of any metal salt due to a bifunctional
tertiary amine/squaramide catalyst, featuring a bulky poly-
aryl sidearm and an unusually short squaramide diamide
H···H interatomic distance in the solid state.
The a-carboxy-pyrrolidine units, generically referred to as pro-
lines, are widespread within natural products and biologically
active substances, and have attracted considerable interest in
peptide chemistry.[1] In this context, a-substituted (quaternary)
prolines constitute a particularly relevant subclass owing to
their unique structural biases, and much attention has been
paid to their stereoselective synthesis.[2] One major thoroughly
investigated convergent approach to the enantioselective syn-
thesis of these heterocyclic systems relies on the catalytic
[3+2] cycloaddition reaction between azomethine ylides and
electron-deficient olefins (Scheme 1a, left).[3] In contrast, the
catalyst-controlled formal [3+2] cycloaddition involving a-iso-
cyanoacetates and olefins (Scheme 1a, right), which also af-
fords the pyrrolidine system through concomitant formation of
the N@C2 and C4@C5 bonds, has been much less developed.[4]
Most studies on catalytic enantioselective cycloadditions of a-
isocyanoacetates involve very reactive olefins, such as malei-
mides,[5] nitroalkenes,[6] b,g-unsaturated a-keto esters,[7] methyl-
eneindolinones[8] and allenoates,[9] and require, with a few ex-
ceptions,[6, 8] combined metal/Brønsted base catalysis. Generali-
zation of this type of cooperative catalysis is often hampered
by the problem of Lewis acid/amine base self-quenching,
which leads to catalyst deactivation and unfavorable reaction
stereocontrol, especially during formation of quaternary stereo-
centers.[10] In this context, a sole example of cycloaddition in-
volving simple vinyl ketones as the reaction partner has been
reported so far, affording the corresponding dehydroproline
adducts with moderate (52–74% ee, R=H) or poor (,36% ee,
R=Me, Et) enantioselectivity.[11]
We were intrigued by the possibility of triggering the a-iso-
cyanoacetate–olefin addition reaction through an alternative
organocatalytic activation mode, whereby the bifunctional cat-
alyst would activate both the donor and acceptor reaction
components in a manner similar to that assumed for the
metal-mediated process (model II vs. I, Figure 1). Eventually,
the absence of a metal catalyst might also slow down the sub-
sequent intramolecular cyclization step[12] (III) thus allowing a-
protonation to occur preferentially (IV) leading to adduct A.
Upon these assumptions, a divergent access to 4,5- and 1,5-de-
Figure 1. Idealized dual activation modes (left) and reaction pathways (right)
in the presence or absence of a metal.
Scheme 1. Convergent approaches to enantioenriched quaternary proline
derivatives. EWG=electron-withdrawing group.
[a] A. Odriozola, Prof. M. Oiarbide, Prof. C. Palomo
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hydroprolines B and C from the common intermediate A
would be conceivable (Scheme 1c), resulting in a substantial
enlargement of product scope. The challenge here is to per-
form the 1,4-addition reaction leading to A efficiently and with
good enantiocontrol.[13] Indeed, the relatively low carbon acidi-
ty of most a-substituted isocyanoacetates means that catalytic
conjugate additions have only been carried out using highly
reactive acceptors,[14] and to the best of our knowledge conju-
gate addition to simple vinyl ketones has been undocumented
so far. Another serious limitation in scope concerns the isocya-
noacetate component; essentially all asymmetric organocata-
lytic reactions hitherto reported have dealt with a-aryl substi-
tuted isocyanoacetates.[15] Aside from these issues, another sig-
nificant challenge concerns the control of stereochemistry
during the generation of the quaternary carbon center.[16]
Herein we report the first enantioselective conjugate addition
of both a-aryl and a-alkyl isocyano(thio)acetates to vinyl ke-
tones enabled by bifunctional Brønsted base catalysts, ulti-
mately resulting in a new approach to enantioenriched quater-
nary dehydroproline products of type B and C.
The investigation was initiated by studying the reaction of
a-phenyl tert-butyl isocyanoacetate 1A with methyl vinyl
ketone 2a in the presence (10 mol%) of a selection of bench-
mark bifunctional Brønsted base organocatalysts.[17] From this
initial screening,[18] the known catalyst C1[19] proved to be su-
perior in terms of reaction conversion and enantioselectivity.
As shown in Table 1, attempts to improve the result using cata-
lysts C2, which has proven to be effective in difficult to control
stereoselective reactions,[20] were unfruitful giving adduct 3Aa
in good yield but poor ee (56%). We then decided to explore
the more sterically demanding gem-diaryl catalysts C3, C4 and
C5, and the gem,gem-(bis)diaryl congener C6, which could be
easily prepared through modification of the meta mono- and
diester group(s) of the aniline fragment through a Grignard re-
action.[18] We presumed that the bulky polyaryl moiety near
the squaramide framework might prevent catalyst self-aggre-
gation, a phenomenon that affects hydrogen-bond-accepting
substrate recognition.[21] Gratifyingly, each catalyst produced a
clean reaction with essentially complete conversion, whereas
the highest selectivities were obtained with the bulkiest cata-
lysts C5 and C6 (92% and 95% ee, respectively). In this re-
spect, the X-ray structure analysis data of crystallized C6 are
worthy of mention. The interatomic diamide H···H distance in
C6 is unusually short (2.446 a) as compared with the typical
values previously reported for related squaramide catalysts
(&2.85 a),[19c,21] and get closer to that found for the parent thi-
osquaramides.[22] On the other hand, squaramide units in the
solid structure of C6 do not self-aggregate through dual hy-
drogen-bonding as is generally assumed. Instead, both N@H
bonds of each squaramide unit point toward the quinoline ni-
trogen of a contiguous molecule.[18] It is likely that these fea-
tures, probably induced by the bulky polyaryl sidearm in C6
would also prevail in solution, and impact the catalytic behav-
ior. For comparison, catalyst C7[23] was also tested, resulting in
lower reactivity and efficiency (14 h, 80% conversion, 74%ee)
probably due to its lower solubility. Further experiments in-
volving 1A and catalyst C6 showed that the stereochemical
outcome of the reaction appears to be independent of the
enone partner. As the data in Table 2 show, both alkyl- and
aryl-vinyl ketones 2a–f upon reaction with 1A provided ad-
ducts 3Aa–f with good isolated yields and ee up to 98%. The
reaction also worked quite well with respect the isocyanoace-
tate component. Thus, each 1B, 1C and 1D reacted with the
corresponding vinyl enone 2 to give products 3Be, 3Ca, 3Cd,
and 3Dd with yields within the 80–90% range and ee values
greater than 96%. Nonetheless, o-substituted aryl isocyanoace-
tates 1E/1F as well as a-alkyl isocyanoacetates were not com-
petent reaction partners. On the other hand, methyl acrylate, a
less-reactive Michael acceptor compared to vinyl ketones, was
not effective in this reaction regardless of the catalyst em-
ployed. However, reactions of a-hydroxy enone 2g, an acrylate
surrogate recently reported within our group,[24] proceeded
smoothly in a reaction with 1A–D to give the corresponding
adducts 3Ag, 3Bg, 3Cg, and 3Dg in good yields and excellent
enantioselectivity. For these reactions a 5 mol% catalyst load-
ing was systematically employed, although both selectivity
and yield remained essentially the same using 2 mol% catalyst
only (products 3Ac and 3Dd).
Next, the inability of a-alkyl isocyanoacetates to react under
the above conditions was addressed by using the correspond-
ing thioesters instead, and assuming that thioesters are gener-
Table 1. Reaction of a-cyanoacetates 1 with enones 2 and catalyst
screening for the reaction of 1A with 2a to give 3Aa.[a]
[a] Reactions conducted on a 0.1 mmol scale in 0.2 mL CH2Cl2 (molar ratio
of 1A/2a/catalyst 1:2:0.1). Data refer to reaction conversion at 14 h
unless otherwise specified. ee determined by chiral HPLC.
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ally more acidic than oxoesters. At the outset, however, it was
not clear whether a-alkyl isocyanoacetate thioesters would be
effective donor substrates in this reaction. In fact, a few classes
of thioesters only, with inherently acidic character, for example,
arylacetic,[25] b,g-unsaturated carboxylic acid,[26] and malonic
acid thioesters,[27] have been successfully employed in catalytic
asymmetric carbon–carbon bond forming reactions and, as far
as we know, a-substituted isocyanoacetic thioesters have
never been reported.[28] In initial attempts, we observed that
the C6-catalyzed reactions of various a-alkyl isocyanoacetate
thioesters 4 (Ar=Ph) with enones 2 provided the Michael ad-
ducts 7 in good ee, but with formation of considerable
amounts (20%–40%) of undesired byproducts such as 10, 11
and sulfa-Michael products.[29] In case of thioester 5 (Ar=1-
naphthyl) and methyl vinyl ketone, compound 11Aa was the
major product formed with no even traces of 8Aa detected. In
view of these complications,[30] some precursors of a-isocyano-
thioesters, such as a-substituted a-formamido thioesters and
N-Boc a-amino acid thioesters, were also evaluated for the
above reactions, but these substrates were completely unreac-
tive under the above catalytic conditions. After some screen-
ing,[18] it was finally found that a-alkyl isocyanoacetate thioest-
er 6A, with a di-ortho substituted phenyl group installed (Ar=
2,6-Me2C6H3), reacted cleanly to produce the corresponding
adduct 9A essentially as the sole reaction product. This reactiv-
ity pattern was quite general for an array of isocyanoacetates 6
bearing short, medium, and longer a-alkyl linear as well as
branched chains. As the data in Table 3 show, upon reaction
with enones 2 the corresponding products 9 were obtained in
good to very good isolated yields and excellent enantioselec-
tivity, without traces of accompanying by-products.[31] Further-
more, as the production of compound 9Fe illustrates, the reac-
tion can be run at 3 mmol scale without any detriment in yield
or selectivity.
The synthetic utility of the method was briefly explored as
shown in Scheme 2. For example, the oxidative cleavage of the
acyloin moiety in adduct 3Ag provided, after methylation of
the intermediate carboxylic acid, ester 12. This product is diffi-
cult to obtain enantioselectively from a direct addition to
methyl acrylate. Of practical interest, acetone is the only
carbon by-product formed during this two-step transforma-
tion. Product 12 could be transformed into the pyroglutamate
ester 13 in good yield. On the other hand, mild acid hydrolysis
of adducts 3Ad and 3Dd, followed by spontaneous cyclisation,
provided the 1,5-dehydroproline esters 14 and 15 in 80% and
70% yield, respectively. Exposure of these adducts to H2 over
Pd on charcoal proceeded with concomitant cleavage of the
benzylic C@N bond to give the corresponding a,a-disubstitut-
ed a-amino esters 16 and 17. Conversely, when 1,5-dehydro-
proline esters 18 and 19, obtained from 3Aa and 3Ab as
above, were submitted to the same hydrogenation conditions,
pyrrolidines 20 and 21 were produced with almost perfect ste-
reocontrol at the newly generated stereocenter (d.r. :>20:1).[32]
The absolute configuration of compounds 13 and 22 was de-
termined by X-ray single crystal structure analysis[33] and that
Table 2. Scope of the conjugate addition of 1 to vinyl ketones 2 cata-
lyzed by C6.[a]
[a] Reactions conducted on a 0.2 mmol scale in 0.4 mL CH2Cl2 (molar ratio
of 1/2/catalyst 1:2:0.05) at room temperature, unless otherwise stated.
Yields of isolated product after column chromatography. Enantioselectivi-
ty determined by chiral HPLC. [b] 2 mol% of C6 used (reaction run for
36 h).
Table 3. Conjugate addition of a-alkylisocyanothioacetates 4–6 to vinyl
ketones 2 catalyzed by C6.[a]
[a] Reactions conducted on a 0.1 mmol scale in 0.2 mL CH2Cl2 (molar ratio
of thioester/2/catalyst 1:2:0.1). Yields of isolated product after column
chromatography. Enantioselectivity determined by chiral HPLC. [b] reac-
tion run for 3 days. [c] about 30% of product 10 formed. [d] 3 equiv. of
2d used. [e] About 35% of product 11 formed. [f] with catalyst C1.
[g] Reaction run for 2 days. [h] Reaction run at 3 mmol scale using
1.3 equiv. of 2e.
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of the remaining adducts by analogy assuming a uniform reac-
tion mechanism. Finally, it was gratifying to observe that ad-
ducts 3Aa, 3Ab, 3Af, 3Ca and 3Dd upon treatment with
10 mol% of DBU (1,8-diazabicyclo[5.4.0]undec-7-ene) and AgF
led to 4,5-dehydroprolines 23–27 in very good yields through
a clean cyclization and isomerization process. Other bases ex-
amined for this process, Et3N and iPr2EtN, were also effective,
but longer reaction times were required for completion,
whereas in the absence of silver salts the reactions did not pro-
ceed.[34] Importantly, using this approach, prolines with an a-
alkyl substituent could be produced, as illustrated with com-
pounds 28 and 29 derived from 9Ae.
In conclusion, we report here a new divergent synthesis of
quaternary D4- and D5-dehydroprolines with broad substitution
patterns based on a catalytic enantioselective two-step formal
[3+2] cycloaddition of a-substituted isocyano(thio)acetates
with vinyl ketones. For the first time, the key to the success
was the development of isocyanoacetic acid thioesters as
donor reagents in asymmetric synthesis, and the design of a
new subtype of squaramide/tertiary amine catalyst featuring a
sterically congested polyaryl side-arm. We anticipate that these
two key elements will find future applications in the realm of
asymmetric catalysis.
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